1 00:00:05,080 --> 00:00:08,880 I THINK EVERYONE IS HERE. 2 00:00:08,880 --> 00:00:17,960 OUR COUNCIL MEMBERS AND GUESTS. 3 00:00:17,960 --> 00:00:22,640 I'M GOING TO IT TO DR. CHIANG 4 00:00:22,640 --> 00:00:24,160 FOR REMARK. 5 00:00:24,160 --> 00:00:25,640 >>THANK YOU FOR PUTTING THIS 6 00:00:25,640 --> 00:00:25,960 TOGETHER. 7 00:00:25,960 --> 00:00:28,440 I'D LIKE TO WELCOME EVERYONE TO 8 00:00:28,440 --> 00:00:32,680 THE 163rd MEETING OF THE 9 00:00:32,680 --> 00:00:35,760 NATIONAL ADVISORY EYE COUNCIL. 10 00:00:35,760 --> 00:00:38,920 WE HAVE A GOOD PROGRAM CATHY HAS 11 00:00:38,920 --> 00:00:41,560 PUT TOGETHER AND TWO FANTASTIC 12 00:00:41,560 --> 00:00:43,000 GUEST SPEAKERS COMING ON LATER 13 00:00:43,000 --> 00:00:45,600 TODAY AND WE'LL INTRODUCE THAT 14 00:00:45,600 --> 00:00:49,080 AS WE GET CLOSER TO TIME. 15 00:00:49,080 --> 00:00:51,920 FOR NOW, I'D LIKE TO DO A ROLL 16 00:00:51,920 --> 00:00:53,360 CALL OF THE COUNCIL MEMBERS. 17 00:00:53,360 --> 00:00:56,240 I'LL CALL PEOPLE'S NAMES IN 18 00:00:56,240 --> 00:00:59,920 ALPHABETICAL ORDER. 19 00:00:59,920 --> 00:01:09,640 IF YOU CAN UNMUTE AND INTRODUCE 20 00:01:09,640 --> 00:01:10,120 YOURSELF. 21 00:01:10,120 --> 00:01:13,440 >>I AM A PROFESSOR EMERITUS AT 22 00:01:13,440 --> 00:01:14,960 THE UNIVERSITY OF NORTH CAROLINA 23 00:01:14,960 --> 00:01:17,600 CHAPEL HILL. 24 00:01:17,600 --> 00:01:24,840 MY INTEREST IS GLAUCOMA AND 25 00:01:24,840 --> 00:01:25,640 VISION. 26 00:01:25,640 --> 00:01:29,280 >>JAMES, PLEASE. 27 00:01:29,280 --> 00:01:33,120 >>I'M A SENIOR SCIENTIST IN SAN 28 00:01:33,120 --> 00:01:33,760 FRANCISCO. 29 00:01:33,760 --> 00:01:40,000 MY RESEARCH FOCUSES ON 30 00:01:40,000 --> 00:01:47,520 ACCESSIBILITY TOOLS MAKING A 31 00:01:47,520 --> 00:01:53,000 SMARTPHONE APP FOR INDOOR TURN 32 00:01:53,000 --> 00:01:59,880 BY TURN SETTINGS OR TOUCHING. 33 00:01:59,880 --> 00:02:00,680 THANK YOU. 34 00:02:00,680 --> 00:02:02,480 >>I'M FROM BOSTON. 35 00:02:02,480 --> 00:02:05,520 I'M PROFESSOR AND SENIOR 36 00:02:05,520 --> 00:02:09,400 SCIENTIST IN OPHTHALMOLOGY AND 37 00:02:09,400 --> 00:02:19,800 IMMUNOLOGY AT HARVARD. 38 00:02:27,680 --> 00:02:33,640 >>NEXT, I HAVE KATIA. 39 00:02:33,640 --> 00:02:34,520 >> 40 00:02:34,520 --> 00:02:37,640 >>MY INTEREST IS TO STUDY EYE 41 00:02:37,640 --> 00:02:43,680 TISSUE REGENERATION USING ANIMAL 42 00:02:43,680 --> 00:02:49,640 MODELS AND FOCUSSING ON 43 00:02:49,640 --> 00:02:53,280 ENDOGENOUS RESOURCES FOR RETINA 44 00:02:53,280 --> 00:02:58,080 REPLACEMENT AND CELLS ALSO. 45 00:02:58,080 --> 00:02:59,800 >>AND TOM. 46 00:02:59,800 --> 00:03:10,320 >>I'M AN OPHTHALMOLOGIST AT THE 47 00:03:17,560 --> 00:03:21,280 UNIVERSITY OF MICHIGAN AND TREAT 48 00:03:21,280 --> 00:03:24,520 RET 49 00:03:24,520 --> 00:03:24,800 RETINOPATHY. 50 00:03:24,800 --> 00:03:26,600 >>I HEAR YOU'RE AROUND THE 51 00:03:26,600 --> 00:03:27,000 WORLD. 52 00:03:27,000 --> 00:03:29,200 >>I'M IN PERTH, AUSTRALIA. 53 00:03:29,200 --> 00:03:38,200 >>THANKS FOR CALLING IN. 54 00:03:38,200 --> 00:03:40,360 >>I'M A PROFESSOR OF 55 00:03:40,360 --> 00:03:41,480 OPHTHALMOLOGY AND VISUAL 56 00:03:41,480 --> 00:03:43,960 SCIENCES AT THE UNIVERSITY OF 57 00:03:43,960 --> 00:03:45,600 UTAH. 58 00:03:45,600 --> 00:03:49,720 MY AREA AND I'M A SURGEON AND I 59 00:03:49,720 --> 00:04:00,240 STUDY THE PATH OF PHYSIOLOGY AND 60 00:04:00,920 --> 00:04:06,240 RETINOPATHY IN MACULAR 61 00:04:06,240 --> 00:04:06,640 DEGENERATION. 62 00:04:06,640 --> 00:04:17,080 >>I STUDY EPIGENETICS AND 63 00:04:21,720 --> 00:04:24,880 MITOMITO 64 00:04:24,880 --> 00:04:25,640 K 65 00:04:25,640 --> 00:04:31,760 MITO 66 00:04:31,760 --> 00:04:32,960 MITOCONDRIA. 67 00:04:32,960 --> 00:04:36,360 >>MY INTEREST IS IN CLINIC 68 00:04:36,360 --> 00:04:37,760 RESEARCH PARTICULARLY 69 00:04:37,760 --> 00:04:38,320 MULTI-CENTERED RESEARCH AND 70 00:04:38,320 --> 00:04:48,600 RETINAL DISEASE. 71 00:04:52,520 --> 00:04:53,920 >>I HAVE BEN. 72 00:04:53,920 --> 00:04:57,040 >>I'M A CLINICAL OPTOMETRIST 73 00:04:57,040 --> 00:05:00,040 AND FIVE MINUTES FROM YOU GUYS 74 00:05:00,040 --> 00:05:05,800 FROM THE ROCKLEDGE COUNCIL AND I 75 00:05:05,800 --> 00:05:16,320 SPECIALIZE IN KERATOKONOSIS AND 76 00:05:16,320 --> 00:05:21,240 A DRY EYE DISEASE. 77 00:05:21,240 --> 00:05:26,240 >>MY UNDERSTANDING IS TERRYN IS 78 00:05:26,240 --> 00:05:36,320 ILL. 79 00:05:40,200 --> 00:05:43,920 >>HE BASICALLY STUDIES NEURAL 80 00:05:43,920 --> 00:05:46,840 MECHANISMS OF VISUAL PERCEPTION 81 00:05:46,840 --> 00:05:52,400 AND VISUALLY GUIDED BEHAVIORS. 82 00:05:52,400 --> 00:05:56,360 I'D LIKE TO INTRODUCE TWO NEW 83 00:05:56,360 --> 00:05:57,560 COUNCIL MEMBERS AND I'D LIKE TO 84 00:05:57,560 --> 00:05:58,480 JUST SHOW TWO SLIDES OF THEM IF 85 00:05:58,480 --> 00:06:08,680 THAT'S OKAY. 86 00:06:13,160 --> 00:06:15,720 I'LL TRY TO INTRODUCE AND THEN 87 00:06:15,720 --> 00:06:23,520 AFTER IF YOU CAN UNMUTE AND SAY 88 00:06:23,520 --> 00:06:24,840 HELLO WE'D LIKE THAT. 89 00:06:24,840 --> 00:06:30,160 THE FIRST IS AN ATTORNEY AND 90 00:06:30,160 --> 00:06:33,640 ADVOCATE AND HAS SERVED AS A 91 00:06:33,640 --> 00:06:36,120 SENIOR DISABILITY POLICY ADVISER 92 00:06:36,120 --> 00:06:37,640 TO PRESIDENTIAL AND 93 00:06:37,640 --> 00:06:39,680 GUBERNATORIAL CAMPAIGNS AND 94 00:06:39,680 --> 00:06:41,040 STATE ELECTION CAMPAIGNS. 95 00:06:41,040 --> 00:06:44,560 JENNY'S HAD A NUMBER OF 96 00:06:44,560 --> 00:06:45,640 SIGNIFICANT NATIONAL BOARD 97 00:06:45,640 --> 00:06:46,560 PROIMENTS INCLUDING TO THE 98 00:06:46,560 --> 00:06:49,520 AMERICAN FOUNDATION FOR THE 99 00:06:49,520 --> 00:06:52,320 BLIND AND THE FIGHTING BLINDNESS 100 00:06:52,320 --> 00:06:56,400 AND TO NASEM AND LECTURED 101 00:06:56,400 --> 00:06:57,480 FREQUENTLY ON ISSUES INVOLVING 102 00:06:57,480 --> 00:07:00,280 PEOPLE WITH DISABILITIES AND 103 00:07:00,280 --> 00:07:02,480 EXCITED TO HAVE JENNY ON THE 104 00:07:02,480 --> 00:07:02,680 COUNCIL. 105 00:07:02,680 --> 00:07:04,960 WOULD YOU LIKE TO UNMUTE AND 106 00:07:04,960 --> 00:07:05,600 INTRODUCE YOURSELF TO THE GROUP? 107 00:07:05,600 --> 00:07:14,960 >>THANK YOU. 108 00:07:14,960 --> 00:07:16,760 >>I KNOW THERE'S A SIGNIFICANT 109 00:07:16,760 --> 00:07:22,120 DIFFERENCE IN THE BACKGROUND 110 00:07:22,120 --> 00:07:28,160 THAT I COME WITH I'M MORE OF THE 111 00:07:28,160 --> 00:07:29,640 KIND THAT SHAKESPEARE REFERRED 112 00:07:29,640 --> 00:07:31,840 TO WHEN HE SAID FIRST THING 113 00:07:31,840 --> 00:07:34,680 WE'LL DO IS LET'S KILL ALL THE 114 00:07:34,680 --> 00:07:34,880 LAWYERS. 115 00:07:34,880 --> 00:07:36,440 MY PERSPECTIVE COMES FROM BEING 116 00:07:36,440 --> 00:07:41,560 A PERSON IMPACTED BY BLINDNESS 117 00:07:41,560 --> 00:07:52,080 AND DIAGNOSED WITH RETINITIS 118 00:07:53,080 --> 00:07:53,560 PIGME 119 00:07:53,560 --> 00:07:56,160 PIGMENTOSA AND THE BOARD YOU 120 00:07:56,160 --> 00:07:58,600 MENTIONED IS ON THE FORUM OF 121 00:07:58,600 --> 00:08:00,840 AGE, DISABILITY AND 122 00:08:00,840 --> 00:08:01,240 INDEPENDENCE. 123 00:08:01,240 --> 00:08:01,880 GLAD TO BE WITH YOU. 124 00:08:01,880 --> 00:08:02,480 >>THANK YOU. 125 00:08:02,480 --> 00:08:04,000 AND WE'RE EXCITED ABOUT THE 126 00:08:04,000 --> 00:08:05,840 PERSPECTIVE YOU'LL ADD TO THIS 127 00:08:05,840 --> 00:08:15,920 GROUP. 128 00:08:18,200 --> 00:08:25,760 >>NEXT IS A PROFESSOR AT DUKE 129 00:08:25,760 --> 00:08:30,400 AND HAS EXPERTISE AND WE'RE 130 00:08:30,400 --> 00:08:31,320 EXCITED HE'LL BRING EXPERTISE 131 00:08:31,320 --> 00:08:34,040 COMBINING THE ROLE OF 132 00:08:34,040 --> 00:08:35,600 INFLAMMATION WITH EYE DISEASE 133 00:08:35,600 --> 00:08:38,960 AND INTERIOR SEGMENTS OF EYE 134 00:08:38,960 --> 00:08:40,160 DISEASE AND HAS EXPERIENCE IN 135 00:08:40,160 --> 00:08:41,600 CLINICAL TRIALS AND LED 136 00:08:41,600 --> 00:08:43,160 INITIATIVES BRIDGING IN 137 00:08:43,160 --> 00:08:45,520 SCIENTISTS FROM GROUPS CURRENTLY 138 00:08:45,520 --> 00:08:46,080 UNDER REPRESENTED IN VISION 139 00:08:46,080 --> 00:08:56,280 RESEARCH. 140 00:08:58,480 --> 00:09:01,440 >>GOOD MORNING, EVERYONE. 141 00:09:01,440 --> 00:09:07,280 IT'S MY PLEASURE TO BE A MEMBER 142 00:09:07,280 --> 00:09:10,640 OF THE COUNCIL. 143 00:09:10,640 --> 00:09:13,040 THE BEST WAY TO PAY BACK IS BY 144 00:09:13,040 --> 00:09:17,880 HELPING THE SYSTEM CONTINUE TO 145 00:09:17,880 --> 00:09:18,120 WORK. 146 00:09:18,120 --> 00:09:21,000 I'M VERY EXCITED TO BE HERE 147 00:09:21,000 --> 00:09:22,160 BRINGING IN A DIFFERENT 148 00:09:22,160 --> 00:09:22,480 PERSPECTIVE. 149 00:09:22,480 --> 00:09:23,560 THANK YOU AND I'M LOOKING 150 00:09:23,560 --> 00:09:25,640 FORWARD TO WORKING WITH ALL OF 151 00:09:25,640 --> 00:09:25,800 YOU. 152 00:09:25,800 --> 00:09:36,200 >>THANK YOU, VICTOR. 153 00:09:40,880 --> 00:09:42,840 CATHY, CAN I TURN TO YOU AND 154 00:09:42,840 --> 00:09:44,640 THEN WE'LL GET STARTED. 155 00:09:44,640 --> 00:09:47,840 >>THANK YOU, EVERYONE. 156 00:09:47,840 --> 00:09:50,680 WELCOME AND ESPECIALLY TO JENNY 157 00:09:50,680 --> 00:09:51,960 AND VICTOR AND HOPE TO HAVE YOU 158 00:09:51,960 --> 00:09:54,240 ONBOARDED SOON AND THANK YOU FOR 159 00:09:54,240 --> 00:09:58,360 YOUR PATIENCE AS WE NAVIGATE THE 160 00:09:58,360 --> 00:10:01,640 HURDLES AND THANKS TO THE 161 00:10:01,640 --> 00:10:02,520 COUNCIL MEMBERS AND STAFF AND 162 00:10:02,520 --> 00:10:03,280 CAREFUL PREPARATION FOR THIS 163 00:10:03,280 --> 00:10:03,520 MEETING. 164 00:10:03,520 --> 00:10:08,120 WE ALSO WANT TO WELCOME THE NIH 165 00:10:08,120 --> 00:10:10,280 RESEARCH AND ADVOCACY COMMUNITY 166 00:10:10,280 --> 00:10:12,800 NEI AND NIH STAFF INCLUDING 167 00:10:12,800 --> 00:10:14,400 STAFF FROM THE CENTER FOR 168 00:10:14,400 --> 00:10:15,680 SCIENTIFIC REVIEW AS WELL AS 169 00:10:15,680 --> 00:10:17,200 MEMBERS OF THE PUBLIC VIEWING 170 00:10:17,200 --> 00:10:20,120 THE MEET ON THE NIH VIDEOCAST. 171 00:10:20,120 --> 00:10:23,520 JUST WANT DO GO OVER SOME NEW 172 00:10:23,520 --> 00:10:24,680 AND USUAL ZOOM MEETING 173 00:10:24,680 --> 00:10:25,160 REMINDERS. 174 00:10:25,160 --> 00:10:29,640 PLEASE IDENTIFY YOURSELF WITH 175 00:10:29,640 --> 00:10:32,640 YOUR FULL NAME EACH TIME YOU 176 00:10:32,640 --> 00:10:34,720 SPEAK SO WE CAN BECOME FAMILIAR. 177 00:10:34,720 --> 00:10:36,120 IF YOU HAVEN'T, INDICATE YOUR 178 00:10:36,120 --> 00:10:41,400 FULL NAME IN THE ZOOM WINDOW TO 179 00:10:41,400 --> 00:10:44,120 CAPTURE ALL THE RECORDS 180 00:10:44,120 --> 00:10:46,200 ACCURATELY AND BE SURE TO 181 00:10:46,200 --> 00:10:47,040 DIRECTLY SPEAK IN THE MICROPHONE 182 00:10:47,040 --> 00:10:48,800 TO HEAR YOU CLEARLY. 183 00:10:48,800 --> 00:10:50,200 SOME ARE A LITTLE BIT FAINT. 184 00:10:50,200 --> 00:10:51,400 I THINK IT WAS CLEAR BUT A 185 00:10:51,400 --> 00:11:01,720 LITTLE BIT FAINT. 186 00:11:05,440 --> 00:11:10,160 NEI STAFF SHOULD HAVE VIDEOS OFF 187 00:11:10,160 --> 00:11:11,040 UNLESS PRESENTING. 188 00:11:11,040 --> 00:11:13,520 AND AS ALWAYS, WE ASK PEOPLE TO 189 00:11:13,520 --> 00:11:15,280 PLEASE MUTE THEMSELVES WHEN NOT 190 00:11:15,280 --> 00:11:16,080 SPEAKING TO ELIMINATE BACKGROUND 191 00:11:16,080 --> 00:11:18,480 NOISE. 192 00:11:18,480 --> 00:11:21,400 IF YOU WANT TO ASK A QUESTION OR 193 00:11:21,400 --> 00:11:24,000 MAKE A COMMENT, PLEASE USE THE 194 00:11:24,000 --> 00:11:25,520 RAISED HAND FUNCTION ON ZOOM AND 195 00:11:25,520 --> 00:11:29,280 REMEMBER TO INTRODUCE YOURSELF. 196 00:11:29,280 --> 00:11:33,520 WE ASK YOU DON'T USE THE CHAT 197 00:11:33,520 --> 00:11:35,680 BOX SINCE PEOPLE ON THE NIH 198 00:11:35,680 --> 00:11:40,840 VIDEOCAST CAN'T SEE THEM AND 199 00:11:40,840 --> 00:11:43,640 THIS IS A PUBLIC SECTION AND IT 200 00:11:43,640 --> 00:11:53,640 WILL BROADCAST LIVE AND WILL BE 201 00:11:53,640 --> 00:12:00,080 ARCHIVED IN PERPETUITY. 202 00:12:00,080 --> 00:12:03,800 AND A SEPARATE INVITATION FOR 203 00:12:03,800 --> 00:12:05,640 THE CLOSED SESSION LATER AND AS 204 00:12:05,640 --> 00:12:07,040 SPECIAL GOVERNMENT EMPLOYEES YOU 205 00:12:07,040 --> 00:12:10,400 MAY NOT ENGAGE IN ANY LOBBYING 206 00:12:10,400 --> 00:12:12,400 ACTIVITIES TODAY WHILE RECEIVING 207 00:12:12,400 --> 00:12:14,640 PAY FROM THE FEDERAL GOVERNMENT. 208 00:12:14,640 --> 00:12:17,160 I USE THAT TERM PAY, LOOSELY. 209 00:12:17,160 --> 00:12:18,760 SO THE DATES FOR THE FUTURE 210 00:12:18,760 --> 00:12:20,720 COUNCIL MEMBERS ARE LISTED ON 211 00:12:20,720 --> 00:12:24,640 THE OPEN SESSION AGENDA AND ON 212 00:12:24,640 --> 00:12:25,960 THE NEI WEBSITE. 213 00:12:25,960 --> 00:12:28,480 I HAVE NOTED THERE'S A CONFLICT 214 00:12:28,480 --> 00:12:30,680 WITH THE OCTOBER 2023 MEETING 215 00:12:30,680 --> 00:12:32,560 AND I'LL WORK TO TRY TO 216 00:12:32,560 --> 00:12:33,080 RESCHEDULE THIS. 217 00:12:33,080 --> 00:12:35,600 OUR NEXT MEETING IS SCHEDULED 218 00:12:35,600 --> 00:12:37,760 FOR FEBRUARY 3, 2023. 219 00:12:37,760 --> 00:12:41,200 AT THIS TIME, WE ARE PLANNING TO 220 00:12:41,200 --> 00:12:44,160 HOLD THAT MEETING IN PERSON IN 221 00:12:44,160 --> 00:12:45,960 BETHESDA BUT THAT IS ALWAYS 222 00:12:45,960 --> 00:12:47,400 SUBJECT TO CONDITIONS ON THE 223 00:12:47,400 --> 00:12:48,760 GROUND DEPENDING ON COVID LEVELS 224 00:12:48,760 --> 00:12:51,680 AND OTHER FACTORS AND NIH 225 00:12:51,680 --> 00:12:53,360 CONTINUES TO CAREFULLY MONITOR 226 00:12:53,360 --> 00:12:56,320 THE SITUATION WITH COVID AND 227 00:12:56,320 --> 00:12:59,240 WILL ADJUST IF NEEDED. 228 00:12:59,240 --> 00:13:02,760 LATIVA WILL FOLLOW-UP ON TRAVEL 229 00:13:02,760 --> 00:13:05,120 AND TRAVEL LOGISTICS FOR THE 230 00:13:05,120 --> 00:13:06,280 FEBRUARY MEETING PROBABLY WITHIN 231 00:13:06,280 --> 00:13:09,520 THE NEXT MONTH TO PLAN 232 00:13:09,520 --> 00:13:10,000 ACCORDINGLY. 233 00:13:10,000 --> 00:13:13,720 ARE THERE ANY QUESTIONS ABOUT 234 00:13:13,720 --> 00:13:17,640 THAT? 235 00:13:17,640 --> 00:13:18,360 OKAY. 236 00:13:18,360 --> 00:13:26,560 ONE MORE THING, WE POSTED THE 237 00:13:26,560 --> 00:13:29,640 MINUTES OF THE LAST MEETING ON 238 00:13:29,640 --> 00:13:31,400 THE ELECTRONIC COUNCIL BOOK. 239 00:13:31,400 --> 00:13:33,720 WOULD ANYONE LIKE TO DISCUSS? 240 00:13:33,720 --> 00:13:37,960 IF NOT, MAY I HAVE A MOTION TO 241 00:13:37,960 --> 00:13:38,200 APPROVE? 242 00:13:38,200 --> 00:13:38,640 THANK YOU. 243 00:13:38,640 --> 00:13:40,320 MAY I HAVE A SECOND? 244 00:13:40,320 --> 00:13:42,360 ALL IN FAVOR OF APPROVING BOTH 245 00:13:42,360 --> 00:13:45,640 THE JUNE AND AUGUST MEETING 246 00:13:45,640 --> 00:13:51,400 MINUTES PLEASE RAISE YOUR HAND. 247 00:13:51,400 --> 00:13:52,840 IS THERE ANYONE OPPOSED? 248 00:13:52,840 --> 00:13:53,120 THANK YOU. 249 00:13:53,120 --> 00:13:54,720 THE MOTION PASSES. 250 00:13:54,720 --> 00:13:55,160 THANK YOU. 251 00:13:55,160 --> 00:13:56,960 I'M NOW GOING TO TURN THE 252 00:13:56,960 --> 00:13:59,760 MEETING BACK TO DR. CHANG FOR 253 00:13:59,760 --> 00:14:10,160 HIS DIRECTOR'S REPORT. 254 00:14:10,160 --> 00:14:12,080 >>THANK YOU FOR DOING THAT. 255 00:14:12,080 --> 00:14:14,040 WE WERE HOPING TO DO THIS IN 256 00:14:14,040 --> 00:14:15,960 PERSON AND IT WASN'T MEANT TO BE 257 00:14:15,960 --> 00:14:17,520 FOR VARIOUS REASONS YOU'RE AWARE 258 00:14:17,520 --> 00:14:19,000 OF BUT HOPING WE CAN DO THAT FOR 259 00:14:19,000 --> 00:14:21,160 THE UPCOMING MEETING. 260 00:14:21,160 --> 00:14:22,880 ANOTHER ISSUE IS THAT WHAT WE'RE 261 00:14:22,880 --> 00:14:26,040 TRYING FOR THIS MEETING AND I 262 00:14:26,040 --> 00:14:26,920 THINK IT CAME ACROSS IN THE 263 00:14:26,920 --> 00:14:29,960 AGENDA AND SOME OF THE 264 00:14:29,960 --> 00:14:34,000 DISCUSSIONS CATHY HAD CIRCULATED 265 00:14:34,000 --> 00:14:37,680 IS THAT WE'RE TRYING TO DO LESS 266 00:14:37,680 --> 00:14:40,040 TALKING AND MORE LISTENING. 267 00:14:40,040 --> 00:14:43,960 IF YOU HAVE COMMENTS, PLEASE 268 00:14:43,960 --> 00:14:46,960 RAISE YOUR HAND OR PRIME UP -- 269 00:14:46,960 --> 00:14:49,640 JUST PLEASE RAISE YOUR HANDS AND 270 00:14:49,640 --> 00:14:53,040 WE'LL GET THAT QUEUED UP OR THE 271 00:14:53,040 --> 00:14:54,440 DISCUSSION, AFTER MY REMARKS AND 272 00:14:54,440 --> 00:14:56,320 IN THE DISCUSSION AT THE ENDS OF 273 00:14:56,320 --> 00:14:57,000 THE OPEN SESSION. 274 00:14:57,000 --> 00:15:00,840 SO WE LOOK FORWARD TO THERE WAS 275 00:15:00,840 --> 00:15:02,280 INTERESTING STUFF THAT CAME FROM 276 00:15:02,280 --> 00:15:03,400 THE COMMENTS LAST TIME. 277 00:15:03,400 --> 00:15:05,400 AND THE ONLY OTHER THING I WANT 278 00:15:05,400 --> 00:15:08,600 TO DO IS ACKNOWLEDGE I SEE THAT 279 00:15:08,600 --> 00:15:17,640 WE HAVE TWO REALLY GOOD 280 00:15:17,640 --> 00:15:17,920 SPEAKERS. 281 00:15:17,920 --> 00:15:20,160 RINAD BIEDAS AND JENNIFER SUN. 282 00:15:20,160 --> 00:15:22,240 WELCOME TO BOTH AND WE'LL 283 00:15:22,240 --> 00:15:25,600 INTRODUCE YOU OFFICIALLY WHEN 284 00:15:25,600 --> 00:15:27,720 THE TIME COMES UP BUT WE'RE 285 00:15:27,720 --> 00:15:28,880 REALLY EXCITED ABOUT THAT AND 286 00:15:28,880 --> 00:15:30,840 IT'S SOMETHING THAT CAME UP. 287 00:15:30,840 --> 00:15:32,160 GOOD TO SEE YOU, JENNY. 288 00:15:32,160 --> 00:15:39,960 IT CAME UP AT THE LAST SESSION 289 00:15:39,960 --> 00:15:41,640 AND GOOD TO SEE YOU. 290 00:15:41,640 --> 00:15:52,040 MORE WHEN IT COMES UP. 291 00:15:57,320 --> 00:15:59,040 I'M PROUD TO BE ABLE TO GIVE 292 00:15:59,040 --> 00:15:59,840 THIS DIRECTOR'S REPORT. 293 00:15:59,840 --> 00:16:01,560 ONE THING I'VE BEEN SAYING AT 294 00:16:01,560 --> 00:16:04,560 THE BEGINNING OF ALL THESE TALKS 295 00:16:04,560 --> 00:16:06,600 IS THAT WE'RE TRYING REALLY HARD 296 00:16:06,600 --> 00:16:08,880 TO COMMUNICATE WHAT WE'RE DOING 297 00:16:08,880 --> 00:16:15,320 AT THE NEI WITH THE REST OF THE 298 00:16:15,320 --> 00:16:17,640 WORLD AND IT'S A CHALLENGE AND 299 00:16:17,640 --> 00:16:19,520 WE'VE BEEN TRYING TO USE SOCIAL 300 00:16:19,520 --> 00:16:22,440 MEDIA TO DO THAT AND THESE ARE 301 00:16:22,440 --> 00:16:26,160 THE TWITTER HANDLES AND NEI 302 00:16:26,160 --> 00:16:28,840 DIRECTOR AND NAT INSTITUTE AND 303 00:16:28,840 --> 00:16:31,280 ONE IS THE INSTITUTE'S ACCOUNT. 304 00:16:31,280 --> 00:16:32,320 CONSIDER FOLLOWING THOSE BECAUSE 305 00:16:32,320 --> 00:16:34,640 WE'RE TRYING TO PUT OUT 306 00:16:34,640 --> 00:16:35,680 INFORMATION LIKE WHAT ARE 307 00:16:35,680 --> 00:16:36,720 OPPORTUNITIES COMING UP AND 308 00:16:36,720 --> 00:16:39,800 WHAT'S NEWS FROM THE VISION 309 00:16:39,800 --> 00:16:41,640 COMMUNITY AND MARIA HAS DONE A 310 00:16:41,640 --> 00:16:45,640 GREAT JOB OF MAINTAINING THE NEI 311 00:16:45,640 --> 00:16:51,000 SOCIAL MEDIA PRESENCE. 312 00:16:51,000 --> 00:16:52,560 I'M GOING TO GIVE MY REPORT, 313 00:16:52,560 --> 00:16:53,600 NEWS YOU SHOULD KNOW OF WHAT'S 314 00:16:53,600 --> 00:16:54,760 GOING ON HERE. 315 00:16:54,760 --> 00:16:57,400 ONE OF THEM -- I WANT TO START 316 00:16:57,400 --> 00:16:58,400 WITH MIKE. 317 00:16:58,400 --> 00:17:04,280 ALL OF YOU KNOW MIKE AND THIS 318 00:17:04,280 --> 00:17:05,160 WAS JUST HORRIBLE. 319 00:17:05,160 --> 00:17:06,720 AT TO THE LAST MEETING IN JUNE, 320 00:17:06,720 --> 00:17:11,720 WE HAD ANNOUNCED THAT MIKE HAD 321 00:17:11,720 --> 00:17:13,640 MADE PLANS TO RETIRE IN 322 00:17:13,640 --> 00:17:14,960 SEPTEMBER 30 WAS GOING TO BE HIS 323 00:17:14,960 --> 00:17:18,320 LAST DAY AND HE PASSED AWAY IN A 324 00:17:18,320 --> 00:17:21,920 BOATING ACCIDENT ON JULY 30. 325 00:17:21,920 --> 00:17:23,000 THE COUNCIL ALL KNOWS THIS. 326 00:17:23,000 --> 00:17:26,320 WE HAD CIRCULATED E-MAILS AND WE 327 00:17:26,320 --> 00:17:31,200 HAD A SPECIAL SESSION IN AUGUST 328 00:17:31,200 --> 00:17:32,440 ABOUT THIS AND THIS HAS BEEN 329 00:17:32,440 --> 00:17:35,760 DIFFICULT FOR ALL OF US AT THE 330 00:17:35,760 --> 00:17:35,920 NEI. 331 00:17:35,920 --> 00:17:38,520 I THINK I'D MENTIONED BEFORE 332 00:17:38,520 --> 00:17:40,920 THAT MIKE WAS VERY UNDER STATED. 333 00:17:40,920 --> 00:17:43,680 BEFORE THE JUNE MEETING I TALKED 334 00:17:43,680 --> 00:17:50,680 TO MIKE AND WANTED TO ANNOUNCE 335 00:17:50,680 --> 00:17:52,560 THAT YOU WANT RETIRE IN 336 00:17:52,560 --> 00:17:53,520 SEPTEMBER AND HE SAID WE DON'T 337 00:17:53,520 --> 00:17:57,640 NEED TO DO THAT AND I WAS GLAD 338 00:17:57,640 --> 00:18:06,040 WE DID. 339 00:18:06,040 --> 00:18:08,360 ALL OF YOU KNOW MIKE AND HE'S A 340 00:18:08,360 --> 00:18:10,400 NEUROSCIENTIST BY BACKGROUND AND 341 00:18:10,400 --> 00:18:12,320 WAS THE DIRECTOR OF EXTRAMURAL 342 00:18:12,320 --> 00:18:14,440 ACTIVITIES AND MIKE HAD A LARGER 343 00:18:14,440 --> 00:18:17,680 THAN LIFE FOOTPRINT NOT ONLY 344 00:18:17,680 --> 00:18:23,320 WITHIN NEI BUT NIH OVER ALL. 345 00:18:23,320 --> 00:18:27,280 JUST HAD A BIG ROLE IN THE NEI 346 00:18:27,280 --> 00:18:31,920 AUDACIOUS GOALS INITIATIVE AND 347 00:18:31,920 --> 00:18:34,600 BRINGING NEI WITHIN THE BRAIN 348 00:18:34,600 --> 00:18:34,880 INITIATIVE. 349 00:18:34,880 --> 00:18:40,280 THE MONDAY AFTER WE GOT THE 350 00:18:40,280 --> 00:18:45,120 NEWS, WE HAD A ZOOM MEETING WITH 351 00:18:45,120 --> 00:18:47,240 OVER 100 PEOPLE GET TOGETHER AND 352 00:18:47,240 --> 00:18:49,520 JUST TALK ABOUT MIKE AND A LOT 353 00:18:49,520 --> 00:18:50,520 OF STORIES CAME OUT ABOUT WHAT 354 00:18:50,520 --> 00:18:55,960 INCREDIBLE OF A MENTOR HE WAS. 355 00:18:55,960 --> 00:19:00,080 THERE WERE THINGS HE TAUGHT 356 00:19:00,080 --> 00:19:02,600 THINGS LIKE HOW TO BE CERTIFIED 357 00:19:02,600 --> 00:19:04,080 FOR SCUBA DIVING. 358 00:19:04,080 --> 00:19:07,400 WE GOT TO KNOW MIKE'S WIFE AND 359 00:19:07,400 --> 00:19:09,640 DAUGHTER, SUSAN AND SARAH 360 00:19:09,640 --> 00:19:13,320 THROUGH IT HIT. 361 00:19:13,320 --> 00:19:14,560 THERE'S NOTHING GOOD THAT COMES 362 00:19:14,560 --> 00:19:16,240 OUT OF THIS BUT I WANT TO SAY TO 363 00:19:16,240 --> 00:19:25,080 MIKE WE REALLY MISS YOU AND WITH 364 00:19:25,080 --> 00:19:25,960 THAT, THESE ARE SOME OF THE 365 00:19:25,960 --> 00:19:32,920 UPDATES I WANT TO GIVE. 366 00:19:32,920 --> 00:19:34,720 MIKE WAS THE DIVISION DIRECTOR 367 00:19:34,720 --> 00:19:36,200 OF THE EXTRAMURAL PROGRAMS AND 368 00:19:36,200 --> 00:19:40,000 CATHY, THANK YOU FOR SERVING AS 369 00:19:40,000 --> 00:19:43,720 THE ACTING DIRECTOR OF DESP WITH 370 00:19:43,720 --> 00:19:47,480 YOUR REGULAR JOB AS THE DIRECTOR 371 00:19:47,480 --> 00:19:50,040 OF THE EXTRAMURAL ACTIVITIES. 372 00:19:50,040 --> 00:19:53,080 EVERYONE HERE KNOWS CATHY BUT I 373 00:19:53,080 --> 00:19:54,880 JUST WANT TO MAKE SURE THAT 374 00:19:54,880 --> 00:19:56,360 BEFORE SHE CAME HERE SHE WAS THE 375 00:19:56,360 --> 00:19:58,880 ACTING DIRECTOR IN THIS POSITION 376 00:19:58,880 --> 00:20:00,680 OF EXTRAMURAL SCIENCE PROGRAMS 377 00:20:00,680 --> 00:20:02,200 AT THE NATIONAL INSTITUTE OF 378 00:20:02,200 --> 00:20:03,400 NURSING RESEARCH. 379 00:20:03,400 --> 00:20:05,560 BEFORE THAT SHE WORKED OVER 10 380 00:20:05,560 --> 00:20:09,640 YEARS AT NIMH MENTAL HEALTH 381 00:20:09,640 --> 00:20:11,840 WHERE SHE WAS A DEPUTY DIVISION 382 00:20:11,840 --> 00:20:13,600 DIRECTOR AND MANAGED A LARGE 383 00:20:13,600 --> 00:20:19,640 GRANT PORTFOLIO. 384 00:20:19,640 --> 00:20:25,360 THE OTHER PERSON I WANT TO 385 00:20:25,360 --> 00:20:35,240 HIGHLIGHT IS ANGEETA BHARGAVA 386 00:20:35,240 --> 00:20:37,600 AND HAS BEEN HERE AND BEFORE 387 00:20:37,600 --> 00:20:43,200 COMING HERE SHE HAD WORKED AS A 388 00:20:43,200 --> 00:20:45,000 PROGRAM OFFICIAL IN NIDCR. 389 00:20:45,000 --> 00:20:49,160 SHE MANAGED A PORTFOLIO OF BASIC 390 00:20:49,160 --> 00:20:51,200 AS WELL AS TRANSLATIONAL GRANTS 391 00:20:51,200 --> 00:20:53,360 AND BEFORE THAT SHE HAD 392 00:20:53,360 --> 00:20:57,160 EXPERIENCE AT CENTER FOR 393 00:20:57,160 --> 00:20:57,600 SCIENTIFIC REVIEW. 394 00:20:57,600 --> 00:21:01,640 SO SANGEETA WILL BE TEMPORARY 395 00:21:01,640 --> 00:21:05,640 ACTING DEPUTY DIRECTOR DURING 396 00:21:05,640 --> 00:21:09,240 THIS PERIOD. 397 00:21:09,240 --> 00:21:13,640 I WANT TO GIVE A SHOUT OUT TO 398 00:21:13,640 --> 00:21:24,240 CATHY AND SANGEETA AND WE 399 00:21:24,240 --> 00:21:25,560 PLANNED FOR THIS BUT IT DIDN'T 400 00:21:25,560 --> 00:21:27,840 TRANSITION THE WAY WE PLANNED 401 00:21:27,840 --> 00:21:29,640 BUT THEY'VE BEEN DOING EXTRA 402 00:21:29,640 --> 00:21:35,480 WORK. 403 00:21:35,480 --> 00:21:39,280 LAST I WANT TO GIVE A SHOUT OUT 404 00:21:39,280 --> 00:21:42,000 TO MONIQUE CLARK WHO HAS BEEN 405 00:21:42,000 --> 00:21:45,640 PROMOTED IN THE MANAGEMENT 406 00:21:45,640 --> 00:21:51,000 BRANCH AND HERE'S CATHY AND 407 00:21:51,000 --> 00:21:51,440 SANGEETA AND MONIQUE. 408 00:21:51,440 --> 00:21:54,640 SHE MENTORS NEW SPECIALISTS AND 409 00:21:54,640 --> 00:21:56,840 PROVIDES EXPERTISE ON NEI AND 410 00:21:56,840 --> 00:21:59,120 NIH POLICIES AND PROCEDURES AND 411 00:21:59,120 --> 00:22:01,640 SHE MANAGES A VERY LARGE GRANT 412 00:22:01,640 --> 00:22:07,240 PORTFOLIO. 413 00:22:07,240 --> 00:22:08,920 MONIQUE HAS BEEN IN THE FEDERAL 414 00:22:08,920 --> 00:22:10,080 GOVERNMENT 20 YEARS NOW AND 415 00:22:10,080 --> 00:22:11,240 TAUGHT ELEMENTARY SCHOOL BEFORE 416 00:22:11,240 --> 00:22:13,480 COMING HERE. 417 00:22:13,480 --> 00:22:15,360 CONGRATULATIONS TO MONIQUE AND 418 00:22:15,360 --> 00:22:24,000 INTO THIS NEW POSITION. 419 00:22:24,000 --> 00:22:27,560 I WANT TO GIVE SOME UPDATES 420 00:22:27,560 --> 00:22:30,320 ABOUT NIH AND NEI LEADERSHIP. 421 00:22:30,320 --> 00:22:34,160 ONE THING YOU ALL KNOW IS 422 00:22:34,160 --> 00:22:35,680 ANTHONY FAUCI IS STEPPING DOWN 423 00:22:35,680 --> 00:22:40,320 IN DECEMBER AS MEMBER OF NIAID 424 00:22:40,320 --> 00:22:47,640 AND CHIEF MEDICAL ADVISER TO 425 00:22:47,640 --> 00:22:49,760 PRESIDENT BIDEN. 426 00:22:49,760 --> 00:22:53,000 MARY TABAK DESCRIBED THIS AS THE 427 00:22:53,000 --> 00:22:56,480 END OF AN ERA AND IT'S BEEN 54 428 00:22:56,480 --> 00:22:59,120 YEARS TONY SERVED IN GOVERNMENT 429 00:22:59,120 --> 00:23:03,000 AND HAS BEEN DIRECTOR OF NIAID 430 00:23:03,000 --> 00:23:05,360 FOR 40 YEARS AND HAS DONE A LOT 431 00:23:05,360 --> 00:23:08,760 TO BRING THE COUNTRY THROUGH 432 00:23:08,760 --> 00:23:13,880 DIFFERENT CRISES FROM HIV TO 433 00:23:13,880 --> 00:23:15,360 EBOLA AND COVID. 434 00:23:15,360 --> 00:23:17,560 I HAD A GREAT TIME INTERVIEWING 435 00:23:17,560 --> 00:23:22,440 FOR PART OF A MEETING WE DID. 436 00:23:22,440 --> 00:23:24,960 THIS IS GOING TO BE A BIG 437 00:23:24,960 --> 00:23:32,520 TRANSITION FOR NIH OVER ALL. 438 00:23:32,520 --> 00:23:35,320 WITHIN NEI WE HAVE A COUPLE 439 00:23:35,320 --> 00:23:35,840 SEARCHS. 440 00:23:35,840 --> 00:23:36,480 ONE IS A CLINICAL DIRECTOR 441 00:23:36,480 --> 00:23:43,000 SEARCH IN PROGRESS. 442 00:23:43,000 --> 00:23:45,640 THERE'S A SCIENTIFIC DIRECTOR 443 00:23:45,640 --> 00:23:49,480 SEARCH WHERE SHELDON MILLER 444 00:23:49,480 --> 00:23:52,520 RETIRED AND WE HAVE HAD AN 445 00:23:52,520 --> 00:23:55,440 ACTING DIRECTOR FOR THREE PLUS 446 00:23:55,440 --> 00:23:57,640 YEARS NOW. 447 00:23:57,640 --> 00:24:00,440 DAVID, THANK YOU FOR DOING THAT. 448 00:24:00,440 --> 00:24:01,600 WE'RE IN THE PROCESS OF 449 00:24:01,600 --> 00:24:03,160 INTERVIEWING WITH THIS SO 450 00:24:03,160 --> 00:24:05,600 HOPEFULLY WE'LL MOVE FORWARD 451 00:24:05,600 --> 00:24:06,800 WITH THAT IN THE NOT TOO DISTANT 452 00:24:06,800 --> 00:24:10,760 FUTURE AND LASTLY OUR EXECUTIVE 453 00:24:10,760 --> 00:24:12,120 POSITION OUR CHIEF OPERATING 454 00:24:12,120 --> 00:24:15,080 OFFICER POSITION, THE SEARCH IS 455 00:24:15,080 --> 00:24:16,760 IN ITS FINAL STAGES AND HOPE 456 00:24:16,760 --> 00:24:18,080 WE'LL HAVE SOMETHING TO ANNOUNCE 457 00:24:18,080 --> 00:24:23,360 RELATIVELY SOON. 458 00:24:23,360 --> 00:24:27,720 THERE'S LOTS OF SIGNIFICANT 459 00:24:27,720 --> 00:24:29,240 CHANGES PERSONNEL WISE AND 460 00:24:29,240 --> 00:24:33,640 LEADERSHIP WISE WITHIN THE NEI. 461 00:24:33,640 --> 00:24:35,680 THIS NEXT SET OF SLIDES, WHAT I 462 00:24:35,680 --> 00:24:38,920 WANT TO DO IS GIVE SOME NEWS 463 00:24:38,920 --> 00:24:40,200 ITEMS THAT ARE GOING TO BE OF 464 00:24:40,200 --> 00:24:41,040 INTEREST TO THE VISION 465 00:24:41,040 --> 00:24:42,960 COMMUNITY. 466 00:24:42,960 --> 00:24:46,280 ONE, IS THAT WITHIN OUR 467 00:24:46,280 --> 00:24:47,680 INTRAMURAL RESEARCH PROGRAM 468 00:24:47,680 --> 00:24:50,680 EXCITING FINDING. 469 00:24:50,680 --> 00:24:58,920 THE FIRST PATIENT RECEIVING AN 470 00:24:58,920 --> 00:24:59,840 AUTOLOGOUS TREATMENT FOR DRY EYE 471 00:24:59,840 --> 00:25:02,400 AND THIS WAS THE PRINCIPLE 472 00:25:02,400 --> 00:25:07,640 INVESTIGATOR OF THIS AND THIS 473 00:25:07,640 --> 00:25:10,080 GROUP HAS SPENT 10 TO 15 YEARS 474 00:25:10,080 --> 00:25:11,680 WORKING ON THE TECHNOLOGY THAT 475 00:25:11,680 --> 00:25:14,760 HAS LED TO ALL OF THIS. 476 00:25:14,760 --> 00:25:17,920 IN A NUTSHELL THEY'VE TAKEN 477 00:25:17,920 --> 00:25:20,840 PERIPHERAL BLOOD CELLS AND 478 00:25:20,840 --> 00:25:25,160 ISOLATING INDUCED -- CONVERTING 479 00:25:25,160 --> 00:25:29,320 TO PLURIPOTENT STEM CELLS AND 480 00:25:29,320 --> 00:25:33,280 BACK TO EPITHELIAL CELLS. 481 00:25:33,280 --> 00:25:36,480 THEY BASICALLY GROW CELLS ON A 482 00:25:36,480 --> 00:25:37,640 BIODEGRADABLE PATCH AND LEFT IS 483 00:25:37,640 --> 00:25:42,800 A PICTURE OF THAT AT LOW MEG AND 484 00:25:42,800 --> 00:25:44,160 HIGHER MAGNIFICATION. 485 00:25:44,160 --> 00:25:47,000 IN AUGUST OF THIS YEAR, THIS IS 486 00:25:47,000 --> 00:25:49,040 THE FIRST IN HUMAN SURGERY. 487 00:25:49,040 --> 00:25:53,640 THE FIRST PERSON RECEIVED A 488 00:25:53,640 --> 00:25:59,280 PATCH AT THE NIH CLINICAL CENTER 489 00:25:59,280 --> 00:25:59,720 HERE IN BETHESDA. 490 00:25:59,720 --> 00:26:06,080 IT'S A PHASE 1-2A CLINICAL TRIAL 491 00:26:06,080 --> 00:26:09,320 AND IT WAS DONE BY THE PERSON ON 492 00:26:09,320 --> 00:26:15,240 THE BOTTOM AT THE NEI WE'RE VERY 493 00:26:15,240 --> 00:26:19,800 EXCITED ABOUT THAT. 494 00:26:19,800 --> 00:26:24,640 IT'S AN NEI INTRAMURAL PROJECT 495 00:26:24,640 --> 00:26:25,240 SUPPORTED BY THE NIH COMMON 496 00:26:25,240 --> 00:26:26,920 FOUND. 497 00:26:26,920 --> 00:26:36,080 CONGRATULATIONS TO THE GROUP. 498 00:26:36,080 --> 00:26:40,600 IN REGENERATIVE MEDICINE WE'VE 499 00:26:40,600 --> 00:26:43,360 BEEN EXCITED ABOUT THE 3-D 500 00:26:43,360 --> 00:26:45,640 RETINAL ORGANOID CHALLENGE AND 501 00:26:45,640 --> 00:26:49,640 IT'S GONE THROUGH PHASES AND 502 00:26:49,640 --> 00:26:52,200 WE'VE HAD AWARDS FOR THE FINAL 503 00:26:52,200 --> 00:26:53,640 PHASE DEVELOPING THE RETINA 504 00:26:53,640 --> 00:26:59,400 DISEASE MODELS IN A DISH, IF YOU 505 00:26:59,400 --> 00:27:01,240 WILL,. 506 00:27:01,240 --> 00:27:05,640 AND THESE THE PEOPLE WHO MANAGE 507 00:27:05,640 --> 00:27:07,960 THIS PROCESS. 508 00:27:07,960 --> 00:27:10,720 A MONTH AGO WE ANNOUNCED THE 509 00:27:10,720 --> 00:27:13,880 THREE WINNERS OF PHASE 3. 510 00:27:13,880 --> 00:27:16,120 ONE WAS PICTURED ON THE UPPER 511 00:27:16,120 --> 00:27:17,640 RIGHT FROM THE UNIVERSITY OF 512 00:27:17,640 --> 00:27:21,800 CALENDAR. 513 00:27:21,800 --> 00:27:24,400 VAL AND HER GROUP WERE AWARDED 514 00:27:24,400 --> 00:27:27,960 $5,000 FOR CREATING THE SYSTEM 515 00:27:27,960 --> 00:27:29,640 WITH FUNCTIONAL PHOTO RECEPTORS 516 00:27:29,640 --> 00:27:30,680 AND CELL LAYERS. 517 00:27:30,680 --> 00:27:33,680 WE WERE EXCITED BECAUSE IT'S A 518 00:27:33,680 --> 00:27:36,280 POTENTIAL RESEARCH MODEL FOR AMD 519 00:27:36,280 --> 00:27:39,480 INCLUDING THE RPE CELL LAYER. 520 00:27:39,480 --> 00:27:44,720 PICTURED ON THE MIDDLE RIGHT IS 521 00:27:44,720 --> 00:27:45,520 NATALIA FROM THE UNIVERSITY OF 522 00:27:45,520 --> 00:27:47,320 COLORADO WHO'S GROUP WAS AWARDED 523 00:27:47,320 --> 00:27:51,760 $250,000 FOR A DEVELOPMENT OF A 524 00:27:51,760 --> 00:27:52,760 DIFFERENT ORGANOID MODEL SYSTEM 525 00:27:52,760 --> 00:27:53,680 THAT'S REPRODUCIBLE. 526 00:27:53,680 --> 00:27:58,600 WE WERE EXCITED ABOUT THAT AS A 527 00:27:58,600 --> 00:27:59,720 POTENTIAL MODEL FOR HIGH 528 00:27:59,720 --> 00:28:00,880 THROUGHPUT DRUG SCREENING AND ON 529 00:28:00,880 --> 00:28:05,560 THE BOTTOM RIGHT IS FROM ALBERT 530 00:28:05,560 --> 00:28:06,880 EINSTEIN IN NEW YORK CITY AND 531 00:28:06,880 --> 00:28:10,840 THE GROUP WAS AWARDED $125,000 532 00:28:10,840 --> 00:28:13,640 FOR DEVELOPING A RETINAL 533 00:28:13,640 --> 00:28:15,080 ORGANOID WITH ALL THE MAJOR 534 00:28:15,080 --> 00:28:16,760 NEURON GROUPS IN THE RETINA AND 535 00:28:16,760 --> 00:28:21,360 WA WAS STRIKING WAS THE CONE 536 00:28:21,360 --> 00:28:23,360 RICH AND WE WERE EXCITED IT MAY 537 00:28:23,360 --> 00:28:27,760 BE USEFUL AS A MODEL FOR TESTING 538 00:28:27,760 --> 00:28:30,680 GENE THERAPIES AND AFFECT ON 539 00:28:30,680 --> 00:28:32,080 NEURONAL FUNCTION. 540 00:28:32,080 --> 00:28:39,560 CONGRATULATIONS TO THEM. 541 00:28:39,560 --> 00:28:40,080 WE WERE GRAD TO MOVE THIS 542 00:28:40,080 --> 00:28:48,040 PROCESS. 543 00:28:48,040 --> 00:28:49,400 A LOT OF PEOPLE DID A LOT OF 544 00:28:49,400 --> 00:28:51,120 WORK IN SHEPHERDING THIS. 545 00:28:51,120 --> 00:28:53,640 NEXT I WANT TO TALK ABOUT WORK 546 00:28:53,640 --> 00:29:01,320 IN IMMUNOLOGY. 547 00:29:01,320 --> 00:29:02,720 THROUGH THE AUDACIOUS GOALS 548 00:29:02,720 --> 00:29:03,800 INITIATIVE WE IDENTIFIED SOME 549 00:29:03,800 --> 00:29:06,720 AREAS WE'RE INTERESTED IN MOVING 550 00:29:06,720 --> 00:29:07,000 FORWARD. 551 00:29:07,000 --> 00:29:09,640 ONE INVOLVES TRANSPLANT 552 00:29:09,640 --> 00:29:12,640 IMMUNOLOGY. 553 00:29:12,640 --> 00:29:17,640 THE GAP IN KNOWLEDGE IS FOR 554 00:29:17,640 --> 00:29:19,440 THERAPIES GENE AND CELL-BASED 555 00:29:19,440 --> 00:29:20,520 THERAPIES. 556 00:29:20,520 --> 00:29:23,720 ONE CONCERN THAT'S COME UP 557 00:29:23,720 --> 00:29:29,320 INCREASINGLY IS IMMUNOLOGICAL 558 00:29:29,320 --> 00:29:29,960 GAPS. 559 00:29:29,960 --> 00:29:31,880 WHERE WILL REACTION LIMIT 560 00:29:31,880 --> 00:29:33,640 RESULTS WE'RE GETTING FROM THE 561 00:29:33,640 --> 00:29:35,320 REGENERATIVE MEDICINE 562 00:29:35,320 --> 00:29:35,800 APPROACHES? 563 00:29:35,800 --> 00:29:41,400 WE HELD A WORKSHOP ON THIS IN 564 00:29:41,400 --> 00:29:44,840 JULY 2022 CO-CHAIRED FROM THE 565 00:29:44,840 --> 00:29:49,600 UNIVERSITY OF COLORADO WITH 566 00:29:49,600 --> 00:29:51,960 VICTOR AT DUKE. 567 00:29:51,960 --> 00:29:53,640 VICTOR, THANK YOU AND THIS WENT 568 00:29:53,640 --> 00:29:54,920 WELL. 569 00:29:54,920 --> 00:30:00,520 THERE WERE ALMOST 30 EXPERTS WHO 570 00:30:00,520 --> 00:30:03,080 SPOKE ON THIS AREA AND THERE 571 00:30:03,080 --> 00:30:04,920 WERE QUESTIONS CAN WE MODULATE 572 00:30:04,920 --> 00:30:06,600 SOMEONE'S IMMUNE SYSTEM TO 573 00:30:06,600 --> 00:30:08,600 IMPROVE TRANSPLANT OUTCOMES AND 574 00:30:08,600 --> 00:30:11,720 HOW DO WE OVERCOME BARRIERS TO 575 00:30:11,720 --> 00:30:14,960 INTRODUCE CELL THERAPIES IN INTO 576 00:30:14,960 --> 00:30:15,640 DISEASED EYES. 577 00:30:15,640 --> 00:30:21,840 THE NEXT STEP HERE IS THAT 578 00:30:21,840 --> 00:30:23,680 THERE'S A MEETING SUMMARY BEING 579 00:30:23,680 --> 00:30:26,080 PREPARED AND REVIEWED BY THE 580 00:30:26,080 --> 00:30:29,640 WORKING GROUP WITH NEI 581 00:30:29,640 --> 00:30:31,920 LEADERSHIP. 582 00:30:31,920 --> 00:30:33,600 EXCITED ABOUT THE INITIATIVES 583 00:30:33,600 --> 00:30:41,400 THAT MAY COME OF IT. 584 00:30:41,400 --> 00:30:44,600 I WANT TO TALK ABOUT INITIATIVES 585 00:30:44,600 --> 00:30:47,920 WITH REGENERATIVE MEDICINE. 586 00:30:47,920 --> 00:30:56,880 THE FIRST IS OCULAR SURFACE 587 00:30:56,880 --> 00:30:58,040 INNERVATION AND THE GAPS THESE 588 00:30:58,040 --> 00:31:01,120 PROJECTS WERE INTENDED TO 589 00:31:01,120 --> 00:31:03,240 ADDRESS IS WE DON'T REALLY HAVE 590 00:31:03,240 --> 00:31:07,720 A VERY GOOD UNDERSTANDING OF 591 00:31:07,720 --> 00:31:10,360 OCULAR SURFACE INNERVATION AND 592 00:31:10,360 --> 00:31:12,680 HOW THE PATHWAYS CONTRIBUTE TO 593 00:31:12,680 --> 00:31:16,000 CORNEAL SENSATION, PAIN, DRY A 594 00:31:16,000 --> 00:31:20,200 PAIN, PHOTO PHOBIA, TEARING 595 00:31:20,200 --> 00:31:20,440 REFLEXES. 596 00:31:20,440 --> 00:31:21,200 THERE WERE EIGHT COOPERATE 597 00:31:21,200 --> 00:31:30,760 AWARDS MADE IN THIS AREA. 598 00:31:30,760 --> 00:31:36,480 AND THERE WERE PEOPLE WHO DID 599 00:31:36,480 --> 00:31:41,640 THE BULK OF THE WORK THERE'S A 600 00:31:41,640 --> 00:31:51,240 CONSORTIUM KICK OFF OCTOBER 28. 601 00:31:51,240 --> 00:31:57,240 TWO IS THE SURFACE MICROBIOME 602 00:31:57,240 --> 00:32:01,880 AND WE HAD A WORKSHOP AND WE HAD 603 00:32:01,880 --> 00:32:03,760 PEOPLE WHO WENT FROM GOING TO 604 00:32:03,760 --> 00:32:05,240 THE WORKSHOP TO THE INITIATIVE 605 00:32:05,240 --> 00:32:06,880 AND THE PURPOSE OF THE FUNDING 606 00:32:06,880 --> 00:32:09,640 INITIATIVE IS BASICALLY TO 607 00:32:09,640 --> 00:32:12,120 CREATE A COMMUNITY-BASED 608 00:32:12,120 --> 00:32:16,440 RESOURCE OF MICROBIAL DATA, FOR 609 00:32:16,440 --> 00:32:20,920 EXAMPLE, HOW CAN WE CHARACTERIZE 610 00:32:20,920 --> 00:32:23,920 THE MICROBIOME IN HEALTHY 611 00:32:23,920 --> 00:32:25,640 INDIVIDUALS AND WE'LL REVIEW IT 612 00:32:25,640 --> 00:32:27,480 IN NOVEMBER AND IT WILL GO TO 613 00:32:27,480 --> 00:32:32,440 COUNCIL IN FEBRUARY. 614 00:32:32,440 --> 00:32:33,320 LASTLY, THE BIOLOGY INITIATIVE. 615 00:32:33,320 --> 00:32:36,680 WE'VE BEEN TALKING ABOUT THIS A 616 00:32:36,680 --> 00:32:37,160 FEW YEARS. 617 00:32:37,160 --> 00:32:38,440 THERE'S BEEN A LOT OF PEOPLE WHO 618 00:32:38,440 --> 00:32:47,360 WORKED ON THIS FOR A LONG TIME. 619 00:32:47,360 --> 00:32:50,320 FROM PROGRAMS IT'S PEOPLE LIKE 620 00:32:50,320 --> 00:32:56,160 CHUCK AND GRAY AND NATALIA AND 621 00:32:56,160 --> 00:32:57,640 JENNIFER THAT GOT THIS OUT 622 00:32:57,640 --> 00:33:02,480 THERE. 623 00:33:02,480 --> 00:33:08,280 THE GOAL IS FROM THE STUDY WE 624 00:33:08,280 --> 00:33:12,360 HAVE A RICH DATA SOURCE. 625 00:33:12,360 --> 00:33:17,720 THERE'S OVER 60 PATIENTS 626 00:33:17,720 --> 00:33:21,160 CHARACTERIZED RICHLY FOR RETINAL 627 00:33:21,160 --> 00:33:25,360 MODALITIES AND GENETIC SEQUENCE 628 00:33:25,360 --> 00:33:29,640 DATA AND ALSO PATIENT DERIVED 629 00:33:29,640 --> 00:33:33,600 PLURIPOTENT STEM CELLS FOR 630 00:33:33,600 --> 00:33:36,880 PEOPLE WITH HIGH RISK ALLELES 631 00:33:36,880 --> 00:33:40,640 AND THE PURPOSE IS TO GIVE 632 00:33:40,640 --> 00:33:44,360 ACCESS TO THE DATA AND LEARN 633 00:33:44,360 --> 00:33:51,000 ABOUT THE UNDERLYING 634 00:33:51,000 --> 00:33:52,520 PATHOPHYSIOLOGY OF AMD. 635 00:33:52,520 --> 00:33:57,600 THESE ARE THINGS WE'RE EXCITED 636 00:33:57,600 --> 00:33:59,720 IN NEUROSCIENCE AND NEUROLOGY 637 00:33:59,720 --> 00:34:02,320 AND REGENERATIVE MEDICINE. 638 00:34:02,320 --> 00:34:05,480 ANOTHER THING WE'VE BECOME 639 00:34:05,480 --> 00:34:08,000 INTERESTED IN THROUGH OUR 640 00:34:08,000 --> 00:34:10,200 STRATEGIC PLANNING PROCESS IS 641 00:34:10,200 --> 00:34:11,680 CEREBRAL IMPAIRMENT. 642 00:34:11,680 --> 00:34:16,160 WE HAVE A CHILD WITH THIS WITH A 643 00:34:16,160 --> 00:34:16,720 CARETAKER. 644 00:34:16,720 --> 00:34:21,320 THIS IS SOMETHING AS A PEDIATRIC 645 00:34:21,320 --> 00:34:23,480 OPHTHALMOLOGIST IT'S BECOME THE 646 00:34:23,480 --> 00:34:25,640 LEADING CAUSE OF CHILDHOOD 647 00:34:25,640 --> 00:34:30,760 BLINDNESS IN THIS COUNTRY. 648 00:34:30,760 --> 00:34:34,840 IT'S ASSOCIATED WITH THINGS LIKE 649 00:34:34,840 --> 00:34:39,360 PREMATURITY AND BRAIN DAMAGE AND 650 00:34:39,360 --> 00:34:44,000 THESE PATIENTS HAVE VISUAL 651 00:34:44,000 --> 00:34:46,040 ACUITY DEFICITS AND ONE HALLMARK 652 00:34:46,040 --> 00:34:47,680 IS HIGHER ORDER VISUAL 653 00:34:47,680 --> 00:34:48,480 PROCESSING DEFICITS. 654 00:34:48,480 --> 00:34:52,840 LIKE NOT BEING ABLE TO RECOGNIZE 655 00:34:52,840 --> 00:34:57,640 THINGS WITHIN A CROWDED 656 00:34:57,640 --> 00:35:00,080 BACKGROUND, FOR EXAMPLE. 657 00:35:00,080 --> 00:35:01,600 LOTS OF GAPS IN KNOWLEDGE. 658 00:35:01,600 --> 00:35:04,080 WE NEED A BETTER UNDERSTAND OF 659 00:35:04,080 --> 00:35:05,760 THE NEURAL BASIS AND HOW IT 660 00:35:05,760 --> 00:35:07,480 DIFFERS FROM THINGS LIKE 661 00:35:07,480 --> 00:35:09,640 TRAUMATIC BRAIN INJURY AND 662 00:35:09,640 --> 00:35:12,160 STROKE. 663 00:35:12,160 --> 00:35:15,440 WE NEED BETTER GUIDELINES FOR 664 00:35:15,440 --> 00:35:18,840 DIAGNOSIS AND CLASSIFICATION AND 665 00:35:18,840 --> 00:35:21,960 NEED TO UNDERSTAND THE 666 00:35:21,960 --> 00:35:24,600 REHABILITATION NEEDS OF WHAT WE 667 00:35:24,600 --> 00:35:28,720 CALL BRAIN-BASED VISUAL 668 00:35:28,720 --> 00:35:31,160 IMPAIRMENT OPPOSED TO OCULAR AND 669 00:35:31,160 --> 00:35:35,360 WHAT WE FOUND LEADING UP TO OUR 670 00:35:35,360 --> 00:35:37,280 STRATEGY PLAN WAS THIS REQUIRES 671 00:35:37,280 --> 00:35:41,640 AN INTERDISCIPLINARY APPROACH. 672 00:35:41,640 --> 00:35:43,120 OPHTHALMOLOGIST AND OPTOMETRISTS 673 00:35:43,120 --> 00:35:45,720 WITH IMAGING AND NEUROSCIENCE 674 00:35:45,720 --> 00:35:47,800 AND PHYSICAL AND OCCUPATIONAL 675 00:35:47,800 --> 00:35:49,640 THERAPY AND EDUCATION AND OTHER 676 00:35:49,640 --> 00:35:56,640 FIELD. 677 00:35:56,640 --> 00:36:01,080 OVER THE SUMMER, MANY OF US 678 00:36:01,080 --> 00:36:03,600 ATTENDED TWO CEREBRAL IMPAIRMENT 679 00:36:03,600 --> 00:36:05,760 MEETINGS ONE WAS AT THE PERKINS 680 00:36:05,760 --> 00:36:07,760 SCHOOL FOR THE BLIND AND THE 681 00:36:07,760 --> 00:36:12,720 OTHER WAS IN JULY IN NEBRASKA. 682 00:36:12,720 --> 00:36:18,960 I WAS THERE ALICIA CARE AND DON 683 00:36:18,960 --> 00:36:21,600 AND SHERRY WIGS AND I HOPE I 684 00:36:21,600 --> 00:36:23,720 DIDN'T LEAVE ANYBODY OUT FROM 685 00:36:23,720 --> 00:36:28,320 OUR GROUP THAT ATTENDED. 686 00:36:28,320 --> 00:36:30,960 WE ANNOUNCED WE'D LIKE TO BUILD 687 00:36:30,960 --> 00:36:36,320 A CVI REGISTRY TO HELP SUPPORT 688 00:36:36,320 --> 00:36:38,160 THE COMMUNITY. 689 00:36:38,160 --> 00:36:40,640 THE GOAL IS TO TRACK AND DEVELOP 690 00:36:40,640 --> 00:36:47,720 THINGS LIKE THE CLASSIFICATION 691 00:36:47,720 --> 00:36:52,320 SCREAMS AND TREATMENT METHODS 692 00:36:52,320 --> 00:36:54,360 AND MAY HELP FACILITATE 693 00:36:54,360 --> 00:36:55,680 RECRUITMENT OF PATIENTS TO NEW 694 00:36:55,680 --> 00:36:56,520 STUDIES AND LOOKING AT 695 00:36:56,520 --> 00:37:04,240 REHABILITATION STRATEGIES. 696 00:37:04,240 --> 00:37:06,040 WE'RE TRYING TO WORK WITH THE 697 00:37:06,040 --> 00:37:11,040 COMMUNITY TO ASK THEM WHAT WOULD 698 00:37:11,040 --> 00:37:13,680 BE THE KEY DATA POINTS PEOPLE 699 00:37:13,680 --> 00:37:15,560 WOULD WANT IN THE REGISTRY AND 700 00:37:15,560 --> 00:37:17,640 WE'RE EXCITED ABOUT GETTING THIS 701 00:37:17,640 --> 00:37:23,320 STARTED BECAUSE IT'S A BIG GAP 702 00:37:23,320 --> 00:37:24,200 WE'VE IDENTIFIED AND WE'RE 703 00:37:24,200 --> 00:37:25,640 EXCITED TO WORK WITH THE 704 00:37:25,640 --> 00:37:33,560 COMMUNITY ON THIS. 705 00:37:33,560 --> 00:37:35,720 ANOTHER THING I WANT TO TALK 706 00:37:35,720 --> 00:37:41,640 ABOUT IS MYOPIA IN THE CONTEXT 707 00:37:41,640 --> 00:37:52,040 OF GENE ENVIRONMENT AND 708 00:37:53,720 --> 00:37:56,520 EPIDEMIOLOGY WE LOOKED AT IS 709 00:37:56,520 --> 00:38:01,520 THIS AND THIS PERM PERCOLATED 710 00:38:01,520 --> 00:38:07,600 TO THE TOP AND THE PREVALENCE IS 711 00:38:07,600 --> 00:38:08,600 INCREASING. 712 00:38:08,600 --> 00:38:17,640 WE KNOW FROM WORK IN EAST ASIA 713 00:38:17,640 --> 00:38:20,040 THE ESTIMATES THERE'S AN 714 00:38:20,040 --> 00:38:23,680 ESTIMATE OF 30% TO 40% RANGE AND 715 00:38:23,680 --> 00:38:25,120 SEEMS TO BE GOING UP WITHIN THE 716 00:38:25,120 --> 00:38:25,480 PANDEMIC. 717 00:38:25,480 --> 00:38:28,120 THERE WAS A STUDY PUBLISHED ON 718 00:38:28,120 --> 00:38:31,560 THE BOTTOM RIGHT THERE'S A GRAPH 719 00:38:31,560 --> 00:38:35,600 LOOKING AT RATES OF MYOPIA ON 720 00:38:35,600 --> 00:38:41,520 THE TOP AND HIGH MYOPIA IN THE 721 00:38:41,520 --> 00:38:44,680 BOTTOM AND BY 2050 THERE'LL BE 5 722 00:38:44,680 --> 00:38:47,440 BILLION PEOPLE WITH MYOPIA IN 723 00:38:47,440 --> 00:38:51,040 THE WORLD AND ALMOST 1 BILLION 724 00:38:51,040 --> 00:38:52,760 WITH HIGH MYOPIA. 725 00:38:52,760 --> 00:38:56,200 WHY'S THAT MATTER? 726 00:38:56,200 --> 00:39:01,640 THERE'S CORRELATIONS BY 75, 40% 727 00:39:01,640 --> 00:39:05,320 OF PEOPLE WILL HAVE UNCORRECTED 728 00:39:05,320 --> 00:39:11,840 VISUAL IMPAIRMENT AND MACULAR 729 00:39:11,840 --> 00:39:13,800 DEGENERATION AND WHAT'S KNOWN 730 00:39:13,800 --> 00:39:17,640 AND WHAT'S UNKNOWN GENETIC 731 00:39:17,640 --> 00:39:20,240 STUDIES HAVE SHOWN OVER 200 LOCI 732 00:39:20,240 --> 00:39:22,600 ED BUT THE MECHANISMS OF MACULAR 733 00:39:22,600 --> 00:39:24,240 GROWTH ARE NOT CLEAR. 734 00:39:24,240 --> 00:39:28,080 THIS GENETICS DOES NOT EXPLAIN 735 00:39:28,080 --> 00:39:38,480 THE RAPID RISE IN RATES. 736 00:39:44,280 --> 00:39:45,640 VISUAL EXPERIENCE DRIVES BUT 737 00:39:45,640 --> 00:39:47,960 THERE'S A HOT DEBATE ON WHAT THE 738 00:39:47,960 --> 00:39:50,680 ENVIRONMENTAL MECHANISMS ARE, IS 739 00:39:50,680 --> 00:39:55,360 IT WORK OR SCREEN TIME AND ONE 740 00:39:55,360 --> 00:39:59,720 THING THAT'S HOT NOW IS BROAD 741 00:39:59,720 --> 00:40:05,120 SPECTRUM SUNLIGHT AND LACK OF 742 00:40:05,120 --> 00:40:07,480 SUNSHINE AND THERE'S RESEARCH IN 743 00:40:07,480 --> 00:40:11,560 AREAS LIKE GENETIC AND ANIMAL 744 00:40:11,560 --> 00:40:14,440 MODELS AND EPIDEMIOLOGY BUT THE 745 00:40:14,440 --> 00:40:16,680 FACTORS IN THE STUDIES ARE 746 00:40:16,680 --> 00:40:17,040 SELF-REPORTED. 747 00:40:17,040 --> 00:40:27,480 SOME ARE TOUGH TO QUANTIFY. 748 00:40:28,160 --> 00:40:29,240 THERE'S BEEN A CONVERSATION WITH 749 00:40:29,240 --> 00:40:30,680 THE NATIONAL ACADEMIES OF 750 00:40:30,680 --> 00:40:33,640 SCIENCE, ENGINEERING AND 751 00:40:33,640 --> 00:40:36,480 MEDICINE AND WE'VE DISCUSSED 752 00:40:36,480 --> 00:40:42,160 WITH THEM LAUNCHING A NASEM 753 00:40:42,160 --> 00:40:44,200 STUDY AND WE AGREED TO BE A 754 00:40:44,200 --> 00:40:50,240 MAJOR SPONSOR OF THE STUDIES AND 755 00:40:50,240 --> 00:40:53,480 IT'S GOING LOOK AT BASIS SCIENCE 756 00:40:53,480 --> 00:40:59,720 AND HEALTH DISPARITIES ASPECTS 757 00:40:59,720 --> 00:41:01,280 OF MYOPIA. 758 00:41:01,280 --> 00:41:03,440 IN TERMS OF THE ACADEMIC 759 00:41:03,440 --> 00:41:05,640 DRIVERS, HOW ARE ENVIRONMENTAL 760 00:41:05,640 --> 00:41:09,640 FACTORS RELATED TO THE INCREASE 761 00:41:09,640 --> 00:41:14,920 IN THE MYOPIA FACTORS AND ARE 762 00:41:14,920 --> 00:41:16,800 THERE CHARACTERISTICS OF 763 00:41:16,800 --> 00:41:17,400 ELECTRONIC DEVICES THAT 764 00:41:17,400 --> 00:41:19,600 CONTRIBUTE TO MYOPIA AND HOW DO 765 00:41:19,600 --> 00:41:20,320 WE MAKE THEM SAFER? 766 00:41:20,320 --> 00:41:22,040 WHAT ARE THE RISKS IN CHILDREN 767 00:41:22,040 --> 00:41:24,640 AND THE UNDERLYING CELLULAR AND 768 00:41:24,640 --> 00:41:29,640 MOLECULAR FACTORS THAT CONTROL 769 00:41:29,640 --> 00:41:34,720 GROWTH OF THE EYE? 770 00:41:34,720 --> 00:41:39,240 AND FROM A SOCIO ECONOMIC 771 00:41:39,240 --> 00:41:41,640 PERSPECTIVE WHY ARE THERE SO 772 00:41:41,640 --> 00:41:43,840 MANY PEOPLE WHO HAVE UNCORRECTED 773 00:41:43,840 --> 00:41:46,080 VISION LOSS FROM MYOPIA AND HOW 774 00:41:46,080 --> 00:41:49,280 DO WE IMPROVE ACCESS TO THE 775 00:41:49,280 --> 00:41:53,040 UNDER SERVED POPULATIONS? 776 00:41:53,040 --> 00:41:55,200 SHERRY AND DON EVERETT ARE 777 00:41:55,200 --> 00:41:57,240 INVOLVED AN THERE'S A LARGE 778 00:41:57,240 --> 00:41:57,920 MEETING PLANNED FOR NEXT YEAR. 779 00:41:57,920 --> 00:42:08,360 WE'RE EXCITED ABOUT THIS. 780 00:42:17,120 --> 00:42:19,360 WE TALKED ABOUT COVID TESTING 781 00:42:19,360 --> 00:42:20,560 AND HOW DIFFICULT THEY ARE TO 782 00:42:20,560 --> 00:42:22,280 USE FOR PEOPLE WITH VISUAL 783 00:42:22,280 --> 00:42:24,800 IMPAIRMENT AND NOT BEING ABLE TO 784 00:42:24,800 --> 00:42:26,600 READ THE INSTRUCTIONS OR SEE 785 00:42:26,600 --> 00:42:29,560 THINGS LIKE THE PINK OR BLUE 786 00:42:29,560 --> 00:42:29,800 LINE. 787 00:42:29,800 --> 00:42:40,000 WE START TO WORK AT THE NEI, 788 00:42:40,000 --> 00:42:43,720 WITH THE RAD X-UP GROUP AND 789 00:42:43,720 --> 00:42:45,320 WORKED ON HOW TO MAKE HOME COVID 790 00:42:45,320 --> 00:42:47,720 TESTS MORE ACCESSIBLE TO PEOPLE 791 00:42:47,720 --> 00:42:49,640 WITH VISUAL LOSS AND THE WHITE 792 00:42:49,640 --> 00:42:52,840 HOUSE LAUNCHED AN INITIATIVE 793 00:42:52,840 --> 00:42:53,560 THROUGH ADMINISTRATION FOR 794 00:42:53,560 --> 00:42:55,760 COMMUNITY LIVING ON GETTING 795 00:42:55,760 --> 00:42:58,160 THESE TESTS OUT THERE AS WELL. 796 00:42:58,160 --> 00:43:08,520 MORE ACCESSIBLE TESTS. 797 00:43:12,080 --> 00:43:17,160 AND WE'VE HAD A SERIES OF 798 00:43:17,160 --> 00:43:18,280 MEETINGS WITH THE NATIONAL 799 00:43:18,280 --> 00:43:19,160 INSTITUTE ON MINORITY HEALTH AND 800 00:43:19,160 --> 00:43:20,160 HEALTH DISPARITY. 801 00:43:20,160 --> 00:43:23,080 WHAT WE'RE DOING IS PLANNING A 802 00:43:23,080 --> 00:43:25,000 WORKSHOP THAT'S GOING TO FOCUS 803 00:43:25,000 --> 00:43:29,800 ON A OUM COUPLE DIFFERENT 804 00:43:29,800 --> 00:43:30,320 THINGS. 805 00:43:30,320 --> 00:43:35,440 AN JIMMY IS LEADING IT FROM OUR 806 00:43:35,440 --> 00:43:37,640 END WHO THE INTENT IS IT WILL 807 00:43:37,640 --> 00:43:39,840 FOCUS ON AREAS LIKE ADDRESSING 808 00:43:39,840 --> 00:43:42,040 HEALTH DISPARITIES IN VISION 809 00:43:42,040 --> 00:43:42,600 CARE. 810 00:43:42,600 --> 00:43:45,240 FOR EXAMPLE, UNOPERATED 811 00:43:45,240 --> 00:43:47,560 CATARACTS AND REFRACTIVE ERROR 812 00:43:47,560 --> 00:43:53,880 AND OTHER THINGS LIKE UNTREATED 813 00:43:53,880 --> 00:43:57,640 GLAUCOMA AND DIABETIC 814 00:43:57,640 --> 00:43:59,120 RETINOPATHY AND WHY ARE PEOPLE 815 00:43:59,120 --> 00:44:01,320 LOSING VISION FROM TREATABLE 816 00:44:01,320 --> 00:44:02,040 DISEASE IN 2022? 817 00:44:02,040 --> 00:44:05,600 THAT'S SOMETHING WE'RE LOOKING 818 00:44:05,600 --> 00:44:15,160 FORWARD TO AS WELL. 819 00:44:15,160 --> 00:44:21,080 CARRIE HAS LED OUR OFFICE OF 820 00:44:21,080 --> 00:44:23,800 DATA SCIENCE AND WE HAD A FEW 821 00:44:23,800 --> 00:44:24,640 WORKSHOPS. 822 00:44:24,640 --> 00:44:28,240 ONE INVOLVING OCULAR IMAGING 823 00:44:28,240 --> 00:44:28,640 INTEROPERABILITY. 824 00:44:28,640 --> 00:44:30,360 WHY DON'T THE IMAGING DEVICES 825 00:44:30,360 --> 00:44:35,320 TALK TO EACH OTHER AND TALK TO 826 00:44:35,320 --> 00:44:35,920 ELECTRONIC HEALTH RECORD AND 827 00:44:35,920 --> 00:44:39,000 HELD IT IN CONJUNCTION WITH THE 828 00:44:39,000 --> 00:44:41,520 OFFICE OF NATIONAL COORDINATOR 829 00:44:41,520 --> 00:44:42,360 FOR HEALTH CARE I.T. 830 00:44:42,360 --> 00:44:44,080 WE WERE EXCITED ABOUT THAT. 831 00:44:44,080 --> 00:44:45,840 IT WAS THREE FEDERAL AGENCIES 832 00:44:45,840 --> 00:44:47,640 CO-HOSTING A WORKSHOP AND TRYING 833 00:44:47,640 --> 00:44:53,080 TO WORK TOGETHER TO COME UP WITH 834 00:44:53,080 --> 00:44:57,960 WAYS TO ADVANCE THE FIELD. 835 00:44:57,960 --> 00:45:01,320 IN FOLLOW-UP TO THAT THE 836 00:45:01,320 --> 00:45:03,480 AMERICAN ACADEMY OF 837 00:45:03,480 --> 00:45:06,440 OPHTHALMOLOGY PUBLISHED AN 838 00:45:06,440 --> 00:45:11,560 EDITORIAL ENDORSING WHAT WE'RE 839 00:45:11,560 --> 00:45:13,560 TRYING TO DO AND THAT IS IN 840 00:45:13,560 --> 00:45:15,800 PRESS AND CARRY AND HER GROUP 841 00:45:15,800 --> 00:45:19,320 ARE WORKING WITH A PLANNING 842 00:45:19,320 --> 00:45:20,480 COMMITTEE ON WHAT FOLLOW UP 843 00:45:20,480 --> 00:45:21,440 STEPS WILL BE AND WE'RE EXCITED 844 00:45:21,440 --> 00:45:21,840 ABOUT THIS. 845 00:45:21,840 --> 00:45:23,720 THE OTHER THING I WANT TO 846 00:45:23,720 --> 00:45:27,640 HIGHLIGHT FROM THIS SLIDE IS UP 847 00:45:27,640 --> 00:45:29,880 AT THE TOP, CARRIE AND HER GROUP 848 00:45:29,880 --> 00:45:37,760 HIRED A DATA SCHOLAR AND NIH 849 00:45:37,760 --> 00:45:40,560 DATA AND TECHNICAL SCHOLAR AND 850 00:45:40,560 --> 00:45:43,200 WE'RE EXCITED ABOUT THIS. 851 00:45:43,200 --> 00:45:46,600 MICHELLE AND CARRIE ARE HERE IN 852 00:45:46,600 --> 00:45:47,600 D.C. TOGETHER AT A CONFERENCE 853 00:45:47,600 --> 00:45:47,800 TODAY. 854 00:45:47,800 --> 00:45:50,520 WHAT MICHELLE IS WORKING ON 855 00:45:50,520 --> 00:45:52,280 SPECIFICALLY IS THE BOTTOM LINE 856 00:45:52,280 --> 00:45:55,480 OF THE SLIDE WHICH IS DEVELOPING 857 00:45:55,480 --> 00:45:59,880 A COMMON DATA MODEL FOR EYE CARE 858 00:45:59,880 --> 00:46:01,600 AND FOR VISUAL RESEARCH. 859 00:46:01,600 --> 00:46:06,560 HOW CAN WE DEVELOP A MODEL THAT 860 00:46:06,560 --> 00:46:08,120 WILL HAVE EVERYBODY IN THE 861 00:46:08,120 --> 00:46:09,400 COUNTRY SPEAK THE SAME LANGUAGE 862 00:46:09,400 --> 00:46:10,960 WHEN IT COMES TO REPRESENTING 863 00:46:10,960 --> 00:46:11,600 DATA. 864 00:46:11,600 --> 00:46:14,640 IT'S A HUGE ADVANCE AND IT'S A 865 00:46:14,640 --> 00:46:15,480 COMPLICATED PROJECT. 866 00:46:15,480 --> 00:46:17,200 MICHELLE, CARRIE WITH THE 867 00:46:17,200 --> 00:46:19,880 PLANNING GROUP FROM THE AMERICAN 868 00:46:19,880 --> 00:46:22,520 ACADEMY OF OPHTHALMOLOGY WITH A 869 00:46:22,520 --> 00:46:23,720 GROUP CALLED ODYSSEY ARE WORKING 870 00:46:23,720 --> 00:46:29,160 ON THIS. 871 00:46:29,160 --> 00:46:29,800 THAT'S GOING TO BE BIG FOR THE 872 00:46:29,800 --> 00:46:36,520 COMMUNITY. 873 00:46:36,520 --> 00:46:39,440 AT THE LAST COUNCIL MEETING WE 874 00:46:39,440 --> 00:46:45,240 TALKED ABOUT DATA SHARING AND 875 00:46:45,240 --> 00:46:47,560 MIKE LAUER WAS TALKING ABOUT THE 876 00:46:47,560 --> 00:46:47,880 POLICY. 877 00:46:47,880 --> 00:46:50,120 SINCE THAT TIME THE WHITE HOUSE 878 00:46:50,120 --> 00:46:51,120 OFFICE OF SCIENCE TECHNOLOGY 879 00:46:51,120 --> 00:46:53,640 POLICY HAS PUBLISHED A PUBLIC 880 00:46:53,640 --> 00:46:56,280 ACCESS MEMO ABOUT ACCESS TO 881 00:46:56,280 --> 00:47:03,200 FEDERALLY FUNDED RESEARCH. 882 00:47:03,200 --> 00:47:05,720 I WANT TO HERE SUMMARIZE SOME OF 883 00:47:05,720 --> 00:47:06,080 THAT. 884 00:47:06,080 --> 00:47:09,640 IN 2013 THERE WAS A PUBLIC 885 00:47:09,640 --> 00:47:12,720 ACCESS MEMO AND IN 2022 THE 886 00:47:12,720 --> 00:47:18,040 CURRENT OSTP MEMO APPLIES TO ALL 887 00:47:18,040 --> 00:47:19,560 FEDERAL AGENCIES NOT JUST THE 888 00:47:19,560 --> 00:47:21,440 BIG ONES IN 2013. 889 00:47:21,440 --> 00:47:25,600 IN 2013 THERE WAS A 12-MONTH 890 00:47:25,600 --> 00:47:28,480 PUBLICATION EMBARGO BEFORE YOUR 891 00:47:28,480 --> 00:47:31,920 RESEARCH PAPERS BECAME PUBLICLY 892 00:47:31,920 --> 00:47:35,000 AS ACCESSIBLE AND IN 2022 THEY 893 00:47:35,000 --> 00:47:35,680 HAVE TO BE MADE AVAILABLE 894 00:47:35,680 --> 00:47:37,800 WITHOUT AN EMBARGO PERIOD. 895 00:47:37,800 --> 00:47:40,480 THIS GOES INTO EFFECT IN A FEW 896 00:47:40,480 --> 00:47:41,640 YEARS AND SCIENTIFIC DATA HAS TO 897 00:47:41,640 --> 00:47:46,880 BE ACCESSIBLE AT THE TIME OF 898 00:47:46,880 --> 00:47:47,160 PUBLICATION. 899 00:47:47,160 --> 00:47:48,320 THIS IS A BIG CHANGE. 900 00:47:48,320 --> 00:47:52,600 RIGHT NOW NIH IS WORKING THROUGH 901 00:47:52,600 --> 00:47:53,960 WITH THE WHITE HOUSE TO MAKE 902 00:47:53,960 --> 00:47:55,800 SURE OUR POLICIES ARE 903 00:47:55,800 --> 00:47:56,080 CONSISTENT. 904 00:47:56,080 --> 00:47:57,400 SO THERE'S GOING TO BE MORE 905 00:47:57,400 --> 00:47:58,040 WE'LL ANNOUNCE ABOUT THIS COMING 906 00:47:58,040 --> 00:48:03,280 UP. 907 00:48:03,280 --> 00:48:05,120 ONE OF THE THINGS YOU KNOW ABOUT 908 00:48:05,120 --> 00:48:07,200 IS BRIDGE TO A.I. 909 00:48:07,200 --> 00:48:12,560 THIS IS AN NIH COMMON FUND 910 00:48:12,560 --> 00:48:13,520 PROJECT INVOLVING A.I. IN 911 00:48:13,520 --> 00:48:14,120 BIOMARKER RESEARCH. 912 00:48:14,120 --> 00:48:17,640 THE GOAL AND THIS IS A DIFFERENT 913 00:48:17,640 --> 00:48:19,960 PARADIGM IT'S DATA GENERATION. 914 00:48:19,960 --> 00:48:22,800 $130 MILLION FOR HYPOTHESIS 915 00:48:22,800 --> 00:48:25,600 GENERATING WORK NOT FOR 916 00:48:25,600 --> 00:48:26,880 HYPOTHESIS DRIVEN WORK. 917 00:48:26,880 --> 00:48:30,640 BIG PARADIGM CHANGE. 918 00:48:30,640 --> 00:48:36,720 IT'S BASICALLY GENERATING 919 00:48:36,720 --> 00:48:38,040 DIVERSE DATA SETS ACROSS 920 00:48:38,040 --> 00:48:39,560 DISCIPLINES AND ONE IS 921 00:48:39,560 --> 00:48:41,080 INTEGRATING EDGE NICKS COMPONENT 922 00:48:41,080 --> 00:48:44,240 TO REDUCE BIAS IN GENERATING THE 923 00:48:44,240 --> 00:48:45,480 DATA SETS AND THE A.I. THAT 924 00:48:45,480 --> 00:48:47,120 COMES OUT OF IT. 925 00:48:47,120 --> 00:48:49,920 HERE'S THE BRIDGE TO A.I. LOGO 926 00:48:49,920 --> 00:48:55,440 AND THE BOTTOM IS THE PROGRAM 927 00:48:55,440 --> 00:48:55,960 OFFICER. 928 00:48:55,960 --> 00:48:57,640 WE'RE ONE OF FIVE INSTITUTES 929 00:48:57,640 --> 00:48:58,240 THAT LEAD THE BRIDGE TO A.I. 930 00:48:58,240 --> 00:49:03,560 PROJECT. 931 00:49:03,560 --> 00:49:06,320 ABOUT A MONTH AGO THERE WERE 932 00:49:06,320 --> 00:49:09,760 FOUR AWARDS MADE AND THE BRIDGE 933 00:49:09,760 --> 00:49:11,720 FUNDED TO INTEGRATE ALL THE 934 00:49:11,720 --> 00:49:19,480 PROJECTS. 935 00:49:19,480 --> 00:49:23,280 ONE OF THE PROJECTS WAS GIVEN TO 936 00:49:23,280 --> 00:49:27,080 UNIVERSITY OF SOUTH FLORIDA FOR 937 00:49:27,080 --> 00:49:30,440 THE DATA SET OF VOICE AND HOW DO 938 00:49:30,440 --> 00:49:31,240 YOU DIAGNOSE DISEASE WITH 939 00:49:31,240 --> 00:49:33,640 PEOPLE'S VOICES AND HOW DOES 940 00:49:33,640 --> 00:49:35,560 THAT CONNECT WITH MENTAL HEALTH 941 00:49:35,560 --> 00:49:38,320 CONDITIONS AND AWARD TWO OF FOUR 942 00:49:38,320 --> 00:49:40,480 WAS TO U.C. SAN DIEGO FOR 943 00:49:40,480 --> 00:49:43,520 BASICALLY GENERATE DATA SET OF 944 00:49:43,520 --> 00:49:44,680 CELL ARCHITECTURE COMBINED 945 00:49:44,680 --> 00:49:46,480 PROTEOMIC AND GENOMIC AND 946 00:49:46,480 --> 00:49:47,640 CELLULAR IMAGING DATA TO LOOK AT 947 00:49:47,640 --> 00:49:51,480 GENE PATHWAYS AND NETWORKS THAT 948 00:49:51,480 --> 00:49:52,680 RELATE TO DISEASE. 949 00:49:52,680 --> 00:49:55,480 AWARD NUMBER THREE WENT TO 950 00:49:55,480 --> 00:49:56,320 MASSACHUSETTS GENERAL HOSPITAL 951 00:49:56,320 --> 00:49:59,200 AND THAT WAS BASICALLY BUILDING 952 00:49:59,200 --> 00:50:04,720 A DATA SET OF PACING DATA FROM 953 00:50:04,720 --> 00:50:08,320 ADULT AND PEDIATRIC ICUs TO 954 00:50:08,320 --> 00:50:09,600 DEVELOP A.I. TECHNOLOGY TO HELP 955 00:50:09,600 --> 00:50:12,040 PEOPLE RECOVER FROM ACUTE 956 00:50:12,040 --> 00:50:12,280 ILLNESS. 957 00:50:12,280 --> 00:50:14,320 AND AWARD NUMBER 4 WAS TO 958 00:50:14,320 --> 00:50:16,600 UNIVERSITY OF WASHINGTON. 959 00:50:16,600 --> 00:50:20,640 THIS WAS LED BY TWO 960 00:50:20,640 --> 00:50:21,040 OPHTHALMOLOGISTS. 961 00:50:21,040 --> 00:50:23,280 ON THE RIGHT IS AND OBVIOUSLY 962 00:50:23,280 --> 00:50:26,680 THIS IS SOMETHING WE WERE 963 00:50:26,680 --> 00:50:27,240 EXCITED ABOUT. 964 00:50:27,240 --> 00:50:29,720 THE TOPIC HERE IS DIABETES. 965 00:50:29,720 --> 00:50:31,720 AND THEY'RE BASICALLY RECRUITING 966 00:50:31,720 --> 00:50:35,240 DATA FROM 4,000 PEOPLE WITH 967 00:50:35,240 --> 00:50:36,920 VARIOUS LEVELS OF TYPE 2 968 00:50:36,920 --> 00:50:37,200 DIABETES. 969 00:50:37,200 --> 00:50:39,360 THIS HAS ALL THE CLINICAL AND 970 00:50:39,360 --> 00:50:41,040 IMAGE DATA YOU'D EXPECT PERFECT 971 00:50:41,040 --> 00:50:44,280 BUILDING A DIABETES DATA SET AND 972 00:50:44,280 --> 00:50:45,600 ALSO INCLUDES THINGS LIKE 973 00:50:45,600 --> 00:50:48,480 CONTINUOUS GLUCOSE MONITORING, 974 00:50:48,480 --> 00:50:50,680 FIT BIT TRACKING AND 975 00:50:50,680 --> 00:50:51,920 ENVIRONMENTAL SENSORS LOOKING AT 976 00:50:51,920 --> 00:50:53,360 THINGS LIKE POLLUTANTS. 977 00:50:53,360 --> 00:50:58,080 THESE ARE NOT THINGS AVAILABLE 978 00:50:58,080 --> 00:50:59,720 IN TRADITIONAL DATA SETS AND 979 00:50:59,720 --> 00:51:02,800 WE'RE EXCITED HOW WE MAY GET A 980 00:51:02,800 --> 00:51:05,640 MORE WHOLISTIC OF PICTURE OF 981 00:51:05,640 --> 00:51:07,360 PEOPLE WHEN THEY'RE NOT IN THE 982 00:51:07,360 --> 00:51:08,760 HOSPITAL LET ALONE WHEN THEY 983 00:51:08,760 --> 00:51:09,440 HAVE DIABETES. 984 00:51:09,440 --> 00:51:14,480 EXCITED ABOUT THIS WHAT I CALL 985 00:51:14,480 --> 00:51:17,640 A.I. FRIENDLY HYPOTHESIS 986 00:51:17,640 --> 00:51:20,040 AGNOSTIC DATA SET INVOLVING 987 00:51:20,040 --> 00:51:25,520 DIABETES AND LED BY TWO 988 00:51:25,520 --> 00:51:25,960 OPHTHALMOLOGISTS. 989 00:51:25,960 --> 00:51:31,840 LAST SLIDE, EYE ON THE FUTURE. 990 00:51:31,840 --> 00:51:34,200 THEY SPENT SIX MONTHS PLANNING 991 00:51:34,200 --> 00:51:34,640 THIS EVENT. 992 00:51:34,640 --> 00:51:37,400 IT WAS A VIDEO CONTEST FOR HIGH 993 00:51:37,400 --> 00:51:39,400 SCHOOL STUDENTS TO MAKE VIDEOS 994 00:51:39,400 --> 00:51:40,320 WHAT THEY'RE INTEREST ABOUT IN 995 00:51:40,320 --> 00:51:43,160 SCIENCE AND WE'RE TRYING TO GET 996 00:51:43,160 --> 00:51:44,920 YOUNG KIDS ESPECIALLY FROM UNDER 997 00:51:44,920 --> 00:51:51,800 REPRESENTED GROUPS INTERESTED IN 998 00:51:51,800 --> 00:51:52,000 SCIENCE. 999 00:51:52,000 --> 00:51:55,200 WE HAD 10 TEENAGERS VISIT THE 1000 00:51:55,200 --> 00:52:01,320 NIH AND MARIE BERNARD IS CHIEF 1001 00:52:01,320 --> 00:52:02,440 OFFICER FOR SCIENTIFIC WORKFORCE 1002 00:52:02,440 --> 00:52:05,640 AT NIH AND HAD TWO VISITING 1003 00:52:05,640 --> 00:52:11,600 FACULTY MATTERS WHO SPOKE ONE 1004 00:52:11,600 --> 00:52:15,720 FROM YALE AND ONE FROM THE 1005 00:52:15,720 --> 00:52:17,280 UNIVERSITY OF MICHIGAN AND WHAT 1006 00:52:17,280 --> 00:52:19,320 I WAS EXCITED ABOUT PARTICULARLY 1007 00:52:19,320 --> 00:52:21,040 HAVING TWO DAUGHTERS, EVERY ONE 1008 00:52:21,040 --> 00:52:24,000 WE HAD VISIT WAS FEMALE. 1009 00:52:24,000 --> 00:52:25,080 SO WE'RE EXCITED. 1010 00:52:25,080 --> 00:52:29,080 THEY DID A GOOD JOB OF 1011 00:52:29,080 --> 00:52:30,240 ORGANIZING THIS AND EXCITED 1012 00:52:30,240 --> 00:52:35,520 ABOUT DOING IT AGAIN NEXT YEAR. 1013 00:52:35,520 --> 00:52:36,640 WITH THAT -- 1014 00:52:36,640 --> 00:52:38,480 >>CAN I INTERRUPT YOU FOR ONE 1015 00:52:38,480 --> 00:52:38,920 SECOND. 1016 00:52:38,920 --> 00:52:44,840 SORRY, I HATE TO DO THIS. 1017 00:52:44,840 --> 00:52:49,640 CAN WE SAVE THE BUDGET UPDATE 1018 00:52:49,640 --> 00:52:56,000 FOR AFTER THE SPEAKER SESSION. 1019 00:52:56,000 --> 00:52:58,760 IF IT'S OKAY WITH KAREN, WE HAVE 1020 00:52:58,760 --> 00:52:59,760 MORE FLEXIBILITY LATER IN THE 1021 00:52:59,760 --> 00:53:07,200 MORNING. 1022 00:53:07,200 --> 00:53:09,080 >>YES, ABSOLUTELY. 1023 00:53:09,080 --> 00:53:11,200 >>AND WE HAVE TIME LATER FOR A 1024 00:53:11,200 --> 00:53:14,200 GENERAL DISCUSSION. 1025 00:53:14,200 --> 00:53:18,440 WE CAN PROBABLY TAKE ONE OR TWO 1026 00:53:18,440 --> 00:53:19,440 QUESTIONS NOW AND THEN I'LL TURN 1027 00:53:19,440 --> 00:53:21,800 IT BACK TO DR. CHIANG TO 1028 00:53:21,800 --> 00:53:32,200 INTRODUCE OUR SPEAKERS. 1029 00:53:35,080 --> 00:53:37,000 >>HOW DO WE LEARN ABOUT THE EYE 1030 00:53:37,000 --> 00:53:40,480 ON THE FUTURE THE ONE FOR NEXT 1031 00:53:40,480 --> 00:53:41,160 YEAR IF WE HAVE INTERESTED HIGH 1032 00:53:41,160 --> 00:53:46,280 SCHOOL STUDENTS THAT MAY BE 1033 00:53:46,280 --> 00:53:52,320 WORKING IN OUR LAB? 1034 00:53:52,320 --> 00:53:54,160 >>WE'LL DO OUR BEST TO PUSH IT 1035 00:53:54,160 --> 00:53:54,400 OUT. 1036 00:53:54,400 --> 00:53:56,840 WIN THING WE TRIED TO DO IS USE 1037 00:53:56,840 --> 00:54:07,240 SOCIAL MEDIA TO DO THAT. 1038 00:54:08,240 --> 00:54:10,400 MAYBE WE CAN BLAST OUT TO 1039 00:54:10,400 --> 00:54:11,800 COUNCIL MEMBERS BUT LOVE IF YOU 1040 00:54:11,800 --> 00:54:13,640 CAN HELP PUBLICIZE THAT BECAUSE 1041 00:54:13,640 --> 00:54:14,840 IT WAS MEANT TO BE A NATIONAL 1042 00:54:14,840 --> 00:54:15,880 CONTEST AND HAD PEOPLE FROM A 1043 00:54:15,880 --> 00:54:24,080 TON OF STATES APPLY. 1044 00:54:24,080 --> 00:54:25,640 THANK YOU AND I APPRECIATE YOUR 1045 00:54:25,640 --> 00:54:27,120 HELP IN PUBLICIZING THIS. 1046 00:54:27,120 --> 00:54:28,360 OTHER COMMENTS OR QUESTIONS 1047 00:54:28,360 --> 00:54:38,880 PEOPLE HAVE ABOUT ANY OF THIS? 1048 00:54:53,520 --> 00:54:57,640 CATHY, WOULD YOU LIKE TO START 1049 00:54:57,640 --> 00:55:00,080 WITH RINAD AND JENNY SPEAKING? 1050 00:55:00,080 --> 00:55:07,200 >>I WOULD LOVE THAT. 1051 00:55:07,200 --> 00:55:09,600 >>THIS MEANS I'LL RESHARE MY 1052 00:55:09,600 --> 00:55:19,760 SCREEN. 1053 00:55:21,640 --> 00:55:24,080 LET ME INTRODUCE -- YOU'RE GOING 1054 00:55:24,080 --> 00:55:25,080 TO GO FIRST. 1055 00:55:25,080 --> 00:55:27,480 LET ME INTRODUCE YOU RIGHT NOW 1056 00:55:27,480 --> 00:55:33,520 AND I'LL INTRODUCE JENNY BEFORE 1057 00:55:33,520 --> 00:55:35,520 SHE SPEAKS. 1058 00:55:35,520 --> 00:55:39,880 THE TOPIC IS PROMOTING 1059 00:55:39,880 --> 00:55:40,640 DISSEMINATION OF CLINIC RESEARCH 1060 00:55:40,640 --> 00:55:43,080 AND THE ORIGIN AND THIS IS AN 1061 00:55:43,080 --> 00:55:44,600 AGE OLD CHALLENGE WE HAVE. 1062 00:55:44,600 --> 00:55:47,480 AT THE LAST COUNCIL MEMBER WE 1063 00:55:47,480 --> 00:55:48,200 HAD A COUPLE PEOPLE COUNCIL 1064 00:55:48,200 --> 00:55:49,880 MEMBERS RAISE THE QUESTION OF 1065 00:55:49,880 --> 00:55:53,400 WHAT IS THE BEST WAY TO -- WHY 1066 00:55:53,400 --> 00:55:56,240 DO WE HAVE THIS GAP UP TERMS OF 1067 00:55:56,240 --> 00:55:57,440 CLINICIANS NOT BEING ABLE OR 1068 00:55:57,440 --> 00:55:59,760 KNOWING ABOUT THE SOME OF THE 1069 00:55:59,760 --> 00:56:02,720 FINDINGS THAT COME OUT. 1070 00:56:02,720 --> 00:56:04,600 SO WE TALKED ABOUT THIS AT 1071 00:56:04,600 --> 00:56:08,120 LENGTH AND WE HAD SOME MEETINGS 1072 00:56:08,120 --> 00:56:09,960 WITHIN NEI ABOUT THIS. 1073 00:56:09,960 --> 00:56:13,680 WE LIKE TO CREATE A COUNCIL WORK 1074 00:56:13,680 --> 00:56:15,360 GROUP ON THIS BUT THOUGHT THE 1075 00:56:15,360 --> 00:56:17,560 BEST WAY TO KICK THIS OFF WOULD 1076 00:56:17,560 --> 00:56:19,440 BE TO HAVE A SPECIAL SESSION ON 1077 00:56:19,440 --> 00:56:20,200 THE TOPIC. 1078 00:56:20,200 --> 00:56:22,560 AND ONE OF THE THINGS I WAS 1079 00:56:22,560 --> 00:56:25,000 EXCITED ABOUT WAS LEARNING ABOUT 1080 00:56:25,000 --> 00:56:25,960 WORK THAT RINAD HAD DONE IN THIS 1081 00:56:25,960 --> 00:56:36,080 AREA. 1082 00:56:39,320 --> 00:56:42,600 WE HAD A CHAIR AT NORTHWESTERN 1083 00:56:42,600 --> 00:56:45,000 UNIVERSITY JUST MOVE THERE FROM 1084 00:56:45,000 --> 00:56:45,960 THE UNIVERSITY OF PENNSYLVANIA 1085 00:56:45,960 --> 00:56:48,400 WHERE SHE WAS FOUNDING DIRECTOR 1086 00:56:48,400 --> 00:56:51,360 OF THE IMPLEMENTATION SCIENCE 1087 00:56:51,360 --> 00:56:53,360 CENTER AT THE LEONARD DAVIS 1088 00:56:53,360 --> 00:56:54,800 INSTITUTE AND DOES SOME 1089 00:56:54,800 --> 00:56:57,640 INTERESTING RESEARCH INVOLVING 1090 00:56:57,640 --> 00:56:59,080 IMPLEMENTATION SCIENCE AND 1091 00:56:59,080 --> 00:57:03,800 BEHAVIORAL ECONOMICS TO 1092 00:57:03,800 --> 00:57:05,280 BASICALLY TRY TO GET 1093 00:57:05,280 --> 00:57:08,160 ORGANIZATIONS TO USE BEST 1094 00:57:08,160 --> 00:57:09,280 PRACTICES TO USE EQUITY OF CARE 1095 00:57:09,280 --> 00:57:19,600 AND HEALTH OUTCOMES. 1096 00:57:23,520 --> 00:57:25,120 >>CAN YOU ALL HEAR ME ALL 1097 00:57:25,120 --> 00:57:25,320 RIGHT? 1098 00:57:25,320 --> 00:57:29,600 I CALLED IN TO MAKE SURE THERE 1099 00:57:29,600 --> 00:57:35,800 WAS NO PROBLEM. 1100 00:57:35,800 --> 00:57:40,760 ARE YOU SEEING THE PRESENTER 1101 00:57:40,760 --> 00:57:41,640 VIEW? 1102 00:57:41,640 --> 00:57:49,520 >>THIS IS THE CORRECT VIEW. 1103 00:57:49,520 --> 00:57:52,360 AND AM I ON DELAY OR DOES 1104 00:57:52,360 --> 00:57:53,160 EVERYTHING SEEM GOOD? 1105 00:57:53,160 --> 00:57:59,080 >>WE'RE GOOD. 1106 00:57:59,080 --> 00:58:01,600 I'M GOING TO GO AHEAD AND JUMP 1107 00:58:01,600 --> 00:58:02,960 IN. 1108 00:58:02,960 --> 00:58:09,240 IF ANYTHING IS AWRY FEEL FREE TO 1109 00:58:09,240 --> 00:58:10,680 SIGNAL VISUALLY SINCE I'LL HAVE 1110 00:58:10,680 --> 00:58:11,240 THIS BELOW TO SEE WHAT IS 1111 00:58:11,240 --> 00:58:15,000 HAPPENING. 1112 00:58:15,000 --> 00:58:18,200 I WANT TO START BY THANKING THE 1113 00:58:18,200 --> 00:58:19,040 NATIONAL EYE INSTITUTE AND MIKE 1114 00:58:19,040 --> 00:58:20,880 FOR THE INVITATION TO COME SPEAK 1115 00:58:20,880 --> 00:58:21,080 TODAY. 1116 00:58:21,080 --> 00:58:23,760 I'M EXCITED TO BE PRESENTING 1117 00:58:23,760 --> 00:58:25,360 ALONG SIDE JOANIE AND I ALSO 1118 00:58:25,360 --> 00:58:28,400 WANT TO THANK MY PARTNER AND 1119 00:58:28,400 --> 00:58:29,800 COLLEAGUE FROM PENN MEDICINE 1120 00:58:29,800 --> 00:58:34,080 DR. LANGFALL WHO WE 1121 00:58:34,080 --> 00:58:34,720 COLLABORATIVELY DEVELOPED THE 1122 00:58:34,720 --> 00:58:35,520 SLIDES IN VARIOUS PRESENTATIONS. 1123 00:58:35,520 --> 00:58:41,640 I WANT TO ACKNOWLEDGE HER 1124 00:58:41,640 --> 00:58:43,680 INTELLECTUAL CONTRIBUTIONS HERE. 1125 00:58:43,680 --> 00:58:45,480 ALSO THE IMPLEMENTATION SCIENCE 1126 00:58:45,480 --> 00:58:47,320 AND PRACTICE COMMUNITY AND ALL 1127 00:58:47,320 --> 00:58:50,480 FOR YOUR ATTENTION AND 1128 00:58:50,480 --> 00:58:50,760 ENGAGEMENT. 1129 00:58:50,760 --> 00:58:52,720 I KNOW IT'S DIFFICULT TO ATTEND 1130 00:58:52,720 --> 00:58:53,680 VIRTUALLY FOR LONG PERIODS SO 1131 00:58:53,680 --> 00:58:56,480 I'LL TRY TO BE ANIMATED AND 1132 00:58:56,480 --> 00:58:58,000 ENTHUSIASTIC AND TRY TO KEEP 1133 00:58:58,000 --> 00:58:59,080 YOUR ATTENTION DURING THE TIME 1134 00:58:59,080 --> 00:58:59,560 WE HAVE TOGETHER. 1135 00:58:59,560 --> 00:59:01,280 TO ORIENT YOU TO WHAT I HOPE 1136 00:59:01,280 --> 00:59:05,520 WE'LL HAVE TIME TO TALK ABOUT 1137 00:59:05,520 --> 00:59:07,400 TODAY I CAN THINK OF THE 1138 00:59:07,400 --> 00:59:08,480 STRUCTURE IN FOUR CHAPTERS. 1139 00:59:08,480 --> 00:59:10,800 I'LL START BY TALKING ABOUT ME 1140 00:59:10,800 --> 00:59:12,240 AS AN INVESTIGATOR AND HUMAN AND 1141 00:59:12,240 --> 00:59:17,640 WHY I THINK THIS IS A REALLY 1142 00:59:17,640 --> 00:59:20,480 IMPORTANT AREA TO ATTEND TO AND 1143 00:59:20,480 --> 00:59:23,760 I'M GLAD TOE HEAR COUNCIL 1144 00:59:23,760 --> 00:59:25,640 MEMBERS SUGGESTED THE EYE 1145 00:59:25,640 --> 00:59:27,120 INSTITUTE PAY ATTENTION TO THIS 1146 00:59:27,120 --> 00:59:29,640 SCIENCE AND LEVEL SETTING OFFER 1147 00:59:29,640 --> 00:59:33,240 WHAT IMPLEMENTATION SCIENCE IS 1148 00:59:33,240 --> 00:59:34,360 AND SHARE INFORMATION WITH YOU 1149 00:59:34,360 --> 00:59:37,000 AS YOU MOVE FORWARD AND THINK OF 1150 00:59:37,000 --> 00:59:40,880 HOW TO INCORPORATE IMPLEM 1151 00:59:40,880 --> 00:59:41,600 IMPLEMENTATION SCIENCE IN YOUR 1152 00:59:41,600 --> 00:59:43,480 PORTFOLIO AND SHARE APPLICATIONS 1153 00:59:43,480 --> 00:59:45,640 IN THIS SPACE IN YOUR CONTENT 1154 00:59:45,640 --> 00:59:47,240 AREA. 1155 00:59:47,240 --> 00:59:49,640 FIRST, I WANT TO TELL YOU A 1156 00:59:49,640 --> 00:59:54,480 LITTLE BIT ABOUT ME. 1157 00:59:54,480 --> 00:59:58,640 MY IDENTITY SHAPED MY 1158 00:59:58,640 --> 01:00:03,160 PERSPECTIVE AND IT'S IMPORTANT 1159 01:00:03,160 --> 01:00:05,280 IT KNOW WHO I AM AND WHAT 1160 01:00:05,280 --> 01:00:06,640 IDENTITIES I BRING. 1161 01:00:06,640 --> 01:00:11,800 I IDENTIFY AS AN IMPLEMENTATION 1162 01:00:11,800 --> 01:00:15,800 SCIENCE -- SCIENTIST I WORK TO 1163 01:00:15,800 --> 01:00:17,760 MAKE IT EASIER FOR STAFF, 1164 01:00:17,760 --> 01:00:20,080 CLINICIANS, LEADERS AND 1165 01:00:20,080 --> 01:00:21,040 ORGANIZATIONS TO USE BEST 1166 01:00:21,040 --> 01:00:23,760 PRACTICES WITH THE END GOAL OF 1167 01:00:23,760 --> 01:00:27,880 IMPROVING THE QUALITY AND EQUITY 1168 01:00:27,880 --> 01:00:32,160 OF HEALTH OUTCOMES AND I'M A 1169 01:00:32,160 --> 01:00:33,640 MIDDLE EASTERN IMMIGRANT AND 1170 01:00:33,640 --> 01:00:36,840 MOTHER AND UP TO RECENTLY A 1171 01:00:36,840 --> 01:00:38,400 PRACTICING PSYCHOLOGIST IN 1172 01:00:38,400 --> 01:00:39,120 PEDIATRIC ANXIETY. 1173 01:00:39,120 --> 01:00:44,000 ALL THESE INFLUENCED MY 1174 01:00:44,000 --> 01:00:45,400 PERSPECTIVE AND I SEE 1175 01:00:45,400 --> 01:00:46,760 IMPLEMENTATION SCIENCE AS THE 1176 01:00:46,760 --> 01:00:50,160 WAY TO AMPLIFY THE NEEDS FOR 1177 01:00:50,160 --> 01:00:52,560 COMMUNITIES IN ACHIEVING POM 1178 01:00:52,560 --> 01:00:53,920 POPULATION HEALTH AND SOCIAL 1179 01:00:53,920 --> 01:00:54,840 JUSTICE AT SCALE. 1180 01:00:54,840 --> 01:00:56,160 I ALSO WANT TO IS A WHAT I'M 1181 01:00:56,160 --> 01:00:57,480 NOT. 1182 01:00:57,480 --> 01:01:00,800 I HAVE NO CONTENT EXPERTISE IN 1183 01:01:00,800 --> 01:01:04,040 VISION RESEARCH BUT I WANT TO 1184 01:01:04,040 --> 01:01:04,840 SAY EVERYTHING I TALK ABOUT WILL 1185 01:01:04,840 --> 01:01:06,440 BE APPLICABLE TO THE RESEARCH 1186 01:01:06,440 --> 01:01:08,680 AND I OFTEN GIVE PRESENTATIONS 1187 01:01:08,680 --> 01:01:13,360 IN MEETINGS WHERE I DON'T HAVE 1188 01:01:13,360 --> 01:01:17,600 CONTENT EXPERTISE BUT THE SAME 1189 01:01:17,600 --> 01:01:21,600 CHALLENGES ACROSS HEALTH CARE 1190 01:01:21,600 --> 01:01:23,760 ARE APPARENT IN AREAS AND 1191 01:01:23,760 --> 01:01:25,000 DRIVING IMPLEMENTATION ACROSS 1192 01:01:25,000 --> 01:01:25,240 CONTENT. 1193 01:01:25,240 --> 01:01:31,320 I DO THIS IN MENTAL HEALTH, 1194 01:01:31,320 --> 01:01:32,720 CANCER, HIV, CARDIOVASCULAR 1195 01:01:32,720 --> 01:01:34,880 DISEASE AND PEDIATRIC HOSPITAL 1196 01:01:34,880 --> 01:01:35,360 MEDICINE. 1197 01:01:35,360 --> 01:01:45,760 I'M CONTENT AGNOSTIC. 1198 01:01:48,960 --> 01:01:50,600 THE REASON I'M HERE IS BECAUSE I 1199 01:01:50,600 --> 01:01:53,640 SAW A PATTERN WHEN I WAS 1200 01:01:53,640 --> 01:01:54,280 PRACTICING CLINICALLY I COULDN'T 1201 01:01:54,280 --> 01:02:02,960 IGNORE. 1202 01:02:02,960 --> 01:02:08,080 WE'LL SHARE THE STORY OF A 1203 01:02:08,080 --> 01:02:09,640 60-YEAR-OLD FEMALE WHO SAW ME 1204 01:02:09,640 --> 01:02:11,760 WITH SEVERE ANXIETY WHO WASN'T 1205 01:02:11,760 --> 01:02:13,960 ABLE TO GO TO SCHOOL OR DO THE 1206 01:02:13,960 --> 01:02:15,480 THINGS A 16-YEAR-OLD WOULD LIKE 1207 01:02:15,480 --> 01:02:17,080 TO DO. 1208 01:02:17,080 --> 01:02:19,280 AN IMPORTANT PART OF THE STORY 1209 01:02:19,280 --> 01:02:22,800 IS JEN HAD SEEN A NUMBER OF 1210 01:02:22,800 --> 01:02:27,280 PROVIDERS AND HADN'T GOTTEN THE 1211 01:02:27,280 --> 01:02:28,960 GOLD STANDARD COGNITIVE 1212 01:02:28,960 --> 01:02:31,120 BEHAVIORAL THERAPY FOR THIS AND 1213 01:02:31,120 --> 01:02:35,760 BY THE TIME SHE GOT TO ME SHE 1214 01:02:35,760 --> 01:02:45,360 WAS FAIRLY UP SET AND YOU SAW 1215 01:02:45,360 --> 01:02:48,880 WHAT SHE WAS ABLE TO DO 1216 01:02:48,880 --> 01:02:50,160 INCLUDING RETURNING TO SCHOOL 1217 01:02:50,160 --> 01:02:52,360 AND SINGING IN THE CHOIR, GOING 1218 01:02:52,360 --> 01:02:55,080 TO THE DENTIST. 1219 01:02:55,080 --> 01:02:58,960 I CAME TO THE CONCLUSION THAT 1220 01:02:58,960 --> 01:02:59,800 YOUNG PEOPLE WEREN'T RECEIVING 1221 01:02:59,800 --> 01:03:01,600 EVIDENCE-BASED PRACTICES IN THE 1222 01:03:01,600 --> 01:03:05,160 COMMUNITY AND IT WENT FROM 1223 01:03:05,160 --> 01:03:06,440 FOCUSSING ON DEVELOPING NEW 1224 01:03:06,440 --> 01:03:11,520 TREATMENTS TO THINKING HOW TO 1225 01:03:11,520 --> 01:03:13,320 DEPLOY THE AFFECTIVE TREATMENTS 1226 01:03:13,320 --> 01:03:13,840 WE HAVE. 1227 01:03:13,840 --> 01:03:16,680 MY OBSERVATION AS A PSYCHOLOGIST 1228 01:03:16,680 --> 01:03:19,600 IS NOT IDIOSYNCRATIC. 1229 01:03:19,600 --> 01:03:24,800 IT'S A BROADER FIELD AND ISSUE 1230 01:03:24,800 --> 01:03:25,200 WE'RE AWARE OF. 1231 01:03:25,200 --> 01:03:29,400 THE PROBLEM HAS NEVER BEEN MORE 1232 01:03:29,400 --> 01:03:31,080 CLEAR WHEN WE LOOK AT THE 1233 01:03:31,080 --> 01:03:31,840 EXAMPLE OF COVID-19. 1234 01:03:31,840 --> 01:03:34,080 THERE'S A SCREEN SHOT OF A PAPER 1235 01:03:34,080 --> 01:03:38,600 THAT WAS A HEALTH AFFAIRS BEST 1236 01:03:38,600 --> 01:03:41,120 PAPER IN 2020 AND SIMULATION 1237 01:03:41,120 --> 01:03:47,680 STUDY LOOKING AT THE OUTCOMES OF 1238 01:03:47,680 --> 01:03:49,480 HYPOTHETICAL COVID-19 VACCINE 1239 01:03:49,480 --> 01:03:51,880 AND THE IMPLEMENTATION WOULD BE 1240 01:03:51,880 --> 01:03:54,080 MORE IMPORTANT THAT BE THE 1241 01:03:54,080 --> 01:03:57,560 EFFICACY OF THE VACCINE ON THE 1242 01:03:57,560 --> 01:03:59,560 IMPACT ON CLINIC OUTCOMES AND 1243 01:03:59,560 --> 01:04:01,480 PLAYED OUT IN MITIGATION 1244 01:04:01,480 --> 01:04:05,200 STRATEGIES AND IN ANTIVIRALS. 1245 01:04:05,200 --> 01:04:10,720 THIS PAPER CAME OUT IN 2021 AND 1246 01:04:10,720 --> 01:04:13,200 LED BY MY COLLEAGUES AT WASH-U 1247 01:04:13,200 --> 01:04:15,280 AND CALLED OUT COVID-19 AND 1248 01:04:15,280 --> 01:04:17,640 KNOWING WHAT TO DO DIDN'T ENSURE 1249 01:04:17,640 --> 01:04:22,320 DOING WHAT WE KNOW. 1250 01:04:22,320 --> 01:04:24,640 THAT'S THE CRUX OF WHY 1251 01:04:24,640 --> 01:04:29,760 IMPLEMENTATION SCIENCE MATTERS. 1252 01:04:29,760 --> 01:04:30,880 SO MY VISION STATEMENT AND 1253 01:04:30,880 --> 01:04:35,760 BELIEF AND THE REASON I GET UP 1254 01:04:35,760 --> 01:04:41,600 IS IT CAN ACHIEVE THE PROMISE OF 1255 01:04:41,600 --> 01:04:42,680 SCIENTIFIC DISCOVERY AND ACHIEVE 1256 01:04:42,680 --> 01:04:44,640 IMPACT AT SCALE. 1257 01:04:44,640 --> 01:04:48,720 WHAT I HOPE IS THAT YOU LISTEN 1258 01:04:48,720 --> 01:04:52,600 CLOSELY AND THINK ABOUT HOW THIS 1259 01:04:52,600 --> 01:04:53,640 DISCIPLINE MIGHT ADVANCE THE 1260 01:04:53,640 --> 01:04:55,400 NATIONAL EYE INSTITUTE AND 1261 01:04:55,400 --> 01:04:58,840 IMPROVE QUALITY OF LIFE THROUGH 1262 01:04:58,840 --> 01:05:01,360 VISION RESEARCH. 1263 01:05:01,360 --> 01:05:03,360 THINK YOU'LL BE ABLE TO LEARN 1264 01:05:03,360 --> 01:05:04,560 ACROSS THE AREAS I'LL BE TALKING 1265 01:05:04,560 --> 01:05:06,640 AND HOPE YOU KEEP THAT IN MIND 1266 01:05:06,640 --> 01:05:08,760 AND FRONT AND CENTER AND I ALSO 1267 01:05:08,760 --> 01:05:12,480 WANT TO CALL OUT IN THE 1268 01:05:12,480 --> 01:05:13,600 PORTFOLIO ANALYSIS DONE THERE'S 1269 01:05:13,600 --> 01:05:16,480 A PAPER BY THE NATIONAL CANCER 1270 01:05:16,480 --> 01:05:17,600 INSTITUTE LOOKING AT HOW MUCH OF 1271 01:05:17,600 --> 01:05:21,240 THE PORTFOLIO IS DEDICATED TO 1272 01:05:21,240 --> 01:05:23,040 DISCOVERY VERSUS IMPLEMENTATION 1273 01:05:23,040 --> 01:05:23,280 RESEARCH. 1274 01:05:23,280 --> 01:05:27,000 AND NCI HAS BEEN PUSHING THE 1275 01:05:27,000 --> 01:05:28,360 ENVELOPE ON DOING THIS KIND OF 1276 01:05:28,360 --> 01:05:29,760 WORK AND THEY'VE BEEN A REAL 1277 01:05:29,760 --> 01:05:31,120 LEADER WITHIN THE NATIONAL 1278 01:05:31,120 --> 01:05:34,360 INSTITUTE OF HEALTH WITH LDI AND 1279 01:05:34,360 --> 01:05:34,920 NIMH. 1280 01:05:34,920 --> 01:05:37,640 IT'S SUCH A MINUSCULE AMOUNT OF 1281 01:05:37,640 --> 01:05:39,960 THE BUDGET GOES TOWARDS ACTUALLY 1282 01:05:39,960 --> 01:05:41,320 IMPLEMENTING OUR DISCOVERY. 1283 01:05:41,320 --> 01:05:46,960 IT'S AMAZING THERE'S SOO -- SO 1284 01:05:46,960 --> 01:05:48,600 MANY DISCOVERIES TO HELP PEOPLE 1285 01:05:48,600 --> 01:05:51,000 BUT WE HAVE TO PAY ATTENTION OF 1286 01:05:51,000 --> 01:05:55,080 AND HAVE TO DO THE WORK WITH THE 1287 01:05:55,080 --> 01:05:57,720 RIGOR AS DISCOVERY RESEARCH. 1288 01:05:57,720 --> 01:05:59,600 NOW I'LL TALK ABOUT 1289 01:05:59,600 --> 01:06:00,360 IMPLEMENTATION SCIENCE IS 1290 01:06:00,360 --> 01:06:00,680 BROADLY. 1291 01:06:00,680 --> 01:06:05,640 ON THIS SLIDE YOU CAN SEE MY 1292 01:06:05,640 --> 01:06:08,920 PERSONAL DEFINITION WHEN I TALK 1293 01:06:08,920 --> 01:06:10,360 ABOUT WHAT DO I IS FUNDAMENTALLY 1294 01:06:10,360 --> 01:06:12,160 MAKING SURE THAT ALL PEOPLE GET 1295 01:06:12,160 --> 01:06:13,640 THE THINGS THAT WORK IN THE 1296 01:06:13,640 --> 01:06:15,960 COMMUNITY OR WHATEVER SETTING IN 1297 01:06:15,960 --> 01:06:18,480 WHICH THEY'RE ARRIVING TOWARDS 1298 01:06:18,480 --> 01:06:20,480 RECEIVING CARE AND MOVING THE 1299 01:06:20,480 --> 01:06:21,600 NEEDLE EQUITABLY IN HEALTH. 1300 01:06:21,600 --> 01:06:25,640 IT'S ABOUT MOVING THE NEEDLE. 1301 01:06:25,640 --> 01:06:30,280 THE NCI DEFINITION AS YOU THINK 1302 01:06:30,280 --> 01:06:32,480 ABOUT WA I'M SHARING WITH YOU 1303 01:06:32,480 --> 01:06:35,000 ALL, THE NCI DEFINITION IS 1304 01:06:35,000 --> 01:06:36,240 IMPLEMENTATION SCIENCE IS THE 1305 01:06:36,240 --> 01:06:38,920 STUDY OF METHOD TO PROMOTE THE 1306 01:06:38,920 --> 01:06:41,640 ADOPTION AND INTEGRATION OF 1307 01:06:41,640 --> 01:06:45,160 EVIDENCE-BASED PRACTICES, 1308 01:06:45,160 --> 01:06:45,840 INTERVENTIONS INTO ROUTINE 1309 01:06:45,840 --> 01:06:47,240 HEALTH CARE AND SETTINGS WITH 1310 01:06:47,240 --> 01:06:48,280 THE END GOAL OF IMPROVING 1311 01:06:48,280 --> 01:06:49,240 POPULATION HEALTH. 1312 01:06:49,240 --> 01:06:50,960 YOU CAN SEE HERE THERE'S 1313 01:06:50,960 --> 01:06:53,600 MULTIPLE TYPES OF THINGS WE MAY 1314 01:06:53,600 --> 01:06:56,280 WANT TO BE DEPLOYING INCLUDING 1315 01:06:56,280 --> 01:07:03,400 PROCEDURES, PROGRAMS, PRODUCTS. 1316 01:07:03,400 --> 01:07:05,320 IT'S NOT SO SIMPLE THERE'S JUST 1317 01:07:05,320 --> 01:07:07,200 ONE THING WE WANT TO IMPLEMENT. 1318 01:07:07,200 --> 01:07:14,520 THERE'S A FLEET OF APPROACHES 1319 01:07:14,520 --> 01:07:16,520 AND MY UNDERSTANDING IS THAT 1320 01:07:16,520 --> 01:07:18,760 IT'S HELPFUL TO OUTLINE THE 1321 01:07:18,760 --> 01:07:19,760 ASSUMPTIONS OF THE FIELD FOR 1322 01:07:19,760 --> 01:07:23,280 FOLKS WHO MAY NOT BE AS FAMILIAR 1323 01:07:23,280 --> 01:07:27,040 WITH IT AND IT'S HELPFUL AS A 1324 01:07:27,040 --> 01:07:30,360 FIELD TO LEVEL SET AT AS THE 1325 01:07:30,360 --> 01:07:31,040 FIELD GROWS. 1326 01:07:31,040 --> 01:07:32,440 THE WORK MUST BE DONE IN 1327 01:07:32,440 --> 01:07:33,440 PARTNERSHIP WITH THE COMMUNITY. 1328 01:07:33,440 --> 01:07:36,080 THE WORK MUST BE DONE IN 1329 01:07:36,080 --> 01:07:37,480 PARTNERSHIP WITH OUR 1330 01:07:37,480 --> 01:07:37,800 COMMUNITIES. 1331 01:07:37,800 --> 01:07:44,480 THIS IS MESSY WORK AND IT'S IN 1332 01:07:44,480 --> 01:07:47,040 THE REAL WORLD AND WHEN I TALK 1333 01:07:47,040 --> 01:07:49,280 ABOUT THE OPPORTUNITIES WITHIN 1334 01:07:49,280 --> 01:07:50,760 THE NATIONAL EYE INSTITUTE AND 1335 01:07:50,760 --> 01:07:51,480 ASKING STAKEHOLDERS OR PARTNERS 1336 01:07:51,480 --> 01:07:54,160 WHAT THEY WANT TO SEE IN 1337 01:07:54,160 --> 01:07:54,560 REGISTRY. 1338 01:07:54,560 --> 01:07:56,920 AND A GREAT EXAMPLE OF 1339 01:07:56,920 --> 01:07:59,400 PARTNERING TO UNDERSTAND HOW OUR 1340 01:07:59,400 --> 01:08:01,600 SCIENCE CAN BE ACTIONABLE AND 1341 01:08:01,600 --> 01:08:01,880 USEFUL. 1342 01:08:01,880 --> 01:08:05,640 THAT'S AN IMPORTANT THING TO 1343 01:08:05,640 --> 01:08:11,600 KEEP IN MIND. 1344 01:08:11,600 --> 01:08:17,720 OUTCOMES MAY BE MORE FAMILIAR 1345 01:08:17,720 --> 01:08:20,920 AND WE LOOK AT BEHAVIOR WITHIN 1346 01:08:20,920 --> 01:08:21,640 ORGANIZATIONAL CONSTRAINTS. 1347 01:08:21,640 --> 01:08:23,760 AND WHEN WE THINK ABOUT WHAT WE 1348 01:08:23,760 --> 01:08:25,560 TARGET WITH OUR STRATEGIES AND 1349 01:08:25,560 --> 01:08:27,680 APPROACHES IT'S TYPICALLY 1350 01:08:27,680 --> 01:08:29,560 FOCUSSED ON CHANGING CLINICIANS' 1351 01:08:29,560 --> 01:08:31,000 BROADLY SPEAKING BEHALF WITHIN 1352 01:08:31,000 --> 01:08:32,200 THE CONSTRAINTS OF THE 1353 01:08:32,200 --> 01:08:37,240 ORGANIZATIONS THEY WORK WITHIN. 1354 01:08:37,240 --> 01:08:42,920 THIRD, WHEN WE DO MULTI-SITE 1355 01:08:42,920 --> 01:08:44,880 STUDIES WE TRY TO REDUCE THE 1356 01:08:44,880 --> 01:08:47,080 NOISE AND ISOLATE THE EFFECT OF 1357 01:08:47,080 --> 01:08:48,480 A PARTICULAR INTERVENTION OR 1358 01:08:48,480 --> 01:08:48,840 PROCEDURE. 1359 01:08:48,840 --> 01:08:50,200 WE WANT TO UNDERSTAND THAT 1360 01:08:50,200 --> 01:08:53,200 CONTEXT AND HOW IT RELATES TO 1361 01:08:53,200 --> 01:08:55,120 IMPLEMENTATION SUCCESS AND 1362 01:08:55,120 --> 01:08:55,320 FAILURE. 1363 01:08:55,320 --> 01:08:59,480 THAT'S A BED ROCK OF THE WORK WE 1364 01:08:59,480 --> 01:09:07,400 DO FOURTH, WE'D LIKE TO SEE AN 1365 01:09:07,400 --> 01:09:09,000 EVIDENCE-BASED END AND THERE'S 1366 01:09:09,000 --> 01:09:10,840 ROOM AND I RECOMMEND WE 1367 01:09:10,840 --> 01:09:13,360 INCORPORATE THESE PRINCIPLES 1368 01:09:13,360 --> 01:09:18,200 SOONER THAN WHEN WE GET TO THE 1369 01:09:18,200 --> 01:09:19,280 POINT OF HAVING AN 1370 01:09:19,280 --> 01:09:21,160 EVIDENCE-BASED THING BUT WHEN 1371 01:09:21,160 --> 01:09:22,480 WE'RE SPENDING A LOT OF MONEY TO 1372 01:09:22,480 --> 01:09:25,440 DEPLOY THINGS WE WANT THEM TO BE 1373 01:09:25,440 --> 01:09:26,320 EVIDENCE BASED. 1374 01:09:26,320 --> 01:09:28,920 FINALLY, WE HAVE A ROBUST AND 1375 01:09:28,920 --> 01:09:30,160 SPECIFIC SET OF FRAME WORKS, 1376 01:09:30,160 --> 01:09:31,880 METHODS AND STRATEGIES. 1377 01:09:31,880 --> 01:09:33,920 I ENCOURAGE YOU ALL TO DRAW FROM 1378 01:09:33,920 --> 01:09:38,960 THE EXISTING INFRASTRUCTURE WE 1379 01:09:38,960 --> 01:09:45,800 HAVE AS A FIELD. 1380 01:09:45,800 --> 01:09:48,600 I KEY RE-INVENTIONING OF THE 1381 01:09:48,600 --> 01:09:52,960 WHEEL AND THERE'S THINGS WE CAN 1382 01:09:52,960 --> 01:09:54,200 DRAW UPON. 1383 01:09:54,200 --> 01:09:56,920 TO SAY SIMPLY, I LEARNED FROM MY 1384 01:09:56,920 --> 01:09:59,440 COLLEAGUE WHO PUBLISHED THIS 1385 01:09:59,440 --> 01:10:01,320 PIECE IN IMPLEMENTATION SCIENCE 1386 01:10:01,320 --> 01:10:04,480 COMMUNICATION, THINK ABOUT THE 1387 01:10:04,480 --> 01:10:06,800 THING WHICH IS, WHEN I SAY 1388 01:10:06,800 --> 01:10:07,800 THING, THE INTERVENTION, 1389 01:10:07,800 --> 01:10:08,840 PROCEDURE, APPROACH WE'RE TRYING 1390 01:10:08,840 --> 01:10:14,960 TO DEPLOY IN A NEW SETTING. 1391 01:10:14,960 --> 01:10:18,160 AND THE IMPLEMENTATION IS ON HOW 1392 01:10:18,160 --> 01:10:21,640 TO HELP PEOPLE AND PLACES DO THE 1393 01:10:21,640 --> 01:10:25,760 THINGS. 1394 01:10:25,760 --> 01:10:28,280 I FOUND OUT HELPFUL TO LOOK AT 1395 01:10:28,280 --> 01:10:30,520 THE STRATEGIES AND WHAT WE USE 1396 01:10:30,520 --> 01:10:32,800 TO DEPLOY AND WE SAY 1397 01:10:32,800 --> 01:10:33,640 IMPLEMENTATION STRATEGIES TO 1398 01:10:33,640 --> 01:10:35,000 REALLY CARVE OUT WHAT WE'RE 1399 01:10:35,000 --> 01:10:37,960 TRYING TO DO HERE SCIENTIFICALLY 1400 01:10:37,960 --> 01:10:39,480 AND I'LL GIVE LOTS MORE EXAMPLES 1401 01:10:39,480 --> 01:10:41,560 THROUGH THE COURSE OF THE TALK 1402 01:10:41,560 --> 01:10:42,040 ABOUT WHAT I MEAN FWHA. 1403 01:10:42,040 --> 01:10:42,160 -- 1404 01:10:43,760 --> 01:10:46,520 WHAT I MEAN BY THAT. 1405 01:10:46,520 --> 01:10:50,920 FINALLY, BEFORE I GET IN THE 1406 01:10:50,920 --> 01:10:52,640 SPECIFIC TOOLS I'D LIKE TO SHARE 1407 01:10:52,640 --> 01:10:58,280 THE TOOL I DEVELOPED WITH MY 1408 01:10:58,280 --> 01:10:59,680 COLLEAGUES AFTER TEACHING 1409 01:10:59,680 --> 01:11:00,880 IMPLEMENTATION SCIENCE FOR YEARS 1410 01:11:00,880 --> 01:11:02,520 AND IT'S IMPERFECT BUT HELPS 1411 01:11:02,520 --> 01:11:04,920 PEOPLE THINK WHERE THEIR WORK 1412 01:11:04,920 --> 01:11:09,160 FITS ON THE IMPLEMENTATION 1413 01:11:09,160 --> 01:11:10,480 SCIENCE AND I'LL WALK YOU 1414 01:11:10,480 --> 01:11:11,120 THROUGH EACH STEP TO UNDERSTAND 1415 01:11:11,120 --> 01:11:12,800 THE SUBWAY. 1416 01:11:12,800 --> 01:11:15,360 THE FIRST PLACE WE OFTEN JOIN 1417 01:11:15,360 --> 01:11:21,120 THE SUBWAY IS IDENTIFYING A 1418 01:11:21,120 --> 01:11:24,200 PRACTICE THE FIRST QUESTION YOU 1419 01:11:24,200 --> 01:11:28,480 MAY ASK YOURSELF IS HAS THAT 1420 01:11:28,480 --> 01:11:29,560 THING SHOWN EFFICACY? 1421 01:11:29,560 --> 01:11:32,120 NOT EVERYTHING IS GOING TO BE 1422 01:11:32,120 --> 01:11:34,480 TESTED IN AN EFFICACY 1423 01:11:34,480 --> 01:11:35,120 TIGHTLY-CONTROLLED LABORATORY 1424 01:11:35,120 --> 01:11:37,000 SETTING BUT MANY THINGS ARE. 1425 01:11:37,000 --> 01:11:41,000 THAT'S WHEN WE'RE REALLY 1426 01:11:41,000 --> 01:11:44,680 EVALUATING INTERNAL VALIDITY 1427 01:11:44,680 --> 01:11:45,280 VERSUS EXTERNAL AND THERE'S 1428 01:11:45,280 --> 01:11:46,560 EXCLUSION CRITERIA AND IF THE 1429 01:11:46,560 --> 01:11:49,640 ANSWER IS NO, THAT THING HAS NOT 1430 01:11:49,640 --> 01:11:53,280 HAD EFFICACY AND TYPICALLY 1431 01:11:53,280 --> 01:11:55,200 EFFICACY RESEARCH AND TESTING IN 1432 01:11:55,200 --> 01:12:01,040 IN A TIGHTLY CONTROLLED SETTING 1433 01:12:01,040 --> 01:12:02,840 TO UNDERSTAND AND YOU CAN DESIGN 1434 01:12:02,840 --> 01:12:04,880 FOR IMPLEMENTATION HERE AND ONE 1435 01:12:04,880 --> 01:12:10,080 KEY TO LEARNING OVER THE PAST 20 1436 01:12:10,080 --> 01:12:15,280 YEARS IS THAT WE WERE 1437 01:12:15,280 --> 01:12:15,880 INCORPORATED STAKEHOLDER 1438 01:12:15,880 --> 01:12:17,400 PARTNERS IN THE PROCESS OF WHAT 1439 01:12:17,400 --> 01:12:19,440 WE'RE DESIGNING TO UNDERSTAND 1440 01:12:19,440 --> 01:12:21,000 IT'S ACCEPTABLE, APPROPRIATE, 1441 01:12:21,000 --> 01:12:23,720 PALATABLE AND CAN BE DEPLOYED IN 1442 01:12:23,720 --> 01:12:26,400 A REAL WORLD CLINICAL SETTING. 1443 01:12:26,400 --> 01:12:28,640 THAT NOT ITSELF IS THE SUBWAY 1444 01:12:28,640 --> 01:12:28,840 LINE. 1445 01:12:28,840 --> 01:12:31,520 IT'S A PARTICULAR TYPE OF WORK 1446 01:12:31,520 --> 01:12:32,520 AROUND INTERVENTION OR THING 1447 01:12:32,520 --> 01:12:33,640 DEVELOPMENT THAT CAN INCORPORATE 1448 01:12:33,640 --> 01:12:40,080 THAT LENS. 1449 01:12:40,080 --> 01:12:43,480 IF THE ANSWER IS YES AND THE 1450 01:12:43,480 --> 01:12:45,520 NEXT SET OF QUESTIONS IS WHETHER 1451 01:12:45,520 --> 01:12:49,120 OR NOT THAT THING HAS SHOWN 1452 01:12:49,120 --> 01:12:49,480 EFFECTIVENESS. 1453 01:12:49,480 --> 01:12:54,960 HAS IT BEEN DELIVERED IN A REAL 1454 01:12:54,960 --> 01:12:57,040 WORLD SETTING AND HAVE WE LOOKED 1455 01:12:57,040 --> 01:13:03,960 AT IMPACTING EXTERNAL OUTCOMES? 1456 01:13:03,960 --> 01:13:05,640 I WOULD ARGUE MUCH OF THE TIME 1457 01:13:05,640 --> 01:13:06,840 IN INTERVENTION DEVELOPMENT WE 1458 01:13:06,840 --> 01:13:08,240 SHOULD BE TESTING INTERVENTIONS 1459 01:13:08,240 --> 01:13:10,760 IN THE SETTINGS IN WHICH THEY 1460 01:13:10,760 --> 01:13:12,360 WERE INTENDED TO BE DEPLOYED. 1461 01:13:12,360 --> 01:13:14,400 THAT'S THE TRUE TEST OF THE 1462 01:13:14,400 --> 01:13:14,680 THING. 1463 01:13:14,680 --> 01:13:17,640 THAT'S THE CONVERSATION WE CAN 1464 01:13:17,640 --> 01:13:22,560 HAVE ANOTHER TIME. 1465 01:13:22,560 --> 01:13:26,120 AND IF YOUR TESTING IT IT'S NOT 1466 01:13:26,120 --> 01:13:28,280 IMPLEMENTATION RESEARCH IF 1467 01:13:28,280 --> 01:13:29,360 YOU'RE ONLY FOCUSSED ON THE 1468 01:13:29,360 --> 01:13:30,960 VISION CLINICAL OUTCOME. 1469 01:13:30,960 --> 01:13:35,200 THAT'S A COMMON SET POINT. 1470 01:13:35,200 --> 01:13:37,480 HOWEVER, IF YOU START TO BRING 1471 01:13:37,480 --> 01:13:38,360 THEM ALONGSIDE PATIENT OUTCOMES 1472 01:13:38,360 --> 01:13:42,960 INCLUDING HOW WELL THE THING WAS 1473 01:13:42,960 --> 01:13:48,920 DEPLOYED OR FACIL ITATORS THAT S 1474 01:13:48,920 --> 01:13:51,040 WHAT WE CALL HYBRID TRIALS AND 1475 01:13:51,040 --> 01:13:53,240 YOU LOOK AT PATIENT AND CLINICAL 1476 01:13:53,240 --> 01:13:55,320 OUTCOMES SIDE BY SIDE AT THE 1477 01:13:55,320 --> 01:13:55,920 IMPLEMENTATION PROCESSES. 1478 01:13:55,920 --> 01:13:57,160 THAT'S ON THE GREEN LINE OF WHAT 1479 01:13:57,160 --> 01:13:58,760 WE DO IN THE IMPLEMENTATION 1480 01:13:58,760 --> 01:14:00,760 SCIENCE PHASE. 1481 01:14:00,760 --> 01:14:03,240 FINALLY, YOU'LL SEE THE BOTTOM 1482 01:14:03,240 --> 01:14:05,240 OF THE GREEN LINE THE BREAD AND 1483 01:14:05,240 --> 01:14:06,680 BUTTER OF THE WORK WE'LL DO AND 1484 01:14:06,680 --> 01:14:08,040 OFFER TWO EXAMPLES THAT WILL 1485 01:14:08,040 --> 01:14:10,320 BRING THIS TO LIGHT FOR YOU AND 1486 01:14:10,320 --> 01:14:11,640 THAT INCLUDES MIXED METHODS 1487 01:14:11,640 --> 01:14:12,760 STUDIES TO UNDERSTAND THE 1488 01:14:12,760 --> 01:14:15,280 CONTEXT IN WHICH WE'RE HOPING TO 1489 01:14:15,280 --> 01:14:16,720 DEPLOY AND DESIGNING THE 1490 01:14:16,720 --> 01:14:18,480 STRATEGIES THAT WE WANT TO 1491 01:14:18,480 --> 01:14:20,680 DEPLOY BASED ON WHAT WE 1492 01:14:20,680 --> 01:14:21,640 UNDERSTAND TO BE THE BARRIERS 1493 01:14:21,640 --> 01:14:23,760 AND FACILITATORS AND 1494 01:14:23,760 --> 01:14:25,640 IMPLEMENTATION AND TESTING 1495 01:14:25,640 --> 01:14:26,560 IMPLEMENTATION ATTORNEY GENERALS 1496 01:14:26,560 --> 01:14:28,520 IN LARGE COMPARATIVE 1497 01:14:28,520 --> 01:14:29,640 EFFECTIVENESS STUDIES OF OUR 1498 01:14:29,640 --> 01:14:33,480 IMPLEMENTATION STRATEGIES. 1499 01:14:33,480 --> 01:14:36,720 WE'RE UP A LEVEL WE'RE LESS 1500 01:14:36,720 --> 01:14:37,640 INTERESTED IN ASKING DOES IT 1501 01:14:37,640 --> 01:14:39,160 WORK FOR A PATIENT POPULATION 1502 01:14:39,160 --> 01:14:40,400 AND MORE INTERESTED IN DOING 1503 01:14:40,400 --> 01:14:45,520 WHAT WE DO TO HELP PEOPLE DO THE 1504 01:14:45,520 --> 01:14:47,160 THINGS RESULTING IN BETTER 1505 01:14:47,160 --> 01:14:49,520 IMPLEMENTATION AND UPTAKE AND 1506 01:14:49,520 --> 01:14:51,760 LOOK AT BETTER OUTCOMES 1507 01:14:51,760 --> 01:14:52,480 ALONGSIDE THAT. 1508 01:14:52,480 --> 01:14:53,840 HOPEFULLY THAT HELPS YOU 1509 01:14:53,840 --> 01:14:56,080 UNDERSTAND WHERE IN THE RESEARCH 1510 01:14:56,080 --> 01:15:01,280 PARADIGM IMPLEMENTATION SCIENCE 1511 01:15:01,280 --> 01:15:01,520 FOCUSES. 1512 01:15:01,520 --> 01:15:03,800 NOW I'LL GO DEEPER IN THE FIELD 1513 01:15:03,800 --> 01:15:05,640 WITH OUR NEXT CHAPTER WHICH IS 1514 01:15:05,640 --> 01:15:09,160 TO FOCUS ON FOUNDATIONAL 1515 01:15:09,160 --> 01:15:09,680 CONCEPTS I THINK WILL BE 1516 01:15:09,680 --> 01:15:13,080 VALUABLE FOR YOU ALL TO HAVE AND 1517 01:15:13,080 --> 01:15:16,160 A VISION FOR WHAT IMPLEMENTATION 1518 01:15:16,160 --> 01:15:17,640 RESEARCH CAN LOOK LIKE AT THE 1519 01:15:17,640 --> 01:15:21,760 NATIONAL EYE INSTITUTE. 1520 01:15:21,760 --> 01:15:23,920 I WANT TO DRAW YOUR ATTENTION TO 1521 01:15:23,920 --> 01:15:29,280 A PAPER WRITTEN BY COLLEAGUES 1522 01:15:29,280 --> 01:15:31,000 THAT OUTLINES 10 CRUCIAL 1523 01:15:31,000 --> 01:15:32,600 INGREDIENTS OF GRANT ROW 1524 01:15:32,600 --> 01:15:32,880 PROPOSALS. 1525 01:15:32,880 --> 01:15:36,240 THEY EXTRACTED WHAT THEY THOUGHT 1526 01:15:36,240 --> 01:15:40,840 WOULD BE KEY IN PROVIDING THING 1527 01:15:40,840 --> 01:15:45,600 ASSISTANCE AND I WANT TO ARGUE 1528 01:15:45,600 --> 01:15:48,360 THESE ARE 10 CRUCIAL INGREDIENTS 1529 01:15:48,360 --> 01:15:54,440 AND HOW WE CONDUCT OUR WORK. 1530 01:15:54,440 --> 01:15:58,360 BECAUSE WE HAVE LIMITED TIME I 1531 01:15:58,360 --> 01:16:00,000 CAN'T FOCUS ON ALL 10 BUT THE 1532 01:16:00,000 --> 01:16:01,600 PAPER IS AN EXCELLENT READ. 1533 01:16:01,600 --> 01:16:03,800 I'LL FOCUS ON THE THREE I THINK 1534 01:16:03,800 --> 01:16:06,240 ARE MOST SALIENT FOR YOU ALL 1535 01:16:06,240 --> 01:16:07,600 INCLUDING THE CONCEPTUAL MODELS 1536 01:16:07,600 --> 01:16:09,640 WE USE TO GUIDE OUR WORK, 1537 01:16:09,640 --> 01:16:13,840 IMPLEMENTATION STRATEGIES WHICH 1538 01:16:13,840 --> 01:16:15,560 ARE OUR INTERVENTIONS HOW WE 1539 01:16:15,560 --> 01:16:19,000 LOOK AT BEHAVIOR WITHIN AGE 1540 01:16:19,000 --> 01:16:21,360 ORGANIZATIONAL CONSTRAINT AND 1541 01:16:21,360 --> 01:16:23,800 THOUGHTFUL APPROACHES IN 1542 01:16:23,800 --> 01:16:29,480 ANALYSIS IN OUR STUDY DESIGN. 1543 01:16:29,480 --> 01:16:31,960 I'LL TALK WITH ABOUT THE 1544 01:16:31,960 --> 01:16:33,160 THEORIES IN THE FIELD OF 1545 01:16:33,160 --> 01:16:36,760 IMPLEMENTATION SCIENCE. 1546 01:16:36,760 --> 01:16:42,720 I'D LIKE TO OFFER STORAGE BOX 1547 01:16:42,720 --> 01:16:48,640 CREDITED FOR SAYING ALL MODELS 1548 01:16:48,640 --> 01:16:50,760 ARE WRONG BUT USEFUL IN HELPING 1549 01:16:50,760 --> 01:16:52,080 GUIDE OUR THINKING. 1550 01:16:52,080 --> 01:16:53,520 IF YOU KNOW THE EXACT QUOTE POP 1551 01:16:53,520 --> 01:16:55,400 IT IN THE CHAT AND I'LL SAY IT 1552 01:16:55,400 --> 01:16:55,640 CORRECTLY. 1553 01:16:55,640 --> 01:16:59,840 I LIKE TO APPROACH MY THINKING 1554 01:16:59,840 --> 01:17:02,200 AROUND FRAMEWORK WITH HUMILITY 1555 01:17:02,200 --> 01:17:04,640 AND I'M NOT BEING DOGMATIC ABOUT 1556 01:17:04,640 --> 01:17:06,280 IT BUT USING IT TO GUIDE OUR 1557 01:17:06,280 --> 01:17:11,320 THINKING BUT UNDERSTANDING 1558 01:17:11,320 --> 01:17:14,720 THEY'RE ALL WRONG AND IT'S 1559 01:17:14,720 --> 01:17:17,240 USEFUL FRAMEWORK AND IF YOU GO 1560 01:17:17,240 --> 01:17:17,840 TO THE LITERATURE, THESE ARE 1561 01:17:17,840 --> 01:17:22,640 HELPFUL ONES. 1562 01:17:22,640 --> 01:17:27,280 THE FIRST WAS FOCUSSED ON RING 1563 01:17:27,280 --> 01:17:29,360 THE EXISTING FRAMEWORKS AND 1564 01:17:29,360 --> 01:17:30,680 MODELS IN THE FIELD. 1565 01:17:30,680 --> 01:17:35,480 WE HAD OVER 151 AND CAN FEEL 1566 01:17:35,480 --> 01:17:37,240 OVERWHELMING AND TO HOW WE THINK 1567 01:17:37,240 --> 01:17:39,880 BIT TO HOW WE MAKE IT LESS 1568 01:17:39,880 --> 01:17:41,840 OVERWHELMING AND THAT COMES IN 1569 01:17:41,840 --> 01:17:44,000 THE FORM OF THE NELSON PAPER 1570 01:17:44,000 --> 01:17:47,680 WHICH WAS PUBLISHED IN 1571 01:17:47,680 --> 01:17:49,640 IMPLEMENTATION SCIENCE IN 2015 1572 01:17:49,640 --> 01:17:52,160 CALLED MAKING SENSE OF 1573 01:17:52,160 --> 01:17:53,360 IMPLEMENTATION SCIENCE MODELS 1574 01:17:53,360 --> 01:17:53,760 AND FRAMEWORK. 1575 01:17:53,760 --> 01:17:56,480 IN THE NEXT SLIDE YOU'LL SEE A 1576 01:17:56,480 --> 01:17:58,320 CORE FIGURE FROM THAT PAPER AND 1577 01:17:58,320 --> 01:18:02,480 I'LL WALK YOU THROUGH IT. 1578 01:18:02,480 --> 01:18:05,800 AND SO NELSON MAKES THE ARGUMENT 1579 01:18:05,800 --> 01:18:07,840 IN THE 151 PLUS THEORIES AND 1580 01:18:07,840 --> 01:18:10,320 MODELS IN THE FIELD, THEY 1581 01:18:10,320 --> 01:18:11,760 ROUGHLY BREAK DOWN INTO THREE 1582 01:18:11,760 --> 01:18:12,560 LARGE BUCKETS. 1583 01:18:12,560 --> 01:18:14,720 ONES THAT ARE LARGELY 1584 01:18:14,720 --> 01:18:15,880 PRESCRIPTIVE OR GUIDE THE 1585 01:18:15,880 --> 01:18:17,560 PROCESS OF TRANSLATING RESEARCH 1586 01:18:17,560 --> 01:18:19,360 INTO PRACTICE AND ONES THAT ARE 1587 01:18:19,360 --> 01:18:21,960 FOCUSSED ON DESCRIBING OR 1588 01:18:21,960 --> 01:18:25,440 UNDERSTANDING WHAT INFLUENCES 1589 01:18:25,440 --> 01:18:27,160 IMPLEMENTATION OUTCOMES AND THE 1590 01:18:27,160 --> 01:18:28,640 THIRD BUCKET IS ONES FOCUSSED ON 1591 01:18:28,640 --> 01:18:31,560 HOW WE EVALUATE OUR 1592 01:18:31,560 --> 01:18:32,520 IMPLEMENTATION OUTCOMES EFFORTS. 1593 01:18:32,520 --> 01:18:35,000 AND SO JUST TO GIVE YOU A FLAVOR 1594 01:18:35,000 --> 01:18:37,480 FOR SOME OF THE EXAMPLES FROM 1595 01:18:37,480 --> 01:18:39,880 THESE BUCKETS, OFTEN WE SEE 1596 01:18:39,880 --> 01:18:42,040 PROCESS MODELS MAPPING ON TO THE 1597 01:18:42,040 --> 01:18:44,680 KIND OF DESCRIPTIVE OR PROCESS 1598 01:18:44,680 --> 01:18:46,160 GUIDING APPROACHES AND THOSE 1599 01:18:46,160 --> 01:18:47,840 INCLUDE THINGS LIKE THE 1600 01:18:47,840 --> 01:18:49,360 KNOWLEDGE TO ACTION FRAMEWORK 1601 01:18:49,360 --> 01:18:52,400 OUT OF CANADA OR THE QUALITY 1602 01:18:52,400 --> 01:18:54,000 IMPROVEMENT MODEL FOR 1603 01:18:54,000 --> 01:18:54,320 IMPROVEMENT. 1604 01:18:54,320 --> 01:18:58,200 STEP 1, ENGAGE STAKEHOLDERS. 1605 01:18:58,200 --> 01:19:03,080 STEP 2, IDENTIFY YOUR 1606 01:19:03,080 --> 01:19:03,680 EVIDENCE-BASED PRACTICES AND 1607 01:19:03,680 --> 01:19:06,240 STEP 3 AND IT WALKS YOU THROUGH 1608 01:19:06,240 --> 01:19:07,800 THE PROCESS. 1609 01:19:07,800 --> 01:19:09,720 THANK YOU TO MAUREEN FOR THE BOX 1610 01:19:09,720 --> 01:19:12,160 QUOTE, ALL MODELS ARE WRONG BUT 1611 01:19:12,160 --> 01:19:13,960 SOME ARE USEFUL. 1612 01:19:13,960 --> 01:19:17,640 THAT'S THE FIRST BUCKET IN OUR 1613 01:19:17,640 --> 01:19:19,960 LARGE OF IMPLEMENTATION SCIENCE 1614 01:19:19,960 --> 01:19:20,240 FRAMEWORK. 1615 01:19:20,240 --> 01:19:23,320 THE SECOND BUCKET ARE THE 1616 01:19:23,320 --> 01:19:25,640 UNDERSTANDING OR EXPLANATORY 1617 01:19:25,640 --> 01:19:26,880 TYPE FRAMEWORKS AND THERE'S 1618 01:19:26,880 --> 01:19:28,680 THREE THAT FOLLOW IN THAT 1619 01:19:28,680 --> 01:19:29,200 BUCKET. 1620 01:19:29,200 --> 01:19:31,840 THE FIRST IS PROBABLY THE MOST 1621 01:19:31,840 --> 01:19:33,640 POPULAR OR AMPLIFIED I SEE IN 1622 01:19:33,640 --> 01:19:35,840 ALL GRANT APPLICATIONS IN ALL 1623 01:19:35,840 --> 01:19:40,160 WORK WHICH IS SOMETHING WE CALL 1624 01:19:40,160 --> 01:19:40,640 DETERMINATE FRAMEWORKS. 1625 01:19:40,640 --> 01:19:43,120 THEY'RE LARGELY LISTS MUCH 1626 01:19:43,120 --> 01:19:45,960 VARIABLES AT MULTIPLE ECOLOGICAL 1627 01:19:45,960 --> 01:19:47,640 DOMAINS THAT DESCRIBE CHALLENGES 1628 01:19:47,640 --> 01:19:51,320 AND BARRIERS AND FACILITATORS. 1629 01:19:51,320 --> 01:19:52,920 AT THE PATIENT LEVEL AND 1630 01:19:52,920 --> 01:19:54,160 CLINICIAN LEVEL AND ORGANIZATION 1631 01:19:54,160 --> 01:19:55,680 LEVEL AND SYSTEM LEVEL AND THESE 1632 01:19:55,680 --> 01:20:03,880 INCLUDE FRAMEWORKS SUCH AS 1633 01:20:03,880 --> 01:20:09,640 EXPLORATION, PREPARATION AND 1634 01:20:09,640 --> 01:20:12,440 IMPLEMENTATION RESEARCH AND 1635 01:20:12,440 --> 01:20:15,040 INCLUDING THE HEALTH EQUITY 1636 01:20:15,040 --> 01:20:20,040 FRAMEWORK BUT THAT INCORPORATES 1637 01:20:20,040 --> 01:20:23,160 THE STRUCTURAL AND HEALTH EQUITY 1638 01:20:23,160 --> 01:20:25,160 FACING NATURE. 1639 01:20:25,160 --> 01:20:26,840 WITHIN THE BUCKET OF 1640 01:20:26,840 --> 01:20:28,280 UNDERSTANDING OUR EXPLANATORY 1641 01:20:28,280 --> 01:20:30,600 FRAMEWORK WE HAVE CLASSIC 1642 01:20:30,600 --> 01:20:31,720 THEORIES LIKE THE THEORY OF 1643 01:20:31,720 --> 01:20:34,520 PLANNED BEHAVIOR APPLIED TO 1644 01:20:34,520 --> 01:20:35,240 UNDERSTANDING CLINICIAN BEHAVIOR 1645 01:20:35,240 --> 01:20:37,320 WITHIN ORGANIZATIONAL 1646 01:20:37,320 --> 01:20:39,360 CONSTRAINTS AND WE HAVE SPECIFIC 1647 01:20:39,360 --> 01:20:39,600 BARRIERS. 1648 01:20:39,600 --> 01:20:42,800 SOMETHING CALLED THE 1649 01:20:42,800 --> 01:20:44,360 IMPLEMENTATION CLIMATE WITHIN AN 1650 01:20:44,360 --> 01:20:46,600 ORGANIZATION AN INTERVENTION OR 1651 01:20:46,600 --> 01:20:48,360 INNERVATION IS SUPPORTED AND 1652 01:20:48,360 --> 01:20:52,120 REWARDED AND POSITED TO BE A 1653 01:20:52,120 --> 01:20:54,600 CAUSAL METHOD THROUGH WHICH 1654 01:20:54,600 --> 01:20:57,640 EFFECTIVE IMPLEMENTATION OCCURS 1655 01:20:57,640 --> 01:20:58,960 AND LASTLY THERE'S EVALUATION 1656 01:20:58,960 --> 01:21:01,280 FRAMEWORK AND YOU MAY BE 1657 01:21:01,280 --> 01:21:03,360 FAMILIAR WITH REAIM WHICH IS A 1658 01:21:03,360 --> 01:21:05,480 LEADING FRAMEWORK WE OFTEN SEE 1659 01:21:05,480 --> 01:21:07,000 IN HEALTH SERVICES RESEARCH AND 1660 01:21:07,000 --> 01:21:08,800 THE PROCTOR IMPLEMENTATION 1661 01:21:08,800 --> 01:21:09,360 OUTCOME FRAMEWORK I'LL BE 1662 01:21:09,360 --> 01:21:14,040 SHOWING IN THE NEXT SLIDE. 1663 01:21:14,040 --> 01:21:16,160 HOPEFULLY THIS GIVES YOU TEETH 1664 01:21:16,160 --> 01:21:17,640 TO SINK INTO IN TERMS OF THE 1665 01:21:17,640 --> 01:21:19,720 DIFFERENT TYPES OF FRAMEWORK. 1666 01:21:19,720 --> 01:21:27,840 I USUALLY USE A DETERMINATE AND 1667 01:21:27,840 --> 01:21:29,640 EVALUATIVE FRAMEWORK AND USE 1668 01:21:29,640 --> 01:21:33,640 DIFFERENT ONES BASED ON THE 1669 01:21:33,640 --> 01:21:35,400 RESEARCH AT HAND AND THIS IS THE 1670 01:21:35,400 --> 01:21:38,760 PROCTOR IMPLEMENTATION OUTCOMES 1671 01:21:38,760 --> 01:21:41,840 FRAMEWORK THAT WAS PUBLISHED IN 1672 01:21:41,840 --> 01:21:45,640 2009 AND OFFERED AN INITIAL 1673 01:21:45,640 --> 01:21:48,880 CONCEPTUALIZATION OF HOW OUR 1674 01:21:48,880 --> 01:21:50,760 OUTCOMES ARE DIFFERENT FROM 1675 01:21:50,760 --> 01:21:52,800 TRADITION HEALTH SERVICES 1676 01:21:52,800 --> 01:21:53,040 OUTCOMES. 1677 01:21:53,040 --> 01:21:55,280 I'M GOING TO WOUK YOU THROUGH 1678 01:21:55,280 --> 01:21:56,800 EACH COLUMNS TO HELP YOU 1679 01:21:56,800 --> 01:21:58,400 UNDERSTAND WHAT IT'S SAYING. 1680 01:21:58,400 --> 01:22:01,640 SO THE FIRST COLUMN IS CALLED 1681 01:22:01,640 --> 01:22:03,240 INTERVENTION STRATEGIES. 1682 01:22:03,240 --> 01:22:05,080 THIS IS DISTINGUISHING THE 1683 01:22:05,080 --> 01:22:06,680 DIFFERENCE BETWEEN THE THING OR 1684 01:22:06,680 --> 01:22:07,360 EVIDENCE-BASED PRACTICE AND THE 1685 01:22:07,360 --> 01:22:09,640 SECOND COLUMN WHICH ARE THE 1686 01:22:09,640 --> 01:22:10,280 IMPLEMENTATION STRATEGIES OR THE 1687 01:22:10,280 --> 01:22:11,840 THINGS WE DO TO HELP PEOPLE DO 1688 01:22:11,840 --> 01:22:19,560 THE THING. 1689 01:22:19,560 --> 01:22:21,640 OFTEN PEOPLE THOUGHT OF 1690 01:22:21,640 --> 01:22:22,600 IMPLEMENTATION OF BEING JUST 1691 01:22:22,600 --> 01:22:26,240 ABOUT THE THING THEY WERE 1692 01:22:26,240 --> 01:22:27,360 STUDYING RATHER THAN A SEPARATE 1693 01:22:27,360 --> 01:22:28,560 SET OF STRATEGIES AND TECHNIQUES 1694 01:22:28,560 --> 01:22:33,640 TO HELP PEOPLE DO THE THING FOR 1695 01:22:33,640 --> 01:22:34,280 A PARTICULAR INTERVENTION. 1696 01:22:34,280 --> 01:22:37,040 IN THE THIRD COLUMN YOU'LL SEE 1697 01:22:37,040 --> 01:22:39,160 THERE'S THREE SETS OF OUTCOMES 1698 01:22:39,160 --> 01:22:40,160 DELINEATED WITHIN THE PROCTOR 1699 01:22:40,160 --> 01:22:40,440 FRAMEWORK. 1700 01:22:40,440 --> 01:22:44,880 WE HAVE OUR IMPLEMENTATION 1701 01:22:44,880 --> 01:22:47,840 OUTCOMES WHICH INCLUDE 1702 01:22:47,840 --> 01:22:52,320 PERCEPTUAL OUTCOMES AND HOW 1703 01:22:52,320 --> 01:22:54,120 FEASIBLE, ACCEPTABLE OR 1704 01:22:54,120 --> 01:22:56,080 APPROPRIATE A PARTICULAR THING 1705 01:22:56,080 --> 01:22:57,600 IS AND AS WELL AS OUR MORE 1706 01:22:57,600 --> 01:22:59,040 BEHAVIORAL IMPLEMENTATION 1707 01:22:59,040 --> 01:23:00,360 OUTCOMES WHICH INCLUDES ADOPTION 1708 01:23:00,360 --> 01:23:03,440 OR THE INITIAL DECISION TO ADOPT 1709 01:23:03,440 --> 01:23:07,920 A PARTICULAR PRACTICE AND 1710 01:23:07,920 --> 01:23:11,840 FIDELITY AND HOW CLOSELY 1711 01:23:11,840 --> 01:23:15,480 CLINICIANS IMPLEMENT THAT 1712 01:23:15,480 --> 01:23:19,120 PRACTICE AND PENETRATION AND 1713 01:23:19,120 --> 01:23:20,320 REACH AND COST AND THREES THREE 1714 01:23:20,320 --> 01:23:23,560 NEW OUTCOMES TO CONSIDER IN 1715 01:23:23,560 --> 01:23:25,480 LIGHT OF COVID-19 INCLUDING 1716 01:23:25,480 --> 01:23:26,760 AVAILABILITY, HEALTH EQUITY AND 1717 01:23:26,760 --> 01:23:27,080 SCALE UP. 1718 01:23:27,080 --> 01:23:29,160 THESE ARE TYPICALLY THE FOCUS OF 1719 01:23:29,160 --> 01:23:29,960 OUR TRIALS. 1720 01:23:29,960 --> 01:23:31,960 THESE ARE THE OUTCOMES WE ARE 1721 01:23:31,960 --> 01:23:37,160 MEASURING AND LOOKING AT AS WE 1722 01:23:37,160 --> 01:23:40,320 TEST DIFFERENT STRATEGIES TO 1723 01:23:40,320 --> 01:23:41,480 IMPLEMENT VARIOUS THINGS. 1724 01:23:41,480 --> 01:23:44,040 PROCESS OUTCOMES ARE DELINEATED 1725 01:23:44,040 --> 01:23:45,800 IN THE SECOND COLUMN AND INCLUDE 1726 01:23:45,800 --> 01:23:48,840 EFFICIENCY, SAFETY, 1727 01:23:48,840 --> 01:23:51,920 EFFECTIVENESS, EQUITY, PATIENT 1728 01:23:51,920 --> 01:23:54,120 CENTEREDNESS AND TIMELINESS AND 1729 01:23:54,120 --> 01:23:57,240 I THINK THE DISTINCTION BETWEEN 1730 01:23:57,240 --> 01:23:58,640 PROCESS AND IMPLEMENTATION 1731 01:23:58,640 --> 01:24:05,560 OUTCOMES IS FUZZY AND FINAL TLI 1732 01:24:05,560 --> 01:24:07,160 THE DISTINCTION, THE HEALTH 1733 01:24:07,160 --> 01:24:13,400 OUTCOMES AND CLINICAL 1734 01:24:13,400 --> 01:24:15,680 EFFECTIVENESS AND THOSE ARE 1735 01:24:15,680 --> 01:24:17,840 DIFFERENT FROM THE 1736 01:24:17,840 --> 01:24:18,880 IMPLEMENTATION PROCESS OUTCOMES. 1737 01:24:18,880 --> 01:24:20,800 WHY DO WE CARE SO MUCH ABOUT 1738 01:24:20,800 --> 01:24:22,360 THEORIES, FRAME WORKS AND 1739 01:24:22,360 --> 01:24:22,600 MODELS? 1740 01:24:22,600 --> 01:24:24,320 THEY OFFER A COMMON LANGUAGE TO 1741 01:24:24,320 --> 01:24:26,320 USE AND GUIDE THE PROCESS OF 1742 01:24:26,320 --> 01:24:28,320 RESEARCH BY ALLOWING US TO 1743 01:24:28,320 --> 01:24:29,800 STRUCTURE OUR STUDIES WITH 1744 01:24:29,800 --> 01:24:32,440 DESIGN AND MEASUREMENT AND 1745 01:24:32,440 --> 01:24:33,640 PRODUCE GENERALIZABLE KNOWLEDGE 1746 01:24:33,640 --> 01:24:35,240 WHICH IS THE ULTIMATE GOAL OF 1747 01:24:35,240 --> 01:24:38,080 THIS TYPE OF RESEARCH AND HELPS 1748 01:24:38,080 --> 01:24:39,960 WITH OPERATIONIZING THEORY AND 1749 01:24:39,960 --> 01:24:42,120 ENSURES WE'RE THINKING ABOUT 1750 01:24:42,120 --> 01:24:44,440 RELEVANT VARIABLES LIKE EQUITY 1751 01:24:44,440 --> 01:24:45,520 AND STRUCTURAL FACTORS. 1752 01:24:45,520 --> 01:24:47,560 NEXT I'LL TALK ABOUT 1753 01:24:47,560 --> 01:24:48,440 IMPLEMENTATION STRATEGIES WHICH 1754 01:24:48,440 --> 01:24:49,640 IS A TOPIC NEAR AND DEAR TO MY 1755 01:24:49,640 --> 01:24:51,280 HEART. 1756 01:24:51,280 --> 01:24:54,560 I WANT TO OFFER YOU TWO SEMINOLE 1757 01:24:54,560 --> 01:24:57,280 PAPERS THAT SHAPE HOW I THINK OF 1758 01:24:57,280 --> 01:24:59,120 THIS FOR FURTHER READING. 1759 01:24:59,120 --> 01:25:01,360 THESE TWO PAPERS DESCRIBE A 1760 01:25:01,360 --> 01:25:05,880 PROCESS OF COMING TO CONSENSUS 1761 01:25:05,880 --> 01:25:08,720 ON STRATEGIES THAT WE OFTEN DRAW 1762 01:25:08,720 --> 01:25:10,160 FROM IN THE IMPLEMENTATION WORLD 1763 01:25:10,160 --> 01:25:13,240 AND THE PROJECT IS CALLED THE 1764 01:25:13,240 --> 01:25:17,600 EXPERT RECOMMENDATION FOR 1765 01:25:17,600 --> 01:25:20,600 IMPLEMENTATION CHANGE AND 1766 01:25:20,600 --> 01:25:22,280 TAXONOMY OF IMPLEMENTATION 1767 01:25:22,280 --> 01:25:23,840 STRATEGIES AND WE HAVE MANY TO 1768 01:25:23,840 --> 01:25:27,080 DRAW FROM AND IT'S NOT AN 1769 01:25:27,080 --> 01:25:28,080 EXHAUSTIVE LIST. 1770 01:25:28,080 --> 01:25:32,400 IT'S FROM A PAPER I SUGGESTED 1771 01:25:32,400 --> 01:25:33,800 YOU LOOK AT IN THE PREVIOUS 1772 01:25:33,800 --> 01:25:34,000 SLIDE. 1773 01:25:34,000 --> 01:25:36,160 THESE ARE THE VARIOUS THINGS WE 1774 01:25:36,160 --> 01:25:38,400 DO TO HELP PEOPLE DO THE THINGS. 1775 01:25:38,400 --> 01:25:40,960 YOU WANT TO MATCH THESE 1776 01:25:40,960 --> 01:25:43,160 STRATEGIES TO WHAT THE BARRIERS 1777 01:25:43,160 --> 01:25:45,600 AND FACILITATORS ARE IN THE 1778 01:25:45,600 --> 01:25:47,000 ENVIRONMENT WHICH YOU'RE TRYING 1779 01:25:47,000 --> 01:25:47,480 TO IMPLEMENT. 1780 01:25:47,480 --> 01:25:49,600 THERE'S A SYSTEMATIC PROCESS TO 1781 01:25:49,600 --> 01:25:59,760 DO THAT. 1782 01:26:00,480 --> 01:26:06,000 IT'S BEEN BROKEN DOWN INTO 1783 01:26:06,000 --> 01:26:16,520 BUCKETS AND THESE ARE THE 73 1784 01:26:17,720 --> 01:26:21,600 STRATEGY BUCKETS AND PLANNING 1785 01:26:21,600 --> 01:26:26,720 STRATEGIES ASSESSING THE CONTENT 1786 01:26:26,720 --> 01:26:29,640 EDUCATE STRATEGIES AND TRAINING 1787 01:26:29,640 --> 01:26:34,480 IS NECESSARY BUT NOT SUFFICIENT. 1788 01:26:34,480 --> 01:26:37,640 RE-STRUCTURING, CREATING NEW 1789 01:26:37,640 --> 01:26:42,160 TEAMS OR REVISING ROLES AND 1790 01:26:42,160 --> 01:26:43,480 AUDIT AND FEEDBACK AND FINANCIAL 1791 01:26:43,480 --> 01:26:43,920 STRATEGIES AND POLICY 1792 01:26:43,920 --> 01:26:48,880 STRATEGIES. 1793 01:26:48,880 --> 01:26:50,600 WE HAVE A WHOLE LITERATURE ON 1794 01:26:50,600 --> 01:26:52,040 THIS AND IT'S IMPORTANT TO 1795 01:26:52,040 --> 01:26:56,960 HIGHLIGHT AND LOOK AT THE 1796 01:26:56,960 --> 01:26:59,480 LITERATURE AND HAVE YOUR 1797 01:26:59,480 --> 01:27:01,240 INVESTIGATORS LOOK AT IT BEFORE 1798 01:27:01,240 --> 01:27:03,240 RE-INVENTING THE WHEEL. 1799 01:27:03,240 --> 01:27:05,080 WE DON'T PICK IMPLEMENTATION 1800 01:27:05,080 --> 01:27:06,520 STRATEGIES FROM THE SKY JUST 1801 01:27:06,520 --> 01:27:08,080 LIKE WE DON'T GIVE EVERYBODY IN 1802 01:27:08,080 --> 01:27:09,600 THE EMERGENCY ROOM ASPIRIN. 1803 01:27:09,600 --> 01:27:11,840 WE HAVE WAYS TO SELECT 1804 01:27:11,840 --> 01:27:12,960 IMPLEMENTATION STRATEGIES 1805 01:27:12,960 --> 01:27:13,320 THOUGHTFULLY. 1806 01:27:13,320 --> 01:27:15,720 YOU CAN SEE AN EXAMPLE OF ONE OF 1807 01:27:15,720 --> 01:27:17,240 THE WAYS CONCEPT MAPPING WHICH 1808 01:27:17,240 --> 01:27:19,240 IS A MIXED METHODS APPROACH TO 1809 01:27:19,240 --> 01:27:21,640 PARTNER WITH PARTNERS AND 1810 01:27:21,640 --> 01:27:24,560 COMMUNITY MEMBERS TO IDENTIFY 1811 01:27:24,560 --> 01:27:27,160 WHAT TYPES OF STRATEGIES ARE 1812 01:27:27,160 --> 01:27:29,600 USEFUL AROUND WAYS TO COLLECT 1813 01:27:29,600 --> 01:27:31,200 THESE STRATEGIES INCLUDE THESE 1814 01:27:31,200 --> 01:27:31,640 CRUCIAL INGREDIENTS. 1815 01:27:31,640 --> 01:27:32,960 DOING A NEEDS ASSESSMENT, TRYING 1816 01:27:32,960 --> 01:27:35,840 TO UNDERSTAND YOUR CONTEXT AND 1817 01:27:35,840 --> 01:27:37,840 PARTNERS AND CONSOLIDATING THE 1818 01:27:37,840 --> 01:27:39,840 INPUTS INTO WORKING LOGIC MODEL 1819 01:27:39,840 --> 01:27:41,640 THAT GUIDES HOW YOU THINK ABOUT 1820 01:27:41,640 --> 01:27:44,000 WHAT STRATEGIES TO USE AND 1821 01:27:44,000 --> 01:27:47,000 THIRD, SPECIFY YOUR THEORY AND 1822 01:27:47,000 --> 01:27:48,120 OPERATIONALIZE YOUR STRATEGIES 1823 01:27:48,120 --> 01:27:50,160 DRAWING ON EXISTING TAXONOMIES. 1824 01:27:50,160 --> 01:27:55,680 WE'RE THINKING ABOUT MECHANISM 1825 01:27:55,680 --> 01:28:04,320 AND HOW OUR STRATEGIES WORK AND 1826 01:28:04,320 --> 01:28:06,080 LOOKING AT THE MECHANISM TO GET 1827 01:28:06,080 --> 01:28:13,160 BEHAVIOR CHANGE. 1828 01:28:13,160 --> 01:28:16,280 I'LL RETURN TO HOW WE CAN 1829 01:28:16,280 --> 01:28:18,240 IMPLEMENT THIS IN OUR WORK AND 1830 01:28:18,240 --> 01:28:23,520 THIS PAPER DESCRIBES HOW WE CAN 1831 01:28:23,520 --> 01:28:26,640 THINK ABOUT THAT INCLUDING 1832 01:28:26,640 --> 01:28:29,160 LOOKING AT MARGINALIZED 1833 01:28:29,160 --> 01:28:33,600 POPULATIONS AND ADDING 1834 01:28:33,600 --> 01:28:35,440 STRATEGIES TO ADDRESS STRUCTURAL 1835 01:28:35,440 --> 01:28:36,280 FACTORS AND UNDERSTAND PARTNER 1836 01:28:36,280 --> 01:28:38,000 PERSPECTIVES ON APPROACHES AND 1837 01:28:38,000 --> 01:28:41,400 THIS IS WORK WE'VE DONE IN OUR 1838 01:28:41,400 --> 01:28:46,680 VARIOUS TRIALS AND I FIND IT 1839 01:28:46,680 --> 01:28:47,640 INCREDIBLY IMPORTANT. 1840 01:28:47,640 --> 01:28:49,680 AND THE HEALTH EQUITY AND 1841 01:28:49,680 --> 01:28:50,680 EFFORTS THE NATIONAL EYE 1842 01:28:50,680 --> 01:28:51,920 INSTITUTE IS PARTNERING AROUND I 1843 01:28:51,920 --> 01:28:55,800 ENCOURAGE YOU TO THINK ABOUT IT 1844 01:28:55,800 --> 01:28:58,680 WITH THE IMPLEMENTATION SCIENCE 1845 01:28:58,680 --> 01:28:59,040 LENS. 1846 01:28:59,040 --> 01:29:00,440 THE LAST CRUCIAL INGREDIENTS 1847 01:29:00,440 --> 01:29:01,640 I'LL COVER IN THE TIME WE HAVE 1848 01:29:01,640 --> 01:29:04,800 IS MEASUREMENT AND ANALYSIS. 1849 01:29:04,800 --> 01:29:06,920 I'LL KEEP THIS HIGH LEVEL AND 1850 01:29:06,920 --> 01:29:09,600 BRING YOU BACK TO THE VISUAL 1851 01:29:09,600 --> 01:29:13,600 AROUND IMPLEMENTATION OUTCOMES 1852 01:29:13,600 --> 01:29:15,080 AND THE PROCTOR FRAMEWORK AND 1853 01:29:15,080 --> 01:29:16,160 THE OUTCOMES ARE DIFFERENT FROM 1854 01:29:16,160 --> 01:29:21,200 OUR HEALTH OUTCOMES. 1855 01:29:21,200 --> 01:29:25,640 WE CAN MEASURE BOTH AND IT'S 1856 01:29:25,640 --> 01:29:27,400 NICE WHEN THERE'S EXISTING 1857 01:29:27,400 --> 01:29:28,600 REGISTRIES TO DRAW FROM SO YOU 1858 01:29:28,600 --> 01:29:33,560 DON'T HAVE TO DO PRIMARY DATA 1859 01:29:33,560 --> 01:29:35,360 COLLECTION FOR BOTH BUCKETS OF 1860 01:29:35,360 --> 01:29:35,760 OUTCOMES. 1861 01:29:35,760 --> 01:29:38,600 MAKE SURE YOU LOOK AT EQUITY 1862 01:29:38,600 --> 01:29:41,160 ACROSS YOUR OUTCOMES SO YOU 1863 01:29:41,160 --> 01:29:42,520 IDENTIFY IF THERE'S EXISTING 1864 01:29:42,520 --> 01:29:44,000 INEQUITIES AND LOOK WHEN YOU DO 1865 01:29:44,000 --> 01:29:46,040 IMPLEMENTATION TO MAKE SURE IT'S 1866 01:29:46,040 --> 01:29:49,640 NOT BEING DEPLOYED UNEVENLY AND 1867 01:29:49,640 --> 01:29:53,000 DO WORK TO IDENTIFY NEW SIGNALS 1868 01:29:53,000 --> 01:29:56,400 THAT MAY COME UP IN THE 1869 01:29:56,400 --> 01:29:57,080 IMPLEMENTATION PROCESS. 1870 01:29:57,080 --> 01:29:58,720 THIS IS WORK MY COLLEAGUE HAS 1871 01:29:58,720 --> 01:30:03,440 BEEN AT THE FOREFRONT OF AND 1872 01:30:03,440 --> 01:30:04,680 HAVE A PAPER IN PRESS THAT 1873 01:30:04,680 --> 01:30:07,240 DESCRIBES HOW WE DID THIS IN A 1874 01:30:07,240 --> 01:30:08,960 RECENT TRIAL THAT PAINT A NICE 1875 01:30:08,960 --> 01:30:11,800 PICTURE HOW THIS CAN BE DONE 1876 01:30:11,800 --> 01:30:17,400 CONCRETELY. 1877 01:30:17,400 --> 01:30:19,040 QUALITATIVE AND MIXED METHODS 1878 01:30:19,040 --> 01:30:20,320 AND ADD TO THE CHARACTERIZATION 1879 01:30:20,320 --> 01:30:21,840 OF OUR IMPLEMENTATION OUTCOMES. 1880 01:30:21,840 --> 01:30:28,560 WE EMBRACE AND WELCOME BOTH 1881 01:30:28,560 --> 01:30:30,600 QUANTITATIVE AND MIXED METHODS 1882 01:30:30,600 --> 01:30:32,720 APPROACH AND ALMOST EVERY BIG 1883 01:30:32,720 --> 01:30:34,720 TRIAL HAS A MIXED METHODS 1884 01:30:34,720 --> 01:30:35,840 COMPONENT TO ENRICH OUR 1885 01:30:35,840 --> 01:30:45,600 UNDERSTANDING. 1886 01:30:45,600 --> 01:30:46,560 I'LL GIVE AN EXAMPLE AND THEN 1887 01:30:46,560 --> 01:30:50,360 OPEN IT UP FOR QUESTIONS. 1888 01:30:50,360 --> 01:30:52,040 I'VE BEEN FORTUNATE OVER THE 1889 01:30:52,040 --> 01:30:53,800 PAST 6, 7 YEARS TO BE FUNDED BY 1890 01:30:53,800 --> 01:30:54,760 THE NATIONAL INSTITUTE OF MENTAL 1891 01:30:54,760 --> 01:30:57,320 HEALTH TO DO WORK AROUND A 1892 01:30:57,320 --> 01:31:01,880 PARTICULAR CHALLENGE THAT WE 1893 01:31:01,880 --> 01:31:04,640 HAVE NATIONALLY WHICH IS SEEING 1894 01:31:04,640 --> 01:31:05,640 INCREASED SUICIDE IN YOUNG 1895 01:31:05,640 --> 01:31:07,680 PEOPLE IN OUR COUNTRY AND ONE OF 1896 01:31:07,680 --> 01:31:10,880 THE MAJOR DRIVERS IS ENSURING 1897 01:31:10,880 --> 01:31:11,840 THAT FIREARMS ARE SECURED SAFELY 1898 01:31:11,840 --> 01:31:13,920 IN HOMES. 1899 01:31:13,920 --> 01:31:17,640 GIVEN 1 IN 3 HOMES HAVE 1900 01:31:17,640 --> 01:31:19,000 FIREARMS, HALF SUICIDE DEATHS 1901 01:31:19,000 --> 01:31:21,320 ARE DUE TO FIREARMS AND KNOW 1902 01:31:21,320 --> 01:31:22,960 MORE SECURE STORAGE WOULD REDUCE 1903 01:31:22,960 --> 01:31:23,320 THE NUMBERS. 1904 01:31:23,320 --> 01:31:25,640 THAT'S THE KIND OF GAP WE HAVE 1905 01:31:25,640 --> 01:31:31,160 BEEN FOCUSSED ON. 1906 01:31:31,160 --> 01:31:33,680 WE'RE FOCUSSED ON A SECURE 1907 01:31:33,680 --> 01:31:35,840 STORAGE PROGRAM TO BE DEPLOYED 1908 01:31:35,840 --> 01:31:38,520 IN PEDIATRIC PRIMARY CARE AS THE 1909 01:31:38,520 --> 01:31:41,640 SUICIDE PREVENTION STRATEGY AND 1910 01:31:41,640 --> 01:31:42,840 SEE THE QUESTION OF THE PRACTICE 1911 01:31:42,840 --> 01:31:46,360 SHOWING EFFECTIVENESS. 1912 01:31:46,360 --> 01:31:49,640 IN 2008 THERE WAS A TRIAL 1913 01:31:49,640 --> 01:31:52,080 DEMONSTRATING DOING THIS THING 1914 01:31:52,080 --> 01:31:53,800 IN PEDIATRIC PRIMARY CARE 1915 01:31:53,800 --> 01:31:55,000 RESULTED IN MORE SECURE STORAGE 1916 01:31:55,000 --> 01:31:55,400 OF FIREARMS. 1917 01:31:55,400 --> 01:32:01,640 AT THE TIME THEY WERE FOCUSSED 1918 01:32:01,640 --> 01:32:08,880 ON UNINTENTIONAL 1919 01:32:11,520 --> 01:32:17,640 AND WE KNEW WE COULD ADAPT 1920 01:32:17,640 --> 01:32:19,600 METHODS FOR PREVENTION AND LOOK 1921 01:32:19,600 --> 01:32:22,800 AT CURRENT USE OF THE COMPONENT 1922 01:32:22,800 --> 01:32:24,600 OF THIS PROGRAM AS WELL AS 1923 01:32:24,600 --> 01:32:26,560 ATTITUDES OF CLINICIANS AND 1924 01:32:26,560 --> 01:32:27,600 LEADERS IN HEALTH SYSTEMS 1925 01:32:27,600 --> 01:32:28,680 TOWARDS THE COMPONENTS OF THIS 1926 01:32:28,680 --> 01:32:28,960 PROGRAM. 1927 01:32:28,960 --> 01:32:33,120 THAT ALLOWED US TO ENGAGE IN A 1928 01:32:33,120 --> 01:32:34,320 PROCESS CALLED IMPLEMENTATION 1929 01:32:34,320 --> 01:32:36,880 MAPPING TO DESIGN A MENU OF 1930 01:32:36,880 --> 01:32:37,640 IMPLEMENTATION STRATEGIES BASED 1931 01:32:37,640 --> 01:32:42,840 ON WHAT WE HEARD WHICH WAS THAT 1932 01:32:42,840 --> 01:32:44,640 INTEGRATION IN THE ELECTRONIC 1933 01:32:44,640 --> 01:32:46,360 HEALTH RECORD AND HELPING 1934 01:32:46,360 --> 01:32:48,480 NAVIGATE THE SENSITIVITY OF THE 1935 01:32:48,480 --> 01:32:49,640 TOPIC WOULD BE CRITICAL TO 1936 01:32:49,640 --> 01:32:50,200 ENSURE THE SUCCESS OF THIS 1937 01:32:50,200 --> 01:32:56,480 APPROACH. 1938 01:32:56,480 --> 01:33:01,800 BECAUSE WE MADE ADAPTATION WE'RE 1939 01:33:01,800 --> 01:33:04,200 DOING A TRIAL ASKING THE 1940 01:33:04,200 --> 01:33:05,640 FOLLOWING QUESTIONS. 1941 01:33:05,640 --> 01:33:10,600 LESS COSTLY AND SCALABLE HEALTH 1942 01:33:10,600 --> 01:33:12,480 RECORDS NUDGE POWERFUL ENOUGH TO 1943 01:33:12,480 --> 01:33:14,360 CHANGE CLINICIAN BEHAVIOR OR IS 1944 01:33:14,360 --> 01:33:15,840 MORE NEEDED TO OVERCOME 1945 01:33:15,840 --> 01:33:17,040 IMPLEMENTATION BARRIERS? 1946 01:33:17,040 --> 01:33:18,080 WE HAVE 30 CLINICS. 1947 01:33:18,080 --> 01:33:20,800 HALF HAVE JUST GETTING A CHANGE 1948 01:33:20,800 --> 01:33:23,680 TO THE WELL CHILD VISIT TEMPLATE 1949 01:33:23,680 --> 01:33:25,520 TO PROMPT CLINICIANS TO DO THE 1950 01:33:25,520 --> 01:33:25,760 PROGRAM. 1951 01:33:25,760 --> 01:33:29,600 THE OTHER HALF ARE GETTING THE 1952 01:33:29,600 --> 01:33:31,000 NUDGE AND CLINICAL LEVEL 1953 01:33:31,000 --> 01:33:33,600 FACILITATION AND DEPLOYING THE 1954 01:33:33,600 --> 01:33:35,200 INTERVENTION AND HOPEFULLY THAT 1955 01:33:35,200 --> 01:33:37,080 GIVES YOU A PICTURE OF HOW ONE 1956 01:33:37,080 --> 01:33:38,600 MIGHT GO THROUGH THE STEPS IN 1957 01:33:38,600 --> 01:33:39,400 DECIDING HOW TO DO AN 1958 01:33:39,400 --> 01:33:43,120 IMPLEMENTATION SETTING. 1959 01:33:43,120 --> 01:33:45,480 AND MY PARTICULAR CONTENT AREA. 1960 01:33:45,480 --> 01:33:48,560 I'LL CLOSE AND TALK ABOUT 1961 01:33:48,560 --> 01:33:51,200 APPLICATION OF IMPLEMENTATION 1962 01:33:51,200 --> 01:33:53,640 SCIENCE AT THE NATIONAL EYE 1963 01:33:53,640 --> 01:33:54,720 INSTITUTE FUNDED WORK AND 1964 01:33:54,720 --> 01:34:01,120 PULLING A UG1 FUNDED TO DR. LU 1965 01:34:01,120 --> 01:34:05,200 AT THE UNIVERSITY OF WISCONSIN 1966 01:34:05,200 --> 01:34:05,920 AS AN EXAMPLE. 1967 01:34:05,920 --> 01:34:08,080 THIS IS NOT MY CONTENT AREA SO 1968 01:34:08,080 --> 01:34:09,640 WELCOME YOUR INPUT AND I'LL DO 1969 01:34:09,640 --> 01:34:10,840 MY BEST TO DESCRIBE IT AND WE'LL 1970 01:34:10,840 --> 01:34:12,040 TAKE IT FROM THERE. 1971 01:34:12,040 --> 01:34:17,640 THE THING WE'RE INTERESTED IN 1972 01:34:17,640 --> 01:34:20,840 HERE IS OPHTHALMOLOGY FOR 1973 01:34:20,840 --> 01:34:21,920 DIABETIC RETINOPATHY AND IT 1974 01:34:21,920 --> 01:34:26,720 SHOWS THE FIELD HAS DEMONSTRATED 1975 01:34:26,720 --> 01:34:28,880 THIS IS EFFICACIOUS AND 1976 01:34:28,880 --> 01:34:33,360 EFFECTIVE AND DR. LU HAD A K23, 1977 01:34:33,360 --> 01:34:34,920 I UNDERSTAND TO DO MIXED METHODS 1978 01:34:34,920 --> 01:34:36,560 WORK TO UNDERSTAND BARRIERS TO 1979 01:34:36,560 --> 01:34:46,160 THE I AM MOMPLEMENTATION AND NOG 1980 01:34:46,160 --> 01:34:49,280 A LARGE TRIAL TESTING THE 1981 01:34:49,280 --> 01:34:50,360 STRATEGIES AND THEY'RE BASED ON 1982 01:34:50,360 --> 01:34:55,880 ANOTHER MODEL ADAPTED FOR THIS 1983 01:34:55,880 --> 01:35:02,360 PARTICULAR USE CASE AND SHE 1984 01:35:02,360 --> 01:35:11,240 DESIGNED AND PILOTED THIS MODEL. 1985 01:35:11,240 --> 01:35:13,360 ON THE LEFT IS THE WORK THAT 1986 01:35:13,360 --> 01:35:16,160 CAME THE EARLIER MIXED METHODS 1987 01:35:16,160 --> 01:35:16,960 IMPLEMENTATION WORK AND SCIENCE 1988 01:35:16,960 --> 01:35:22,240 COMMUNICATION AND THE AIMS OF 1989 01:35:22,240 --> 01:35:24,440 HER STUDY. 1990 01:35:24,440 --> 01:35:25,960 SHE'S TESTING THE EFFECTIVENESS 1991 01:35:25,960 --> 01:35:29,840 OF THE IMPLEMENTATION STRATEGY, 1992 01:35:29,840 --> 01:35:31,280 EYESIGHT, VERSUS USUAL PAIR TO 1993 01:35:31,280 --> 01:35:35,840 LOOK AT WHETHER OR NOT THAT 1994 01:35:35,840 --> 01:35:37,640 INCREASES DIABETIC SCREENING 1995 01:35:37,640 --> 01:35:40,240 RATE AND LOOKING AT IT ACROSS 1996 01:35:40,240 --> 01:35:41,160 EIGHT RURAL HEALTH SYSTEMS IN 1997 01:35:41,160 --> 01:35:42,200 FIVE STATES. 1998 01:35:42,200 --> 01:35:44,640 THE INITIAL WORK WAS DONE IN THE 1999 01:35:44,640 --> 01:35:46,760 SMALLER NUMBER AND NOW WHEN WE 2000 01:35:46,760 --> 01:35:49,000 DO IMPLEMENTATION WORK WE'RE 2001 01:35:49,000 --> 01:35:50,560 DOING IT IN MANY MORE SITES. 2002 01:35:50,560 --> 01:35:53,640 THE SECOND IS TO UNDERSTAND KEY 2003 01:35:53,640 --> 01:35:55,840 FACTORS AND IMPLEMENTATION 2004 01:35:55,840 --> 01:35:56,920 COMPONENTS YOU CAN SEE IN HIGH 2005 01:35:56,920 --> 01:36:04,480 AND LOW USE HEALTH SYSTEMS. 2006 01:36:04,480 --> 01:36:05,640 THAT'S UNDERSTANDING WHAT 2007 01:36:05,640 --> 01:36:07,320 CHARACTERIZES HIGH AND LOW USING 2008 01:36:07,320 --> 01:36:11,520 AND HER THIRD AIM IS TO LOOK AT 2009 01:36:11,520 --> 01:36:12,960 IMPLEMENTATION OUTCOME WHICH IS 2010 01:36:12,960 --> 01:36:13,720 IMPORTANT AND COST. 2011 01:36:13,720 --> 01:36:16,800 AND YOU CAN SEE HOW THE EXAMPLE 2012 01:36:16,800 --> 01:36:21,200 BRINGS TOGETHER THE THINGS WE'VE 2013 01:36:21,200 --> 01:36:22,560 BEEN TALKING ABOUT. 2014 01:36:22,560 --> 01:36:24,440 THERE'S LOTS OF OTHER 2015 01:36:24,440 --> 01:36:25,760 OPPORTUNITIES IN IMPLEMENTATION 2016 01:36:25,760 --> 01:36:28,320 SCIENCE AND WE HEARD THAT IN THE 2017 01:36:28,320 --> 01:36:29,640 COMMENTS MIKE MADE LEADING UP TO 2018 01:36:29,640 --> 01:36:30,120 THE TALK. 2019 01:36:30,120 --> 01:36:34,040 IT SEEMS LIKE IN YOUR FIELD 2020 01:36:34,040 --> 01:36:36,920 THERE'S A LOT OF WELL 2021 01:36:36,920 --> 01:36:38,480 ARTICULATED DATA SCIENCE AND 2022 01:36:38,480 --> 01:36:40,840 REGISTRIES WHICH CAN BE USED TO 2023 01:36:40,840 --> 01:36:42,680 ASCERTAIN OUTCOMES AND IDENTIFY 2024 01:36:42,680 --> 01:36:44,120 CARE GAPS AND INEQUITIES. 2025 01:36:44,120 --> 01:36:47,520 THAT GIVES A FOOT UP BECAUSE IF 2026 01:36:47,520 --> 01:36:49,600 YOU'RE ABLE IT DRAW FROM THOSE 2027 01:36:49,600 --> 01:36:51,040 INFRASTRUCTURE RESOURCES IT 2028 01:36:51,040 --> 01:36:53,800 MAKES FOR EASIER GOING FORWARD. 2029 01:36:53,800 --> 01:36:56,560 SECOND, AND YOU'LL BE HEARING 2030 01:36:56,560 --> 01:37:00,760 FROM JENNY AFTER ME, THERE'S AN 2031 01:37:00,760 --> 01:37:04,080 OPPORTUNITY TO LEVERAGE THE 2032 01:37:04,080 --> 01:37:05,040 NETWORKS INCLUDING OVER 100 2033 01:37:05,040 --> 01:37:07,280 CLINICAL SITES AND THE STUDY I 2034 01:37:07,280 --> 01:37:11,680 WAS DESCRIBING THAT REFLECTS MY 2035 01:37:11,680 --> 01:37:15,760 OWN WORK LEVERAGES AN NIMH 2036 01:37:15,760 --> 01:37:17,680 NETWORK THAT'S HOW WE WERE ABLE 2037 01:37:17,680 --> 01:37:20,360 TO DO THE WORK I COULDN'T HAVE 2038 01:37:20,360 --> 01:37:21,240 DONE IT WITHOUT THE 2039 01:37:21,240 --> 01:37:21,600 INFRASTRUCTURE. 2040 01:37:21,600 --> 01:37:22,960 THE THIRD AREA AND I KNOW 2041 01:37:22,960 --> 01:37:25,440 THERE'S BASIC SCIENTISTS ON THE 2042 01:37:25,440 --> 01:37:26,840 CALL PARTNERING WITH 2043 01:37:26,840 --> 01:37:28,000 IMPLEMENTATION SCIENCES TO 2044 01:37:28,000 --> 01:37:29,840 PRODUCE MEANINGFUL TEAM SCIENCE 2045 01:37:29,840 --> 01:37:32,840 FROM BENCH TO BEDSIDE TO ADVANCE 2046 01:37:32,840 --> 01:37:34,320 THE MISSION IS MISSION CRITICAL. 2047 01:37:34,320 --> 01:37:36,640 I'D LIKE TO SEE A FUTURE WHERE 2048 01:37:36,640 --> 01:37:40,080 THERE'S MORE TEAM SCIENCE FROM 2049 01:37:40,080 --> 01:37:42,600 THE BEGINNING RATHER THAN 2050 01:37:42,600 --> 01:37:44,520 CALLING ONCE YOU HAVE THE THING. 2051 01:37:44,520 --> 01:37:46,640 IT TENDS TO RESULT IN A HARDER 2052 01:37:46,640 --> 01:37:48,720 PATHWAY FORWARD AND THINKING HOW 2053 01:37:48,720 --> 01:37:52,160 TO PRIORITIZE HYBRID TRIALS OF 2054 01:37:52,160 --> 01:37:53,600 CLINICAL EFFECTIVENESS AND REAL 2055 01:37:53,600 --> 01:37:59,840 WORLD IMPLEMENTATION OUTCOMES 2056 01:37:59,840 --> 01:38:02,600 EARLIER WE SHOULD THINK ABOUT 2057 01:38:02,600 --> 01:38:03,200 IMPLEMENTATION BECAUSE WE'RE 2058 01:38:03,200 --> 01:38:09,040 DOING THINGS TO MAKE THE THING 2059 01:38:09,040 --> 01:38:12,240 WORK I HAVE A COLLEAGUE THAT 2060 01:38:12,240 --> 01:38:14,320 WROTE A PAPER CALLING FOR 2061 01:38:14,320 --> 01:38:15,840 REPORTING THE STRATEGIES, USED 2062 01:38:15,840 --> 01:38:17,880 IN THE EARLIER EFFECTIVENESS 2063 01:38:17,880 --> 01:38:22,360 STUDIES. 2064 01:38:22,360 --> 01:38:26,040 I BELIEVE IMPLEMENTATION SCIENCE 2065 01:38:26,040 --> 01:38:32,480 CAN HELP MOVE THE NEEDLE AND 2066 01:38:32,480 --> 01:38:34,400 ACHIEVE IMPACT AT SCALE AND HOPE 2067 01:38:34,400 --> 01:38:42,240 THIS HAS GENERATED IDEAS AND 2068 01:38:42,240 --> 01:38:45,640 THINK WE'RE AT A PIVOTAL TIME. 2069 01:38:45,640 --> 01:38:47,840 THE SCIENCE EDITORIAL IS A GOOD 2070 01:38:47,840 --> 01:38:48,680 INDICATOR OF THE FUTURE AND THE 2071 01:38:48,680 --> 01:38:50,360 FACT THAT PEOPLE ARE COMING 2072 01:38:50,360 --> 01:38:51,280 AROUND TO HOW IMPORTANT THIS 2073 01:38:51,280 --> 01:38:52,840 WORK IS. 2074 01:38:52,840 --> 01:38:54,760 I'VE BEEN DOING IT 20 YEARS AND 2075 01:38:54,760 --> 01:38:56,720 IT'S VERY FULFILLING TO SEE IT 2076 01:38:56,720 --> 01:38:59,320 COME TO FRUITION IN THIS WAY. 2077 01:38:59,320 --> 01:39:01,320 AND I WANT TO GIVE DEEP 2078 01:39:01,320 --> 01:39:02,640 GRATITUDE TO THE TEAM AND OUR 2079 01:39:02,640 --> 01:39:09,600 COLLEAGUES AND FAMILY AND OF 2080 01:39:09,600 --> 01:39:11,000 COURSE MY INSTITUTION AND 2081 01:39:11,000 --> 01:39:12,800 PREVIOUS INSTITUTION WHICH 2082 01:39:12,800 --> 01:39:13,760 SUPPORTS THE IMPORTANT WORK. 2083 01:39:13,760 --> 01:39:17,640 MY E-MAIL IS HERE AND TWITTER 2084 01:39:17,640 --> 01:39:24,080 HANDLE AND FOLLOWED THE HASHTAG 2085 01:39:24,080 --> 01:39:27,000 EYE INSTITUTE AND I USE IT A LOT 2086 01:39:27,000 --> 01:39:28,480 TO SHARE IMPLEMENTATION SCIENCE 2087 01:39:28,480 --> 01:39:29,760 WORK AND I'LL CLOSE AND SEE IF 2088 01:39:29,760 --> 01:39:31,800 THERE'S ANY QUESTIONS THAT 2089 01:39:31,800 --> 01:39:33,640 PEOPLE HAVE IN THE TIME I HAVE 2090 01:39:33,640 --> 01:39:43,280 REMAINING. 2091 01:39:43,280 --> 01:39:44,360 >>THANK YOU. 2092 01:39:44,360 --> 01:39:45,640 AWESOME TOUR AND I APPRECIATED 2093 01:39:45,640 --> 01:39:49,640 YOUR INTEGRATING WHAT IS GOING 2094 01:39:49,640 --> 01:39:53,640 ON HERE WITH WHAT YOU'RE DOING. 2095 01:39:53,640 --> 01:39:54,920 LET ME -- WHAT QUESTIONS DO 2096 01:39:54,920 --> 01:40:05,120 PEOPLE HAVE? 2097 01:40:05,720 --> 01:40:05,880 MAUREEN. 2098 01:40:05,880 --> 01:40:07,040 >>THAT WAS AN INTERESTING TALK. 2099 01:40:07,040 --> 01:40:09,360 SINCE YOU'VE BEEN WORKING THIS 2100 01:40:09,360 --> 01:40:12,640 FIELD SO LONG, ARE THERE SORT OF 2101 01:40:12,640 --> 01:40:15,200 SOME LOW HANGING FRUIT -- 2102 01:40:15,200 --> 01:40:16,800 DOESN'T MATTER WHAT DISCIPLINE 2103 01:40:16,800 --> 01:40:17,520 YOU'RE IN. 2104 01:40:17,520 --> 01:40:19,640 ARE THERE CERTAIN STRATEGIES 2105 01:40:19,640 --> 01:40:24,040 THAT SEEM TO WORK ACROSS 2106 01:40:24,040 --> 01:40:24,280 MEDICINE? 2107 01:40:24,280 --> 01:40:27,720 SOME BASIC ABCs OUT THERE FOR 2108 01:40:27,720 --> 01:40:29,640 DISSEMINATING INFORMATION AND 2109 01:40:29,640 --> 01:40:34,360 HAVING IT ADOPTED? 2110 01:40:34,360 --> 01:40:35,680 >>THAT'S A GREAT QUESTION, 2111 01:40:35,680 --> 01:40:36,120 MAUREEN. 2112 01:40:36,120 --> 01:40:38,320 THANK YOU FOR ASKING IT. 2113 01:40:38,320 --> 01:40:40,720 I CAN'T GIVE YOU A PLAY BOOK OF 2114 01:40:40,720 --> 01:40:44,520 HOW THIS IS HOW YOU CAN 2115 01:40:44,520 --> 01:40:46,200 IMPLEMENT EVERYTHING AT EVERY 2116 01:40:46,200 --> 01:40:47,000 PLACE BECAUSE THAT DOESN'T EXIST 2117 01:40:47,000 --> 01:40:49,120 BUT THE PROCESS I OUTLINED WHERE 2118 01:40:49,120 --> 01:40:51,440 YOU DIAGNOSE THE FACILITATORS 2119 01:40:51,440 --> 01:40:55,480 AND PICK STRATEGIES AND DEPLOY 2120 01:40:55,480 --> 01:40:59,840 THEM IS A PROCESS THAT'S 2121 01:40:59,840 --> 01:41:01,640 UBIQUITOUS AND ONE, WE ALWAYS 2122 01:41:01,640 --> 01:41:05,560 WANT TO GO FOR INDIVIDUAL LEVEL 2123 01:41:05,560 --> 01:41:07,320 STRATEGIES TO CHANGE BEHAVIOR. 2124 01:41:07,320 --> 01:41:08,360 WE ALWAYS THINK THE CLINICIANS 2125 01:41:08,360 --> 01:41:10,320 DON'T KNOW HOW TO USE IT SO WE 2126 01:41:10,320 --> 01:41:11,840 TRAIN THEM AND GIVE THEM 2127 01:41:11,840 --> 01:41:12,840 INFORMATION THEY'LL CHANGE THEIR 2128 01:41:12,840 --> 01:41:13,120 BEHAVIOR. 2129 01:41:13,120 --> 01:41:17,920 I CAN TELL YOU THAT DOESN'T WORK 2130 01:41:17,920 --> 01:41:20,080 AND WE KNOW THAT. 2131 01:41:20,080 --> 01:41:22,400 I THINK THERE'S LOW HANGING 2132 01:41:22,400 --> 01:41:24,360 FRUIT FROM BEHAVIORAL SCIENCE OR 2133 01:41:24,360 --> 01:41:26,240 ECONOMICS TO RESTRUCTURE THE 2134 01:41:26,240 --> 01:41:31,840 ENVIRONMENT TO MAKE IT EASIER 2135 01:41:31,840 --> 01:41:34,000 FOR CLINICIANS AND PATIENT TO DO 2136 01:41:34,000 --> 01:41:35,120 THE RIGHT THING. 2137 01:41:35,120 --> 01:41:37,480 TO ME NUDGING THE ELECTRONIC 2138 01:41:37,480 --> 01:41:40,520 HEALTH RECORD IS A LOW COST 2139 01:41:40,520 --> 01:41:41,320 APPROACH TO NUDGE WHAT YOU 2140 01:41:41,320 --> 01:41:43,720 SHOULD ATTEND TO AND FOR THE 2141 01:41:43,720 --> 01:41:45,000 THINGS WE CARE ABOUT IN A HEALTH 2142 01:41:45,000 --> 01:41:46,760 SYSTEM WE'LL HAVE TO DO MORE. 2143 01:41:46,760 --> 01:41:48,840 THAT COULD BE AUDIT AND 2144 01:41:48,840 --> 01:41:49,120 FEEDBACK. 2145 01:41:49,120 --> 01:41:51,680 THAT'S GOING TO BE ORGANIZE OF 2146 01:41:51,680 --> 01:41:53,600 ORGANIZATIONAL STRATEGY TO MAKE 2147 01:41:53,600 --> 01:41:54,440 SURE WE SIGNAL TO THE 2148 01:41:54,440 --> 01:41:55,920 ORGANIZATION AT THE MATTERS AND 2149 01:41:55,920 --> 01:41:58,960 WE EXPECT PEOPLE TO DO IT. 2150 01:41:58,960 --> 01:42:00,640 AND THOSE ORGANIZATIONAL-LEVEL 2151 01:42:00,640 --> 01:42:03,360 STRATEGIES ARE HARDER AND MORE 2152 01:42:03,360 --> 01:42:03,640 EXPENSIVE. 2153 01:42:03,640 --> 01:42:05,360 WE CAN'T DO IT FOR EVERYTHING SO 2154 01:42:05,360 --> 01:42:09,280 WE HAVE TO BE MORE TARGETED AND 2155 01:42:09,280 --> 01:42:10,080 PRIORITIZE WHAT NEEDS TO BE 2156 01:42:10,080 --> 01:42:10,800 DONE. 2157 01:42:10,800 --> 01:42:13,680 FINALLY, THERE'S NO SILVER 2158 01:42:13,680 --> 01:42:13,920 BULLET. 2159 01:42:13,920 --> 01:42:17,640 AS THE INCREMENTAL CHANGE AND 2160 01:42:17,640 --> 01:42:21,640 MEASUREMENT AND LOOKING AT WHAT 2161 01:42:21,640 --> 01:42:23,120 HAPPENS AND CONTINUE TO SHIFT 2162 01:42:23,120 --> 01:42:23,840 FROM HEARING WHAT IS HAPPENING 2163 01:42:23,840 --> 01:42:34,080 ON THE GROUND. 2164 01:42:40,800 --> 01:42:42,400 >>THAT'S TERRIFIC. 2165 01:42:42,400 --> 01:42:45,640 I GUESS THERE'S BITS AND PIECES 2166 01:42:45,640 --> 01:42:46,720 OF IMPLEMENTATION SCIENCE BUT 2167 01:42:46,720 --> 01:42:48,280 MAYBE I'D LIKE TO FIGURE OUT HOW 2168 01:42:48,280 --> 01:42:50,680 TO LEARN MORE ABOUT IT AND FROM 2169 01:42:50,680 --> 01:42:53,840 THE LITERATURE AND READ IT. 2170 01:42:53,840 --> 01:42:58,360 ARE THERE SPECIFIC JOURNALS FOR 2171 01:42:58,360 --> 01:42:59,840 EXAMPLE OR CAN YOU SUGGEST AREAS 2172 01:42:59,840 --> 01:43:03,440 TO GO TO TO LEARN MORE? 2173 01:43:03,440 --> 01:43:09,640 >>ABSOLUTELY, THANK YOU, EMMY. 2174 01:43:09,640 --> 01:43:12,880 GREAT QUESTION. 2175 01:43:12,880 --> 01:43:14,720 I THINK IT'S IMPORTANT TO DO 2176 01:43:14,720 --> 01:43:16,160 MORE LEARNING AND IF I GO IN THE 2177 01:43:16,160 --> 01:43:23,840 LAB AND PICK UP AN iPAD IT'S A 2178 01:43:23,840 --> 01:43:27,000 DISTINCT FIELD THAT REQUIRES 2179 01:43:27,000 --> 01:43:28,440 LEARNING. 2180 01:43:28,440 --> 01:43:33,920 THERE'S ABOUT TO BE A TEXTBOOK 2181 01:43:33,920 --> 01:43:35,360 THAT'S A GOOD STARTING PLACE. 2182 01:43:35,360 --> 01:43:37,600 THERE'S A JOURNAL CALLED 2183 01:43:37,600 --> 01:43:39,760 IMPLEMENTATION SCIENCE AND NOW A 2184 01:43:39,760 --> 01:43:42,640 SISTER JOURNAL, IMPLEMENTATION 2185 01:43:42,640 --> 01:43:43,400 SCIENCE COMMUNICATION FOR 2186 01:43:43,400 --> 01:43:44,520 EARLIER STAGE WORK THAT'S A 2187 01:43:44,520 --> 01:43:47,000 GREAT PLACE TO GO. 2188 01:43:47,000 --> 01:43:49,600 AND THERE'S A WHOLE OUTCROP OF 2189 01:43:49,600 --> 01:43:51,680 NEW JOURNALS COMING OUT AND I'M 2190 01:43:51,680 --> 01:43:53,840 SEEING IT MORE IN SOME OF OUR 2191 01:43:53,840 --> 01:43:57,040 WELL KNOWN MEDICAL JOURNALS. 2192 01:43:57,040 --> 01:43:58,720 THERE'S A CONFERENCE ANNUALLY 2193 01:43:58,720 --> 01:44:02,400 THAT NIH AND ACADEMY HEALTH 2194 01:44:02,400 --> 01:44:05,600 SPONSOR AND REPRESENTS WORK 2195 01:44:05,600 --> 01:44:06,640 ACROSS DISEASE AREAS AND IT'S IN 2196 01:44:06,640 --> 01:44:08,000 DECEMBER AND IT'S A GREAT WAY 2197 01:44:08,000 --> 01:44:10,560 AND I'D ENCOURAGE YOU TO 2198 01:44:10,560 --> 01:44:11,120 PARTNER. 2199 01:44:11,120 --> 01:44:12,320 MY MOST SUCCESSFUL PROJECT 2200 01:44:12,320 --> 01:44:13,760 OUTSIDE MY CONTENT AREAS ARE 2201 01:44:13,760 --> 01:44:16,840 ONES IN WHICH I PARTNER WITH 2202 01:44:16,840 --> 01:44:18,320 CLINICAL EXPERTS DOING PRAGMATIC 2203 01:44:18,320 --> 01:44:21,200 TRIALS AND THEIR SETTINGS TO 2204 01:44:21,200 --> 01:44:23,640 DESIGN AND IMPLEMENT A STUDY. 2205 01:44:23,640 --> 01:44:25,640 IT'S IMPORTANT THE 2206 01:44:25,640 --> 01:44:27,280 IMPLEMENTATION SCIENTISTS BE 2207 01:44:27,280 --> 01:44:27,640 FULLY INVOLVED. 2208 01:44:27,640 --> 01:44:29,840 WHEN PEOPLE COME TO ME AND SAY 2209 01:44:29,840 --> 01:44:31,960 I'VE NEVER DONE THIS BEFORE, CAN 2210 01:44:31,960 --> 01:44:34,960 YOU BE 3% TO 5% AND HELP THE 2211 01:44:34,960 --> 01:44:35,920 STUDY I SAY NO. 2212 01:44:35,920 --> 01:44:40,360 YOU CAN'T DO IT WELL. 2213 01:44:40,360 --> 01:44:42,600 I COULDN'T GO IN THE WET LAB AND 2214 01:44:42,600 --> 01:44:48,360 HELP GUIDE WHAT I'M DOING. 2215 01:44:48,360 --> 01:44:49,640 HOPEFULLY THAT ANSWERS YOUR 2216 01:44:49,640 --> 01:44:53,320 QUESTION. 2217 01:44:53,320 --> 01:44:56,880 >>MY UNDERSTANDING IS YOU HAVE 2218 01:44:56,880 --> 01:44:59,840 A HARD STOP IN A MINUTE OR 2219 01:44:59,840 --> 01:45:00,680 SHOULD WE STOP? 2220 01:45:00,680 --> 01:45:03,120 >>WE HAVE A MINUTE BUFFER. 2221 01:45:03,120 --> 01:45:08,000 I'M HAPPY TO ANSWER THE 2222 01:45:08,000 --> 01:45:08,320 QUESTION. 2223 01:45:08,320 --> 01:45:13,360 >>WHAT RESONATED WITH ME IS THE 2224 01:45:13,360 --> 01:45:18,720 DISCONNECT BETWEEN BASIC AND 2225 01:45:18,720 --> 01:45:29,040 CLINICAL RESEARCH. 2226 01:45:53,920 --> 01:45:56,040 AND PARTNERING WOULD BE KEY AND 2227 01:45:56,040 --> 01:45:57,640 SOME PROGRAMS TO PROMOTE THAT 2228 01:45:57,640 --> 01:46:08,080 WOULD BE NICE. 2229 01:46:08,080 --> 01:46:09,720 >>WHEN PEOPLE TALK ABOUT CELLS 2230 01:46:09,720 --> 01:46:12,880 AND MICE IT'S NOT MY LOVE 2231 01:46:12,880 --> 01:46:13,480 LANGUAGE. 2232 01:46:13,480 --> 01:46:14,720 IT'S TALKING ABOUT CLINICIANS 2233 01:46:14,720 --> 01:46:16,000 AND PATIENTS AND ORGANIZATION. 2234 01:46:16,000 --> 01:46:17,760 WE NEED TO DO BETTER AT BRIDGING 2235 01:46:17,760 --> 01:46:19,720 THE GAP AND I'M SURE IT'S TRUE 2236 01:46:19,720 --> 01:46:21,520 FOR BASIC SCIENTISTS WHEN THEY 2237 01:46:21,520 --> 01:46:24,160 START HEARING ME DESCRIBE IT'S 2238 01:46:24,160 --> 01:46:25,600 MESSY AND LARGE ECO SYSTEM WE'RE 2239 01:46:25,600 --> 01:46:26,360 DOING WORK IN. 2240 01:46:26,360 --> 01:46:29,560 I THINK IT'S REALLY IMPORTANT 2241 01:46:29,560 --> 01:46:32,200 AND I THINK WE NEED TO 2242 01:46:32,200 --> 01:46:33,200 INCORPORATE TRAINING EARLIER TO 2243 01:46:33,200 --> 01:46:35,200 BUILD CAPACITY AND THERE'S A 2244 01:46:35,200 --> 01:46:36,560 REAL SUPPLY AND DEMAND ISSUE. 2245 01:46:36,560 --> 01:46:39,240 THERE'S NOT A LOT OF 2246 01:46:39,240 --> 01:46:39,920 IMPLEMENTATION SCIENTISTS. 2247 01:46:39,920 --> 01:46:40,880 THERE'S NOT ENOUGH THAT HAVE 2248 01:46:40,880 --> 01:46:43,880 BEEN TRAINED TO MEET THE NEEDS 2249 01:46:43,880 --> 01:46:45,640 AS NEW AREAS ARE IDENTIFYING 2250 01:46:45,640 --> 01:46:47,720 THIS AS A NEED THANK YOU ALL SO 2251 01:46:47,720 --> 01:46:49,360 MUCH FOR THE INVITATION. 2252 01:46:49,360 --> 01:46:50,920 HAVE YOU MY CONTACT INFORMATION. 2253 01:46:50,920 --> 01:46:57,400 I HOPE TO SEE THIS WORK EXPLODE 2254 01:46:57,400 --> 01:47:01,280 WITHIN THE NEI PORTFOLIO AND 2255 01:47:01,280 --> 01:47:02,600 LOOK FORWARD TO CONTINUING THE 2256 01:47:02,600 --> 01:47:03,040 CONVERSATION. 2257 01:47:03,040 --> 01:47:06,120 >>THANK YOU FOR DOING THIS 2258 01:47:06,120 --> 01:47:08,200 ESPECIALLY IN THE MIDDLE OF A 2259 01:47:08,200 --> 01:47:09,240 BUSY JOB AN LIFE TRANSITION FOR 2260 01:47:09,240 --> 01:47:11,680 YOU AND WE'LL LOOK FORWARD TO 2261 01:47:11,680 --> 01:47:13,280 STAYING IN TOUCH. 2262 01:47:13,280 --> 01:47:15,320 OBVIOUSLY FINDING WAYS WE CAN DO 2263 01:47:15,320 --> 01:47:15,680 THINGS TOGETHER. 2264 01:47:15,680 --> 01:47:16,040 THANK YOU AGAIN. 2265 01:47:16,040 --> 01:47:25,200 >>THANK YOU. 2266 01:47:25,200 --> 01:47:28,440 >>JENNY, MAY I INTRODUCE YOU? 2267 01:47:28,440 --> 01:47:30,760 >>ABSOLUTELY. 2268 01:47:30,760 --> 01:47:34,240 THANK YOU, MIKE. 2269 01:47:34,240 --> 01:47:37,400 >>THIS IS GOING TO BE A GREAT 2270 01:47:37,400 --> 01:47:42,680 TALK TO FOLLOW ON WHAT RINAD HAD 2271 01:47:42,680 --> 01:47:44,400 TALKED ABOUT. 2272 01:47:44,400 --> 01:47:48,120 LET ME -- JENNIFER SUN IS AN 2273 01:47:48,120 --> 01:47:49,640 ASSOCIATE PROFESSOR AT HARVARD 2274 01:47:49,640 --> 01:47:51,880 AT THE JOCELYN DIABETES CENTER 2275 01:47:51,880 --> 01:47:53,160 AND DIRECTS CLINICAL EYE 2276 01:47:53,160 --> 01:47:56,920 RESEARCH THERE AND SHE IS 2277 01:47:56,920 --> 01:47:59,680 BASICALLY HAS BEEN REELECTED AS 2278 01:47:59,680 --> 01:48:01,600 A SECOND TERM OF THE CHAIR FOR 2279 01:48:01,600 --> 01:48:03,760 DIABETES INITIATIVES AT THE DRCR 2280 01:48:03,760 --> 01:48:07,520 RETINA NETWORK WHICH IS ONE OF 2281 01:48:07,520 --> 01:48:09,880 OUR TWO MAIN NEI FUNDED 2282 01:48:09,880 --> 01:48:11,600 COLLABORATIVE RESEARCH NETWORKS. 2283 01:48:11,600 --> 01:48:17,640 IT HAS ORIGINS IN DIABETIC 2284 01:48:17,640 --> 01:48:19,320 RETINOPATHY AND DOES RESEARCH 2285 01:48:19,320 --> 01:48:22,880 MORE BROADLY. 2286 01:48:22,880 --> 01:48:29,600 JENNY'S BEEN CHAIR ON DRCR 2287 01:48:29,600 --> 01:48:34,160 RETINA STUDIES. 2288 01:48:34,160 --> 01:48:35,280 SHE'S THE CO-SCIENTIFIC DIRECTOR 2289 01:48:35,280 --> 01:48:39,560 FOR THE MARY TYLER MOORE VISION 2290 01:48:39,560 --> 01:48:41,400 INITIATIVE BASICALLY LOOKING AT 2291 01:48:41,400 --> 01:48:42,600 RETINOPATHY STAGING. 2292 01:48:42,600 --> 01:48:45,320 AND IN DOING THAT SHE WORKS WITH 2293 01:48:45,320 --> 01:48:50,400 PEOPLE LIKE TOM GARDNER AND WITH 2294 01:48:50,400 --> 01:48:53,240 THAT EXCITED TO HEAR JENNY TALK 2295 01:48:53,240 --> 01:48:53,960 ABOUT DISSEMINATION OF CLINICAL 2296 01:48:53,960 --> 01:48:55,840 TRIAL RESULTS. 2297 01:48:55,840 --> 01:48:57,640 MAY I TURN TO YOU? 2298 01:48:57,640 --> 01:49:02,520 THANK YOU FOR BEING HERE. 2299 01:49:02,520 --> 01:49:03,600 >>THANK YOU SO MUCH. 2300 01:49:03,600 --> 01:49:09,600 I'LL SHARE MY SCREEN AND SLIDES 2301 01:49:09,600 --> 01:49:20,040 AND HOPEFULLY I APPRECIATE THE 2302 01:49:20,040 --> 01:49:21,240 OPPORTUNITY TO BE HERE AND 2303 01:49:21,240 --> 01:49:24,360 EXCITING TO BE PART OF THE 2304 01:49:24,360 --> 01:49:24,680 CONVERSATION. 2305 01:49:24,680 --> 01:49:26,720 I KNOW A LITTLE ABOUT 2306 01:49:26,720 --> 01:49:28,400 IMPLEMENTATION SCIENCE AND I'LL 2307 01:49:28,400 --> 01:49:29,640 TALK ABOUT THE THINGS RI NARD 2308 01:49:29,640 --> 01:49:32,320 TALKED ABOUT IN TERMS OF THE 2309 01:49:32,320 --> 01:49:33,600 THINGS WE'RE LOOKING TO 2310 01:49:33,600 --> 01:49:35,360 UNDERSTAND WITH IMPLEMENTATION 2311 01:49:35,360 --> 01:49:35,640 SCIENCE. 2312 01:49:35,640 --> 01:49:38,760 HERE'S MY FINANCIAL DISCLOSURES. 2313 01:49:38,760 --> 01:49:39,920 RINAD I'LL TRANSITION FROM HER 2314 01:49:39,920 --> 01:49:44,800 TALK BY SHOWING ONE OF HER 2315 01:49:44,800 --> 01:49:45,040 SLIDES. 2316 01:49:45,040 --> 01:49:48,960 SHE MENTIONED ONE OF THE 2317 01:49:48,960 --> 01:49:49,520 ASSUMPTIONS IS THERE'S AN 2318 01:49:49,520 --> 01:49:50,720 EVIDENCE-BASED THING TO BE 2319 01:49:50,720 --> 01:49:51,240 IMPLEMENTED. 2320 01:49:51,240 --> 01:49:54,520 MY TALK WILL FOCUS ON WHAT ARE 2321 01:49:54,520 --> 01:49:56,640 THE EVIDENCE-BASED THINGS OR 2322 01:49:56,640 --> 01:49:59,320 PRACTICES THAT WE HAVE IN 2323 01:49:59,320 --> 01:50:00,760 OPHTHALMOLOGY AND THOUGHT I'D 2324 01:50:00,760 --> 01:50:04,760 FOCUS ON THIS SET OF MAJOR 2325 01:50:04,760 --> 01:50:05,120 QUESTIONS. 2326 01:50:05,120 --> 01:50:07,400 HOW DO WE DEVELOP NEW PRACTICES 2327 01:50:07,400 --> 01:50:10,400 AND HOW DO WE DETERMINE WHICH 2328 01:50:10,400 --> 01:50:13,600 PRACTICES WILL BENEFIT OUR 2329 01:50:13,600 --> 01:50:17,440 PATIENTS AND DISSEMINATE 2330 01:50:17,440 --> 01:50:18,680 INFORMATION TO THE COMMUNITY AND 2331 01:50:18,680 --> 01:50:20,920 ONE THING I'LL POSE IS HOW DO WE 2332 01:50:20,920 --> 01:50:22,800 KNOW WHETHER THE PRACTICES ARE 2333 01:50:22,800 --> 01:50:25,640 BEING SUCCESSFULLY IMPLEMENTED 2334 01:50:25,640 --> 01:50:26,040 IN CLINICAL CARE? 2335 01:50:26,040 --> 01:50:28,800 I'M GOING IT TALK ABOUT THIS 2336 01:50:28,800 --> 01:50:31,480 THROUGH THE LENS OF MY VERY 2337 01:50:31,480 --> 01:50:34,920 SPECIFIC WORK IN DIABETIC 2338 01:50:34,920 --> 01:50:35,840 RETINAL DISEASE. 2339 01:50:35,840 --> 01:50:37,920 THOUGH THERE'S A WIDE RANGE OF 2340 01:50:37,920 --> 01:50:38,920 EXPERTISE IN THE COUNCIL MANY 2341 01:50:38,920 --> 01:50:41,600 ARE FAMILIAR WITH THE STAGING 2342 01:50:41,600 --> 01:50:46,200 SYSTEM THAT WAS DEVELOPED IN THE 2343 01:50:46,200 --> 01:50:47,840 EARLY TREATMENT OF DIABETIC 2344 01:50:47,840 --> 01:50:52,600 RETINOPATHY TO GRADE SEVERITY 2345 01:50:52,600 --> 01:50:55,000 BASED ON THE LESIONS THAT 2346 01:50:55,000 --> 01:50:57,640 DEVELOP THAT MOVE THROUGH THE 2347 01:50:57,640 --> 01:51:02,880 SPECTRUM OF NO DIABETIC 2348 01:51:02,880 --> 01:51:05,080 RETINOPATHY TO MILD, AND MORE 2349 01:51:05,080 --> 01:51:08,000 ADVANCED STAGES WHERE PATIENTS 2350 01:51:08,000 --> 01:51:09,640 MAY DEVELOP NEW ABNORMAL VESSELS 2351 01:51:09,640 --> 01:51:16,360 AND AT RISK OF BLEEDING AND 2352 01:51:16,360 --> 01:51:16,760 VISION LOSS. 2353 01:51:16,760 --> 01:51:19,720 AND OVER THE DECADES WE'VE GROWN 2354 01:51:19,720 --> 01:51:21,600 TO UNDERSTAND THERE'S A LARGE 2355 01:51:21,600 --> 01:51:23,120 DEGREE OF NEURAL RETINAL 2356 01:51:23,120 --> 01:51:26,680 DEGENERATION THAT ACCOMPANIES 2357 01:51:26,680 --> 01:51:32,080 THESE STAGES THAT'S NOT 2358 01:51:32,080 --> 01:51:36,200 ADDRESSED AND PARTS CAN GET 2359 01:51:36,200 --> 01:51:40,800 SWELLING OF THE RETINA WHICH IS 2360 01:51:40,800 --> 01:51:42,560 A COMMON VISION LOSS CAUSE. 2361 01:51:42,560 --> 01:51:44,520 MIKE MENTIONED THE VISION 2362 01:51:44,520 --> 01:51:49,720 INITIATIVE AND TOM IS A LARGE 2363 01:51:49,720 --> 01:51:52,760 PART OF THAT AND WE FOCUS ON AN 2364 01:51:52,760 --> 01:51:58,200 EARLIER EFFORT AND BROADEN THE 2365 01:51:58,200 --> 01:52:01,920 UNDERSTANDING OF DIABETIC 2366 01:52:01,920 --> 01:52:03,920 RETINAL DISEASE AND LOOKING AT 2367 01:52:03,920 --> 01:52:07,200 ONE THAT'S MORE WHOLISTIC 2368 01:52:07,200 --> 01:52:08,120 ENCOMPASSING NEURAL FUNCTION AND 2369 01:52:08,120 --> 01:52:10,520 THE RETINA AND THE SYSTEMIC 2370 01:52:10,520 --> 01:52:11,760 HEALTH OF THE PATIENT THAT'S 2371 01:52:11,760 --> 01:52:13,600 IMPORTANT IN TERMS OF GLYCEMIC 2372 01:52:13,600 --> 01:52:15,280 CONTROL AND CONTROL OF OTHER 2373 01:52:15,280 --> 01:52:18,200 RISK FACTORS. 2374 01:52:18,200 --> 01:52:20,560 ALL THOSE TIE INTO HOW PATIENT'S 2375 01:52:20,560 --> 01:52:22,080 VISUAL FUNCTION CHANGES OVER THE 2376 01:52:22,080 --> 01:52:23,440 COURSE OF THEIR LIFE AND QUALITY 2377 01:52:23,440 --> 01:52:24,680 OF LIFE AS WELL WHICH IS 2378 01:52:24,680 --> 01:52:26,760 IMPORTANT TO CONSIDER AS WE 2379 01:52:26,760 --> 01:52:28,400 THINK ABOUT NEW TREATMENTS, HOW 2380 01:52:28,400 --> 01:52:31,800 IT AFFECTS PATIENTS DIRECTLY. 2381 01:52:31,800 --> 01:52:33,960 I'LL TALK ABOUT DIABETIC RETINAL 2382 01:52:33,960 --> 01:52:35,440 DISEASE AND SPECIFICALLY THE 2383 01:52:35,440 --> 01:52:38,640 EFFORTS THAT HAVE BEEN PERFORMED 2384 01:52:38,640 --> 01:52:41,640 IN DIABETIC RETINAL DISEASE IN 2385 01:52:41,640 --> 01:52:44,520 STUDIES FROM THE RETINA NETWORK. 2386 01:52:44,520 --> 01:52:47,520 IT'S KNOWN AS THE DIABETIC 2387 01:52:47,520 --> 01:52:49,120 RETINOPATHY CLINIC STUDIES 2388 01:52:49,120 --> 01:52:52,680 NETWORK AND WE'RE A 2389 01:52:52,680 --> 01:52:53,400 COLLABORATIVE NETWORK OF DIVERSE 2390 01:52:53,400 --> 01:52:54,880 SITES ACROSS NORTH AMERICA, 2391 01:52:54,880 --> 01:52:57,000 U.S. AND CANADA AND DEDICATED TO 2392 01:52:57,000 --> 01:52:59,840 WHAT WE HOPE IS VIGOROUS 2393 01:52:59,840 --> 01:53:05,120 IMPACTFUL RESEARCH OF RETINAL 2394 01:53:05,120 --> 01:53:06,400 DISEASES. 2395 01:53:06,400 --> 01:53:09,520 AND I'LL USE OUR STUDIES AS AN 2396 01:53:09,520 --> 01:53:12,840 EXAMPLE MOVING FORWARD, THIS 2397 01:53:12,840 --> 01:53:15,200 NETWORK WAS INITIALLY CONCEIVED 2398 01:53:15,200 --> 01:53:17,640 OF IN 2002 WHEN THE NATIONAL EYE 2399 01:53:17,640 --> 01:53:19,440 INSTITUTE DISTRIBUTED THE RFA TO 2400 01:53:19,440 --> 01:53:21,640 CREATE AN INFRASTRUCTURE TO 2401 01:53:21,640 --> 01:53:23,840 ACCELERATE DEVELOPMENT AND 2402 01:53:23,840 --> 01:53:25,600 CONDUCT CLINICAL STUDIES IN 2403 01:53:25,600 --> 01:53:28,640 DIABETIC RETINOPATHY AND IT WAS 2404 01:53:28,640 --> 01:53:33,280 CREATED IN CONTEXT OF TWO 2405 01:53:33,280 --> 01:53:34,080 REALIZATIONS. 2406 01:53:34,080 --> 01:53:37,000 ONE WAS THAT THERE HAD NOT BEEN 2407 01:53:37,000 --> 01:53:38,720 A MAJOR ADVANCE SINCE THE 2408 01:53:38,720 --> 01:53:40,240 DEVELOPMENT OF THE LASER WHICH 2409 01:53:40,240 --> 01:53:41,840 WAS FIRST CONCEIVED IN THE LATE 2410 01:53:41,840 --> 01:53:42,880 1960s. 2411 01:53:42,880 --> 01:53:52,280 AND SECONDLY, THIS WAS A VERY 2412 01:53:52,280 --> 01:53:53,640 EXCITING TIMES BECAUSE THERE 2413 01:53:53,640 --> 01:53:58,480 WERE NEW PATHWAYS AND VASCULAR 2414 01:53:58,480 --> 01:53:59,520 ENDOTHELIAL GROWTH FACTOR AND IT 2415 01:53:59,520 --> 01:54:01,360 WAS UNDERSTOOD THIS WOULD BE A 2416 01:54:01,360 --> 01:54:03,040 NEW ERA IN THE UNDERSTANDING OF 2417 01:54:03,040 --> 01:54:05,080 THE NEW MOLECULAR PATHWAYS OF 2418 01:54:05,080 --> 01:54:07,560 THERAPEUTICS TO TARGET THEM. 2419 01:54:07,560 --> 01:54:09,600 IN 2002 THE DIABETIC RETINOPATHY 2420 01:54:09,600 --> 01:54:11,800 RESEARCH NETWORK WAS CREATED AND 2421 01:54:11,800 --> 01:54:15,240 OVER THE SUBSEQUENT 20 YEARS 2422 01:54:15,240 --> 01:54:17,440 WE'VE PERFORMED AND BEGUN 38 2423 01:54:17,440 --> 01:54:20,720 MULTI-CENTER STUDIES WITH 117 2424 01:54:20,720 --> 01:54:22,400 PUBLICATIONS IN THE 2425 01:54:22,400 --> 01:54:23,880 PEER-REVIEWED LITERATURE. 2426 01:54:23,880 --> 01:54:26,520 WE WERE HONORED AND PLEASED IN 2427 01:54:26,520 --> 01:54:30,320 2017 THE NATIONAL EYE INSTITUTE 2428 01:54:30,320 --> 01:54:33,560 RECOGNIZED OUR SUCCESS IN THE BY 2429 01:54:33,560 --> 01:54:36,440 EXPANDING OUR SCOPE TO ALL 2430 01:54:36,440 --> 01:54:41,080 RETINAL DISEASES. 2431 01:54:41,080 --> 01:54:46,080 OUR COLLABORATIVE NETWORK IS ONE 2432 01:54:46,080 --> 01:54:52,320 OF THE CENTRAL CORES AND WE HAVE 2433 01:54:52,320 --> 01:54:55,480 BEEN GUIDED THROUGH MANY YEARS 2434 01:54:55,480 --> 01:54:59,040 NOW OF OUR WORK TOGETHER. 2435 01:54:59,040 --> 01:55:01,960 AND OUR COORDINATING CENTER IS 2436 01:55:01,960 --> 01:55:02,320 EXTRAORDINARY. 2437 01:55:02,320 --> 01:55:06,960 AND WE HAVE THE EXECUTIVE 2438 01:55:06,960 --> 01:55:08,400 DIRECTOR AND WE ARE PRIVILEGED 2439 01:55:08,400 --> 01:55:11,840 TO WORK WITH THEM AND TALENTED 2440 01:55:11,840 --> 01:55:13,720 FOLKS ON THE STUDIES. 2441 01:55:13,720 --> 01:55:18,400 AND DAN MARTIN AND I HAVE AND 2442 01:55:18,400 --> 01:55:21,600 HE'S FROM THE CLEVELAND CLINIC 2443 01:55:21,600 --> 01:55:26,240 AND WE HAVE A CHAIR FROM OTHER 2444 01:55:26,240 --> 01:55:27,600 RETINAL DISEASES AND OUR SITES 2445 01:55:27,600 --> 01:55:29,640 ARE THE LIFE BLOOD OF OUR 2446 01:55:29,640 --> 01:55:31,800 NETWORK AND TO GIVE A SNAPSHOT 2447 01:55:31,800 --> 01:55:35,840 OF OUR PARTICIPATION WE HAD 139 2448 01:55:35,840 --> 01:55:39,200 ACTIVE SITES AND 389 2449 01:55:39,200 --> 01:55:42,720 INVESTIGATORS AND OTHER 2450 01:55:42,720 --> 01:55:43,600 PERSONNEL IN THE UNITED STATES 2451 01:55:43,600 --> 01:55:44,280 AND CANADA. 2452 01:55:44,280 --> 01:55:46,240 THIS IS FAR REACHING IN NORTH 2453 01:55:46,240 --> 01:55:47,120 AMERICA. 2454 01:55:47,120 --> 01:55:51,840 TO DATE WE'VE COMPLETED 30 2455 01:55:51,840 --> 01:55:52,200 STUDIES. 2456 01:55:52,200 --> 01:55:57,640 THIS IS COMPLETED NETWORK 2457 01:55:57,640 --> 01:55:57,880 PROTOCOL. 2458 01:55:57,880 --> 01:55:58,040 S. 2459 01:55:58,040 --> 01:55:59,680 YOU SEE THE TIME LINES FOR 2460 01:55:59,680 --> 01:56:01,240 EQUIPMENT AND THE NUMBER OF 2461 01:56:01,240 --> 01:56:03,160 STUDIES WE PERFORMED HAS ALLOWED 2462 01:56:03,160 --> 01:56:08,840 US TO REACH ACROSS THE BREADTH 2463 01:56:08,840 --> 01:56:10,080 OF COMPLICATIONS AND THE 2464 01:56:10,080 --> 01:56:11,960 SEVERITY STAGES OF RETINOPATHY. 2465 01:56:11,960 --> 01:56:14,640 I'LL TALK ABOUT THESE AS WE GO 2466 01:56:14,640 --> 01:56:14,920 FORWARD. 2467 01:56:14,920 --> 01:56:16,280 AND ANOTHER THING TO NOTE IS WE 2468 01:56:16,280 --> 01:56:19,520 NAME OUR PROTOCOLS BY LETTERS OF 2469 01:56:19,520 --> 01:56:23,520 THE ALPHABET AND PART WITH 2470 01:56:23,520 --> 01:56:25,600 PROTOCOL A, OUR LASER PROTOCOL 2471 01:56:25,600 --> 01:56:27,720 AND NOW IN OUR SECOND ALPHABET. 2472 01:56:27,720 --> 01:56:30,040 OUR NEXT STUDY TO BE STOOD UP 2473 01:56:30,040 --> 01:56:32,200 WILL BE PROTOCOL AO. 2474 01:56:32,200 --> 01:56:35,720 LET'S START TALKING ABOUT 2475 01:56:35,720 --> 01:56:37,520 DEVELOPMENT, DETERMINATION AND 2476 01:56:37,520 --> 01:56:37,880 DISSEMINATION. 2477 01:56:37,880 --> 01:56:40,360 I'LL START BY ASKING HOW DO WE 2478 01:56:40,360 --> 01:56:43,120 EVOLVE NEW PRACTICES THAT CAN BE 2479 01:56:43,120 --> 01:56:45,600 EVALUATED FOR USE IN CLINICAL 2480 01:56:45,600 --> 01:56:46,640 CARE? 2481 01:56:46,640 --> 01:56:52,480 WE DO THIS THROUGH OUR CLINICAL 2482 01:56:52,480 --> 01:56:52,960 STUDIES. 2483 01:56:52,960 --> 01:56:55,960 IT'S WORTHWHILE TO TALK ABOUT 2484 01:56:55,960 --> 01:56:58,600 THE REVOLUTION OF OUR STUDIES 2485 01:56:58,600 --> 01:56:59,920 AND HOW THEY'VE DEVELOPED. 2486 01:56:59,920 --> 01:57:02,160 WE ACCEPT IDEAS TO THE NETWORK 2487 01:57:02,160 --> 01:57:07,400 THROUGH THE COORDINATING CENTER 2488 01:57:07,400 --> 01:57:09,640 AND WE'LL TYPICALLY REQUEST NEW 2489 01:57:09,640 --> 01:57:11,280 PROTOCOL IDEAS FROM 2490 01:57:11,280 --> 01:57:13,000 INVESTIGATORS TWICE A YEAR AND 2491 01:57:13,000 --> 01:57:15,720 WE WELCOME THEM ANY TIME OF THE 2492 01:57:15,720 --> 01:57:21,040 YEAR INTERNAL. 2493 01:57:21,040 --> 01:57:29,320 THE FORMS ARE PUBLIC AVAILABLE 2494 01:57:29,320 --> 01:57:31,200 ONLINE AND ONE STEERING 2495 01:57:31,200 --> 01:57:32,240 COMMITTEE THAT FOCUSES ON THE 2496 01:57:32,240 --> 01:57:34,160 DIABETES STUDIES AND ONE THAT 2497 01:57:34,160 --> 01:57:36,760 FOCUSES ON THE RETINAL STUDIES. 2498 01:57:36,760 --> 01:57:39,480 THE STEERING COMMITTEE REVIEWS 2499 01:57:39,480 --> 01:57:40,760 PROPOSALS FOR SCIENTIFIC MERIT 2500 01:57:40,760 --> 01:57:42,680 AND IF THERE'S ENTHUSIASM TO 2501 01:57:42,680 --> 01:57:44,720 MOVE FORWARD AND THERE'S A LARGE 2502 01:57:44,720 --> 01:57:48,600 FUNNEL BECAUSE WE FIND THAT 2503 01:57:48,600 --> 01:57:49,400 FREQUENTLY THERE ARE QUESTIONS 2504 01:57:49,400 --> 01:57:52,120 OF INTEREST TO THE PUBLIC OR 2505 01:57:52,120 --> 01:57:54,040 PROPOSERS WE MAY HAVE CONSIDERED 2506 01:57:54,040 --> 01:57:57,000 BEFORE AND KNOW FOR SURE IT'S 2507 01:57:57,000 --> 01:58:00,880 NOT GOING TO MOVE FORWARD FOR 2508 01:58:00,880 --> 01:58:02,720 FEASIBILITY REASONS OR EXPERTISE 2509 01:58:02,720 --> 01:58:08,160 IN THE NETWORK AND IDEAS WE 2510 01:58:08,160 --> 01:58:10,040 THINK HAVE POTENTIAL TO MOVE 2511 01:58:10,040 --> 01:58:11,640 FORWARD ARE PRESENTED AND WE GO 2512 01:58:11,640 --> 01:58:15,160 BACK TO IN-PERSON MEETINGS FOR 2513 01:58:15,160 --> 01:58:17,240 THE FIRST TIME THIS AUGUST. 2514 01:58:17,240 --> 01:58:19,360 WE REVIEWED THE IDEAS IN THE 2515 01:58:19,360 --> 01:58:20,520 STEERING COMMITTEES TO SEE IF 2516 01:58:20,520 --> 01:58:22,800 THERE'S ANY FEEDBACK THAT HAS 2517 01:58:22,800 --> 01:58:25,960 CHANGED OUR APPROACH PERHAPS OR 2518 01:58:25,960 --> 01:58:27,480 CAN WE GIVE ADDITIONAL TIPS TO 2519 01:58:27,480 --> 01:58:30,640 THE PEOPLE THAT ROW POSE THE 2520 01:58:30,640 --> 01:58:31,960 IDEA TO TWEAK PROTOCOL PROPOSALS 2521 01:58:31,960 --> 01:58:35,120 TO MAKE THEM MORE LIKELY TO MOVE 2522 01:58:35,120 --> 01:58:36,880 FORWARD AND THEN PRIORITIZED 2523 01:58:36,880 --> 01:58:38,840 IDEAS ARE PRESENTED TO OUR 2524 01:58:38,840 --> 01:58:40,640 EXECUTIVE COMMITTEE AND IT'S THE 2525 01:58:40,640 --> 01:58:42,680 BODY THAT PRIORITIZES PROTOCOL 2526 01:58:42,680 --> 01:58:43,840 DEVELOPMENT BASED ON OUR NETWORK 2527 01:58:43,840 --> 01:58:45,640 RESOURCES AND WHAT WE THINK IS 2528 01:58:45,640 --> 01:58:47,880 THE PUBLIC HEALTH IMPORTANCE OF 2529 01:58:47,880 --> 01:58:48,480 THESE IDEAS. 2530 01:58:48,480 --> 01:58:52,280 IF AN IDEA MAKES IT THROUGH 2531 01:58:52,280 --> 01:58:55,360 THAT, IT'S JUST THE BEGINNING OF 2532 01:58:55,360 --> 01:58:58,040 THE PROTOCOL DEVELOPMENT 2533 01:58:58,040 --> 01:58:58,960 PROCESS. 2534 01:58:58,960 --> 01:59:01,600 INITIAL PROTOCOLS ARE CREATED 2535 01:59:01,600 --> 01:59:04,160 AND TYPICALLY OUR COMMITTEES WE 2536 01:59:04,160 --> 01:59:08,040 SPEND THREE MONTHS TO A YEAR ON 2537 01:59:08,040 --> 01:59:16,400 THE PROTOCOL DRAFTING. 2538 01:59:16,400 --> 01:59:18,640 IT'S THEN REVIEWED BY OUR 2539 01:59:18,640 --> 01:59:21,640 NETWORK AND COLLABORATORS AND 2540 01:59:21,640 --> 01:59:23,880 ASK FOR COMMITTEE MEMBERS TO DO 2541 01:59:23,880 --> 01:59:27,320 DETAILED REVIEW AND WE WANT 2542 01:59:27,320 --> 01:59:28,760 SOMEBODY LOOKING AT THIS WITH 2543 01:59:28,760 --> 01:59:30,080 FRESH EYES AND SIGH IF THERE'S 2544 01:59:30,080 --> 01:59:33,640 ANYTHING WE MISSED DURING THE 2545 01:59:33,640 --> 01:59:41,200 DEVELOPMENT PROCESS. 2546 01:59:41,200 --> 01:59:47,840 WE UNDER GO REVIEW FROM THE 2547 01:59:47,840 --> 01:59:50,920 COMMITTEE AND THEN THE 2548 01:59:50,920 --> 01:59:53,120 PROTOCOL'S REVIEWED AND REVISED 2549 01:59:53,120 --> 01:59:54,480 WITH COMMENTS AND HOPEFULLY GET 2550 01:59:54,480 --> 01:59:55,720 APPROVAL TO PROCEED WITH THE 2551 01:59:55,720 --> 01:59:56,920 STUDY. 2552 01:59:56,920 --> 01:59:59,400 WE ALSO HAVE A PROTOCOL APPROVED 2553 01:59:59,400 --> 02:00:01,680 BY OUR DATA SAFETY MONITORING 2554 02:00:01,680 --> 02:00:05,520 COMMITTEE AND REVISED BASED ON 2555 02:00:05,520 --> 02:00:06,400 THE COMMENTS. 2556 02:00:06,400 --> 02:00:10,560 ALL THESE STEPS LEAD TO A FINAL 2557 02:00:10,560 --> 02:00:10,920 PROTOCOL. 2558 02:00:10,920 --> 02:00:15,280 AND YOU CAN IMAGINE THERE'S AN 2559 02:00:15,280 --> 02:00:19,000 ENORMOUS AMOUNT OF REVISION AND 2560 02:00:19,000 --> 02:00:19,760 DISCUSSION AND RICH DISCUSSION 2561 02:00:19,760 --> 02:00:23,200 OVER THE COURSE OF ALL THESE 2562 02:00:23,200 --> 02:00:25,440 VARIOUS STEPS OF MULTI-LAYERED 2563 02:00:25,440 --> 02:00:25,720 APPROVAL. 2564 02:00:25,720 --> 02:00:29,600 OUR MOST RECENT STUDY WE 2565 02:00:29,600 --> 02:00:32,160 COMPLETED WAS PUBLISHED IN 2566 02:00:32,160 --> 02:00:33,000 AUGUST IN THE NEW ENGLAND 2567 02:00:33,000 --> 02:00:34,680 JOURNAL OF MEDICINE. 2568 02:00:34,680 --> 02:00:37,880 THIS WAS THE FIRST PHASE 3 STUDY 2569 02:00:37,880 --> 02:00:41,360 FOR MACULAR EDEMA AND TYPICALLY 2570 02:00:41,360 --> 02:00:43,200 YOU USE A LESS EXPENSIVE 2571 02:00:43,200 --> 02:00:44,600 MEDICATION OR INTERVENTION FIRST 2572 02:00:44,600 --> 02:00:46,760 AND ONLY MOVING TO MORE 2573 02:00:46,760 --> 02:00:49,600 EXPENSIVE AND OFFICIALLY MORE 2574 02:00:49,600 --> 02:00:52,040 EFFICACIOUS MEDICATIONS OR 2575 02:00:52,040 --> 02:00:55,560 INTERVENTIONS AFTER. 2576 02:00:55,560 --> 02:00:59,480 THIS STUDY LOOKED AT PATIENTS 2577 02:00:59,480 --> 02:01:01,320 WITH MACULAR EDEMA AND 2578 02:01:01,320 --> 02:01:06,960 RANDOMIZED THEM TO THE CURRENT 2579 02:01:06,960 --> 02:01:09,400 STANDARD THERAPY AND THERE'S A 2580 02:01:09,400 --> 02:01:11,200 MEDICATION INJECTED IN THE EYES. 2581 02:01:11,200 --> 02:01:16,200 IT'S BEEN SHOWN TO BE THE MOST 2582 02:01:16,200 --> 02:01:17,600 EFFECTIVE IN THREE OF OUR MOST 2583 02:01:17,600 --> 02:01:20,440 USED MEDICATION IN A PRIOR 2584 02:01:20,440 --> 02:01:24,040 NETWORK STUDY AND WE COMPARED IT 2585 02:01:24,040 --> 02:01:28,680 TO THE FIRST STRATEGY AND 2586 02:01:28,680 --> 02:01:37,480 STARTED LOOKING AT BEVACIZUMAB 2587 02:01:37,480 --> 02:01:39,320 AND A SWITCH IF MORE OPTIMAL AND 2588 02:01:39,320 --> 02:01:42,400 FOUND THAT STRATEGY WAS 2589 02:01:42,400 --> 02:01:44,440 EFFECTIVE AT IMPROVING VISION 2590 02:01:44,440 --> 02:01:46,320 OVER TWO YEARS STARTING 2591 02:01:46,320 --> 02:01:46,600 IMMEDIATELY. 2592 02:01:46,600 --> 02:01:49,400 THERE'S LARGE COST AVAILABILITY 2593 02:01:49,400 --> 02:01:53,120 WITHIN THE DRUGS. 2594 02:01:53,120 --> 02:02:03,520 THERE'S A 26 FOLD COST 2595 02:02:05,120 --> 02:02:09,240 DIFFERENCE AND I THINK THE STUDY 2596 02:02:09,240 --> 02:02:11,880 OUTLINES A STANDARDIZED REGIMENT 2597 02:02:11,880 --> 02:02:14,560 USING OUR INJECTIONS OF 2598 02:02:14,560 --> 02:02:17,360 MEDICATION AND CRITERIA WE USED 2599 02:02:17,360 --> 02:02:19,920 TO DETERMINE WHEN PATIENTS 2600 02:02:19,920 --> 02:02:21,600 SHOULD SWITCH THAT CAN BE USED 2601 02:02:21,600 --> 02:02:23,280 IN CLINICAL CARE. 2602 02:02:23,280 --> 02:02:26,360 AND SO I'M GOING TO WALK YOU 2603 02:02:26,360 --> 02:02:29,600 THROUGH A LITTLE BIT OF A 2604 02:02:29,600 --> 02:02:32,800 PROCESS OF OUR SWITCH CRITERIA. 2605 02:02:32,800 --> 02:02:36,800 THIS WAS A CRITICAL PART OF OUR 2606 02:02:36,800 --> 02:02:37,000 STUDY. 2607 02:02:37,000 --> 02:02:40,480 WE STARTED THE DISCUSSION BACK 2608 02:02:40,480 --> 02:02:46,640 IN APRIL 2016 AND WE ASKED THE 2609 02:02:46,640 --> 02:02:50,920 COMMITTEE IN THE STUDY, HOW MUCH 2610 02:02:50,920 --> 02:02:52,880 SHOULD THE SWITCH CRITERIA BE 2611 02:02:52,880 --> 02:02:53,320 DEFINED? 2612 02:02:53,320 --> 02:02:53,880 WE GAVE OUR COMMITTEE SIX 2613 02:02:53,880 --> 02:03:00,760 OPTIONS. 2614 02:03:00,760 --> 02:03:02,920 AND BASICALLY WE PRIORITIZED 2615 02:03:02,920 --> 02:03:04,800 SWITCHING IN DIFFERENT WAYS. 2616 02:03:04,800 --> 02:03:08,920 WE SAID DO YOU PRIORITIZE VISUAL 2617 02:03:08,920 --> 02:03:14,560 ACUITY BY ITSELF OR AS WELL AS 2618 02:03:14,560 --> 02:03:16,320 WHAT'S HAPPENING WITH THE 2619 02:03:16,320 --> 02:03:16,640 THICKENING. 2620 02:03:16,640 --> 02:03:18,520 WHAT ABOUT TRENDS OR CHANGES 2621 02:03:18,520 --> 02:03:19,000 OVER TIME? 2622 02:03:19,000 --> 02:03:22,240 DO YOU THINK WE WANT TO SWITCH 2623 02:03:22,240 --> 02:03:24,880 EYES THAT ARE GETTING WORSE IN 2624 02:03:24,880 --> 02:03:25,120 VISION. 2625 02:03:25,120 --> 02:03:29,200 THIS FRANKLY DOESN'T HAPPEN 2626 02:03:29,200 --> 02:03:32,480 OFTEN SO PERHAPS WE WANT TO 2627 02:03:32,480 --> 02:03:35,920 SWITCH THE EYE ARE NOT IMPROVING 2628 02:03:35,920 --> 02:03:37,520 SUFFICIENTLY AND THIS IS FROM A 2629 02:03:37,520 --> 02:03:39,800 DEDICATED GROUP OF PEOPLE ON 2630 02:03:39,800 --> 02:03:43,840 THIS ULTIMATELY WE DECIDED WE 2631 02:03:43,840 --> 02:03:45,080 WANTED PHILOSOPHICALLY TO SWITCH 2632 02:03:45,080 --> 02:03:47,040 EYES THAT WERE NOT IMPROVING 2633 02:03:47,040 --> 02:03:48,320 SUFFICIENTLY AND CAME UP WITH A 2634 02:03:48,320 --> 02:03:49,720 SWITCH CRITERIA. 2635 02:03:49,720 --> 02:03:51,400 THIS IS OUR FINAL SWITCH 2636 02:03:51,400 --> 02:03:53,040 CRITERIA IB A FLOW CHART AND YOU 2637 02:03:53,040 --> 02:03:55,600 CAN SEE IT'S QUITE DETAILED. 2638 02:03:55,600 --> 02:04:00,520 THIS IS ONE OF THE THINGS WE TRY 2639 02:04:00,520 --> 02:04:08,600 TO BALANCE AS WE WRITE ALGOR 2640 02:04:08,600 --> 02:04:10,360 ALGORITHMS IN CLINICAL TRIALS 2641 02:04:10,360 --> 02:04:13,280 AND WE'RE TRYING TO REDUCE 2642 02:04:13,280 --> 02:04:15,760 INVESTIGATOR DISCRETION OR 2643 02:04:15,760 --> 02:04:16,840 POTENTIAL CONFOUNDERS IN HOW 2644 02:04:16,840 --> 02:04:17,360 DECISIONS ARE MADE. 2645 02:04:17,360 --> 02:04:20,040 WE'RE ABLE TO DO THIS IN THE 2646 02:04:20,040 --> 02:04:23,600 RETINA NETWORK STUDIES BECAUSE 2647 02:04:23,600 --> 02:04:25,560 WE HAVE COMPUTER SUPPORT BEHIND 2648 02:04:25,560 --> 02:04:28,360 OUR DECISION MAKING AND BUILD IN 2649 02:04:28,360 --> 02:04:32,600 ALGORITHMS AND THEY'RE ABLE TO 2650 02:04:32,600 --> 02:04:41,600 ENTER IN THE VISUAL ACUITY DATA 2651 02:04:41,600 --> 02:04:45,880 AND GIVEN ALL THE DATA THIS IS 2652 02:04:45,880 --> 02:04:47,400 WHAT YOU SHOULD DO IF YOU 2653 02:04:47,400 --> 02:04:48,400 DISAGREE WITH THE TREATMENT 2654 02:04:48,400 --> 02:04:50,480 PLAN. 2655 02:04:50,480 --> 02:04:54,320 WE HAVE REMARKABLE ADHERENCE TO 2656 02:04:54,320 --> 02:04:59,320 THESE KINDS OF ALGORITHMS IN OUR 2657 02:04:59,320 --> 02:05:01,320 CLINIC STUDIES. 2658 02:05:01,320 --> 02:05:09,240 IT'S NOT ALWAYS VEIL. 2659 02:05:09,240 --> 02:05:11,360 THE NEXT PHASE IS WHAT HAPPENED 2660 02:05:11,360 --> 02:05:19,000 AS WE MOVED FROM THE SWITCH 2661 02:05:19,000 --> 02:05:20,440 TREATMENT AND IN AUGUST OF THIS 2662 02:05:20,440 --> 02:05:22,880 YEAR WE STARTED TO THINK ABOUT 2663 02:05:22,880 --> 02:05:23,760 PRESENTING THE SWITCH CRITERIA 2664 02:05:23,760 --> 02:05:25,520 AND CAME UP WITH WHAT WE HOPE IS 2665 02:05:25,520 --> 02:05:29,320 AN EASY TO REMEMBER AND EASY TO 2666 02:05:29,320 --> 02:05:31,880 IMPLEMENT WAY TO DEFINE THE 2667 02:05:31,880 --> 02:05:33,760 CRITERIA BASED ON FOUR 2668 02:05:33,760 --> 02:05:34,120 CONSIDERATIONS. 2669 02:05:34,120 --> 02:05:37,000 WE SAID SWITCH IF YOU START WITH 2670 02:05:37,000 --> 02:05:38,160 THE FIRST. 2671 02:05:38,160 --> 02:05:45,840 AND IF ALL FOUR CRITERIA MET AT 2672 02:05:45,840 --> 02:05:47,600 AT THE TIME FRAME AND HAVE IT 2673 02:05:47,600 --> 02:05:50,200 GIVEN IN THE LAST TWO VISITS. 2674 02:05:50,200 --> 02:05:52,480 IF THE EYES HAVEN'T VISIBLY 2675 02:05:52,480 --> 02:05:55,640 IMPROVED OR THE PATIENT REMAINS 2676 02:05:55,640 --> 02:05:55,960 SUB OPTIMAL. 2677 02:05:55,960 --> 02:05:59,320 WE HOPE THE SIMPLIFIED MESSAGE 2678 02:05:59,320 --> 02:06:01,640 IS EASIER FOR CLINICIANS TO 2679 02:06:01,640 --> 02:06:12,120 RETAIN AND REMEMBER TO USE IT. 2680 02:06:14,040 --> 02:06:16,960 AND LOOKING AT THE PRACTICE AND 2681 02:06:16,960 --> 02:06:21,960 LOOKING AT MACULAR EDEMA AND 2682 02:06:21,960 --> 02:06:25,800 RETINOPATHY, I'LL SAY MY VIEW IS 2683 02:06:25,800 --> 02:06:29,520 STRENGTHENED WHEN WE GET DIVERSE 2684 02:06:29,520 --> 02:06:31,960 INPUT AND THE PROCESS CAN BE 2685 02:06:31,960 --> 02:06:32,720 VERY DIFFERENT FROM WHAT YOU END 2686 02:06:32,720 --> 02:06:37,120 UP WITH BUT IS A BETTER PROCESS 2687 02:06:37,120 --> 02:06:37,800 AND PROCESS FROM THE REVIEW AND 2688 02:06:37,800 --> 02:06:42,320 INPUT. 2689 02:06:42,320 --> 02:06:44,800 ALGORITHMS NIGHT TO BE ROOTED IN 2690 02:06:44,800 --> 02:06:46,000 CURRENT CLINICAL PRACTICE 2691 02:06:46,000 --> 02:06:48,480 BECAUSE IT'S DIFFICULT TO GET 2692 02:06:48,480 --> 02:06:50,040 FOLKS TO SWITCH OVER TO 2693 02:06:50,040 --> 02:06:50,960 SOMETHING THERE'S NO RESEMBLANCE 2694 02:06:50,960 --> 02:06:53,840 OF WHAT THEY'RE DOING AS A 2695 02:06:53,840 --> 02:06:57,160 SENSIBLE WAY AND NEED TO BE 2696 02:06:57,160 --> 02:06:58,640 REMEMBERED AND IMPLEMENTED BY 2697 02:06:58,640 --> 02:06:59,040 CLINICIANS. 2698 02:06:59,040 --> 02:07:01,920 WE LEARNED THAT OVER THE COURSE 2699 02:07:01,920 --> 02:07:05,640 OF OUR STUDIES WHERE WE'LL WRITE 2700 02:07:05,640 --> 02:07:11,800 A SECONDARY PAPER DESCRIBING 2701 02:07:11,800 --> 02:07:17,640 PHILOSOPHY BEHIND HE'S AND 2702 02:07:17,640 --> 02:07:26,160 ADDRESSING SCENARIOS. 2703 02:07:26,160 --> 02:07:27,800 IDEALLY TRANSLATABLE FROM LOW TO 2704 02:07:27,800 --> 02:07:28,720 HIGH RESOURCE SETTINGS. 2705 02:07:28,720 --> 02:07:32,400 ONCE WE HAVE THE PRACTICES, HOW 2706 02:07:32,400 --> 02:07:33,600 DO WE EVALUATE WHETHER THEY'LL 2707 02:07:33,600 --> 02:07:38,720 BENEFIT PATIENTS? 2708 02:07:38,720 --> 02:07:41,120 IT'S NO SURPRISE THERE'S A 2709 02:07:41,120 --> 02:07:42,760 HIERARCHY OF EVIDENCE IN 2710 02:07:42,760 --> 02:07:43,920 CLINICAL RESEARCH AND WE'LL 2711 02:07:43,920 --> 02:07:45,280 SOMETIMES SEE THE EMERGENCE OF 2712 02:07:45,280 --> 02:07:50,840 NEW PRACTICES OR INTERVENTIONS 2713 02:07:50,840 --> 02:07:59,040 IN CASE REPORTS THERE'S THE 2714 02:07:59,040 --> 02:08:00,320 HIGHEST QUALITY OF EVIDENCE WHEN 2715 02:08:00,320 --> 02:08:03,240 TALKING ABOUT UNFILTERED DATA 2716 02:08:03,240 --> 02:08:05,600 COMING FROM RANDOMIZED CONTROL 2717 02:08:05,600 --> 02:08:11,240 TRIALS. 2718 02:08:11,240 --> 02:08:14,160 AND WHEN HE YOU LOOK AT THE CARE 2719 02:08:14,160 --> 02:08:21,320 FOR EDEMA AND RETINOPATHY 2720 02:08:21,320 --> 02:08:24,520 BECAUSE THEY CAN BE EVALUATED. 2721 02:08:24,520 --> 02:08:31,920 MACULAR EDEMA WE USUALLY USE A 2722 02:08:31,920 --> 02:08:34,320 FIRST-LINE THERAPY AND WE VARY 2723 02:08:34,320 --> 02:08:35,840 OUR APPROACH DEPENDING ON THE 2724 02:08:35,840 --> 02:08:40,280 VISION AND PATIENTS WITH GOOD 2725 02:08:40,280 --> 02:08:42,640 VISION KNOW WE OFTEN FREQUENTLY 2726 02:08:42,640 --> 02:08:46,840 OBSERVE THE PATIENTS AND WATCH 2727 02:08:46,840 --> 02:08:48,080 THEM AND TREAT IF THE VISION 2728 02:08:48,080 --> 02:08:56,440 WORSENS. 2729 02:08:56,440 --> 02:09:03,600 AND SOME MEDICATIONS ARE SIMILAR 2730 02:09:03,600 --> 02:09:13,800 IN OUTCOMES AND ONE IS SUPERIOR 2731 02:09:13,800 --> 02:09:23,360 TO BEVICUZMAB AND IT MAY BE AN 2732 02:09:23,360 --> 02:09:33,880 ACCEPTABLE APPROACH AND WHAT 2733 02:09:36,480 --> 02:09:41,800 ABOUT DIABETIC RETINOPATHY ? 2734 02:09:41,800 --> 02:09:45,400 MANY USE A COMBINATION OF THE 2735 02:09:45,400 --> 02:09:47,360 TREATMENTS. 2736 02:09:47,360 --> 02:09:53,640 WE ALSO USE VIRTUAL AND SOME 2737 02:09:53,640 --> 02:09:57,240 EYES HAVE HAD HEMORRHAGING AND 2738 02:09:57,240 --> 02:10:00,080 WITHOUT MACULAR EDEMA MANY OF US 2739 02:10:00,080 --> 02:10:02,480 HOLD TREATMENT BECAUSE THERE'S 2740 02:10:02,480 --> 02:10:09,600 NOT A VISUAL BENEFIT TO EARLY 2741 02:10:09,600 --> 02:10:13,440 TREATMENT BUT WE CAN BE 2742 02:10:13,440 --> 02:10:17,600 PREVENTIVE IN NON PROLIFERATIVE 2743 02:10:17,600 --> 02:10:19,800 DIABETIC RETINOPATHY AND THERE'S 2744 02:10:19,800 --> 02:10:21,640 TREATMENT FOR DIABETIC 2745 02:10:21,640 --> 02:10:23,360 RETINOPATHY AND EDEMA AND I WANT 2746 02:10:23,360 --> 02:10:25,640 TO POINT OUT I THINK WE ARE 2747 02:10:25,640 --> 02:10:28,680 BELIEVED IN THE FIELD IN THAT 2748 02:10:28,680 --> 02:10:30,680 ALL OF THESE COMMON WAYS IN 2749 02:10:30,680 --> 02:10:33,640 WHICH WE MANAGE PATIENTS HAVE 2750 02:10:33,640 --> 02:10:36,760 BEEN INFLUENCED AND IN FACT 2751 02:10:36,760 --> 02:10:40,280 OUTLINED BY OUR CLINICAL 2752 02:10:40,280 --> 02:10:40,520 STUDIES. 2753 02:10:40,520 --> 02:10:43,840 I PUT WHAT IS RELEVANT TO EACH 2754 02:10:43,840 --> 02:10:49,600 ASPECT OF CLINICAL CARE BUT WE 2755 02:10:49,600 --> 02:10:57,640 HAVE STUDIES AND PERHAPS THE 2756 02:10:57,640 --> 02:10:59,400 BEST WAY TO TREAT PATIENTS AS A 2757 02:10:59,400 --> 02:11:00,200 WHOLE. 2758 02:11:00,200 --> 02:11:02,920 IN THIS STUDY IN THE 2759 02:11:02,920 --> 02:11:03,880 OPHTHALMOLOGY SPACE WE'RE 2760 02:11:03,880 --> 02:11:05,960 FORTUNATE NOT ONLY DO WE HAVE A 2761 02:11:05,960 --> 02:11:09,640 WEALTH OF RANDOMIZED CONTROL 2762 02:11:09,640 --> 02:11:11,760 TRIALS TO DIRECT OUR CARE IN 2763 02:11:11,760 --> 02:11:12,360 TERMS OF EVIDENCE-BASED 2764 02:11:12,360 --> 02:11:14,640 PRACTICES BUT ALSO THE BENEFIT 2765 02:11:14,640 --> 02:11:16,960 OF SYSTEMATIC REVIEWS AND 2766 02:11:16,960 --> 02:11:17,960 META-ANALYSIS FOR ORGANIZATIONS 2767 02:11:17,960 --> 02:11:21,040 LIKE THE COCHRAN GROUP. 2768 02:11:21,040 --> 02:11:25,600 THEY HAVE PERFORMED 255 REVIEWS 2769 02:11:25,600 --> 02:11:30,440 IN THE OPHTHALMOLOGY SPACE AND 2770 02:11:30,440 --> 02:11:31,320 SYSTEMATIC REVIEWS OF DISEASE 2771 02:11:31,320 --> 02:11:35,480 AND IT GIVES THE ABILITY TO MOVE 2772 02:11:35,480 --> 02:11:39,400 BEYOND AN INDIVIDUAL RANDOMIZED 2773 02:11:39,400 --> 02:11:43,360 CONTROL TRIALS THAN TO LOOK AT 2774 02:11:43,360 --> 02:11:44,640 SIGNALS ACROSS TRIALS AND 2775 02:11:44,640 --> 02:11:47,360 STUDIES AND ARE VALUABLE. 2776 02:11:47,360 --> 02:11:51,120 WE HAVE ALL THIS WONDERFUL FROM 2777 02:11:51,120 --> 02:11:52,560 THE CLINICAL TRIALS STANDPOINT. 2778 02:11:52,560 --> 02:11:57,880 HOW DOES THE COMMUNITY LEARN 2779 02:11:57,880 --> 02:12:00,120 ABOUT EVIDENCE-BASED PRACTICES? 2780 02:12:00,120 --> 02:12:02,040 THIS IS AN AVENUE FOR 2781 02:12:02,040 --> 02:12:06,040 DISSEMINATION AND RESULTS. 2782 02:12:06,040 --> 02:12:11,040 FROM A SCIENTIFIC PERSPECTIVE 2783 02:12:11,040 --> 02:12:17,520 LOOK AT THE LIST AND PUB 2784 02:12:17,520 --> 02:12:19,200 PUBLICATIONS AND SYSTEMIC 2785 02:12:19,200 --> 02:12:21,000 REVIEWS AND MANY OF US GET 2786 02:12:21,000 --> 02:12:27,280 INVOLVED IN GUIDELINES THAT ARE 2787 02:12:27,280 --> 02:12:29,800 DERIVED FROM THE CLINICAL TRIAL 2788 02:12:29,800 --> 02:12:30,120 EVIDENCE. 2789 02:12:30,120 --> 02:12:32,720 IT'S EASY TO TRACK THE FIRST TWO 2790 02:12:32,720 --> 02:12:34,280 THINGS AT PRESENTATIONS AND 2791 02:12:34,280 --> 02:12:37,640 PUBLICATIONS WE CAN TELL YOU IN 2792 02:12:37,640 --> 02:12:41,640 A MOMENT HOW MANY WE'VE DONE 2793 02:12:41,640 --> 02:12:47,840 OVER THE YEARS AND COMING FROM 2794 02:12:47,840 --> 02:12:50,600 MANY WAYS AND BROKEN DOWN BY 2795 02:12:50,600 --> 02:12:51,040 ASSOCIATED METRICS. 2796 02:12:51,040 --> 02:12:54,840 WHAT'S HARDER TO UNDERSTAND IS 2797 02:12:54,840 --> 02:12:57,600 HOW INFORMATION IS DISSEMINATED 2798 02:12:57,600 --> 02:13:00,560 PARTICULARLY IN THE LAST SET OF 2799 02:13:00,560 --> 02:13:01,840 OPTIONS IN TERMS OF PUBLICATIONS 2800 02:13:01,840 --> 02:13:04,600 AND PRESS RELEASES, CONTINUING 2801 02:13:04,600 --> 02:13:06,400 MEDICAL EDUCATION MEETINGS, 2802 02:13:06,400 --> 02:13:08,280 WEBSITES, WEBINARS, SOCIAL 2803 02:13:08,280 --> 02:13:09,640 MEDIA. 2804 02:13:09,640 --> 02:13:11,840 WE DON'T ALWAYS KNOW HOW 2805 02:13:11,840 --> 02:13:13,040 INFORMATION EVEN ABOUT THE 2806 02:13:13,040 --> 02:13:18,360 TRIALS WE PERFORMED IS BEING 2807 02:13:18,360 --> 02:13:20,040 DISSEMINATED THROUGH THESE 2808 02:13:20,040 --> 02:13:22,080 AVENUES AND IT'S CLEAR THE 2809 02:13:22,080 --> 02:13:26,320 INFORMATION CAN VARY AND YES 2810 02:13:26,320 --> 02:13:28,000 I'LL POINT OUT THAT MANY OF US 2811 02:13:28,000 --> 02:13:29,240 IN THE COMMUNITY ARE GETTING A 2812 02:13:29,240 --> 02:13:31,960 LOT OF INFORMATION FROM THESE 2813 02:13:31,960 --> 02:13:33,840 SOURCES AND IN PARTICULAR OUR 2814 02:13:33,840 --> 02:13:36,040 YOUNGER COLLEAGUES IN 2815 02:13:36,040 --> 02:13:37,600 OPHTHALMOLOGY ARE TURNING TO 2816 02:13:37,600 --> 02:13:41,640 THINGS LIKE PODCAST AND WEBSITE 2817 02:13:41,640 --> 02:13:44,640 AND SOCIAL MEDIA FOR THEIR 2818 02:13:44,640 --> 02:13:47,160 INFORMATION AND FOR THE 2819 02:13:47,160 --> 02:13:48,720 DISCUSSION TO THEN DECIDE HOW TO 2820 02:13:48,720 --> 02:13:51,400 TREAT PATIENTS. 2821 02:13:51,400 --> 02:13:54,680 THIS CAN YIELD INFLUENCE ON 2822 02:13:54,680 --> 02:13:55,120 CLINICAL PRACTICE. 2823 02:13:55,120 --> 02:13:59,880 THE CHALLENGES WE HAVE IN 2824 02:13:59,880 --> 02:14:05,200 TRACKING INFORMATION 2825 02:14:05,200 --> 02:14:06,160 DISSEMINATION AND THEY START TO 2826 02:14:06,160 --> 02:14:09,320 SPEAK TO OUR DIFFICULTIES AND 2827 02:14:09,320 --> 02:14:11,000 UNDERSTANDING HOW AND WHEN 2828 02:14:11,000 --> 02:14:12,840 EVIDENCE-BASED PRACTICES ARE 2829 02:14:12,840 --> 02:14:13,800 IMPLEMENTED IN ACTUAL PRACTICE. 2830 02:14:13,800 --> 02:14:17,640 SO HOW DO WE KNOW WHETHER OUR 2831 02:14:17,640 --> 02:14:21,280 EVIDENCE-BASED PRACTICES ARE 2832 02:14:21,280 --> 02:14:21,840 BEING IMPLEMENTED BECAUSE 2833 02:14:21,840 --> 02:14:23,880 THEY'RE THE BOAST CHANCE WE HAVE 2834 02:14:23,880 --> 02:14:29,640 IN OPTIMIZING VISUAL OUTCOMES 2835 02:14:29,640 --> 02:14:31,400 FOR PATIENTS BUT DON'T ALWAYS 2836 02:14:31,400 --> 02:14:33,200 KN 2837 02:14:33,200 --> 02:14:33,400 KNOW. 2838 02:14:33,400 --> 02:14:35,000 THERE'S METHODS TO UNDERSTAND 2839 02:14:35,000 --> 02:14:38,960 AND WE CAB RELY ON CERTAIN SICK 2840 02:14:38,960 --> 02:14:45,360 AND SURVEY IS AVAILABLE AND A 2841 02:14:45,360 --> 02:14:49,640 SURVEY IS A COMMON WAY TO LOOK 2842 02:14:49,640 --> 02:14:53,840 AT THE CURRENT PRACTICES AND 2843 02:14:53,840 --> 02:14:54,640 THERE'S INFORMATION ABOUT TRENDS 2844 02:14:54,640 --> 02:14:55,600 OVER TIME. 2845 02:14:55,600 --> 02:14:59,200 IN THE SLIDE I'M SHOWING HERE 2846 02:14:59,200 --> 02:15:01,400 I'M SHOWING ANSWERS FROM 2007 TO 2847 02:15:01,400 --> 02:15:04,520 2017 TO THE QUESTION HOW DO WE 2848 02:15:04,520 --> 02:15:07,600 TREAT A YOUNG PATIENT WITH 2849 02:15:07,600 --> 02:15:09,600 DIABETES WHO HAS SEVERE 2850 02:15:09,600 --> 02:15:12,720 CLINICALLY SIGNIFICANT MACULAR 2851 02:15:12,720 --> 02:15:14,400 EDEMA AND RETINOPATHY. 2852 02:15:14,400 --> 02:15:16,560 I WON'T GO INTO DETAIL ABOUT THE 2853 02:15:16,560 --> 02:15:23,840 TREATMENT OPTIONS BUT THE GREEN 2854 02:15:23,840 --> 02:15:24,560 BARS THAT INCLUDE TREATMENT JUMP 2855 02:15:24,560 --> 02:15:29,520 UP DRAMATICALLY OVER THE DECADE 2856 02:15:29,520 --> 02:15:34,120 FROM SOMEWHERE AROUND 25%, 30% 2857 02:15:34,120 --> 02:15:37,600 IN THE YEAR 2017 AND THE BLUE 2858 02:15:37,600 --> 02:15:41,160 BAR WHICH WAS AN OPTION FOLLOWED 2859 02:15:41,160 --> 02:15:42,720 BY ADDITIONAL LASER TREATMENT 2860 02:15:42,720 --> 02:15:45,200 DECREASES OVER THE YEARS FROM 2861 02:15:45,200 --> 02:15:50,440 ABOUT 25%, 30% TO LESS THAN 5%. 2862 02:15:50,440 --> 02:15:52,360 WE CAN USE THESE. 2863 02:15:52,360 --> 02:15:55,320 THE QUESTIONS ASKED ARE NOT 2864 02:15:55,320 --> 02:15:58,880 ALWAYS THE ONES WE WANT TO KNOW 2865 02:15:58,880 --> 02:16:05,360 ABOUT AND WE HAVE THE ELECTRONIC 2866 02:16:05,360 --> 02:16:09,480 HEALTH RECORD DATABASES AND THE 2867 02:16:09,480 --> 02:16:10,480 IRIS REGISTRY AND ELECTRONIC 2868 02:16:10,480 --> 02:16:11,320 HEALTH RECORD SYSTEMS. 2869 02:16:11,320 --> 02:16:14,280 THIS IS POTENTIALLY A WONDERFUL 2870 02:16:14,280 --> 02:16:17,040 RESOURCE AND REPRESENTS 2871 02:16:17,040 --> 02:16:18,880 APPROXIMATELY 95% OF 2872 02:16:18,880 --> 02:16:23,840 U.S. OPHTHALMOLOGY PRACTICES TO 2873 02:16:23,840 --> 02:16:27,720 DATE MANY RECORDED IN THE 2874 02:16:27,720 --> 02:16:28,000 DATABASE. 2875 02:16:28,000 --> 02:16:30,840 THERE'S BEEN REGISTRIES STARTED 2876 02:16:30,840 --> 02:16:33,840 TO DESCRIBE PRACTICE PATTERNS 2877 02:16:33,840 --> 02:16:35,240 AND I THINK THERE'S A LOT OF 2878 02:16:35,240 --> 02:16:35,480 PROMISE. 2879 02:16:35,480 --> 02:16:39,200 THERE'S LIMITATIONS TO THIS 2880 02:16:39,200 --> 02:16:44,480 DATABASE WHICH FALL INTO THE 2881 02:16:44,480 --> 02:16:46,600 QUESTIONS OF HOW ELECTRONIC 2882 02:16:46,600 --> 02:16:49,240 HEALTH RECORD DATA IS NOT 2883 02:16:49,240 --> 02:16:51,160 STANDARDIZED AND THE FACT THAT 2884 02:16:51,160 --> 02:16:53,600 ANY CLINICAL CARE RECORD WILL 2885 02:16:53,600 --> 02:16:56,800 HAVE ISSUES WITH MISSING DATA 2886 02:16:56,800 --> 02:16:58,800 AND MESSINESS OF DATA THAT WE 2887 02:16:58,800 --> 02:17:00,160 THEN NEED TO FIGURE OUT HOW TO 2888 02:17:00,160 --> 02:17:02,440 DEAL WITH OR CLEAN AS WE DRAW 2889 02:17:02,440 --> 02:17:05,400 CONCLUSIONS FROM THE DATA ABOUT 2890 02:17:05,400 --> 02:17:06,000 SPECIFIC PATTERNS OR CHANGES 2891 02:17:06,000 --> 02:17:12,280 OVER TIME. 2892 02:17:12,280 --> 02:17:17,600 OTHERS HAVE LOOKED AT DATABASES 2893 02:17:17,600 --> 02:17:21,280 AND LOOK TO SEE WHAT'S BEEN 2894 02:17:21,280 --> 02:17:25,600 BUILT FOR SPECIFIC PRACTICES 2895 02:17:25,600 --> 02:17:31,800 OVER TIME AND PUBLIC HEALTH 2896 02:17:31,800 --> 02:17:33,600 REPORTING SYSTEMS AVAILABLE AND 2897 02:17:33,600 --> 02:17:35,840 MORE TO DO WITH DIFFERENT 2898 02:17:35,840 --> 02:17:39,280 DISEASE THAN PERHAPS COULD BE 2899 02:17:39,280 --> 02:17:41,400 USED IN THE IMPLEMENTATION 2900 02:17:41,400 --> 02:17:45,600 RESEARCH DOWN THE ROAD. 2901 02:17:45,600 --> 02:17:47,880 I MENTIONED THE DRC RETINA 2902 02:17:47,880 --> 02:17:50,320 NETWORK AND THE MISSION 2903 02:17:50,320 --> 02:17:50,600 STATEMENT. 2904 02:17:50,600 --> 02:17:53,960 AND PART OF YOU'RE MISSION IS TO 2905 02:17:53,960 --> 02:17:56,960 HOPE WE'RE IMPACTFUL IN RESEARCH 2906 02:17:56,960 --> 02:17:58,840 OF OUR RED NAL DISEASES. 2907 02:17:58,840 --> 02:18:04,600 DO WE KNOW OUR RESEARCH HAS AN 2908 02:18:04,600 --> 02:18:05,240 IMPACT? 2909 02:18:05,240 --> 02:18:08,040 WE THINK THERE'S BEEN A DRAMATIC 2910 02:18:08,040 --> 02:18:11,280 EVOLUTION IN PART DRIVEN BY THE 2911 02:18:11,280 --> 02:18:12,280 NETWORK STUDIES AS WELL AS OTHER 2912 02:18:12,280 --> 02:18:14,520 EXCELLENT STUDIES IN THE FIELD. 2913 02:18:14,520 --> 02:18:16,520 THEY HAVE CHANGED THE STANDARD 2914 02:18:16,520 --> 02:18:20,520 OF CARE FROM LASER TREATMENT IN 2915 02:18:20,520 --> 02:18:22,720 2002 WHEN THE NETWORK WAS FORMED 2916 02:18:22,720 --> 02:18:26,320 INTO TREATMENT OPTIONS AND 2917 02:18:26,320 --> 02:18:29,160 INJECTIONS FOR THE EYE AND WHEN 2918 02:18:29,160 --> 02:18:32,000 WE GO TO TRACK, WE KNOW FROM 2919 02:18:32,000 --> 02:18:33,600 CONVERSATIONS WITH COLLEAGUES 2920 02:18:33,600 --> 02:18:35,800 AND CONVERSATIONS AT MEETINGS 2921 02:18:35,800 --> 02:18:38,720 FROM SOME OF THE SURVEYS AND 2922 02:18:38,720 --> 02:18:44,080 REGISTRY DATA THAT'S COME OUT, I 2923 02:18:44,080 --> 02:18:45,640 PULLED A PARAGRAPH FROM THE 2924 02:18:45,640 --> 02:18:47,920 GRANT SUBMISSION BECAUSE THIS IS 2925 02:18:47,920 --> 02:18:51,680 A QUESTION WE ASKED, DO RESULTS 2926 02:18:51,680 --> 02:18:56,120 ARE THEY IMPLEMENTED AND IMP 2927 02:18:56,120 --> 02:18:56,960 IMPACTING CLINICAL CARE. 2928 02:18:56,960 --> 02:18:58,720 WE SAID YES THEY WERE. 2929 02:18:58,720 --> 02:19:06,720 AND THE WAYS OR EVIDENCE WE KNOW 2930 02:19:06,720 --> 02:19:09,600 THEY'RE REFLECTED IN MANY 2931 02:19:09,600 --> 02:19:10,600 PRACTICE GUIDELINES FROM 2932 02:19:10,600 --> 02:19:12,720 ORGANIZATIONS LIKE AMERICAN 2933 02:19:12,720 --> 02:19:15,520 ACADEMY OF OPHTHALMOLOGY AND 2934 02:19:15,520 --> 02:19:20,320 COUNCIL OF OPHTHALMOLOGY AND THE 2935 02:19:20,320 --> 02:19:22,360 CHAPTER OF THE COURSE RETINA 2936 02:19:22,360 --> 02:19:25,480 BOOK WHICH IS THE FOUNDATION OF 2937 02:19:25,480 --> 02:19:28,240 THE RESIDENT AND HOW DO WE KNEW 2938 02:19:28,240 --> 02:19:28,440 THIS? 2939 02:19:28,440 --> 02:19:34,680 BECAUSE THOSE OF US SAT ON THE 2940 02:19:34,680 --> 02:19:35,320 COMMIT 2941 02:19:35,320 --> 02:19:35,960 COMMITTEES AND PUTTING THESE IN 2942 02:19:35,960 --> 02:19:38,160 THE GUIDELINES. 2943 02:19:38,160 --> 02:19:41,280 WE SAID THE STUDIES HAVE 2944 02:19:41,280 --> 02:19:43,000 PRACTICE GUIDELINES 2945 02:19:43,000 --> 02:19:45,600 INTERNATIONALLY FOR MULTIPLE 2946 02:19:45,600 --> 02:19:49,640 INTERNATIONAL SOCIETIES 2947 02:19:49,640 --> 02:19:54,440 INCLUDING THE UNITED KINGDOM 2948 02:19:54,440 --> 02:19:57,640 GROUP AND THE REALITY IS WE WERE 2949 02:19:57,640 --> 02:20:05,680 DEPENDENT ON WORTH OF MOUTH AND 2950 02:20:05,680 --> 02:20:10,560 LOOK AT PRACTICE GUIDELINES AND 2951 02:20:10,560 --> 02:20:21,320 CRDR -- DRCR AND WE WOULD LIKE 2952 02:20:21,320 --> 02:20:23,040 TO UNDERSTAND HOW ARE OUR 2953 02:20:23,040 --> 02:20:24,160 CLINICAL RESEARCH IMPACTS 2954 02:20:24,160 --> 02:20:28,520 CLINICAL CARE AND WHY DO WE NEED 2955 02:20:28,520 --> 02:20:31,840 TO KNOW WHAT EVIDENCE-BASED 2956 02:20:31,840 --> 02:20:33,040 PRACTICES REPUBLIC IMPLEMENTED? 2957 02:20:33,040 --> 02:20:39,920 WE THINK THEY CAN DEFINE GAPS IN 2958 02:20:39,920 --> 02:20:41,680 CARE AND THE CYCLE OF RESEARCH 2959 02:20:41,680 --> 02:20:46,760 UNDERSTANDING AND STRATEGIES 2960 02:20:46,760 --> 02:20:51,120 THAT WE TALKED ABOUT KNOWING THE 2961 02:20:51,120 --> 02:20:52,960 PRACTICES WILL HELP DESIGN 2962 02:20:52,960 --> 02:20:54,880 FUTURE STUDIES AND TRIALS THAT 2963 02:20:54,880 --> 02:20:59,320 CAN ADDITIONALLY EM IMPROVE THE 2964 02:20:59,320 --> 02:21:03,720 PRACTICES AND THE DETERMINATION 2965 02:21:03,720 --> 02:21:05,520 OF CLINICAL CARE AND PRACTICE 2966 02:21:05,520 --> 02:21:07,360 DISSEMINATION ARE ALL INTERWOVEN 2967 02:21:07,360 --> 02:21:13,600 EFFORTS OR SHOULD BE THAT CAN 2968 02:21:13,600 --> 02:21:15,280 HELP STRENGTHEN EACH OF THE 2969 02:21:15,280 --> 02:21:17,720 OTHER AREAS AS WE MOVE THEM 2970 02:21:17,720 --> 02:21:17,960 FORWARD. 2971 02:21:17,960 --> 02:21:18,560 WHAT ARE OPPORTUNITIES IN THE 2972 02:21:18,560 --> 02:21:23,720 SPACE? 2973 02:21:23,720 --> 02:21:29,600 I HOPE I'VE SHOWN THE FIELD IS 2974 02:21:29,600 --> 02:21:30,480 RICH WITH CLINICAL TRIAL DATA 2975 02:21:30,480 --> 02:21:33,400 AND I DON'T THINK IT'S JUST 2976 02:21:33,400 --> 02:21:35,080 ALONE FOR DIABETIC RETINAL 2977 02:21:35,080 --> 02:21:35,400 DISEASE. 2978 02:21:35,400 --> 02:21:39,800 I LOOK AT MY COLLEAGUES IN THE 2979 02:21:39,800 --> 02:21:43,960 CORNEA AND GLAUCOMA SEE CLINICAL 2980 02:21:43,960 --> 02:21:45,640 TRIAL HAVE DRIVEN CHANGES IN 2981 02:21:45,640 --> 02:21:54,960 CARE OVER TIME. 2982 02:21:54,960 --> 02:21:59,840 HOWEVER WE LACK COORDINATED 2983 02:21:59,840 --> 02:22:05,280 METHODS AND EFFORTS ARE NEEDED 2984 02:22:05,280 --> 02:22:06,440 TO DEVELOP EFFORTS. 2985 02:22:06,440 --> 02:22:09,120 CONSIDERATION FOR UPTAKE OF 2986 02:22:09,120 --> 02:22:09,680 EVIDENCE-BASED PRACTICES. 2987 02:22:09,680 --> 02:22:11,680 I THINK IT'S WONDERFUL THE NEI 2988 02:22:11,680 --> 02:22:17,080 IS STANDING UP A WORKING GROUP 2989 02:22:17,080 --> 02:22:18,720 TO DO THIS ANOTHER OPTION MAY BE 2990 02:22:18,720 --> 02:22:20,920 THE CREATION OF A STANDING 2991 02:22:20,920 --> 02:22:22,560 INFRASTRUCTURE TO CONSISTENTLY 2992 02:22:22,560 --> 02:22:25,600 AND ROUTINE QUERY THE UPTAKE OF 2993 02:22:25,600 --> 02:22:27,360 CLINICAL TRIAL FINDINGS. 2994 02:22:27,360 --> 02:22:31,320 I'LL BRING US BACK TO THE DRCR 2995 02:22:31,320 --> 02:22:33,840 NETWORK AND I WAS THINKING WHAT 2996 02:22:33,840 --> 02:22:36,920 WOULD IT BE LIKE TO HAVE AN 2997 02:22:36,920 --> 02:22:39,320 IMPLEMENTATION NETWORK OR 2998 02:22:39,320 --> 02:22:41,760 COLLABORATIVE EFFORT OVER TIME? 2999 02:22:41,760 --> 02:22:45,120 WOULD WE UNDERSTAND THE 3000 02:22:45,120 --> 02:22:46,840 IMPLEMENTATION OF OUR PRACTICE 3001 02:22:46,840 --> 02:22:52,360 COMES OUT OF THE COUNCIL WORKING 3002 02:22:52,360 --> 02:23:00,120 GROUP EFFORTS? 3003 02:23:00,120 --> 02:23:02,720 AND DATA SCIENTISTS CAN HELP 3004 02:23:02,720 --> 02:23:05,600 DEFINE AND CREATE THE WORKS AND 3005 02:23:05,600 --> 02:23:09,640 CARE PROVIDERS AND OTHER 3006 02:23:09,640 --> 02:23:11,960 STAKEHOLDERS AND FOUNDATIONS AND 3007 02:23:11,960 --> 02:23:15,600 RESEARCH FOR THE BLINDNESS, 3008 02:23:15,600 --> 02:23:17,640 AMERICAN DIABETES ASSOCIATION, 3009 02:23:17,640 --> 02:23:19,080 MARRY TYLER MOORE VISION NETWORK 3010 02:23:19,080 --> 02:23:20,320 AND PATIENTS WITH DIABETES. 3011 02:23:20,320 --> 02:23:22,760 OVER THE NEXT 20 YEARS I WOULD 3012 02:23:22,760 --> 02:23:29,600 LOVE TO SEE SIMILAR TO HOW WE'VE 3013 02:23:29,600 --> 02:23:32,040 SEEN WITH OTHER PIPELINES AND 3014 02:23:32,040 --> 02:23:33,960 WHEN HAVE YOU EVERY ASPECT OF 3015 02:23:33,960 --> 02:23:36,120 PROPOSAL, IMPLEMENTATION AND 3016 02:23:36,120 --> 02:23:37,600 REPORTING, YOU HAVE A LOT OF 3017 02:23:37,600 --> 02:23:38,520 EFFICIENCIES IN THAT 3018 02:23:38,520 --> 02:23:40,840 INFRASTRUCTURE THAT CAN HELP YOU 3019 02:23:40,840 --> 02:23:43,240 MOVE THINGS ALONG EFFECTIVELY. 3020 02:23:43,240 --> 02:23:47,840 SO A PIPELINE THAT INFORMS 3021 02:23:47,840 --> 02:23:50,880 ONGOING DEVELOPMENT THAT SPARKS 3022 02:23:50,880 --> 02:23:52,320 NEW IMPLEMENTATION EFFORTS WITH 3023 02:23:52,320 --> 02:23:56,160 THE GOAL OF PERHAPS EXPANDING 3024 02:23:56,160 --> 02:23:57,600 BEYOND PERHAPS MY DREAM OF 3025 02:23:57,600 --> 02:23:59,960 DIABETIC RETINAL DISEASE EFFORTS 3026 02:23:59,960 --> 02:24:02,600 INTO ALL AREAS OF OPHTHALMOLOGY. 3027 02:24:02,600 --> 02:24:05,600 I'LL LEAVE YOU WITH THAT VISION. 3028 02:24:05,600 --> 02:24:07,680 I'LL SAY HAPPY WORLD SIGHT DAY. 3029 02:24:07,680 --> 02:24:13,000 IT WAS YESTERDAY BUT I DO THINK 3030 02:24:13,000 --> 02:24:15,440 THIS IS A REALLY FABULOUS 3031 02:24:15,440 --> 02:24:16,560 CONVERSATION WITH THE 3032 02:24:16,560 --> 02:24:18,600 ACKNOWLEDGEMENT THAT WHEN WE 3033 02:24:18,600 --> 02:24:20,440 LOOK AT OUR GLOBAL MAP AND 3034 02:24:20,440 --> 02:24:23,800 VISION LOSS BY COUNTRY, IT'S 3035 02:24:23,800 --> 02:24:25,640 CLEAR THAT THOUGH WE'RE DOING 3036 02:24:25,640 --> 02:24:28,080 RELATIVELY WELL IN U.S. AND 3037 02:24:28,080 --> 02:24:29,840 OTHER DEVELOPED COUNTRIES ON A 3038 02:24:29,840 --> 02:24:31,720 GLOBAL SCALE THE PREVALENCE OF 3039 02:24:31,720 --> 02:24:33,600 VISION LOSS IS ESTIMATED TO BE 3040 02:24:33,600 --> 02:24:35,600 AS HIGH AS 20% AND OVER. 3041 02:24:35,600 --> 02:24:37,600 AND THIS IS REALLY SOMETHING 3042 02:24:37,600 --> 02:24:39,560 THAT WE NEED TO ADDRESS THROUGH 3043 02:24:39,560 --> 02:24:40,840 EFFORTS LIKE UNDERSTANDING 3044 02:24:40,840 --> 02:24:42,440 IMPLEMENTATION OF BEST PRACTICES 3045 02:24:42,440 --> 02:24:44,800 SO WE CAN IMPROVE THOSE PRACTICE 3046 02:24:44,800 --> 02:24:48,880 AND WHAT'S BEING PERFORMED IN 3047 02:24:48,880 --> 02:24:50,200 CLINICAL CARE TO OPTIMIZE VISION 3048 02:24:50,200 --> 02:24:52,240 OUTCOMES FOR ALL PATIENT TO 3049 02:24:52,240 --> 02:24:53,840 REDUCE THAT PREVALENCE OF VISION 3050 02:24:53,840 --> 02:25:00,600 LOSS TO A RATE OF ZERO PERCENT 3051 02:25:00,600 --> 02:25:01,240 IN THE FUTURE. 3052 02:25:01,240 --> 02:25:03,600 THANK YOU AND THIS SLIDE SAY 3053 02:25:03,600 --> 02:25:05,600 GROUP OF LOGOS OF MANY OF THE 3054 02:25:05,600 --> 02:25:09,600 ORGANIZATIONS THAT HAVE 3055 02:25:09,600 --> 02:25:10,960 CONTRIBUTED TO EFFORTS IN 3056 02:25:10,960 --> 02:25:16,080 DIABETIC RETINAL DISEASE THAT 3057 02:25:16,080 --> 02:25:17,600 HAVE BEEN INFLUENTIAL IN THE 3058 02:25:17,600 --> 02:25:20,560 AREA AND I END TO EXPRESS MY 3059 02:25:20,560 --> 02:25:22,280 GRATITUDE AND TO SAY THAT IN MY 3060 02:25:22,280 --> 02:25:23,840 OWN EXPERIENCE THERE'S BEEN A 3061 02:25:23,840 --> 02:25:25,000 TREMENDOUS AMOUNT OF 3062 02:25:25,000 --> 02:25:28,040 COLLABORATION IN THE SPACE OF 3063 02:25:28,040 --> 02:25:33,520 DEVELOPING NEW PRACTICES AND 3064 02:25:33,520 --> 02:25:34,120 VALIDATING THEM FOR CLINICAL 3065 02:25:34,120 --> 02:25:37,640 TRIAL EFFECTIVENESS OVER TIME 3066 02:25:37,640 --> 02:25:41,600 AND GIVES ME HOPE ADDITIONAL 3067 02:25:41,600 --> 02:25:46,760 EFFORTS AND HAVE PARTNERSHIPS IN 3068 02:25:46,760 --> 02:25:48,680 THIS AREA AND THANK YOU FOR 3069 02:25:48,680 --> 02:25:51,440 INVITING ME AND THANK YOU TO THE 3070 02:25:51,440 --> 02:25:53,120 NEI COUNCIL FOR YOUR ATTENTION 3071 02:25:53,120 --> 02:25:53,920 AND LISTENING AND I'M HAPPY TO 3072 02:25:53,920 --> 02:25:58,640 TAKE QUESTIONS. 3073 02:25:58,640 --> 02:25:59,880 >>JENNY, THANK YOU VERY MUCH 3074 02:25:59,880 --> 02:26:01,640 FOR PUTTING THAT ALL TOGETHER 3075 02:26:01,640 --> 02:26:04,960 AND ESPECIALLY FOR YOUR 3076 02:26:04,960 --> 02:26:05,880 THOUGHTFUL SYNTHESIS ON THE END 3077 02:26:05,880 --> 02:26:10,120 WHERE WE MIGHT BE GOING NEXT. 3078 02:26:10,120 --> 02:26:11,960 LET ME OPEN IT UP. 3079 02:26:11,960 --> 02:26:14,600 WHAT COMMENTS OR QUESTIONS DO 3080 02:26:14,600 --> 02:26:16,040 PEOPLE HAVE? 3081 02:26:16,040 --> 02:26:21,200 I THINK YOU RAISED A LOT OF 3082 02:26:21,200 --> 02:26:23,000 IMPORTANT ISSUES ABOUT 3083 02:26:23,000 --> 02:26:25,600 DISSEMINATE RESEARCH FINDINGS 3084 02:26:25,600 --> 02:26:36,080 INTO REAL WORLD PRACTICE. 3085 02:26:36,360 --> 02:26:39,280 >>I WILL SAY I WAS PLEASED TO 3086 02:26:39,280 --> 02:26:44,560 HEAR FROM RINAD BECAUSE I THINK 3087 02:26:44,560 --> 02:26:46,920 WE'RE GOOD AT PUTTING TOGETHER 3088 02:26:46,920 --> 02:26:50,480 THE CLINICAL TRIALS BUT I 3089 02:26:50,480 --> 02:26:53,600 REALIZED I RAISED MORE QUESTIONS 3090 02:26:53,600 --> 02:26:54,360 THAN I ANSWERED. 3091 02:26:54,360 --> 02:26:58,720 >>I HAVE EMMY AND THEN 3092 02:26:58,720 --> 02:27:00,520 MAUREEN'S HAND'S UP. 3093 02:27:00,520 --> 02:27:04,560 >>THAT WAS A TERRIFIC 3094 02:27:04,560 --> 02:27:04,880 PRESENTATION. 3095 02:27:04,880 --> 02:27:05,440 THANK YOU VERY MUCH. 3096 02:27:05,440 --> 02:27:09,240 ONE THING I ALSO WOULD LIKE TO 3097 02:27:09,240 --> 02:27:12,880 SAY I FIND IMPORTANT ABOUT THE 3098 02:27:12,880 --> 02:27:17,960 ORGANIZATIONS LIKE DRCR, RETINA 3099 02:27:17,960 --> 02:27:22,840 NETWORK IS THAT IT TALKS ABOUT 3100 02:27:22,840 --> 02:27:24,960 THE IMPORTANCE OF SCIENCE IT 3101 02:27:24,960 --> 02:27:27,040 SHOWS THE IMPORTANCE OF SCIENCE 3102 02:27:27,040 --> 02:27:31,760 TO NOT JUST ACADEMICS WHO WORK 3103 02:27:31,760 --> 02:27:34,200 IN SCIENCE BUT ALSO TO PRIVATE 3104 02:27:34,200 --> 02:27:36,640 PRACTITIONERS WHO ARE MAYBE OUT 3105 02:27:36,640 --> 02:27:41,680 OF SCIENCE FOR A WHILE AND ARE 3106 02:27:41,680 --> 02:27:43,200 INFLUENCED VERY MUCH BY TREATING 3107 02:27:43,200 --> 02:27:46,400 A PATIENT, ANECDOTAL EVIDENCE 3108 02:27:46,400 --> 02:27:49,280 AND TREATING A PATIENT AND NOT 3109 02:27:49,280 --> 02:27:50,600 KNOWING THE LONG-TERM BENEFIT. 3110 02:27:50,600 --> 02:27:54,720 IDEAL WITH THIS A LOT IN 3111 02:27:54,720 --> 02:27:55,560 PEDIATRIC RETINA BECAUSE THERE'S 3112 02:27:55,560 --> 02:27:59,720 RARE DISEASES SO EXPERIENCE IS 3113 02:27:59,720 --> 02:28:00,160 IMPORTANT. 3114 02:28:00,160 --> 02:28:03,320 THE VALUE OF SCIENCE AND HAVING 3115 02:28:03,320 --> 02:28:04,040 CLINICAL TRIALS TO FOLLOW 3116 02:28:04,040 --> 02:28:06,520 PATIENTS AND LOOK AT OUTCOMES 3117 02:28:06,520 --> 02:28:08,000 LONG-TERM AND HAVE COMPARISON 3118 02:28:08,000 --> 02:28:09,000 GROUPS ARE IMPORTANT. 3119 02:28:09,000 --> 02:28:13,640 WHEN I WAS ON DRCR NET THERE 3120 02:28:13,640 --> 02:28:15,080 WERE TIMES IN THE AUDIENCE WHERE 3121 02:28:15,080 --> 02:28:20,480 INVESTIGATORS WOULD SAY, I DON'T 3122 02:28:20,480 --> 02:28:21,240 BELIEVE THE DATA. 3123 02:28:21,240 --> 02:28:23,920 I THINK IT WAS A GREAT VALUE FOR 3124 02:28:23,920 --> 02:28:25,080 PUBLIC HEALTH. 3125 02:28:25,080 --> 02:28:26,760 >>THANK YOU FOR THE COMMENT. 3126 02:28:26,760 --> 02:28:31,960 I AGREE. 3127 02:28:31,960 --> 02:28:35,000 WE KNOW CLINICAL PRACTICE CAN BE 3128 02:28:35,000 --> 02:28:36,880 LIKE THE CHILD WEST AND WE STILL 3129 02:28:36,880 --> 02:28:38,440 HAVE CONVERSATIONS AS WE PLAN 3130 02:28:38,440 --> 02:28:40,960 STUDIES AND RAISE QUESTIONS THAT 3131 02:28:40,960 --> 02:28:43,080 ARE SOMETIMES QUITE STRONG 3132 02:28:43,080 --> 02:28:44,120 CONVERSATION WITH PEOPLE HAVING 3133 02:28:44,120 --> 02:28:44,560 DIFFERENT OPINIONS. 3134 02:28:44,560 --> 02:28:55,080 GOING BACK TO THE AND SCIENCE, 3135 02:28:57,720 --> 02:29:05,160 AND WE TALK WITH THE TRAINING 3136 02:29:05,160 --> 02:29:09,160 GROUND AND WHAT WE FOUND WAS 3137 02:29:09,160 --> 02:29:11,280 THAT FREQUENTLY SOME OF THE 3138 02:29:11,280 --> 02:29:15,520 SIGNS WILL COME FROM COMMUNITY 3139 02:29:15,520 --> 02:29:17,840 AND THE PRACTITIONERS ARE THE 3140 02:29:17,840 --> 02:29:20,360 LIFE BLOOD OF THOSE THAT ENROLL 3141 02:29:20,360 --> 02:29:21,960 PATIENT AND MAKE THE TRIALS 3142 02:29:21,960 --> 02:29:23,440 HAPPEN BUT THERE'S A MASSIVE 3143 02:29:23,440 --> 02:29:27,560 BENEFIT IN GETTING A LARGE 3144 02:29:27,560 --> 02:29:32,720 NUMBER OF PRACTITIONERS IN 3145 02:29:32,720 --> 02:29:34,840 UNDERSTANDING THE DATA BETTER 3146 02:29:34,840 --> 02:29:35,760 AND BETTER. 3147 02:29:35,760 --> 02:29:38,720 ADDING THEM THE DISCUSSION OF 3148 02:29:38,720 --> 02:29:40,520 IMPLEMENTATION ON TO THE 3149 02:29:40,520 --> 02:29:45,600 DISCUSSION WE ALREADY HAD WITH 3150 02:29:45,600 --> 02:29:47,000 OUR GROUPS ABOUT THE CLINICAL 3151 02:29:47,000 --> 02:29:48,040 TRIAL DATA COULD BE A NICE 3152 02:29:48,040 --> 02:29:54,520 LEARNING OPPORTUNITY. 3153 02:29:54,520 --> 02:29:56,000 >>THANKS, JENNY. 3154 02:29:56,000 --> 02:29:56,360 MAUREEN. 3155 02:29:56,360 --> 02:30:01,480 >>THANK YOU FOR THE NICE TALK 3156 02:30:01,480 --> 02:30:05,040 AND WE'VE BEEN EMPHASIZING I AM 3157 02:30:05,040 --> 02:30:06,280 IMPLEMENTATION IN TERMS OF 3158 02:30:06,280 --> 02:30:06,960 EDUCATING AND CHANGING THE 3159 02:30:06,960 --> 02:30:12,800 PRACTICE OF THE CLINICIANS. 3160 02:30:12,800 --> 02:30:13,600 I'D LIKE TO ALSO PAY ATTENTION 3161 02:30:13,600 --> 02:30:18,360 TO THE PATIENT. 3162 02:30:18,360 --> 02:30:22,720 IN MY AREA, AMD, 25% OF PEOPLE 3163 02:30:22,720 --> 02:30:25,120 STOP INJECTIONS AFTER THE FIRST 3164 02:30:25,120 --> 02:30:26,840 INJECTION ACCORDING TO SOME 3165 02:30:26,840 --> 02:30:29,640 MEDICARE DATA. 3166 02:30:29,640 --> 02:30:32,680 REGISTRY DATA OVER TIME 50%, 60% 3167 02:30:32,680 --> 02:30:33,840 STOP TREATMENT OVER THE FIRST 3168 02:30:33,840 --> 02:30:39,440 FIVE YEARS. 3169 02:30:39,440 --> 02:30:41,720 THERE'S RESISTANCE ON THE 3170 02:30:41,720 --> 02:30:43,560 PATIENT SIDE TO AND WANT TO MAKE 3171 02:30:43,560 --> 02:30:44,960 SURE OUR CLINICIANS ARE 3172 02:30:44,960 --> 02:30:49,840 EDUCATING OUR PATIENTS AND WE DO 3173 02:30:49,840 --> 02:30:51,520 EVERYTHING POSSIBLE TO HAVE 3174 02:30:51,520 --> 02:30:52,680 PATIENTS TAKE ADVANTAGE OF THE 3175 02:30:52,680 --> 02:30:53,760 VERY EFFECTIVE TREATMENTS WE 3176 02:30:53,760 --> 02:30:54,000 HAVE. 3177 02:30:54,000 --> 02:30:56,000 >>IT'S A WONDERFUL POINT. 3178 02:30:56,000 --> 02:31:00,400 I COULDN'T AGREE MORE AND A KNOW 3179 02:31:00,400 --> 02:31:02,520 YOU WORKED ON PAPERS LOOKING AT 3180 02:31:02,520 --> 02:31:04,960 FOLLOW-UP AND WHAT A CHALLENGE 3181 02:31:04,960 --> 02:31:07,440 IT IS NOT JUST CLINICAL TRIAL 3182 02:31:07,440 --> 02:31:10,440 BUT WE KNOW THERE'S AN ENORMOUS 3183 02:31:10,440 --> 02:31:11,720 CHALLENGE IN CLINICAL PRACTICE. 3184 02:31:11,720 --> 02:31:13,560 YOU CAN'T IMPLEMENT CARE UNLESS 3185 02:31:13,560 --> 02:31:14,560 HAVE YOU THE PATIENT TO BE A 3186 02:31:14,560 --> 02:31:21,280 PARTNER IN THAT IMPLEMENTATION. 3187 02:31:21,280 --> 02:31:29,640 >>THANK YOU FOR RAISING THAT 3188 02:31:29,640 --> 02:31:35,880 ISS 3189 02:31:35,880 --> 02:31:37,600 ISSUE. 3190 02:31:37,600 --> 02:31:42,800 THERE'S BEEN ORIGIN AND WE 3191 02:31:42,800 --> 02:31:45,640 TALKED ABOUT ISSUES LIKE GIVING 3192 02:31:45,640 --> 02:31:50,360 THE 200 SOME PRESENTATIONS FROM 3193 02:31:50,360 --> 02:31:59,960 DRCR RETINA NETWORK IS AMAZING. 3194 02:31:59,960 --> 02:32:01,520 GIVING TALKS ABOUT RESEARCH 3195 02:32:01,520 --> 02:32:03,320 SOMETIMES I WONDER AM I TALKING 3196 02:32:03,320 --> 02:32:05,240 TO MYSELF OR TALKING TO PEOPLE 3197 02:32:05,240 --> 02:32:06,680 LIKE ME WHERE WE AS WE ALL 3198 02:32:06,680 --> 02:32:12,360 LEARNED FROM THE PANDEMIC IF IT 3199 02:32:12,360 --> 02:32:13,760 WASN'T ALREADY OBVIOUS, HOW MUCH 3200 02:32:13,760 --> 02:32:15,240 OF A GAP THERE IS SOMETIMES IN 3201 02:32:15,240 --> 02:32:17,320 TERMS OF TAKING SCIENCE AND 3202 02:32:17,320 --> 02:32:18,440 TRANSLATING IT INTO REAL WORLD. 3203 02:32:18,440 --> 02:32:22,960 I THINK THAT CAME OUT IN YOUR 3204 02:32:22,960 --> 02:32:28,000 TALK AND RINAD'S. 3205 02:32:28,000 --> 02:32:30,320 I HOPE THAT IN THE DISCUSSION 3206 02:32:30,320 --> 02:32:32,200 THAT COMES UP AT THE END OF THE 3207 02:32:32,200 --> 02:32:35,200 OPEN SESSION WE CAN TALK ABOUT 3208 02:32:35,200 --> 02:32:37,640 WHERE A COUNCIL WORK GROUP MAY 3209 02:32:37,640 --> 02:32:45,080 HEAD IN THESE DIRECTIONS AND 3210 02:32:45,080 --> 02:32:49,320 WE'LL BE IN TOUCH ABOUT ALL 3211 02:32:49,320 --> 02:32:49,640 THIS. 3212 02:32:49,640 --> 02:32:55,680 I SEE A HAND UP. 3213 02:32:55,680 --> 02:32:56,880 >>AS AS ALWAYS A GREAT 3214 02:32:56,880 --> 02:32:57,200 PRESENTATION. 3215 02:32:57,200 --> 02:33:00,800 IT'S MORE OF A COMMENT THAN A 3216 02:33:00,800 --> 02:33:02,320 QUESTION AS A PRACTICING 3217 02:33:02,320 --> 02:33:02,960 PHYSICIAN AS WELL. 3218 02:33:02,960 --> 02:33:05,080 THAT'S SCIENCE IS JUST ONE OF 3219 02:33:05,080 --> 02:33:07,560 THE CRITICAL BARRIERS TO 3220 02:33:07,560 --> 02:33:11,480 PROVIDING OPTIMAL HEALTH TO OUR 3221 02:33:11,480 --> 02:33:16,520 PATIENTS AND THERE ARE OTHERS. 3222 02:33:16,520 --> 02:33:20,080 WE HEARD THERE'S FINANCIAL ONES 3223 02:33:20,080 --> 02:33:21,480 WE FACE ALL THE TIME. 3224 02:33:21,480 --> 02:33:23,720 ONE OF THE KEY ASPECTS FOR THE 3225 02:33:23,720 --> 02:33:29,600 PHS I'M NOT SURE HOW TO 3226 02:33:29,600 --> 02:33:33,600 OPERATIONALIZE MORE EFFECTIVELY 3227 02:33:33,600 --> 02:33:38,000 BUT GET THE THIRD-PARTY INSURERS 3228 02:33:38,000 --> 02:33:40,200 TO COVER NECESSARY 3229 02:33:40,200 --> 02:33:40,600 INTERVENTIONS. 3230 02:33:40,600 --> 02:33:44,600 AS A PRACTICING PHYSICIAN WE 3231 02:33:44,600 --> 02:33:47,760 OFTEN HAVE TO DELAY THERAPY OR 3232 02:33:47,760 --> 02:33:49,640 WAIT FOR INSURANCE COMPANIES TO 3233 02:33:49,640 --> 02:33:54,880 ACCEPT PAYMENT OR COVERAGE FOR 3234 02:33:54,880 --> 02:33:55,640 APPROVED DRUGS. 3235 02:33:55,640 --> 02:33:57,640 IT IMPACTS THE CARE WE PROVIDE 3236 02:33:57,640 --> 02:34:07,560 OUR PATIENTS. 3237 02:34:07,560 --> 02:34:09,480 THERE'S STILL A BARRIER BETWEEN 3238 02:34:09,480 --> 02:34:16,400 DETERMINING THE STANDARDS AND 3239 02:34:16,400 --> 02:34:17,880 IMPLEMENTING THEM IN REAL WORLD 3240 02:34:17,880 --> 02:34:21,640 AND NEED TO BE ADDRESSED NOR 3241 02:34:21,640 --> 02:34:26,200 PATIENTS. 3242 02:34:26,200 --> 02:34:29,640 >>WE SEE IT ALL THE TIME. 3243 02:34:29,640 --> 02:34:33,120 THE CONVERSATION AROUND STEP 3244 02:34:33,120 --> 02:34:33,880 THERAPY IS REFLECTED IN THAT 3245 02:34:33,880 --> 02:34:40,680 STUDY. 3246 02:34:40,680 --> 02:34:44,360 WE SEE BARRIERS IN TERMS OF 3247 02:34:44,360 --> 02:34:45,600 INSURERS DEMANDING OR SAYING 3248 02:34:45,600 --> 02:34:50,360 THAT CERTAIN THINGS WILL NOT BE 3249 02:34:50,360 --> 02:34:51,040 COVERED BUT WHERE THERE'S LITTLE 3250 02:34:51,040 --> 02:35:00,640 EVIDENCE FOR THE OTHERS. 3251 02:35:00,640 --> 02:35:02,440 THE SOCIAL DETERMINATES OF WHICH 3252 02:35:02,440 --> 02:35:05,640 PATIENTS GET CARE ARE CRITICAL 3253 02:35:05,640 --> 02:35:15,760 AS WELL. 3254 02:35:15,760 --> 02:35:16,120 >>BEN. 3255 02:35:16,120 --> 02:35:17,400 >>THANK YOU, JENNY. 3256 02:35:17,400 --> 02:35:18,160 I LIKE THE LAST SLIDE YOU HAVE 3257 02:35:18,160 --> 02:35:24,360 THERE. 3258 02:35:24,360 --> 02:35:26,840 GETTING DOWN TO ZERO PERCENT 3259 02:35:26,840 --> 02:35:29,800 THERE. 3260 02:35:29,800 --> 02:35:33,640 IN COUNCIL WE'VE DISCUSSED 3261 02:35:33,640 --> 02:35:38,840 SEVERAL TELEHEALTH AND MEDICINE 3262 02:35:38,840 --> 02:35:40,680 INTELLIGENCE TO DETECTING 3263 02:35:40,680 --> 02:35:40,960 RETINOPATHY. 3264 02:35:40,960 --> 02:35:42,680 WHERE DO YOU SEE THE FUTURE AND 3265 02:35:42,680 --> 02:35:43,520 HOW SOON DO YOU THINK ALL THIS 3266 02:35:43,520 --> 02:35:54,000 CAN BE IMPLEMENTED? 3267 02:35:54,000 --> 02:35:56,920 >>I THINK THESE AREAS ARE 3268 02:35:56,920 --> 02:35:57,200 PROMISING. 3269 02:35:57,200 --> 02:35:59,080 WE'RE USING ARTIFICIAL 3270 02:35:59,080 --> 02:36:00,840 INTELLIGENCE AND THE DEVELOPMENT 3271 02:36:00,840 --> 02:36:05,000 OF LESS EXPENSIVE CAMERAS THAT 3272 02:36:05,000 --> 02:36:08,160 CAN REACH FURTHER OUT IN THE 3273 02:36:08,160 --> 02:36:10,280 RETINAL PERIPHERY ARE THINGS I'M 3274 02:36:10,280 --> 02:36:11,640 ENTHUSIASTIC ABOUT AND I WAS 3275 02:36:11,640 --> 02:36:14,360 THRILLED TO SEE THE BRIDGE TO 3276 02:36:14,360 --> 02:36:17,520 A.I. PROJECTS DISCUSSED IN 3277 02:36:17,520 --> 02:36:18,960 PARTICULAR THE ONE IN DIABETIC 3278 02:36:18,960 --> 02:36:21,600 RETINOPATHY. 3279 02:36:21,600 --> 02:36:27,520 WE SEE MANY OF THESE PROJECTS 3280 02:36:27,520 --> 02:36:29,240 EVEN KNOW AND WE HAVE 3281 02:36:29,240 --> 02:36:33,000 TELEMEDICINE EFFORTS IN 3282 02:36:33,000 --> 02:36:34,440 PARTNERSHIP WITH INDIAN HEALTH 3283 02:36:34,440 --> 02:36:39,400 SERVICE AS WELL AS CENTERS IN 3284 02:36:39,400 --> 02:36:47,480 THE PHILIPPINES IT'S EXCITING TO 3285 02:36:47,480 --> 02:36:51,240 SEE THE POTENTIAL REACH OF 3286 02:36:51,240 --> 02:36:52,360 TELEHEALTH SCREENING INITIATIVES 3287 02:36:52,360 --> 02:36:55,360 THAT MAY NOT JUST BE DEPENDENT 3288 02:36:55,360 --> 02:36:58,800 ON THE PATIENT COMING TO THE 3289 02:36:58,800 --> 02:37:00,320 MEDICAL CENTER BUT GOING DOOR TO 3290 02:37:00,320 --> 02:37:02,280 DOOR AND ASKING PATIENT TO DO 3291 02:37:02,280 --> 02:37:02,680 RETINAL SCREENING. 3292 02:37:02,680 --> 02:37:07,960 I DON'T THINK IT'S A NEW 3293 02:37:07,960 --> 02:37:08,360 APPROACH. 3294 02:37:08,360 --> 02:37:12,560 IT'S BEEN AROUND FOREVER AND 3295 02:37:12,560 --> 02:37:14,680 THEY WERE DOING THAT IN THE '80s 3296 02:37:14,680 --> 02:37:17,640 AS WELL BUT THERE'S SCALABILITY 3297 02:37:17,640 --> 02:37:18,280 THE INTELLIGENCE AND EVALUATION 3298 02:37:18,280 --> 02:37:24,360 CAN PROVIDE. 3299 02:37:24,360 --> 02:37:27,200 WE'RE NOT DEPENDENT ON LOOKING 3300 02:37:27,200 --> 02:37:29,040 AT THE IMAGES AND THERE'S HUMAN 3301 02:37:29,040 --> 02:37:36,080 VARIABILITY IN THE RATING. 3302 02:37:36,080 --> 02:37:41,840 WE'VE SEEN APPROVAL FOR THE 3303 02:37:41,840 --> 02:37:45,040 SYSTEMS OF RETINAL DETECTION AND 3304 02:37:45,040 --> 02:37:46,880 THERE'S EFFORTS AND I THINK IN 3305 02:37:46,880 --> 02:37:49,720 THE NEXT FIVE TO 10 YEARS IS AN 3306 02:37:49,720 --> 02:37:51,920 ACHIEVABLE GOAL TO DO THIS ON A 3307 02:37:51,920 --> 02:37:52,560 DOUBLE SCALE. 3308 02:37:52,560 --> 02:37:57,600 THE QUESTION WILL BE CAN WE GET 3309 02:37:57,600 --> 02:37:59,880 THE COLLABORATION ACROSS 3310 02:37:59,880 --> 02:38:03,760 STAKEHOLDER GROUPS AND COUNTRIES 3311 02:38:03,760 --> 02:38:05,880 TO ADDRESS INEQUITIES IN HEALTH 3312 02:38:05,880 --> 02:38:08,640 CARE AND GET THIS TO THE UNDER 3313 02:38:08,640 --> 02:38:09,320 SERVED POPULATIONS THAT NEED IT 3314 02:38:09,320 --> 02:38:14,840 MOST. 3315 02:38:14,840 --> 02:38:17,680 >>CATHY, I HAVE A FEELING WE 3316 02:38:17,680 --> 02:38:19,960 NEED TO CLOSE OUT THIS PART OF 3317 02:38:19,960 --> 02:38:22,560 THE SESSION BECAUSE OF TIMING. 3318 02:38:22,560 --> 02:38:24,400 IS THAT ACCURATE? 3319 02:38:24,400 --> 02:38:27,320 >>WE SHOULD PROBABLY GIVE FOLKS 3320 02:38:27,320 --> 02:38:27,920 A BREAK. 3321 02:38:27,920 --> 02:38:31,360 DOESN'T HAVE TO BE A LONG BREAK. 3322 02:38:31,360 --> 02:38:34,160 WE DO HAVE STILL A FULL AGENDA. 3323 02:38:34,160 --> 02:38:38,440 SO LET'S TAKE A 10-MINUTE BREAK 3324 02:38:38,440 --> 02:38:41,920 AND WHEN WE GET BACK WE'LL 3325 02:38:41,920 --> 02:38:44,240 CIRCLE BACK TO THE BUDGET UPDATE 3326 02:38:44,240 --> 02:38:47,960 WHICH IS ALWAYS OF MOST INTEREST 3327 02:38:47,960 --> 02:38:51,520 I THINK TO PEOPLE AND VERY 3328 02:38:51,520 --> 02:38:51,840 INTERESTING. 3329 02:38:51,840 --> 02:38:58,320 WE'LL DO THAT WHEN WE COME BACK 3330 02:38:58,320 --> 02:38:59,120 AT 10 TO 1:00. 3331 02:38:59,120 --> 02:39:00,080 IS THAT OKAY? 3332 02:39:00,080 --> 02:39:00,840 KAREN. 3333 02:39:00,840 --> 02:39:01,200 >>THAT'S FINE. 3334 02:39:01,200 --> 02:39:01,480 THANK YOU. 3335 02:39:01,480 --> 02:39:05,080 >>GREAT. 3336 02:39:05,080 --> 02:39:08,040 I'LL SEE EVERYBODY THEN. 3337 02:39:08,040 --> 02:39:08,680 THANK YOU EVERYBODY FOR A NICE 3338 02:39:08,680 --> 02:39:57,640 DISCUSSION. 3339 02:39:57,640 --> 02:40:01,160 >>WE'RE A LITTLE BIT 3340 02:40:01,160 --> 02:40:02,960 OFF SCHEDULE SO KAREN WILL GET 3341 02:40:02,960 --> 02:40:04,400 THE BUDGET OVERVIEW WHICH WE 3342 02:40:04,400 --> 02:40:06,040 DIDN'T GET TO EARLIER IN THE DAY 3343 02:40:06,040 --> 02:40:09,600 SO YOUR PRESENTATION WILL BE 3344 02:40:09,600 --> 02:40:14,920 SHIFTED YOURS AND MARYANN'S 3345 02:40:14,920 --> 02:40:18,080 SHIFTED A BIT. 3346 02:40:18,080 --> 02:40:22,360 KAREN, GO AHEAD. 3347 02:40:22,360 --> 02:40:24,280 >>GOOD AFTERNOON, EVERYONE. 3348 02:40:24,280 --> 02:40:29,080 IT'S NIS TO BE WITH YOU ON THIS 3349 02:40:29,080 --> 02:40:30,960 BEAUTIFUL FALL DAY TO SHARE THE 3350 02:40:30,960 --> 02:40:31,640 BUDGET UPDATE. 3351 02:40:31,640 --> 02:40:33,720 I'LL START WITH A RECAP OF HOW 3352 02:40:33,720 --> 02:40:41,320 WE ENDED LAST FISCAL YEAR WHICH 3353 02:40:41,320 --> 02:40:42,800 CONCLUDED AND SHARE THE BUDGET 3354 02:40:42,800 --> 02:40:48,280 THAT STARTED OCTOBER 1. 3355 02:40:48,280 --> 02:40:52,280 AS YOU KNOW, THE VAST MAJORITY 3356 02:40:52,280 --> 02:40:53,640 OF THE BUDGET IS SPENT ON 3357 02:40:53,640 --> 02:40:54,880 EXTRAMURAL PROGRAMS. 3358 02:40:54,880 --> 02:40:57,760 THIS SLIDE REPRESENTS NEI 3359 02:40:57,760 --> 02:40:59,080 SPENDING FOR THE FISCAL YEAR 3360 02:40:59,080 --> 02:41:04,120 THAT JUST ENDED. 3361 02:41:04,120 --> 02:41:07,680 I'LL SAY THAT UNTIL OUR DATA IS 3362 02:41:07,680 --> 02:41:09,360 APPROVED BY CONGRESS IT'S AN 3363 02:41:09,360 --> 02:41:10,120 ESTIMATE BUT IT'S A GOOD 3364 02:41:10,120 --> 02:41:12,400 REPRESENTATION OF HOW WE ENDED 3365 02:41:12,400 --> 02:41:13,200 THE FISCAL YEAR. 3366 02:41:13,200 --> 02:41:18,600 ON THE LEFT IS A PIE CHART THAT 3367 02:41:18,600 --> 02:41:20,320 DIVIDES SPENDING INTO FUNDING 3368 02:41:20,320 --> 02:41:22,600 CATEGORIES WITH THE PERCENTAGE 3369 02:41:22,600 --> 02:41:24,480 RELATIVE TO THE TOTAL NEI 3370 02:41:24,480 --> 02:41:24,720 BUDGET. 3371 02:41:24,720 --> 02:41:28,280 THE LARGEST SLICE IS FOR 3372 02:41:28,280 --> 02:41:31,160 RESEARCH PROJECT GRANTS AT 63% 3373 02:41:31,160 --> 02:41:32,680 OF THE BUDGET THEN WE HAVE 3374 02:41:32,680 --> 02:41:38,800 RESEARCH CENTERS AT 3% OF THE 3375 02:41:38,800 --> 02:41:43,440 BUDGET OTHER RESEARCH AT 10% 3376 02:41:43,440 --> 02:41:44,640 TRAINING GRANTS AT 2% AND 3377 02:41:44,640 --> 02:41:49,600 RESEARCH AND DEVELOPMENT 3378 02:41:49,600 --> 02:41:51,080 CONTRACT AT 5 PACIFIC AND 3379 02:41:51,080 --> 02:41:54,040 RESEARCH SUPPORT AT 5%. 3380 02:41:54,040 --> 02:41:55,960 TO THE RIGHT IS A BAR CHART THAT 3381 02:41:55,960 --> 02:41:57,520 GIVES A HIGHER LEVEL LOOK AT THE 3382 02:41:57,520 --> 02:42:01,800 MAJOR FUNDING MECHANISMS, 3383 02:42:01,800 --> 02:42:02,760 EXTRAMURAL RESEARCH INTRAMURAL 3384 02:42:02,760 --> 02:42:04,080 RESEARCH AND RESEARCH SUPPORT 3385 02:42:04,080 --> 02:42:05,360 AND EXTRAMURAL RESEARCH IS A 3386 02:42:05,360 --> 02:42:07,000 COMBINATION OF THE GRANT 3387 02:42:07,000 --> 02:42:09,480 ACTIVITIES AND RESEARCH AND 3388 02:42:09,480 --> 02:42:10,800 DEVELOPMENT CONTRACTS WHICH 3389 02:42:10,800 --> 02:42:13,400 COMBINED MAKE UP A TOTAL OF 83% 3390 02:42:13,400 --> 02:42:17,120 OF THE TOTAL NEI BUDGET. 3391 02:42:17,120 --> 02:42:21,800 THEN OF COURSE WE HAVE 3392 02:42:21,800 --> 02:42:22,920 INTRAMURAL RESEARCH AND SUPPORT. 3393 02:42:22,920 --> 02:42:24,280 THESE FUNDING LEVELS ARE TYPICAL 3394 02:42:24,280 --> 02:42:27,080 OF WHAT WE SEE IN A GIVEN FISCAL 3395 02:42:27,080 --> 02:42:29,080 YEAR AND HAVE REMAINED 3396 02:42:29,080 --> 02:42:37,800 CONSISTENT OVER TIME. 3397 02:42:37,800 --> 02:42:39,200 NOW WE MOVE IT ON THE BUDGET FOR 3398 02:42:39,200 --> 02:42:40,320 THE CURRENT YEAR. 3399 02:42:40,320 --> 02:42:41,600 WE'RE OPERATING UNDER WHAT'S 3400 02:42:41,600 --> 02:42:44,200 CALLED A CONTINUING RESOLUTION. 3401 02:42:44,200 --> 02:42:46,800 AND THIS CURRENT RESOLUTION IS 3402 02:42:46,800 --> 02:42:48,800 EFFECTIVE THROUGH DECEMBER 16. 3403 02:42:48,800 --> 02:42:52,240 WE CALL THOSE CR. 3404 02:42:52,240 --> 02:42:56,160 A CR IS SHORT-TERM LEGISLATION 3405 02:42:56,160 --> 02:42:57,880 THAT AVERTS GOVERNMENT SHUTDOWN 3406 02:42:57,880 --> 02:42:59,400 AND GIVES US THE OPPORTUNITY TO 3407 02:42:59,400 --> 02:43:00,880 OPERATE UNTIL CONGRESS GIVES THE 3408 02:43:00,880 --> 02:43:03,680 BUDGET FOR THE CURRENT FISCAL 3409 02:43:03,680 --> 02:43:03,920 YEAR. 3410 02:43:03,920 --> 02:43:06,480 A C.R. CAN BE PUT IN PLACE FOR 3411 02:43:06,480 --> 02:43:09,520 DAYS, WEEKS, MONTHS OR A FULL 3412 02:43:09,520 --> 02:43:10,160 FISCAL YEAR. 3413 02:43:10,160 --> 02:43:11,240 THE CURRENT C.R. GIVES CONGRESS 3414 02:43:11,240 --> 02:43:12,680 MORE TIME TO COMPLETE THEIR WORK 3415 02:43:12,680 --> 02:43:14,800 OF PROVIDING APPROPRIATION FOR 3416 02:43:14,800 --> 02:43:17,600 THE YEAR. 3417 02:43:17,600 --> 02:43:20,480 WHEN WE ARE UNDER C.R. WE DO NOT 3418 02:43:20,480 --> 02:43:21,920 RECEIVE OUR FULL BUDGET FOR THE 3419 02:43:21,920 --> 02:43:22,120 YEAR. 3420 02:43:22,120 --> 02:43:26,600 WE RECEIVE FUNDING BASED ON THE 3421 02:43:26,600 --> 02:43:29,080 NUMBER OF DAYS IN THE BILL. 3422 02:43:29,080 --> 02:43:30,120 FOR EXAMPLE THROUGH DECEMBER 16 3423 02:43:30,120 --> 02:43:34,640 IT REPRESENTS 77 DAYS OF THE 3424 02:43:34,640 --> 02:43:36,520 FISCAL YEAR AND GIVES 21.1% OF 3425 02:43:36,520 --> 02:43:38,760 WHAT OUR BUDGET WAS IN FY2022 TO 3426 02:43:38,760 --> 02:43:42,960 OPERATE WITH. 3427 02:43:42,960 --> 02:43:45,840 ONE OF THE FACTORS IMPACTING THE 3428 02:43:45,840 --> 02:43:48,240 TIMING OF WHEN WE MAY RECEIVE A 3429 02:43:48,240 --> 02:43:52,320 BUDGET THIS YEAR IS THE MIDTERM 3430 02:43:52,320 --> 02:43:53,760 ELECTIONS IN NOVEMBER. 3431 02:43:53,760 --> 02:43:55,240 WE'LL NOD HAVE ADDITIONAL 3432 02:43:55,240 --> 02:43:55,880 INFORMATION ABOUT THE BUDGET 3433 02:43:55,880 --> 02:44:02,840 UNTIL THOSE ELECTIONS ARE OVER. 3434 02:44:02,840 --> 02:44:05,080 WE KNOW THERE'S NO EXPECTATION 3435 02:44:05,080 --> 02:44:06,760 OF HAVING TO OPERATE UNDER 3436 02:44:06,760 --> 02:44:10,520 CONTINUING RESOLUTION FOR THE 3437 02:44:10,520 --> 02:44:11,760 FULL YEAR THAT'S IMPORTANT TO 3438 02:44:11,760 --> 02:44:15,560 KNOW BECAUSE A C.R. HOLDS US AT 3439 02:44:15,560 --> 02:44:16,360 THE APPROPRIATION FOR THE 3440 02:44:16,360 --> 02:44:20,000 PREVIOUS FISCAL YEAR. 3441 02:44:20,000 --> 02:44:22,800 SO IF WE WERE TO TO HAVE TO 3442 02:44:22,800 --> 02:44:25,400 MANAGER OUR PROGRAMS THAT'S 3443 02:44:25,400 --> 02:44:27,960 EFFECTIVELY A CUT BECAUSE OF OUR 3444 02:44:27,960 --> 02:44:31,920 MANDATORY COSTS WILL INCREASE. 3445 02:44:31,920 --> 02:44:33,320 WHEN THIS CURRENT C.R. EXPIRES 3446 02:44:33,320 --> 02:44:36,480 IN DECEMBER IT'S LIKELY WE'LL 3447 02:44:36,480 --> 02:44:38,640 SEE ADDITIONAL SHORT-TERM C.R.s 3448 02:44:38,640 --> 02:44:42,760 AS CONGRESS FIGURES OUT THE PLAN 3449 02:44:42,760 --> 02:44:47,080 TO PROGRESS TO COMPLETE THE 3450 02:44:47,080 --> 02:44:47,440 BUDGET PROCESS. 3451 02:44:47,440 --> 02:44:50,280 AFTER THE ELECTIONS IN NOVEMBER, 3452 02:44:50,280 --> 02:44:51,640 CONGRESS WILL COME UP WITH A 3453 02:44:51,640 --> 02:44:56,440 PLAN TO MOVE FORWARD TO GIVE US 3454 02:44:56,440 --> 02:44:57,040 OUR APPROPRIATION. 3455 02:44:57,040 --> 02:45:00,080 THERE IS SPECULATION THE OUTGOM 3456 02:45:00,080 --> 02:45:01,360 GOING MEMBERS MAY PUSH THE 3457 02:45:01,360 --> 02:45:06,640 PROCESS ALONG TO TAKE CARE OF 3458 02:45:06,640 --> 02:45:09,680 THAT BEFORE THEY LEAVE. 3459 02:45:09,680 --> 02:45:12,840 FOR NOW WE WAIT WITH FULL 3460 02:45:12,840 --> 02:45:14,160 EXPECTATION CONGRESS WILL 3461 02:45:14,160 --> 02:45:16,200 PROVIDE AN OMNIBUS BILL TO FUND 3462 02:45:16,200 --> 02:45:18,080 US FOR THE CURRENT FISCAL YEAR. 3463 02:45:18,080 --> 02:45:22,040 TO EXPLAIN WHAT AN OMNIBUS BILL 3464 02:45:22,040 --> 02:45:24,000 IS, IT'S ESSENTIALLY MULTIPLE 3465 02:45:24,000 --> 02:45:25,560 BILLS FOR DIFFERENT GOVERNMENT 3466 02:45:25,560 --> 02:45:26,760 AGENCIES OR DEPARTMENTS 3467 02:45:26,760 --> 02:45:29,520 CONSOLIDATED AND VOTED ON AS A 3468 02:45:29,520 --> 02:45:31,760 PACKAGE VERSUS SEPARATELY AS IS 3469 02:45:31,760 --> 02:45:35,240 THE TRADITIONAL PROCESS. 3470 02:45:35,240 --> 02:45:37,240 THE TRADITIONAL PROCESS HAS 12 3471 02:45:37,240 --> 02:45:37,880 DIFFERENT APPROPRIATION BILLS 3472 02:45:37,880 --> 02:45:39,040 THAT NEED TO BE PASSED EACH YEAR 3473 02:45:39,040 --> 02:45:41,560 TO FUND THE GOVERNMENT AND AVOID 3474 02:45:41,560 --> 02:45:45,960 SHUTDOWN BUT AN OMNIBUS BILL 3475 02:45:45,960 --> 02:45:47,680 GETS US TO THE FINISH LINE WHEN 3476 02:45:47,680 --> 02:45:48,520 THE 12 APPROPRIATIONS ARE NOT 3477 02:45:48,520 --> 02:45:55,480 PASSED INDIVIDUALLY. 3478 02:45:55,480 --> 02:45:58,440 THIS SLIDE COMPARES FUNDING 3479 02:45:58,440 --> 02:46:02,120 LEVELS '21, '22, AND '23. 3480 02:46:02,120 --> 02:46:04,400 FOR 2023 WE HAVE THE PRESIDENT'S 3481 02:46:04,400 --> 02:46:09,480 BUDGET REQUEST AT $853.3 MILLION 3482 02:46:09,480 --> 02:46:11,880 RELEASED LAST WINTER. 3483 02:46:11,880 --> 02:46:14,520 THE HOUSE AND SENATE LEVELS IN 3484 02:46:14,520 --> 02:46:19,200 THE SPRING AND SUMMER ARE $891.2 3485 02:46:19,200 --> 02:46:22,920 MILLION AND $890 MILLION 3486 02:46:22,920 --> 02:46:23,360 RESPECTIVELY. 3487 02:46:23,360 --> 02:46:24,600 THE SLIDE SHOWS THE 3488 02:46:24,600 --> 02:46:25,560 APPROPRIATION AND BUDGET 3489 02:46:25,560 --> 02:46:29,520 AUTHORITY AS YET TO BE 3490 02:46:29,520 --> 02:46:31,480 DETERMINED AND TELL YOU THE 3491 02:46:31,480 --> 02:46:32,760 DIFFERENCE BETWEEN BUDGET 3492 02:46:32,760 --> 02:46:33,520 AUTHORITY AND APPROPRIATION. 3493 02:46:33,520 --> 02:46:36,560 THE BUDGET AUTHORITY IS OUR 3494 02:46:36,560 --> 02:46:37,800 APPROPRIATION MINUS TRANSFERS 3495 02:46:37,800 --> 02:46:42,320 OUT OF OUR BUDGET INITIATED BY 3496 02:46:42,320 --> 02:46:44,080 NIH THE DEPARTMENT OF HEALTH AND 3497 02:46:44,080 --> 02:46:51,600 HUMAN SERVICES OF WHICH HINIH IA 3498 02:46:51,600 --> 02:46:54,560 DIVISION AND THE BUDGET 3499 02:46:54,560 --> 02:46:55,520 AUTHORITY WILL BE AMOUNT IN HAND 3500 02:46:55,520 --> 02:46:59,760 TO FUND OPERATIONS FOR THE YEAR. 3501 02:46:59,760 --> 02:47:01,160 THE PRESIDENT'S BUDGET REQUEST 3502 02:47:01,160 --> 02:47:03,240 IS SOMETHING THAT'S PUBLIC AND 3503 02:47:03,240 --> 02:47:05,760 SO I WANTED TO PROVIDE A LITTLE 3504 02:47:05,760 --> 02:47:11,000 BIT OF CONTEXT FOR THAT REQUEST. 3505 02:47:11,000 --> 02:47:15,120 THE FY2023 BUDGET REQUEST IS 3506 02:47:15,120 --> 02:47:16,480 LOWER THAN WHAT THE HOUSE AND 3507 02:47:16,480 --> 02:47:18,320 SENATE HAS PROPOSED FOR THIS 3508 02:47:18,320 --> 02:47:23,040 YEAR BUT FIRST AND FOREMOST IT'S 3509 02:47:23,040 --> 02:47:24,480 A PLANNING DOCUMENT AND DOES NOT 3510 02:47:24,480 --> 02:47:27,640 ESTABLISH APPROPRIATIONS. 3511 02:47:27,640 --> 02:47:32,680 I'LL MENTION THAT THE 2023 PB 3512 02:47:32,680 --> 02:47:34,280 LEVEL WAS LOW BECAUSE WHEN IT 3513 02:47:34,280 --> 02:47:38,000 WAS DEVELOPED WE DID NOT HAVE 3514 02:47:38,000 --> 02:47:39,000 THE 2022 APPROPRIATION. 3515 02:47:39,000 --> 02:47:45,040 BECAUSE OF THAT THE BUDGET 3516 02:47:45,040 --> 02:47:46,600 NUMBER USED FOR THE BASE ASSUMED 3517 02:47:46,600 --> 02:47:47,720 A FULL YEAR CONTINUING 3518 02:47:47,720 --> 02:47:52,440 RESOLUTION WHICH HELD THE SAME 3519 02:47:52,440 --> 02:47:56,080 FUNDING LEVEL AS FISCAL YEAR 3520 02:47:56,080 --> 02:47:56,680 2021 APPROPRIATION. 3521 02:47:56,680 --> 02:47:58,760 SO WHEN WE RECEIVE THE 3522 02:47:58,760 --> 02:48:01,320 APPROPRIATION FOR FISCAL 2022 3523 02:48:01,320 --> 02:48:05,360 THERE WAS A SIGNIFICANT INCREASE 3524 02:48:05,360 --> 02:48:10,760 ABOVE THE LEVEL FROM THE 2022 3525 02:48:10,760 --> 02:48:11,560 PRESIDENT'S BUDGET. 3526 02:48:11,560 --> 02:48:15,720 RIGHT NOW WE'RE UNDER SIMILAR 3527 02:48:15,720 --> 02:48:17,080 CIRCUMSTANCES AND STARTING TO 3528 02:48:17,080 --> 02:48:22,440 WORK ON THE FISCAL YEAR 2024 3529 02:48:22,440 --> 02:48:23,120 PRESIDENT'S BUDGET REQUEST 3530 02:48:23,120 --> 02:48:26,800 WITHOUT A CURRENT APPROPRIATION 3531 02:48:26,800 --> 02:48:29,880 IN PLACE. 3532 02:48:29,880 --> 02:48:34,760 MUCH OF THE PROCESS IS TO BE 3533 02:48:34,760 --> 02:48:36,720 DERMED SO EVERYTHING HINGES ON 3534 02:48:36,720 --> 02:48:39,720 THE RESULT OF THE NOVEMBER 3535 02:48:39,720 --> 02:48:41,800 ELECTION AND THE HOUSE AND 3536 02:48:41,800 --> 02:48:43,640 SENATE PROPOSED APPROXIMATELY 3% 3537 02:48:43,640 --> 02:48:45,040 INCREASE FOR NEI. 3538 02:48:45,040 --> 02:48:46,680 THE HOUSE AND SENATE WILL STILL 3539 02:48:46,680 --> 02:48:48,920 HAVE TO GO INTO CONFERENCE AND 3540 02:48:48,920 --> 02:48:50,400 OUR BUDGET COULD BE HIGHER, IT 3541 02:48:50,400 --> 02:48:54,800 COULD BE LOWER BUT AT THIS POINT 3542 02:48:54,800 --> 02:48:59,080 WE WAIT AND SEE. 3543 02:48:59,080 --> 02:49:00,920 FINALLY HERE ARE HIGHLIGHTS OF 3544 02:49:00,920 --> 02:49:04,280 HOUSE AND SENATE BILLS THAT 3545 02:49:04,280 --> 02:49:05,680 SPEAK TO FUNDING AT THE NIH 3546 02:49:05,680 --> 02:49:06,160 LEVEL. 3547 02:49:06,160 --> 02:49:11,200 THE HOUSE PROPOSED A $2.5 3548 02:49:11,200 --> 02:49:14,200 BILLION INCREASE FOR NIH 3549 02:49:14,200 --> 02:49:15,720 EXCLUDING ARPA-H THE ADVANCED 3550 02:49:15,720 --> 02:49:16,920 RESEARCH PROJECTS AGENCY FOR 3551 02:49:16,920 --> 02:49:20,000 HEALTH WHILE THE SENATE PROPOSED 3552 02:49:20,000 --> 02:49:22,800 A $2 BILLION INCLUDING NIH BUT 3553 02:49:22,800 --> 02:49:25,440 AT THE SAME FUNDING LEVEL AS 3554 02:49:25,440 --> 02:49:27,200 LAST YEAR WHICH IS $1 BILLION. 3555 02:49:27,200 --> 02:49:29,440 ALSO INCLUDED IN THE SENATE BILL 3556 02:49:29,440 --> 02:49:33,360 IS A MINIMUM 3% INCREASE FOR 3557 02:49:33,360 --> 02:49:36,160 MOST NIH INSTITUTES AND CENTERS 3558 02:49:36,160 --> 02:49:38,120 WITH SOME I.C.s RECEIVING 3559 02:49:38,120 --> 02:49:41,320 TARGETED INCREASES FOR SPECIFIC 3560 02:49:41,320 --> 02:49:42,680 PRIORITIES INCLUDING OPIOIDS 3561 02:49:42,680 --> 02:49:46,760 RESEARCH, HEALTH DISPARITIES AND 3562 02:49:46,760 --> 02:49:50,280 ENVIRONMENTAL HEALTH. 3563 02:49:50,280 --> 02:49:52,160 THAT CONCLUDES MY UPDATE AND 3564 02:49:52,160 --> 02:49:53,640 HAPPY TO ANSWER QUESTIONS. 3565 02:49:53,640 --> 02:49:55,840 THIS IS MY CONTACT INFORMATION. 3566 02:49:55,840 --> 02:49:58,800 IF YOU HAVE QUESTIONS ABOUT THE 3567 02:49:58,800 --> 02:50:02,800 BUDGET CONTACT ME AT ANY TIME. 3568 02:50:02,800 --> 02:50:12,960 THANK YOU. 3569 02:50:15,840 --> 02:50:18,200 >>DOES THE NIH DO WE HAVE 3570 02:50:18,200 --> 02:50:18,520 LOBBYISTS? 3571 02:50:18,520 --> 02:50:23,760 HOW MANY LOBBYISTS DO WE HAVE 3572 02:50:23,760 --> 02:50:29,160 AND WHAT'S THE PROCESS? 3573 02:50:29,160 --> 02:50:39,680 I WOULD REFER TO SHEPPA GORDON. 3574 02:50:43,560 --> 02:50:52,120 >>CAN YOU HEAR ME? 3575 02:50:52,120 --> 02:50:58,760 WE AS FEDERAL EMPLOYEE NOT TO 3576 02:50:58,760 --> 02:50:59,080 LOBBY. 3577 02:50:59,080 --> 02:51:00,680 THERE ARE VARIOUS GROUPS THAT 3578 02:51:00,680 --> 02:51:08,400 WILL LOPY ON BEHALF OF NIH SO 3579 02:51:08,400 --> 02:51:15,680 THERE'S AN AD HOC GROUP AND 3580 02:51:15,680 --> 02:51:22,000 THERE'S A GROUP OF DIFFERENT 3581 02:51:22,000 --> 02:51:23,480 INTERESTING ORGANIZATIONS LIKE 3582 02:51:23,480 --> 02:51:24,520 UNIVERSITIES OR PATIENT ADVOCACY 3583 02:51:24,520 --> 02:51:30,560 GROUPS AND UNDER ONE BIG 3584 02:51:30,560 --> 02:51:31,280 UMBRELLA THEIR GENERAL POLICY IS 3585 02:51:31,280 --> 02:51:33,160 THEY DON'T WANT TO PICK ONCE 3586 02:51:33,160 --> 02:51:33,880 AGAINST THE OTHER. 3587 02:51:33,880 --> 02:51:40,200 THEY LOBBY ON BEHALF OF ALL OF 3588 02:51:40,200 --> 02:51:40,880 NIH. 3589 02:51:40,880 --> 02:51:47,320 THERE'S ALSO A FRIENDS OF NEI 3590 02:51:47,320 --> 02:51:52,440 GROUP FOR EYE AND VISION 3591 02:51:52,440 --> 02:51:52,720 RESEARCH. 3592 02:51:52,720 --> 02:51:59,840 THEY DO EDUCATION ACTIVITIES FOR 3593 02:51:59,840 --> 02:52:05,360 MEMBERS OF CONGRESS AND A SECOND 3594 02:52:05,360 --> 02:52:07,040 GROUP LOBBYING AND EDUCATE 3595 02:52:07,040 --> 02:52:09,480 CONGRESS ON WHAT NEI IS DOING 3596 02:52:09,480 --> 02:52:17,080 AND WHAT WE COULD DO WITH MORE 3597 02:52:17,080 --> 02:52:21,160 RESEARCH 3598 02:52:21,160 --> 02:52:23,080 >>THANK YOU VERY MUCH AND BEN 3599 02:52:23,080 --> 02:52:24,040 THANKS FOR ASKING. 3600 02:52:24,040 --> 02:52:24,960 KAREN, THANK YOU FOR THE 3601 02:52:24,960 --> 02:52:25,280 PRESENTATION. 3602 02:52:25,280 --> 02:52:26,760 >>ABSOLUTELY. 3603 02:52:26,760 --> 02:52:32,680 THANK YOU. 3604 02:52:32,680 --> 02:52:35,480 >>CATHY, DO WE TURN BACK TO 3605 02:52:35,480 --> 02:52:35,920 YOU? 3606 02:52:35,920 --> 02:52:37,240 >>THANK YOU. 3607 02:52:37,240 --> 02:52:40,920 I APPRECIATE YOUR COMPLEXABILITY 3608 02:52:40,920 --> 02:52:43,000 WITH THE SCHEDULING. 3609 02:52:43,000 --> 02:52:46,840 SO WHAT WE HAVE NEXT ON THE 3610 02:52:46,840 --> 02:52:48,880 AGENDA IS SOMETHING WE HAVE BEEN 3611 02:52:48,880 --> 02:52:53,200 DOING FOR THE PAST COUPLE OF 3612 02:52:53,200 --> 02:52:54,800 MEETINGS, WE ARE GOING TO HAVE 3613 02:52:54,800 --> 02:52:56,080 TWO PORTFOLIO OVERVIEWS. 3614 02:52:56,080 --> 02:52:59,600 ONE FROM THE COLLABORATIVE 3615 02:52:59,600 --> 02:53:01,640 CLINICAL RESEARCH PROGRAM THAT 3616 02:53:01,640 --> 02:53:03,240 SUPPORTS MOST OF THE CLINICAL 3617 02:53:03,240 --> 02:53:05,120 TRIALS NEI SUPPORTS AND WE 3618 02:53:05,120 --> 02:53:06,760 THOUGHT THAT WOULD BE GOOD TO 3619 02:53:06,760 --> 02:53:10,960 HEAR ABOUT GIVEN WE JUST HEARD 3620 02:53:10,960 --> 02:53:13,040 ABOUT THE DCRC AND THE 3621 02:53:13,040 --> 02:53:13,920 IMPORTANCE OF IMPLEMENTATION 3622 02:53:13,920 --> 02:53:20,920 RESEARCH AND WHAT THAT IS. 3623 02:53:20,920 --> 02:53:24,360 AND DR. MARYANN REDFORD WILL 3624 02:53:24,360 --> 02:53:25,120 TALK WITH THE PROGRAM THAT 3625 02:53:25,120 --> 02:53:27,160 SUPPORTS NEI CLINICAL TRIALS. 3626 02:53:27,160 --> 02:53:28,240 MARYANN, GO AHEAD AND TAKE IT 3627 02:53:28,240 --> 02:53:38,320 AWAY. 3628 02:53:41,560 --> 02:53:43,640 >>I'M HAPPY TO PROVIDE THE 3629 02:53:43,640 --> 02:53:45,040 OVERVIEW OF THE COLLABORATIVE 3630 02:53:45,040 --> 02:53:46,560 CLINICAL RESEARCH PROGRAM WHICH 3631 02:53:46,560 --> 02:53:51,000 I THINK COUNCIL WILL HEAR IF IT 3632 02:53:51,000 --> 02:53:53,120 DOESN'T ALREADY APPRECIATE THAT 3633 02:53:53,120 --> 02:54:00,920 IT'S APTLY NAMED. 3634 02:54:00,920 --> 02:54:05,080 WE WORKED CLOSELY AND WITH OUR 3635 02:54:05,080 --> 02:54:06,520 INVESTIGATIVE TEAMS TO MANAGER 3636 02:54:06,520 --> 02:54:07,680 THE PORTFOLIO. 3637 02:54:07,680 --> 02:54:10,760 THE FOUR OF US ARE IN DAILY 3638 02:54:10,760 --> 02:54:15,160 CONTACT AND COLLECTIVELY BRING 3639 02:54:15,160 --> 02:54:19,960 103 YEARS OF NIH EXPERIENCE TO 3640 02:54:19,960 --> 02:54:21,960 THE TABLE WE SUPPORT THE 3641 02:54:21,960 --> 02:54:23,520 INSTITUTE'S PHASE 3 TRIALS AND 3642 02:54:23,520 --> 02:54:25,200 GENE AND CELLULAR THERAPY TRIALS 3643 02:54:25,200 --> 02:54:30,840 AND TWO RESEARCH NETWORKS, 3644 02:54:30,840 --> 02:54:34,040 MULTI-SITE EPIDEMIOLOGIC STUDIES 3645 02:54:34,040 --> 02:54:38,160 AND SYSTEMATIC REVIEW. 3646 02:54:38,160 --> 02:54:41,080 THE PORTFOLIO IS HEAVILY EXUDE 3647 02:54:41,080 --> 02:54:43,360 TOWARDS THE U MECHANISM. 3648 02:54:43,360 --> 02:54:48,760 NIH UTILIZES COOPERATIVE 3649 02:54:48,760 --> 02:54:50,760 AGREEMENTS WHEN IT ANTICIPATE 3650 02:54:50,760 --> 02:54:57,800 SUBSTANTIAL STAFF INVOLVEMENT 3651 02:54:57,800 --> 02:54:59,560 AND DIRECTORS PARTICIPATE IN 3652 02:54:59,560 --> 02:55:01,280 DISCUSSION AND TAKE PART IN 3653 02:55:01,280 --> 02:55:03,120 STEERING AND OVERSIGHT COMMITTEE 3654 02:55:03,120 --> 02:55:03,520 MEETINGS. 3655 02:55:03,520 --> 02:55:05,640 IN THAT WAY WE'RE ABLE TO TAKE 3656 02:55:05,640 --> 02:55:08,000 THE PULSE OF OUR STUDIES IN REAL 3657 02:55:08,000 --> 02:55:14,040 TIME AND PROVIDE THE KINDS OF 3658 02:55:14,040 --> 02:55:14,800 STEWARDSHIP IS THE PROFILE THE 3659 02:55:14,800 --> 02:55:16,520 COMPLEX PROJECTS DESERVE. 3660 02:55:16,520 --> 02:55:17,880 I MENTIONED THE EXTENSIVE OF OUR 3661 02:55:17,880 --> 02:55:25,560 GROUP. 3662 02:55:25,560 --> 02:55:27,160 OUR SUPER POWER IS OUR ABILITY 3663 02:55:27,160 --> 02:55:28,360 TO LEVERAGE THE EXPERIENCE AND 3664 02:55:28,360 --> 02:55:30,560 EXPERTISE OF PEOPLE WHO SERVE ON 3665 02:55:30,560 --> 02:55:35,360 OUR MONITORING COMMITTEES FOR 3666 02:55:35,360 --> 02:55:38,840 CLINICAL TRIALS COMMITTEES AND 3667 02:55:38,840 --> 02:55:45,080 FOR EPIDEMIOLOGIC STUDIES AND 3668 02:55:45,080 --> 02:55:47,960 THEY ASSIST NEA IN PROTECTING 3669 02:55:47,960 --> 02:55:49,400 RESEARCH PARTICIPANTS AND 3670 02:55:49,400 --> 02:55:50,760 MONITORING QUALITY, TIMELINESS 3671 02:55:50,760 --> 02:55:53,480 AND INTEGRATE. 3672 02:55:53,480 --> 02:56:00,000 -- INTEGRITY. 3673 02:56:00,000 --> 02:56:01,280 THE BAR IS SET VERY HIGH. 3674 02:56:01,280 --> 02:56:05,200 THIS STARTS AT THE APPLICATION 3675 02:56:05,200 --> 02:56:05,720 PHASE. 3676 02:56:05,720 --> 02:56:08,000 ALL CCR COOPERATE AGREEMENT 3677 02:56:08,000 --> 02:56:10,560 STUDIES MUST RESPOND TO NEI 3678 02:56:10,560 --> 02:56:12,720 SPECIFIC FUNDING OPPORTUNITY 3679 02:56:12,720 --> 02:56:13,840 ANNOUNCEMENTS WHICH ELICIT 3680 02:56:13,840 --> 02:56:14,560 DETAILS ON THE STUDY DESIGN AND 3681 02:56:14,560 --> 02:56:16,480 IMPLEMENTATION. 3682 02:56:16,480 --> 02:56:19,360 THESE APPLICATIONS ARE REVIEWED 3683 02:56:19,360 --> 02:56:23,000 IN HOUSE BY NEI CONVENED SPECIAL 3684 02:56:23,000 --> 02:56:26,720 EMPHASIS PANEL AND OUR SROs GO 3685 02:56:26,720 --> 02:56:29,120 TO GREAT LENGTHS TO ENSURE 3686 02:56:29,120 --> 02:56:34,200 RIGOROUS REVIEW. 3687 02:56:34,200 --> 02:56:35,600 OUR CLINICAL RESEARCH COMMUNITY 3688 02:56:35,600 --> 02:56:40,200 MAKES GOOD USE OF OUR SECONDARY 3689 02:56:40,200 --> 02:56:43,600 DATA ANALYSIS AND PLANNING 3690 02:56:43,600 --> 02:56:44,560 OPPORTUNITIES AND SOME SMALL 3691 02:56:44,560 --> 02:56:46,560 LESS COMPLEX STUDIES COME TO CCR 3692 02:56:46,560 --> 02:56:53,800 TO DO THE PARENT RO1. 3693 02:56:53,800 --> 02:56:57,640 WE'RE EXCITING TO SUPPORT 3694 02:56:57,640 --> 02:56:59,440 STUDIES WITH CUTTING EDGE 3695 02:56:59,440 --> 02:57:02,200 STUDIES IN HUMANS AND PROSTHESIS 3696 02:57:02,200 --> 02:57:05,720 AND STEM CELL AND INTERVENTIONS 3697 02:57:05,720 --> 02:57:06,880 AND TWO STEM CELL STUDIES ARE 3698 02:57:06,880 --> 02:57:09,080 BEING SUPPORTED BY THE 3699 02:57:09,080 --> 02:57:14,800 GENERATIVE MEDICINE INNOVATION 3700 02:57:14,800 --> 02:57:16,400 PROJECT. 3701 02:57:16,400 --> 02:57:20,240 ONE WAS TO ACCELERATE PROGRESS 3702 02:57:20,240 --> 02:57:21,960 IN THE FIELD A TRANS-NIH 3703 02:57:21,960 --> 02:57:24,040 INITIATIVE AND APPLICATIONS 3704 02:57:24,040 --> 02:57:26,760 COVER THE SCOPE OF SCIENCE 3705 02:57:26,760 --> 02:57:28,200 ACROSS ALL NIH DISCIPLINES AND 3706 02:57:28,200 --> 02:57:30,760 YET IN THE LAST FUNDING ROUND, 3707 02:57:30,760 --> 02:57:34,360 THREE APPLICATIONS WERE SELECTED 3708 02:57:34,360 --> 02:57:42,800 AND TWO WERE I- WE SUPPORT A 3709 02:57:42,800 --> 02:57:46,800 WIDE ARRAY OF CLINICAL TRIALS 3710 02:57:46,800 --> 02:57:47,360 ACROSS THE UNITED STATES. 3711 02:57:47,360 --> 02:57:50,800 THESE PLAY A CRITICAL ROLE 3712 02:57:50,800 --> 02:57:53,080 ADDRESSING ISSUES WHERE THE 3713 02:57:53,080 --> 02:57:57,080 PRIVATE SECTOR WOULDN'T GO. 3714 02:57:57,080 --> 02:57:59,000 NEA HAS A SOPHISTICATED RESEARCH 3715 02:57:59,000 --> 02:58:05,120 COMMUNITY AND SCIENTISTS, 3716 02:58:05,120 --> 02:58:08,560 TRIALISTS AND EPIDEMIOLOGISTS 3717 02:58:08,560 --> 02:58:09,360 AND ALL COLLABORATE TO EXECUTE 3718 02:58:09,360 --> 02:58:13,960 HIGH QUALITY STUDIES. 3719 02:58:13,960 --> 02:58:17,080 OUR DISCIPLINE ALSO STANDS OUT 3720 02:58:17,080 --> 02:58:20,000 AND MOST STUDIES USE ACADEMIC 3721 02:58:20,000 --> 02:58:21,560 AND PRIVATE PRACTICE BASED 3722 02:58:21,560 --> 02:58:22,560 ENROLLMENT CENTERS. 3723 02:58:22,560 --> 02:58:26,080 WE'RE SEEING AN UPTICK IN 3724 02:58:26,080 --> 02:58:26,720 INTERNATIONAL SITE 3725 02:58:26,720 --> 02:58:27,040 PARTICIPATION. 3726 02:58:27,040 --> 02:58:30,760 THIS ENHANCES ENROLLMENT, MAKES 3727 02:58:30,760 --> 02:58:33,640 THE TRIAL MORE REAL WORLD AND 3728 02:58:33,640 --> 02:58:34,760 ACCELERATES THE TRANSLATION OF 3729 02:58:34,760 --> 02:58:43,960 RESEARCH TO PRACTICE. 3730 02:58:43,960 --> 02:58:46,760 TAKEN TOGETHER THE ANTERIOR 3731 02:58:46,760 --> 02:58:52,320 SEGMENT AND BACK OF THE EYE AND 3732 02:58:52,320 --> 02:58:54,600 ADDRESSES IMPORTANT ISSUES 3733 02:58:54,600 --> 02:59:00,000 INCLUDING A AND D IN OLDER 3734 02:59:00,000 --> 02:59:06,680 INDIVIDUALS AND RETINOPATHY OF 3735 02:59:06,680 --> 02:59:07,000 PREMATURITY. 3736 02:59:07,000 --> 02:59:11,320 AND WE HAVE GOOD OF WOMEN AND 3737 02:59:11,320 --> 02:59:17,360 MINORITIES. 3738 02:59:17,360 --> 02:59:21,160 WE ALSO HEARD THERE'S A NEED AND 3739 02:59:21,160 --> 02:59:23,480 NEI IS ADDRESSING THAT WITH TWO 3740 02:59:23,480 --> 02:59:25,880 INTERNATIONAL RESEARCH PROJECTS 3741 02:59:25,880 --> 02:59:26,800 IN COUNTRY PUBLIC HEALTH 3742 02:59:26,800 --> 02:59:28,920 FOCUSSED STUDIES BEING CONDUCTED 3743 02:59:28,920 --> 02:59:34,800 IN ETHIOPIA AND NEPAL AND NIGER. 3744 02:59:34,800 --> 02:59:38,040 THEY COME WITH THEIR OWN 3745 02:59:38,040 --> 02:59:40,000 CHALLENGES UNIQUE SET OF 3746 02:59:40,000 --> 02:59:42,880 CHALLENGE BUT THANKFULLY NEI HAS 3747 02:59:42,880 --> 02:59:45,040 A CADRE OF EXPERIENCED 3748 02:59:45,040 --> 02:59:46,760 INVESTIGATORS PASSIONATE ABOUT 3749 02:59:46,760 --> 02:59:51,040 THE WORK. 3750 02:59:51,040 --> 02:59:53,600 WE SUPPORT TWO RESEARCH NETWORKS 3751 02:59:53,600 --> 02:59:56,320 AND YOU'VE BEEN INTRODUCED TO AT 3752 02:59:56,320 --> 02:59:57,000 LEAST ONE. 3753 02:59:57,000 --> 02:59:59,720 AND BOTH RESEARCH NETWORKS ARE 3754 02:59:59,720 --> 03:00:06,480 OPEN WHICH AGAIN I THINK IS A 3755 03:00:06,480 --> 03:00:08,400 UNIQUE ASPECT OF NEI SUPPORTED 3756 03:00:08,400 --> 03:00:09,080 RESEARCH. 3757 03:00:09,080 --> 03:00:11,720 THAT MEANS ANYONE QUALIFIED AND 3758 03:00:11,720 --> 03:00:14,040 ABLE TO ENROLL AND EXECUTE THE 3759 03:00:14,040 --> 03:00:15,440 PROTOCOL CAN PARTICIPATE. 3760 03:00:15,440 --> 03:00:20,880 YOU HEARD ANYONE CAN SUGGEST 3761 03:00:20,880 --> 03:00:21,960 RESEARCH IDEAS FOR CONSIDERATION 3762 03:00:21,960 --> 03:00:24,800 AND SCIENTIFIC CONTRIBUTIONS CAN 3763 03:00:24,800 --> 03:00:26,760 PARTICIPATE IN THE MANUSCRIPT 3764 03:00:26,760 --> 03:00:27,680 WRITING PROCESS. 3765 03:00:27,680 --> 03:00:33,000 THE PEDIATRIC EYE DISEASE 3766 03:00:33,000 --> 03:00:34,520 INVESTIGATIVE STUDIES HAVE 3767 03:00:34,520 --> 03:00:35,160 INFLUENCED CLINICAL PEDIATRIC 3768 03:00:35,160 --> 03:00:39,800 CARE WORLDWIDE. 3769 03:00:39,800 --> 03:00:42,600 300 OPHTHALMOLOGISTS ARE ENGAGED 3770 03:00:42,600 --> 03:00:49,360 IN RESEARCH AND 130 MANUSCRIPTS 3771 03:00:49,360 --> 03:00:55,920 HAVE BEEN PUBLISHED AND THERE'S 3772 03:00:55,920 --> 03:00:57,120 EVIDENCE-BASED PREFERRED 3773 03:00:57,120 --> 03:01:00,400 PRACTICE FOR AMBLIOPIA. 3774 03:01:00,400 --> 03:01:04,760 YOU'VE HEARD ABOUT THE DRCR 3775 03:01:04,760 --> 03:01:07,240 RETINAL NETWORK AND I'LL DIVERGE 3776 03:01:07,240 --> 03:01:17,800 FROM WHAT I HAD PLANNED TO SAY. 3777 03:01:22,360 --> 03:01:25,240 THE PUBLICATION JUST HIT THE 3778 03:01:25,240 --> 03:01:26,760 PRESS IN 2022 AND THAT GIVES YOU 3779 03:01:26,760 --> 03:01:30,440 THE IDEA -- THAT'S TRUE FOR ALL 3780 03:01:30,440 --> 03:01:31,440 HER STUDIES. 3781 03:01:31,440 --> 03:01:34,240 THE PLANNING AND LAG TIME, IF 3782 03:01:34,240 --> 03:01:36,320 YOU HAVE A PRIMARY OUTCOME OR 3783 03:01:36,320 --> 03:01:37,680 FOUR-YEAR PRIMARY OUTCOME, 3784 03:01:37,680 --> 03:01:39,000 WHATEVER IT IS, YOU'RE NOT 3785 03:01:39,000 --> 03:01:41,120 PUBLISHING THE RESULTS OF YOUR 3786 03:01:41,120 --> 03:01:44,480 STUDY UNTIL YOU HIT THAT. 3787 03:01:44,480 --> 03:01:46,160 KEEP THAT IN MIND WHEN YOU HEAR 3788 03:01:46,160 --> 03:01:46,480 THE NUMBERS. 3789 03:01:46,480 --> 03:01:49,960 THE OTHER THING SHE SAID WAS 3790 03:01:49,960 --> 03:01:52,320 INTERESTED SHE NOTED 398 3791 03:01:52,320 --> 03:01:53,960 PRACTITIONERS INVOLVED IN THE 3792 03:01:53,960 --> 03:01:58,000 RESEARCH BUT THEY WERE 1,000 3793 03:01:58,000 --> 03:02:01,280 OTHER PERSONNEL ENGAGED IN 3794 03:02:01,280 --> 03:02:01,760 RETINA RESEARCH. 3795 03:02:01,760 --> 03:02:02,760 THE CLINICIANS ARE VERY 3796 03:02:02,760 --> 03:02:04,520 IMPORTANT OF COURSE. 3797 03:02:04,520 --> 03:02:08,160 BUT THERE'S A WHOLE TEAM BEHIND 3798 03:02:08,160 --> 03:02:09,320 EVERY ENROLLMENT CENTER P.I. 3799 03:02:09,320 --> 03:02:12,000 THERE'S A TEAM SUPPORTING THAT 3800 03:02:12,000 --> 03:02:15,400 RESEARCH SO THERE'S STUDY 3801 03:02:15,400 --> 03:02:17,440 COORDINATORS AND A GOOD STUDY 3802 03:02:17,440 --> 03:02:18,200 COORDINATOR IS WORTH THEIR 3803 03:02:18,200 --> 03:02:19,440 WEIGHT IN GOAL. 3804 03:02:19,440 --> 03:02:21,440 MOST STUDIES HAVE IMAGING. 3805 03:02:21,440 --> 03:02:25,400 THERE'LL BE OCT TECHNICIANS AND 3806 03:02:25,400 --> 03:02:26,920 IT TAKES A VILLAGE. 3807 03:02:26,920 --> 03:02:29,120 ALL THE STUDIES ARE ROUTINE 3808 03:02:29,120 --> 03:02:33,920 RESEARCH. 3809 03:02:33,920 --> 03:02:40,000 AN THERE'S COLLABORATIONS DRCR 3810 03:02:40,000 --> 03:02:44,640 HAS ALREADY AFFECT ED THE 3811 03:02:44,640 --> 03:02:50,080 COLLABORATION BETWEEN NEI AND 3812 03:02:50,080 --> 03:02:52,160 NIDDK AND GARNERED THE SUPPORT 3813 03:02:52,160 --> 03:02:53,720 OF PARTNERS. 3814 03:02:53,720 --> 03:02:55,480 IT'S HARD TO OVER EMPHASIZE THE 3815 03:02:55,480 --> 03:03:00,600 INFLUENCE THE NETWORK STUDIES 3816 03:03:00,600 --> 03:03:02,720 HAVE HAD ON CLINIC PRACTICE AND 3817 03:03:02,720 --> 03:03:11,440 THE ALGORITHMS ARE REMREFLECTED 3818 03:03:11,440 --> 03:03:13,360 GUIDELINES AND THE AMERICAN 3819 03:03:13,360 --> 03:03:14,680 DIABETES ASSOCIATION AND THE 3820 03:03:14,680 --> 03:03:17,120 INTERNATIONAL COUNCIL IN 3821 03:03:17,120 --> 03:03:26,400 OPHTHALMOLOGY. 3822 03:03:26,400 --> 03:03:30,760 IT'S FITTING AS WE ROUND OUT 3823 03:03:30,760 --> 03:03:34,760 HISPANIC HERITAGE MONTH THERE'S 3824 03:03:34,760 --> 03:03:40,320 A STUDY THAT'S PIGGY BACKED TO 3825 03:03:40,320 --> 03:03:41,720 THE NHLBI HISPANIC COMMUNITY 3826 03:03:41,720 --> 03:03:43,240 HEALTH STUDIES. 3827 03:03:43,240 --> 03:03:46,360 IT WILL BE ABLE TO LEVERAGE HIGH 3828 03:03:46,360 --> 03:03:53,080 QUALITY PHENOTYPIC AND GENOTYPIC 3829 03:03:53,080 --> 03:03:55,640 DATA AND CONDUCTING EYE EXAMPLES 3830 03:03:55,640 --> 03:03:58,560 ON PARTICIPANTS IN CHICAGO AND 3831 03:03:58,560 --> 03:03:58,880 MIAMI. 3832 03:03:58,880 --> 03:04:01,640 AND IT REPRESENTS A UNIQUE 3833 03:04:01,640 --> 03:04:05,120 OPPORTUNITY TO RELATIONS AMONG 3834 03:04:05,120 --> 03:04:10,160 EYE CONDITIONS AND NOVEL 3835 03:04:10,160 --> 03:04:14,480 CARDIOVASCULAR DISEASE, OTHER 3836 03:04:14,480 --> 03:04:19,400 SOCIAL CULTURAL RISK FACTORS AND 3837 03:04:19,400 --> 03:04:22,080 MANY KNOW THE COLLABORATION IS 3838 03:04:22,080 --> 03:04:22,720 AN INTERNATIONAL ORGANIZATION 3839 03:04:22,720 --> 03:04:25,400 WITH THE GOAL OF HELPING PEOPLE 3840 03:04:25,400 --> 03:04:26,800 MAKE INFORMED DECISIONS ABOUT 3841 03:04:26,800 --> 03:04:31,240 HEALTH CARE. 3842 03:04:31,240 --> 03:04:34,080 COCHRANE EYE USES IT TO 3843 03:04:34,080 --> 03:04:37,000 SYNTHESIZE THE LITERATURE AND 3844 03:04:37,000 --> 03:04:40,040 EXPAND THE EVIDENCE BASE FOR EYE 3845 03:04:40,040 --> 03:04:40,280 CARE. 3846 03:04:40,280 --> 03:04:42,120 WITH THAT I'LL WRAP IT UP. 3847 03:04:42,120 --> 03:04:43,640 I KNOW IT WAS A HIGH-LEVEL 3848 03:04:43,640 --> 03:04:45,320 OVERVIEW BUT BEFORE I DO I WANT 3849 03:04:45,320 --> 03:04:47,560 TO DO A SHOUT OUT AS DON EVERETT 3850 03:04:47,560 --> 03:04:53,120 ALWAYS REMINDS US, WE HAVE A 3851 03:04:53,120 --> 03:04:57,480 GOOD STORY TO TELL AND THAT'S 3852 03:04:57,480 --> 03:04:58,960 TRUE FOR OUR STUDIES AND 3853 03:04:58,960 --> 03:05:04,080 INVESTIGATIVE GROUPS. 3854 03:05:04,080 --> 03:05:08,760 THIS IS FOR MEMBERS OF THE 3855 03:05:08,760 --> 03:05:10,080 OCULAR HYPER TREATMENT STUDY. 3856 03:05:10,080 --> 03:05:14,360 IN A RECENT RANKING FROM THE 3857 03:05:14,360 --> 03:05:15,720 AMERICANS AMERICAN GLAUCOMA 3858 03:05:15,720 --> 03:05:20,920 STUDY AND THOSE WITH IMPACT ON 3859 03:05:20,920 --> 03:05:22,360 CLINICAL GLAUCOMA CARE THEY 3860 03:05:22,360 --> 03:05:23,920 GARNERED THE NUMBER ONE, TWO AND 3861 03:05:23,920 --> 03:05:25,960 THREE RANKING. 3862 03:05:25,960 --> 03:05:30,960 CONGRATULATIONS TO EVERYONE WHO 3863 03:05:30,960 --> 03:05:36,400 WAS INVOLVED IN THOSE AND MY 3864 03:05:36,400 --> 03:05:41,120 CAST AND YOU NOT ONLY TOOK HOME 3865 03:05:41,120 --> 03:05:42,080 THE BRONZE, THE SILVER AND THE 3866 03:05:42,080 --> 03:05:42,800 GOLD. 3867 03:05:42,800 --> 03:05:52,960 THANK YOU. 3868 03:05:54,840 --> 03:06:05,120 QUESTIONS, COMMENTS? 3869 03:06:13,800 --> 03:06:15,200 I DIDN'T KNOW IF YOU WANTED TO 3870 03:06:15,200 --> 03:06:20,200 SAY A FEW WORDS? 3871 03:06:20,200 --> 03:06:22,760 >>I'VE HAD THE PRIVILEGE ON 3872 03:06:22,760 --> 03:06:24,320 SERVING ON BOTH SIDES OF THE 3873 03:06:24,320 --> 03:06:26,760 TABLE, CONDUCTING COLLABORATIVE 3874 03:06:26,760 --> 03:06:28,480 STUDIES I THINK ARE DONE AT SUCH 3875 03:06:28,480 --> 03:06:31,480 A HIGH LEVEL BECAUSE WE WERE 3876 03:06:31,480 --> 03:06:33,120 ABLE TO BRING IN THE BEST PEOPLE 3877 03:06:33,120 --> 03:06:40,880 FROM MANY DIFFERENT DISCIPLINES. 3878 03:06:40,880 --> 03:06:42,360 THAT'S BEEN WONDERFUL AND THE 3879 03:06:42,360 --> 03:06:43,040 PRESENTATIONS SHOWING THE NUMBER 3880 03:06:43,040 --> 03:06:45,440 OF PUBLICATIONS AND THE 3881 03:06:45,440 --> 03:06:48,680 INFLUENCE OF THE STUDIES HAVE 3882 03:06:48,680 --> 03:06:53,120 REALLY DEMONSTRATED THE VALUE OF 3883 03:06:53,120 --> 03:07:00,120 THESE VERY EXPENSIVE STUDIES AND 3884 03:07:00,120 --> 03:07:03,160 FROM THE OTHER SIDE WE HAVE 3885 03:07:03,160 --> 03:07:08,160 GREAT DIVERSITY OF EXPERTISE AND 3886 03:07:08,160 --> 03:07:12,600 I THINK IT'S ALWAYS GOOD TO HAVE 3887 03:07:12,600 --> 03:07:16,280 PEOPLE TO STEP AWAY FROM THE 3888 03:07:16,280 --> 03:07:17,880 STUDIES AND GIVE ADVICE AND MAKE 3889 03:07:17,880 --> 03:07:19,640 SURE EVERYTHING'S RUNNING AS 3890 03:07:19,640 --> 03:07:20,760 WELL AS IT CAN. 3891 03:07:20,760 --> 03:07:22,800 VERY NICE PRESENTATION, MARYANN. 3892 03:07:22,800 --> 03:07:28,560 >>THANK YOU. 3893 03:07:28,560 --> 03:07:30,760 >>THANK YOU AND I CONGRATULATE 3894 03:07:30,760 --> 03:07:32,240 YOU FOR ALL YOU AND YOUR 3895 03:07:32,240 --> 03:07:34,520 COLLEAGUES HAVE DONE AT THE NEI 3896 03:07:34,520 --> 03:07:39,000 TO SUPPORT THESE STUDIES MANY OF 3897 03:07:39,000 --> 03:07:43,200 WHICH ARE NOT TOP CANDIDATES FOR 3898 03:07:43,200 --> 03:07:44,120 INDUSTRY SUPPORT. 3899 03:07:44,120 --> 03:07:45,760 THEY'RE LENGTHY AND THEY'RE 3900 03:07:45,760 --> 03:07:46,800 REPORTING QUESTION TAKE A LONG 3901 03:07:46,800 --> 03:07:53,080 TIME TO GET ANSWERS ON AND FOR 3902 03:07:53,080 --> 03:07:54,720 OBVIOUS REASONS INDUSTRY CANNOT 3903 03:07:54,720 --> 03:07:55,480 MAKE INVESTMENTS INTO THE 3904 03:07:55,480 --> 03:07:56,040 QUESTIONS BECAUSE OF THEIR 3905 03:07:56,040 --> 03:08:00,240 NATURE. 3906 03:08:00,240 --> 03:08:05,120 YOU FILL AN IMPORTANT NICHE SO 3907 03:08:05,120 --> 03:08:05,600 THANK YOU. 3908 03:08:05,600 --> 03:08:16,120 >>AND REZA DOES A STUDY FOR 3909 03:08:17,200 --> 03:08:21,400 LIMBAL EPITHELIAL STEM CELL AND 3910 03:08:21,400 --> 03:08:22,800 THE FIRST STAGE WORK OUR 3911 03:08:22,800 --> 03:08:26,800 INVESTIGATORS NEED TO OVERCOME 3912 03:08:26,800 --> 03:08:30,840 ARE REALLY LENGTHY AND WITHOUT 3913 03:08:30,840 --> 03:08:33,040 INFRASTRUCTURE SUPPORT TO 3914 03:08:33,040 --> 03:08:37,640 FACILITATE THE RESEARCH. 3915 03:08:37,640 --> 03:08:44,560 SHE WAS ABLE TO LEVERAGE 3916 03:08:44,560 --> 03:08:47,760 OPPORTUNITIES TO DO THE 3917 03:08:47,760 --> 03:08:54,600 PRELIMINARY PRECLINICAL WORK AND 3918 03:08:54,600 --> 03:08:59,600 THAT WAS IMPORTANT. 3919 03:08:59,600 --> 03:09:04,400 >>I WAS CURIOUS ABOUT THE SOL 3920 03:09:04,400 --> 03:09:05,320 OJOS PROJECT. 3921 03:09:05,320 --> 03:09:07,120 HOW IS THAT REACHING POPULATIONS 3922 03:09:07,120 --> 03:09:07,760 ALREADY DIFFICULT TO REACH FOR 3923 03:09:07,760 --> 03:09:16,200 THE STUDIES? 3924 03:09:16,200 --> 03:09:17,760 >>WE'RE LEVERAGING WHAT NHLBI 3925 03:09:17,760 --> 03:09:23,040 HAS PUT INTO PLACE AND IT'S NOT 3926 03:09:23,040 --> 03:09:26,800 THE EYE COMPONENT BUT A 3927 03:09:26,800 --> 03:09:29,040 LONGITUDINAL STUDY AND THEY WENT 3928 03:09:29,040 --> 03:09:32,160 TO GREAT LENGTHS TO GET DIVERSE 3929 03:09:32,160 --> 03:09:36,080 POPULATIONS OF LATINAS TO 3930 03:09:36,080 --> 03:09:37,640 PARTICIPATE WE'RE BENEFITING NOT 3931 03:09:37,640 --> 03:09:40,880 ONLY ON THAT DATA BUT ON THE 3932 03:09:40,880 --> 03:09:44,360 WORK THEY DID TO MAKE THE 3933 03:09:44,360 --> 03:09:45,320 COHORT. 3934 03:09:45,320 --> 03:09:48,560 >>DO WE KNOW WHAT THE 3935 03:09:48,560 --> 03:09:49,200 IMPLEMENTATION PLANS ARE AND 3936 03:09:49,200 --> 03:09:51,560 WHAT THEY'LL DO WITH THE DATA 3937 03:09:51,560 --> 03:09:53,160 AFTER THEY GET THE DATA AND HOW 3938 03:09:53,160 --> 03:09:57,000 IT WILL BE IMPLEMENTED TO 3939 03:09:57,000 --> 03:10:02,800 IMPROVE THE VISION OF THESE 3940 03:10:02,800 --> 03:10:06,800 COMMUNITIES? 3941 03:10:06,800 --> 03:10:10,280 >>THERE'S A PLANNED AIM OF THAT 3942 03:10:10,280 --> 03:10:12,320 WORK BUT I THINK IN THE EYE 3943 03:10:12,320 --> 03:10:15,920 FIELD, WE'RE LOOKING TO SEE THE 3944 03:10:15,920 --> 03:10:16,240 CONDITIONS. 3945 03:10:16,240 --> 03:10:19,120 RIGHT NOW THEY'RE DOING 3,000 3946 03:10:19,120 --> 03:10:22,800 COMPREHENSIVE EYE EXAMS AND 3947 03:10:22,800 --> 03:10:25,040 INTERESTED IN SEEING HOW THAT 3948 03:10:25,040 --> 03:10:26,640 CORRELATES WITH THE SYSTEMIC 3949 03:10:26,640 --> 03:10:32,240 DATA AND GENETIC DATA THAT'S 3950 03:10:32,240 --> 03:10:32,960 AVAILABLE. 3951 03:10:32,960 --> 03:10:41,120 YOU'RE RIGHT, AND WE HAVE 3952 03:10:41,120 --> 03:10:46,800 DISPARI 3953 03:10:46,800 --> 03:10:54,120 DISPARITIES. 3954 03:10:54,120 --> 03:10:58,760 >>DO YOU HAVE A QUESTION? 3955 03:10:58,760 --> 03:11:09,040 >>I'M SORRY. 3956 03:11:12,480 --> 03:11:17,080 >>I HAVE A COMMENT. 3957 03:11:17,080 --> 03:11:19,240 I GUESS THE COMMENT TO 3958 03:11:19,240 --> 03:11:29,760 IMPORTANCE OF THAT TRIAL FOR THE 3959 03:11:32,200 --> 03:11:36,160 OCULAR STUDY AND THE RESOURCE 3960 03:11:36,160 --> 03:11:38,400 HELPED TREMENDOUSLY AND HOPE TO 3961 03:11:38,400 --> 03:11:41,440 RESOLVE MANY DIFFERENT ISSUES. 3962 03:11:41,440 --> 03:11:45,760 I'M SURPRISED IT WAS THE FIRST 3963 03:11:45,760 --> 03:11:45,920 ONE. 3964 03:11:45,920 --> 03:11:48,200 I HAVEN'T SEEN A PAPER ABOUT THE 3965 03:11:48,200 --> 03:11:50,800 PRESSURE BUT IT DOES NOT MENTION 3966 03:11:50,800 --> 03:11:54,480 THE PAPER. 3967 03:11:54,480 --> 03:11:57,240 >>YES, I THINK IT WAS WONDERFUL 3968 03:11:57,240 --> 03:12:00,040 THEY GOT THAT RECOGNITION AND 3969 03:12:00,040 --> 03:12:01,480 FRANKLY IN THE TOP 10 OR 3970 03:12:01,480 --> 03:12:03,320 WHATEVER RANKINGS, THERE WERE A 3971 03:12:03,320 --> 03:12:07,760 NUMBER OF NEI SUPPORTED GLAUCOMA 3972 03:12:07,760 --> 03:12:12,400 TRIALS AND IT WAS NOT JUST THEY 3973 03:12:12,400 --> 03:12:16,920 GOT THE TOP THREE. 3974 03:12:16,920 --> 03:12:18,800 >>THANK YOU. 3975 03:12:18,800 --> 03:12:23,680 >>THANK YOU, MARYANN. 3976 03:12:23,680 --> 03:12:28,560 >>OUR NEXT PORTFOLIO IS ONE WE 3977 03:12:28,560 --> 03:12:30,320 HAVE PRESENTED EVERY FALL AND IT 3978 03:12:30,320 --> 03:12:34,200 INCLUDES SOME THINGS WE'RE 3979 03:12:34,200 --> 03:12:35,960 REQUIRED TO PRESENT TO YOU SO 3980 03:12:35,960 --> 03:12:37,480 OUR TRAINING OFFICER IS GOING TO 3981 03:12:37,480 --> 03:12:41,160 PRESENT AN OVERVIEW OF THE NEI 3982 03:12:41,160 --> 03:12:42,080 TRAINING PORTFOLIO. 3983 03:12:42,080 --> 03:12:45,040 GOOD AFTERNOON AND THANK YOU FOR 3984 03:12:45,040 --> 03:12:55,400 DOING SUCH A GOOD JOB. 3985 03:12:59,160 --> 03:13:09,520 AND THERE'S INDIVIDUAL 3986 03:13:15,080 --> 03:13:18,560 FELLOWSHIPS AND F31 IS A 3987 03:13:18,560 --> 03:13:20,720 FELLOWSHIP FOR GRADUATE STUDENTS 3988 03:13:20,720 --> 03:13:23,520 ENROLLED IN Ph.D. PROGRAM AND 3989 03:13:23,520 --> 03:13:30,120 F32 IS A POSTDOCTORAL 3990 03:13:30,120 --> 03:13:30,720 FELLOWSHIP. 3991 03:13:30,720 --> 03:13:38,000 WHEREAS THE CAREER DEVELOPMENT 3992 03:13:38,000 --> 03:13:44,040 PROGRAM CONSISTS OF K08 AND A 3993 03:13:44,040 --> 03:13:47,120 WARD FOR BASIC DIDACTIC 3994 03:13:47,120 --> 03:13:47,560 RESEARCH. 3995 03:13:47,560 --> 03:13:54,160 K23 IS AN AWARD FOR CLINICALLY 3996 03:13:54,160 --> 03:13:55,960 ORIENTED RESEARCH. 3997 03:13:55,960 --> 03:14:00,480 THOSE PEOPLE WHO WILL BE 3998 03:14:00,480 --> 03:14:03,280 CARRYING OUT WHAT MARYANN 3999 03:14:03,280 --> 03:14:08,960 ALLUDED TO AND K99/R00 IS A 4000 03:14:08,960 --> 03:14:11,440 TRANSITION AWARD FOR POSTDOCS 4001 03:14:11,440 --> 03:14:13,960 AFTER FINISHING Ph.D. AND HAVING 4002 03:14:13,960 --> 03:14:16,640 SAID THAT, EVEN CLINICAL 4003 03:14:16,640 --> 03:14:18,520 SCIENTISTS ARE ELIGIBLE TO APPLY 4004 03:14:18,520 --> 03:14:21,080 FOR THIS PROGRAM. 4005 03:14:21,080 --> 03:14:23,000 FINALLY, WE HAVE INSTITUTIONAL 4006 03:14:23,000 --> 03:14:25,120 TRAINING GROUNDS, T32 IS 4007 03:14:25,120 --> 03:14:26,080 INSTITUTIONAL TRAINING GROUND 4008 03:14:26,080 --> 03:14:31,200 FOR PRE AND POSTDOCTORAL 4009 03:14:31,200 --> 03:14:33,360 STUDENTS AND T35 IS A PROGRAM 4010 03:14:33,360 --> 03:14:34,800 FOR MAINLY MEDICAL STUDENTS 4011 03:14:34,800 --> 03:14:36,400 BETWEEN FIRST AND SECOND YEAR OF 4012 03:14:36,400 --> 03:14:38,400 THEIR SUMMER AND FIRST YEAR OF 4013 03:14:38,400 --> 03:14:41,320 SUMMER BEFORE STARTING SECOND 4014 03:14:41,320 --> 03:14:44,680 YEAR. 4015 03:14:44,680 --> 03:14:47,680 AND K12 IS THE CAREER 4016 03:14:47,680 --> 03:14:48,680 DEVELOPMENT PROGRAM FOR 4017 03:14:48,680 --> 03:14:49,440 CLINICIAN SCIENTISTS. 4018 03:14:49,440 --> 03:14:54,360 ONE HAS TO BE A U.S. CITIZEN TO 4019 03:14:54,360 --> 03:14:57,320 APPLY FOR INDIVIDUAL FELLOWSHIPS 4020 03:14:57,320 --> 03:15:00,200 AS WELL K08 AND K23. 4021 03:15:00,200 --> 03:15:07,480 BUT FOR K99 AND R00 ONE DOESN'T 4022 03:15:07,480 --> 03:15:09,480 HAVE TO BE A RESIDENT. 4023 03:15:09,480 --> 03:15:13,320 NOW, GOING ON I'LL BE USING 4024 03:15:13,320 --> 03:15:17,840 THESE NOMENCLATURE AT 30 AND 4025 03:15:17,840 --> 03:15:19,960 30K08 AND IF YOU HAVE CONFUSION, 4026 03:15:19,960 --> 03:15:21,280 RAISE YOUR HAND AND I'LL BE ABLE 4027 03:15:21,280 --> 03:15:23,800 TO ANSWER YOU BUT I'LL TRY TO 4028 03:15:23,800 --> 03:15:26,520 KEEP IT STRAIGHT. 4029 03:15:26,520 --> 03:15:30,000 ALL RIGHT. 4030 03:15:30,000 --> 03:15:40,560 SO THIS SLIDE SHOWS AND THERE'S 4031 03:15:48,840 --> 03:15:52,560 A PREDOC FELLOWSHIP FOR 4032 03:15:52,560 --> 03:15:53,200 CLINICIAN SCIENTISTS AND Ph.D. 4033 03:15:53,200 --> 03:15:57,000 STUDENTS AT 31 IS THE PREDOM 4034 03:15:57,000 --> 03:15:59,720 FELLOWSHIP FOUR GRADUATE 4035 03:15:59,720 --> 03:16:03,120 STUDENTS INVOLVING Ph.D. PROGRAM 4036 03:16:03,120 --> 03:16:07,880 AND K08, K23 AND K99 ARE CAREER 4037 03:16:07,880 --> 03:16:11,040 DEVELOPMENT AND CAREER 4038 03:16:11,040 --> 03:16:11,760 TRANSITION AWARD. 4039 03:16:11,760 --> 03:16:13,440 T32 IS THE INSTITUTIONAL 4040 03:16:13,440 --> 03:16:16,000 TRAINING GROUND FOR PRE AND POST 4041 03:16:16,000 --> 03:16:18,080 DOCK AND T35 IS THE 4042 03:16:18,080 --> 03:16:19,000 INSTITUTIONAL TRAINING GROUND 4043 03:16:19,000 --> 03:16:21,320 FOR SHORT TERM TRAINING AND K12 4044 03:16:21,320 --> 03:16:25,240 IS THE INSTITUTIONAL TRAINING 4045 03:16:25,240 --> 03:16:25,760 FOR CAREER DEVELOPMENT 4046 03:16:25,760 --> 03:16:35,960 SCIENTISTS. 4047 03:16:41,400 --> 03:16:46,160 THIS IS THE DISTRIBUTION. 4048 03:16:46,160 --> 03:16:47,760 THE RESEARCH PROGRAMS ARE 4049 03:16:47,760 --> 03:16:53,320 DIVIDED INTO RETINA, CORNEA, 4050 03:16:53,320 --> 03:16:55,040 GLAUCOMA AND VISUAL PROCESSING 4051 03:16:55,040 --> 03:16:57,080 AND LOW VISION. 4052 03:16:57,080 --> 03:16:59,000 THESE SIX PERHAPS. 4053 03:16:59,000 --> 03:17:01,680 SO HERE I'M COMPARING MY 4054 03:17:01,680 --> 03:17:06,720 PORTFOLIO AND HOW THEY ARE 4055 03:17:06,720 --> 03:17:09,600 DISTRIBUT 4056 03:17:09,600 --> 03:17:12,960 DISTRIBUTED AMONG THE RESEARCH 4057 03:17:12,960 --> 03:17:14,000 PROGRAMS. 4058 03:17:14,000 --> 03:17:18,040 YOU SEE HERE THE BLUE PART OF 4059 03:17:18,040 --> 03:17:26,240 THE PIE 43% FOR FELLOWSHIPS AND 4060 03:17:26,240 --> 03:17:31,800 44% FOR THE OTHER SERVICE AND 4061 03:17:31,800 --> 03:17:39,440 THE OTHER IS MYOPIA AND VISUAL 4062 03:17:39,440 --> 03:17:41,320 PROCESSING IS HALF AND SAME TO 4063 03:17:41,320 --> 03:17:44,240 THAT OF RETINA. 4064 03:17:44,240 --> 03:17:54,800 IN THE CASE IT'S HALF THE REST 4065 03:17:55,720 --> 03:17:57,320 OF THE PROGRAMS ARE CONSISTING 4066 03:17:57,320 --> 03:17:59,760 OF 10% OF THE RESEARCH PROGRAM 4067 03:17:59,760 --> 03:18:05,120 FOR NEI. 4068 03:18:05,120 --> 03:18:06,600 THIS SLIDE SHOWS THE SUCCESS 4069 03:18:06,600 --> 03:18:09,080 RATE OF FELLOWSHIPS? 4070 03:18:09,080 --> 03:18:11,400 HOW DO YOU CALCULATE IT? 4071 03:18:11,400 --> 03:18:14,360 YOU LOOK AT THE AWARDED 4072 03:18:14,360 --> 03:18:17,400 FELLOWSHIPS COMPARED TO THE 4073 03:18:17,400 --> 03:18:19,920 FELLOWSHIPS AND YOU GO 100 4074 03:18:19,920 --> 03:18:21,720 APPLICATIONS AND WE FUNDED 50 SO 4075 03:18:21,720 --> 03:18:29,920 THE RATE IS 50%. 4076 03:18:29,920 --> 03:18:33,320 HERE WE CALCULATED THE DATA AND 4077 03:18:33,320 --> 03:18:39,440 THE BLUE BAR REPRESENTS THE 4078 03:18:39,440 --> 03:18:44,760 VALUES AT 31 AND YOU CAN SEE 4079 03:18:44,760 --> 03:18:46,680 HERE OUR FELLOWSHIP ARE DOING 4080 03:18:46,680 --> 03:18:48,000 VERY WELL. 4081 03:18:48,000 --> 03:18:49,960 THEY WERE HIGHER THAN THE NIH AS 4082 03:18:49,960 --> 03:18:50,960 A WHOLE. 4083 03:18:50,960 --> 03:18:54,520 WHEREAS AT 31 AND AT 32 ARE AT 4084 03:18:54,520 --> 03:19:02,800 PAR WITH NIH AS A WHOLE. 4085 03:19:02,800 --> 03:19:07,920 IT'S GOING TO BE IMPORTANT TO 4086 03:19:07,920 --> 03:19:17,320 SEE HOW MANY OF THESE WILL GO 4087 03:19:17,320 --> 03:19:19,000 INTO OPHTHALMOLOGY. 4088 03:19:19,000 --> 03:19:21,040 WE'RE PUTTING OUR MONEY IN THE 4089 03:19:21,040 --> 03:19:23,720 TRAINING OF THE Ph.D.s SO WOULD 4090 03:19:23,720 --> 03:19:30,640 LIKE TO SEE THEM GO INTO 4091 03:19:30,640 --> 03:19:31,240 OPHTHALMOLOGY. 4092 03:19:31,240 --> 03:19:32,960 WE STARTED TO PARTICIPATE IN THE 4093 03:19:32,960 --> 03:19:43,440 PROGRAM IN 2015 AND BEYOND. 4094 03:20:10,720 --> 03:20:17,160 THE SUCCESS OF A PROGRAM IS HOW 4095 03:20:17,160 --> 03:20:21,320 MANY R01s YOU GET AND WE LOOKED 4096 03:20:21,320 --> 03:20:23,480 AT THE POSTDOCTORAL FELLOWSHIP. 4097 03:20:23,480 --> 03:20:28,320 THE TOTAL NUMBER OF F32 AWARDED 4098 03:20:28,320 --> 03:20:33,960 BETWEEN THE FISCAL YEAR 2012 AND 4099 03:20:33,960 --> 03:20:35,320 2022, 168. 4100 03:20:35,320 --> 03:20:42,600 OF WHICH 30 APPLIED FOR RO1 4101 03:20:42,600 --> 03:20:44,080 EQUIVALENT AND 12 WERE 4102 03:20:44,080 --> 03:20:46,400 SUCCESSFUL WITH A 40% SUCCESS 4103 03:20:46,400 --> 03:20:50,360 RATE AND THE AVERAGE NUMBER OF 4104 03:20:50,360 --> 03:20:51,040 YEARS WAS ONE YEAR. 4105 03:20:51,040 --> 03:20:57,320 AND THEY WERE ABLE TO GET IT OR 4106 03:20:57,320 --> 03:21:00,080 APPLIED IN TWO OVERLAPS AND WERE 4107 03:21:00,080 --> 03:21:02,480 ABLE TO GET THE R01 IN THAT. 4108 03:21:02,480 --> 03:21:04,640 IN THIS CALCULATION THE 4109 03:21:04,640 --> 03:21:07,400 POST-DOCTORAL FELLOWSHIPS ARE TO 4110 03:21:07,400 --> 03:21:11,200 APPLY K99 AND R OO THE 4111 03:21:11,200 --> 03:21:12,400 TRANSITION AWARD PROGRAM IN 4112 03:21:12,400 --> 03:21:14,560 WHICH THEY GET TWO YEARS OF 4113 03:21:14,560 --> 03:21:17,080 MENTORED FELLOWSHIP AND MENTORED 4114 03:21:17,080 --> 03:21:20,520 RESEARCH, K99 AND THEN IN THOSE 4115 03:21:20,520 --> 03:21:23,040 TWO YEARS THEY FIND THEIR JOB 4116 03:21:23,040 --> 03:21:28,480 AND LOOK FOR INDEPENDENT 4117 03:21:28,480 --> 03:21:32,880 POSITION AND MOVE THE MONEY TO A 4118 03:21:32,880 --> 03:21:33,400 DIFFERENT PLACE. 4119 03:21:33,400 --> 03:21:36,400 NOTE INCLUDED IS THE K99 AWARDEE 4120 03:21:36,400 --> 03:21:37,720 THEY'RE ABLE TO. 4121 03:21:37,720 --> 03:21:40,760 16 WERE ALSO SUCCESSFUL TO GET 4122 03:21:40,760 --> 03:21:42,280 K99s. 4123 03:21:42,280 --> 03:21:43,200 THIS SUCCESS RATE WILL BE HIGHER 4124 03:21:43,200 --> 03:21:44,680 THAN 40%. 4125 03:21:44,680 --> 03:21:46,200 AND ALSO I WOULD LIKE TO MAKE 4126 03:21:46,200 --> 03:21:49,080 ONE MORE COMMENT AT THIS POINT 4127 03:21:49,080 --> 03:21:51,480 HERE BECAUSE MANY OF THEM ARE 4128 03:21:51,480 --> 03:21:55,440 STILL FRESH WITH THEIR 4129 03:21:55,440 --> 03:21:57,800 FELLOWSHIP BECAUSE 2022 WE JUST 4130 03:21:57,800 --> 03:21:59,560 AWARDED THEM LAST PHYSICAL YEAR 4131 03:21:59,560 --> 03:22:03,880 AND 2021 AND 2020 AND 2019 STILL 4132 03:22:03,880 --> 03:22:05,120 MIGHT BE FINISHING THEIR 4133 03:22:05,120 --> 03:22:06,920 FELLOWSHIPS AND GETTING INTO THE 4134 03:22:06,920 --> 03:22:07,480 JOBS. 4135 03:22:07,480 --> 03:22:09,440 THEY'RE NOT EVEN APPLYING. 4136 03:22:09,440 --> 03:22:12,240 SO THE NUMBERS WE DID THE 4137 03:22:12,240 --> 03:22:14,560 CALCULATION FROM 2012 TO 2016 4138 03:22:14,560 --> 03:22:15,880 AND 2017 THE NUMBERS WILL BE 4139 03:22:15,880 --> 03:22:17,400 BETTER THAN WHAT THEY'RE SHOWING 4140 03:22:17,400 --> 03:22:26,920 YOU RIGHT NOW. 4141 03:22:26,920 --> 03:22:28,840 CHANGING GEARS HERE'S THE DATA 4142 03:22:28,840 --> 03:22:30,600 FOR THE INSTITUTIONAL TRAINING 4143 03:22:30,600 --> 03:22:32,040 GROUNDS AND THEY'RE SUCCESS RATE 4144 03:22:32,040 --> 03:22:34,440 AND I'VE DONE THIS FOR THE LAST 4145 03:22:34,440 --> 03:22:35,880 FISCAL YEAR, 2022. 4146 03:22:35,880 --> 03:22:38,200 LAST FISCAL YEAR WE RECEIVED TWO 4147 03:22:38,200 --> 03:22:43,240 K12 APPLICATIONS. 4148 03:22:43,240 --> 03:22:50,080 ONE WAS TYPE II AND ONE WAS A 4149 03:22:50,080 --> 03:22:50,480 NEW APPLICATION. 4150 03:22:50,480 --> 03:22:53,440 WE FUNDED BOTH OF THEM. 4151 03:22:53,440 --> 03:22:57,520 THE SUCCESS RATE FOR LAST YEAR 4152 03:22:57,520 --> 03:22:59,480 K12 WAS 100%. 4153 03:22:59,480 --> 03:23:00,800 FOR INSTITUTIONAL TRAINING 4154 03:23:00,800 --> 03:23:04,920 GROUNDS FOR PRE AND POST DOCS 4155 03:23:04,920 --> 03:23:08,320 WAS 63% AND WE RECEIVED 11 4156 03:23:08,320 --> 03:23:10,480 APPLICATIONS NEW AND REPEAT AND 4157 03:23:10,480 --> 03:23:12,880 OUT OF THAT WE FUNDED 7. 4158 03:23:12,880 --> 03:23:16,920 OUR SUCCESS RATE WAS 63%. 4159 03:23:16,920 --> 03:23:20,360 WHEREAS T35 THE SHORT TERM 4160 03:23:20,360 --> 03:23:21,360 SUMMER TRAINING INSTITUTIONAL 4161 03:23:21,360 --> 03:23:23,120 GRANT WE RECEIVED FOUR 4162 03:23:23,120 --> 03:23:24,640 APPLICATIONS AND WE FUNDED ALL 4163 03:23:24,640 --> 03:23:25,960 FOUR OF THEM TO THE SUCCESS RATE 4164 03:23:25,960 --> 03:23:30,800 WAS 100%. 4165 03:23:30,800 --> 03:23:36,440 THE CURRENT YEAR, FISCAL YEAR 4166 03:23:36,440 --> 03:23:38,840 2022 I HAVE TWO WE FUNDED IN 4167 03:23:38,840 --> 03:23:41,360 2022 AND THE TOTAL NUMBER OF 4168 03:23:41,360 --> 03:23:44,160 SLOTS IS 18 IN THOSE SO EIGHT 4169 03:23:44,160 --> 03:23:45,680 HAVE TWO SLOTS EACH AND TWO OF 4170 03:23:45,680 --> 03:23:49,760 THEM HAVE ONE SLOT EACH. 4171 03:23:49,760 --> 03:23:52,280 WHEREAS TOTAL NUMBER OF T32 IN 4172 03:23:52,280 --> 03:23:55,600 MY PORTFOLIO IS 30 AND THE 4173 03:23:55,600 --> 03:24:03,880 NUMBER OF POST DOCS IN 19 AND I 4174 03:24:03,880 --> 03:24:06,000 HAVE 11, T35'S AND THE NUMBER OF 4175 03:24:06,000 --> 03:24:16,480 SLOTS IS 91 SLOTS. 4176 03:24:16,480 --> 03:24:19,080 FROM TRAINING GROUNDS AND 4177 03:24:19,080 --> 03:24:21,320 FELLOWSHIP TO THE DEVELOPMENTAL 4178 03:24:21,320 --> 03:24:23,680 MENTOR AWARD THIS SHOWS THE K 4179 03:24:23,680 --> 03:24:25,320 AWARD FOR K PORTFOLIO AND 4180 03:24:25,320 --> 03:24:26,920 COMPARE THEM TO RESEARCH GRANTS 4181 03:24:26,920 --> 03:24:29,360 PORTFOLIO AS I DID FOR 4182 03:24:29,360 --> 03:24:34,720 FELLOWSHIPS IF YOU REMEMBER. 4183 03:24:34,720 --> 03:24:38,840 AND WE HAVE RETINA, CORNEA, 4184 03:24:38,840 --> 03:24:43,600 LENS, GLAUCOMA, SAVP WHICH IS 4185 03:24:43,600 --> 03:24:45,280 VISUAL PROCESSING AND LOW 4186 03:24:45,280 --> 03:24:45,640 VISION. 4187 03:24:45,640 --> 03:24:47,680 THERE'S ALMOST IDENTICAL EXCEPT 4188 03:24:47,680 --> 03:24:49,320 FOR THE GLAUCOMA PROGRAM FOR 4189 03:24:49,320 --> 03:24:51,160 CAREER DEVELOPMENT AWARDS. 4190 03:24:51,160 --> 03:24:54,360 IT'S TWICE AS BIG AS THAT OF THE 4191 03:24:54,360 --> 03:24:55,480 RESEARCH GRANTS PORTFOLIO. 4192 03:24:55,480 --> 03:24:57,320 AND THIS IS RIGHTLY SO BECAUSE 4193 03:24:57,320 --> 03:25:01,160 THIS IS COMING STRAIGHT FROM THE 4194 03:25:01,160 --> 03:25:03,360 CLINICIANS TO SUBMIT MORE 4195 03:25:03,360 --> 03:25:07,840 APPLICATION IN GAU COMA FIELD. 4196 03:25:07,840 --> 03:25:08,840 -- GLAUCOMA FIELD. 4197 03:25:08,840 --> 03:25:12,160 THIS IS THE COMPARISON AND THE K 4198 03:25:12,160 --> 03:25:13,360 AWARD SUCCESS RATE AGAIN THE 4199 03:25:13,360 --> 03:25:16,200 SUCCESS RATE IS THE NUMBER OF 4200 03:25:16,200 --> 03:25:17,040 APPLICATION AWARDED VERSUS 4201 03:25:17,040 --> 03:25:17,520 NUMBER OF APPLICATIONS 4202 03:25:17,520 --> 03:25:19,600 SUBMITTED. 4203 03:25:19,600 --> 03:25:25,120 THE BLUE BAR IS K08 AND ORANGE 4204 03:25:25,120 --> 03:25:29,280 IS K23 AND THE GREEN IS K99 FOR 4205 03:25:29,280 --> 03:25:32,320 THE FISCAL YEARS OF 2017 TO 4206 03:25:32,320 --> 03:25:32,720 2022. 4207 03:25:32,720 --> 03:25:35,760 YOU CAN SEE OUR SUCCESS RATE OF 4208 03:25:35,760 --> 03:25:39,720 K AWARDEES IS QUITE GOOD AND 4209 03:25:39,720 --> 03:25:41,200 COMPARED TO NIH AND WE ARE DOING 4210 03:25:41,200 --> 03:25:48,520 WELL IN THAT ARENA ALSO. 4211 03:25:48,520 --> 03:25:50,560 AGAIN TO ASSESS HOW SUCCESSFUL 4212 03:25:50,560 --> 03:25:52,760 IS THE K DEVELOPMENT AWARD? 4213 03:25:52,760 --> 03:25:56,120 I DID THE R01 SUCCESS RATE FOR 4214 03:25:56,120 --> 03:25:58,280 THIS CAREER DEVELOPMENT 4215 03:25:58,280 --> 03:26:01,520 AWARDEES, K23 AND K99 FOR THE 4216 03:26:01,520 --> 03:26:07,200 FISCAL YEAR 2012 AND 2022. 4217 03:26:07,200 --> 03:26:10,800 YOU CAN SEE HERE THE NUMBER OF 4218 03:26:10,800 --> 03:26:14,520 K08 AWARDED FOR THE SIX, SEVEN, 4219 03:26:14,520 --> 03:26:16,800 EIGHT YEARS OF THE PHYSICAL YEAR 4220 03:26:16,800 --> 03:26:25,240 PERIOD, 91, OUT OF THOSE 91, 51 4221 03:26:25,240 --> 03:26:28,080 SUBMITTED OR APPLIED FOR R01 4222 03:26:28,080 --> 03:26:31,080 EQUIVALENT AND 61 WERE 4223 03:26:31,080 --> 03:26:32,560 SUCCESSFUL TO GET IT AND SO HE 4224 03:26:32,560 --> 03:26:34,640 THE SUCCESS RATE IS 49%. 4225 03:26:34,640 --> 03:26:37,120 AND THE AVERAGE NUMBER OF YEARS 4226 03:26:37,120 --> 03:26:40,840 TO GET THE FIRST R01 WAS 1.3 4227 03:26:40,840 --> 03:26:41,080 YEARS. 4228 03:26:41,080 --> 03:26:43,680 A LITTLE BIT MORE THAN WHAT I 4229 03:26:43,680 --> 03:26:47,600 PRESENTED TO THE F23 POST 4230 03:26:47,600 --> 03:26:53,240 POST-DOCTORAL FELLOWSHIPS. 4231 03:26:53,240 --> 03:26:57,120 WE AWARDED 59D DURING THIS TIME 4232 03:26:57,120 --> 03:27:02,760 PERIOD OF 2023 TO 2022 OF WHICH 4233 03:27:02,760 --> 03:27:06,480 39 HARD ALREADY APPLIED FOR R01 4234 03:27:06,480 --> 03:27:08,000 EQUIVALENT OR 16 HAVE BEEN 4235 03:27:08,000 --> 03:27:09,040 ALREADY SUCCESSFUL. 4236 03:27:09,040 --> 03:27:13,120 THE SUCCESS RATE IS ALMOST 55%. 4237 03:27:13,120 --> 03:27:16,160 AND THE TIME TO TAKE THE FIRST 4238 03:27:16,160 --> 03:27:17,800 R01 WAS ONE YEAR. 4239 03:27:17,800 --> 03:27:23,440 IN THIS CALCULATION I'D LIKE 4240 03:27:23,440 --> 03:27:26,720 MENTION MANY OF THESE CLINICIAN 4241 03:27:26,720 --> 03:27:28,920 SCIENTISTS GO TO CLINICAL TRIAL 4242 03:27:28,920 --> 03:27:31,440 AND SUBMIT U01 GRANT AND NOT 4243 03:27:31,440 --> 03:27:35,520 INCLUDED THAT CALCULATION IS SO 4244 03:27:35,520 --> 03:27:38,080 IF YOU INCLUDE THOSE GRANTS ALSO 4245 03:27:38,080 --> 03:27:40,760 THE SUCCESS RATE OF THE K23 4246 03:27:40,760 --> 03:27:41,760 AWARDEES WILL BE EVEN BETTER 4247 03:27:41,760 --> 03:27:46,960 THAN 55%. 4248 03:27:46,960 --> 03:27:53,760 COMING LASTLY TO K99 A CAREER 4249 03:27:53,760 --> 03:27:57,360 TRANSITION AWARD FOR 4250 03:27:57,360 --> 03:28:01,320 POST-DOCTORAL FELLOW I DON'T 4251 03:28:01,320 --> 03:28:05,640 HAVE ANY AND WE AWARDED 115 OF 4252 03:28:05,640 --> 03:28:08,960 THOSE K99 AWARDEES FOR THE 4253 03:28:08,960 --> 03:28:13,320 FISCAL YEAR 2012, 2022 OF WHICH 4254 03:28:13,320 --> 03:28:17,320 39 HAVE ALREADY APPLIED FOR R01 4255 03:28:17,320 --> 03:28:20,360 EQUIVALENT OF WHICH 23 WERE 4256 03:28:20,360 --> 03:28:23,760 SUCCESSFUL AND THE SUCCESS RATE 4257 03:28:23,760 --> 03:28:27,360 IS 59% AND THE AVERAGE NUMBER OF 4258 03:28:27,360 --> 03:28:29,360 YEARS TO GET THE FIRST R01 IS 4259 03:28:29,360 --> 03:28:37,840 1.3 YEARS. 4260 03:28:37,840 --> 03:28:40,160 CHANGING GEARS I'D LIKE TO TALK 4261 03:28:40,160 --> 03:28:41,280 ABOUT THE TRAINING INITIATIVES. 4262 03:28:41,280 --> 03:28:47,520 THERE'S A BUNCH OF OTHER 4263 03:28:47,520 --> 03:28:49,320 TRAINING INITIATIVES WHICH ARE 4264 03:28:49,320 --> 03:28:53,680 INSTITUTED BY OTHER INSTITUTES. 4265 03:28:53,680 --> 03:28:59,240 NIGMS COMES UP WITH A MOSAIC 4266 03:28:59,240 --> 03:29:02,040 K99/R00 TO PROMOTE DIVERSITY FOR 4267 03:29:02,040 --> 03:29:05,200 THESE RESEARCH AREAS AND MOSAIC 4268 03:29:05,200 --> 03:29:06,200 STARS FOR MAXIMIZING 4269 03:29:06,200 --> 03:29:08,920 OPPORTUNITIES FOR SCIENTIFIC AND 4270 03:29:08,920 --> 03:29:14,400 ACADEMIC INDEPENDENT CAREERS. 4271 03:29:14,400 --> 03:29:20,160 AND BRAIN INITIATIVE DIVERSITY 4272 03:29:20,160 --> 03:29:20,400 R00. 4273 03:29:20,400 --> 03:29:22,680 THERE'S DIFFERENCES AND IN CASE 4274 03:29:22,680 --> 03:29:23,480 ANYBODY'S INTERESTED I'D BE 4275 03:29:23,480 --> 03:29:30,200 HAPPY TO TALK ABOUT IT. 4276 03:29:30,200 --> 03:29:34,120 WE HAVE THE NIH BLUEPRINT 4277 03:29:34,120 --> 03:29:37,520 DIVERSITY SPECIALIZED IN 4278 03:29:37,520 --> 03:29:39,080 PREDOCTORAL TO POSTDOCTORAL 4279 03:29:39,080 --> 03:29:39,760 ADVANCEMENT IN NEUROSCIENCE AND 4280 03:29:39,760 --> 03:29:43,000 THE AWARD IS F99 AND K00. 4281 03:29:43,000 --> 03:29:47,480 THIS IS ANALOGOUS TO K99 AND R00 4282 03:29:47,480 --> 03:29:50,560 BECAUSE IN THIS CASE YOU START 4283 03:29:50,560 --> 03:29:54,320 YOUR F99 IN YOUR SENIOR LAST TWO 4284 03:29:54,320 --> 03:29:57,320 YEARS OF GRADUATE STUDIES AND 4285 03:29:57,320 --> 03:29:58,640 AFTER FINISHING THOSE TWO YEARS 4286 03:29:58,640 --> 03:30:00,520 IN YOUR MENTORS LAB AND GETTING 4287 03:30:00,520 --> 03:30:05,840 YOUR Ph.D. YOU MOVE ON TO A 4288 03:30:05,840 --> 03:30:08,440 POSTDOCTORAL FELLOWSHIP LAB IN 4289 03:30:08,440 --> 03:30:12,240 YOUR K00 AND SPEND THREE YEAR IN 4290 03:30:12,240 --> 03:30:12,760 THAT LAB. 4291 03:30:12,760 --> 03:30:16,760 AND THEY'RE ELIGIBLE TO APPLY 4292 03:30:16,760 --> 03:30:21,760 FOR K99 AND R00 AND THEN GET THE 4293 03:30:21,760 --> 03:30:25,320 K99, R00 AND ESTABLISH THEIR 4294 03:30:25,320 --> 03:30:28,080 INDEPENDENT LAB WITH R00. 4295 03:30:28,080 --> 03:30:31,840 THIRDLY, I'D LIKE TO TALK ABOUT 4296 03:30:31,840 --> 03:30:33,240 AN INSTITUTIONAL TRAINING 4297 03:30:33,240 --> 03:30:38,160 PROGRAM WHICH IS INSTITUTED BY 4298 03:30:38,160 --> 03:30:40,400 TRANS-NIH PRINT CALLED JOINTLY 4299 03:30:40,400 --> 03:30:42,880 SPONSORED INSTITUTIONAL 4300 03:30:42,880 --> 03:30:46,440 PREDOCTORAL TRAINING PROGRAM. 4301 03:30:46,440 --> 03:30:54,960 IT'S FOR PREDOC INSTITUTIONAL 4302 03:30:54,960 --> 03:30:57,320 TRAINING PROGRAM AND A NUMBER 4303 03:30:57,320 --> 03:31:03,520 ARE FUNDED BY THAT. 4304 03:31:03,520 --> 03:31:06,480 COMING TO LOAN REPAYMENT PROGRAM 4305 03:31:06,480 --> 03:31:09,160 CATHY MENTIONED WE ARE MANDATED 4306 03:31:09,160 --> 03:31:12,560 BY CONGRESS TO PRESENT TO YOU 4307 03:31:12,560 --> 03:31:14,000 THE STATE OF LOAN REPAYMENT 4308 03:31:14,000 --> 03:31:15,680 PROGRAM FOR THE LAST FISCAL YEAR 4309 03:31:15,680 --> 03:31:18,400 WE JUST FINISHED. 4310 03:31:18,400 --> 03:31:22,480 WHAT IS LOAN REPAYMENT PROGRAM? 4311 03:31:22,480 --> 03:31:25,600 THE PURPOSE IS TO ATTRACT HEALTH 4312 03:31:25,600 --> 03:31:29,000 PROFESSIONALS TO A CAREER IN 4313 03:31:29,000 --> 03:31:30,400 RESEARCH AND PAY THEIR 4314 03:31:30,400 --> 03:31:33,080 EDUCATIONAL DEBT OR THE DEBT 4315 03:31:33,080 --> 03:31:36,320 THEY INCURRED DURING MEDICAL 4316 03:31:36,320 --> 03:31:41,760 SCHOOL AND EVEN UNDERGRADUATE. 4317 03:31:41,760 --> 03:31:47,600 SO WHAT IT DOES IT WILL PAY 4318 03:31:47,600 --> 03:31:49,960 $50,000 OF THEIR DEBT PER YEAR 4319 03:31:49,960 --> 03:31:51,680 AND ALSO THE IRS TAXES WHICH 4320 03:31:51,680 --> 03:31:53,200 WILL BE COMING OUT OF THIS 4321 03:31:53,200 --> 03:31:56,480 $50,000 WHICH WILL BE ADDED TO 4322 03:31:56,480 --> 03:31:58,560 YOUR INCOME SO IT COMES AROUND 4323 03:31:58,560 --> 03:32:02,440 $65,000 TO $70,000 NIH PAYS. 4324 03:32:02,440 --> 03:32:05,480 YOU HAVE TO BE A U.S. CITIZEN OR 4325 03:32:05,480 --> 03:32:07,280 U.S. PERMANENT RESIDENT AS WAS 4326 03:32:07,280 --> 03:32:10,000 THE CASE FOR NISA FELLOWSHIP IN 4327 03:32:10,000 --> 03:32:13,000 CAREER DEVELOPMENT AWARDEES. 4328 03:32:13,000 --> 03:32:19,360 AND ONE HAS TO COMMIT 50% TIME 4329 03:32:19,360 --> 03:32:22,280 TOWARDS RESEARCH SO YOU KEEP 4330 03:32:22,280 --> 03:32:33,000 APPLYINGFUL YOUR DE-- APPLYING 4331 03:32:35,440 --> 03:32:37,480 UNTIL YOU GET IT AND YOU DON'T 4332 03:32:37,480 --> 03:32:41,240 HAVE TO HAVE AN R01 OR R21 OR 4333 03:32:41,240 --> 03:32:45,920 ANY OTHER KINDS. 4334 03:32:45,920 --> 03:32:50,000 YOU CAN JUST SUPPLY THE 4335 03:32:50,000 --> 03:32:50,440 REQUIREMENTS. 4336 03:32:50,440 --> 03:32:51,560 ONLINE APPLICATION IS EASY. 4337 03:32:51,560 --> 03:32:53,560 IT'S NOT A BIG APPLICATION. 4338 03:32:53,560 --> 03:32:55,120 IT'S PEER REVIEWED AND THE 4339 03:32:55,120 --> 03:32:56,400 DEADLINE IS NOVEMBER 15. 4340 03:32:56,400 --> 03:33:01,160 THE DEADLINE IS COMING SO I 4341 03:33:01,160 --> 03:33:02,040 REQUEST MY COUNCIL MEMBERS TO GO 4342 03:33:02,040 --> 03:33:04,200 BACK AND PROMOTE IT AND 4343 03:33:04,200 --> 03:33:09,040 ESPECIALLY I GOT AN E-MAIL 4344 03:33:09,040 --> 03:33:13,840 YESTERDAY BECAUSE OF THE NEW LAW 4345 03:33:13,840 --> 03:33:21,320 PASSED BY PRESIDENT BIDEN AND 4346 03:33:21,320 --> 03:33:23,520 THE EDUCATIONAL DEBT WILL BE 4347 03:33:23,520 --> 03:33:26,760 TAKEN CARE OF AND THE NUMBER OF 4348 03:33:26,760 --> 03:33:31,880 APPLICATION HAS GONE DOWN BY 4349 03:33:31,880 --> 03:33:39,400 THIS TIME OF THE YEAR SO NEI 4350 03:33:39,400 --> 03:33:41,680 PARTICIPATE IN THE LOAN PROGRAM 4351 03:33:41,680 --> 03:33:44,280 AND CLINICAL RESEARCH AND HAZARD 4352 03:33:44,280 --> 03:33:47,120 DISPARITY RESEARCH, PEDIATRIC 4353 03:33:47,120 --> 03:33:55,640 AND CLINICAL 30 HEALTH D 4354 03:33:55,640 --> 03:33:57,360 DISPARITIES AND WE STARTED IN 4355 03:33:57,360 --> 03:34:01,000 RESEARCH IN EMERGING AREAS TO 4356 03:34:01,000 --> 03:34:03,840 HUMAN HEALTH THAT IS REACH. 4357 03:34:03,840 --> 03:34:07,200 TO SHOW YOU THE PAST FISCAL 4358 03:34:07,200 --> 03:34:10,800 YEAR'S DATA WE RECEIVED NEW SIX 4359 03:34:10,800 --> 03:34:12,240 APPLICATION FOR THE FIRST-TIME 4360 03:34:12,240 --> 03:34:13,920 APPLICANTS AND 70 WERE REPEAT. 4361 03:34:13,920 --> 03:34:19,240 YOU CAN APPLY MULTIPLE TIMES AND 4362 03:34:19,240 --> 03:34:23,080 THEY KEEP COMING BACK AND 4363 03:34:23,080 --> 03:34:25,120 REAPPLYING AND WE FUNDED 20. 4364 03:34:25,120 --> 03:34:28,240 SO THE FUNDING DATE WAS PRETTY 4365 03:34:28,240 --> 03:34:30,120 GOOD, 87%. 4366 03:34:30,120 --> 03:34:37,360 AS YOU COMPARE THIS TO NIH THIS 4367 03:34:37,360 --> 03:34:47,360 IS 59% AND WE FUNDED 1,268, 59% 4368 03:34:47,360 --> 03:34:48,400 AND THE DOLLAR BUDGET ALLOCATED 4369 03:34:48,400 --> 03:34:52,600 TO US TO TAKE CARE OF THIS LRP 4370 03:34:52,600 --> 03:34:57,320 FOR FISCAL YEAR 2022 WAS $1.3 4371 03:34:57,320 --> 03:35:04,760 MILLION. 4372 03:35:04,760 --> 03:35:06,160 WHAT ARE THESE PEOPLE AND WHAT 4373 03:35:06,160 --> 03:35:09,680 KIND OF DEGREE DO THEY HAVE, 4374 03:35:09,680 --> 03:35:11,720 M.D. OR Ph.D. AND I THINK THE 4375 03:35:11,720 --> 03:35:13,840 ANALYSIS FOR THE FISCAL YEAR 4376 03:35:13,840 --> 03:35:16,160 2017 TO 2021 AND THE TOTAL 4377 03:35:16,160 --> 03:35:19,720 NUMBER OF LRP FUNDED 4378 03:35:19,720 --> 03:35:21,920 APPLICATIONS WAS 140. 4379 03:35:21,920 --> 03:35:28,280 AND OUT OF WHICH 41% WERE M.D., 4380 03:35:28,280 --> 03:35:28,480 PH.D. 4381 03:35:28,480 --> 03:35:32,240 31% WERE OD, Ph.D. AND Ph.D.s 4382 03:35:32,240 --> 03:35:33,960 ALONE WERE 28%. 4383 03:35:33,960 --> 03:35:35,840 AND IF YOU SEE OTHER 4384 03:35:35,840 --> 03:35:37,360 DEMOGRAPHICS OF THE FUNDING 4385 03:35:37,360 --> 03:35:41,440 HISTORY OF THESE CANDIDATES WHO 4386 03:35:41,440 --> 03:35:46,680 ARE LYING AND GETTING SUCCESS, 4387 03:35:46,680 --> 03:35:50,600 72% OF THEM HAD INDIVIDUAL Ks OR 4388 03:35:50,600 --> 03:35:54,400 R01 OR R21 FUNDING. 4389 03:35:54,400 --> 03:35:59,880 30% OF THE OD/Ph.D.s HAD Ks AND 4390 03:35:59,880 --> 03:36:04,080 Rs AND Ph.D.s WERE 62% HAD 4391 03:36:04,080 --> 03:36:08,720 HISTORY OF FELLOWSHIP FUNDING, 4392 03:36:08,720 --> 03:36:13,920 K99 FUNDING AND R01, ETCETERA 4393 03:36:13,920 --> 03:36:15,120 FUNDING. 4394 03:36:15,120 --> 03:36:17,720 AGAIN, GOING FURTHER A LITTLE 4395 03:36:17,720 --> 03:36:21,720 BIT, FOR THE PHYSICAL YEAR 2012 4396 03:36:21,720 --> 03:36:23,880 TO 2022 LRP ANALYSIS THE NUMBER 4397 03:36:23,880 --> 03:36:26,720 OF APPLICATIONS SUBMITTED DURING 4398 03:36:26,720 --> 03:36:33,320 THESE PHYSICAL YEARS, AND THE 4399 03:36:33,320 --> 03:36:36,000 SUCCESS RATE WAS 74%. 4400 03:36:36,000 --> 03:36:42,560 AND THE TOTAL NUMBER OF PEOPLE 4401 03:36:42,560 --> 03:36:45,360 APPLYING WAS 42%. 4402 03:36:45,360 --> 03:36:53,320 AND THE AVERAGE NUMBER 1.6 4403 03:36:53,320 --> 03:36:55,400 YEARS. 4404 03:36:55,400 --> 03:36:57,640 INCLUSION OUR TRAINING PROGRAM 4405 03:36:57,640 --> 03:36:59,400 IS QUITE SUCCESSFUL AND DOING 4406 03:36:59,400 --> 03:37:03,080 WELL. 4407 03:37:03,080 --> 03:37:06,560 I ALSO WISH TO THANK FOR ALL WHO 4408 03:37:06,560 --> 03:37:08,000 HELPED WITH THE DATA ANALYSIS 4409 03:37:08,000 --> 03:37:11,000 AND I'LL STOP HERE AND THANK YOU 4410 03:37:11,000 --> 03:37:12,600 FOR YOUR ATTENTION. 4411 03:37:12,600 --> 03:37:13,880 I'D BE HAPPY TO ANSWER ANY 4412 03:37:13,880 --> 03:37:23,720 QUESTIONS YOU HAVE. 4413 03:37:23,720 --> 03:37:24,600 >>THANK YOU. 4414 03:37:24,600 --> 03:37:28,040 I SEE JAMES' HAND UP. 4415 03:37:28,040 --> 03:37:29,920 >>THANK YOU FOR THAT 4416 03:37:29,920 --> 03:37:30,280 PRESENTATION. 4417 03:37:30,280 --> 03:37:31,840 THAT WAS INFORMATIVE. 4418 03:37:31,840 --> 03:37:38,280 I'M WONDERING, IF THERE ARE ANY 4419 03:37:38,280 --> 03:37:42,720 IDEAS ABOUT TWEAKING EXISTING 4420 03:37:42,720 --> 03:37:43,040 MECHANISMS. 4421 03:37:43,040 --> 03:37:45,320 IF YOU'RE A YOUNG INVESTIGATOR 4422 03:37:45,320 --> 03:37:47,320 YOU HAVE THE NEW INVESTIGATOR 4423 03:37:47,320 --> 03:37:50,040 STATUS WHEN YOU APPLY FOR THE 4424 03:37:50,040 --> 03:37:50,320 R01. 4425 03:37:50,320 --> 03:37:56,520 IN SOME CASES I FEEL LIKE YOUNG 4426 03:37:56,520 --> 03:37:59,160 INVESTIGATORS ARE ATTEMPTED TO 4427 03:37:59,160 --> 03:38:00,800 APPLY FOR AN R31 BECAUSE THERE'S 4428 03:38:00,800 --> 03:38:02,680 NO PRIOR REQUIREMENT BUT THE 4429 03:38:02,680 --> 03:38:09,080 STATISTICS SHOW R21s ARE MORE 4430 03:38:09,080 --> 03:38:10,520 COMPETITIVE AND HARDER TO GET 4431 03:38:10,520 --> 03:38:12,800 THAN R01s. 4432 03:38:12,800 --> 03:38:14,920 I'M WONDERING IF YOU HAVE A 4433 03:38:14,920 --> 03:38:15,320 COMMENT. 4434 03:38:15,320 --> 03:38:17,120 >>WHENEVER ANY OF MY YOUNG 4435 03:38:17,120 --> 03:38:19,400 INVESTIGATORS CALL ME AND HAVE 4436 03:38:19,400 --> 03:38:23,360 THE NOTION THAT R21 DOESN'T 4437 03:38:23,360 --> 03:38:24,960 REQUIRE ANY DATA, THEN FOR TWO 4438 03:38:24,960 --> 03:38:26,280 YEARS THE BUDGET IS LOW SO IT 4439 03:38:26,280 --> 03:38:28,680 SHOULD BE EASIER TO GET, THAT'S 4440 03:38:28,680 --> 03:38:31,000 NOT THE CASE AND THE DATA SHOWS 4441 03:38:31,000 --> 03:38:34,600 FOR THE LPG PROGRAM THE SUCCESS 4442 03:38:34,600 --> 03:38:38,080 RATE AT NEI IS 14% TO 15% 4443 03:38:38,080 --> 03:38:44,760 COMPARED TO 22% TO 25% FOR R01s. 4444 03:38:44,760 --> 03:38:49,320 I ALWAYS SHOW A SLIDE TO SHOW 4445 03:38:49,320 --> 03:38:53,320 THE R01 YOU HAVE THE ADVANTAGE 4446 03:38:53,320 --> 03:38:57,360 OF EARLY STAGE INVESTIGATOR 4447 03:38:57,360 --> 03:39:02,600 STATUS IN TERMS OF YOUR R01 4448 03:39:02,600 --> 03:39:04,360 COMMISSION. 4449 03:39:04,360 --> 03:39:06,160 YOU ARE REVIEWED AND NEED ONE OR 4450 03:39:06,160 --> 03:39:09,440 TWO DATA TO BASE YOUR HYPOTHESIS 4451 03:39:09,440 --> 03:39:12,120 ON ONE OR TWO PIECES OF DATA. 4452 03:39:12,120 --> 03:39:17,960 IT'S EASIER FOR THEM TO GO FOR 4453 03:39:17,960 --> 03:39:20,680 AN R01. 4454 03:39:20,680 --> 03:39:21,360 YOU'RE RIGHT. 4455 03:39:21,360 --> 03:39:23,040 I KEEP TELLING THEM BUT THE 4456 03:39:23,040 --> 03:39:24,800 MAJORITY ARE HERE BUT SOME OF 4457 03:39:24,800 --> 03:39:27,360 THEM STILL -- LIKE SOME ARE 4458 03:39:27,360 --> 03:39:29,680 BETTER AND I'M NOT SAYING IT'S 4459 03:39:29,680 --> 03:39:32,160 IMPOSSIBLE TO GET R21 BUT IT'S 4460 03:39:32,160 --> 03:39:35,000 NOT A GOOD IDEA FOR THEIR TIME. 4461 03:39:35,000 --> 03:39:39,040 ALMOST SPEND THE SAME TIME 4462 03:39:39,040 --> 03:39:42,480 WRITING AN R21 AND YOU'RE 4463 03:39:42,480 --> 03:39:43,680 WRITING SIX PAGES AND THE FORMS 4464 03:39:43,680 --> 03:39:49,080 AND EVERYTHING ELSE IS THE SAME 4465 03:39:49,080 --> 03:39:50,520 AND EVERYTHING. 4466 03:39:50,520 --> 03:39:52,280 THERE'S MORE WORK TO YOU GET THE 4467 03:39:52,280 --> 03:39:53,800 MONEY FOR FIVE YEARS AND IF FOR 4468 03:39:53,800 --> 03:39:57,320 TWO YEARS, THE CLOCK IS TICKING 4469 03:39:57,320 --> 03:40:05,760 BY THE TIME THEY GET THE PROFS 4470 03:40:05,760 --> 03:40:13,000 OF PROCESS AND THE R01 IS 4471 03:40:13,000 --> 03:40:17,320 REVIEWED MORE STRINGENTLY. 4472 03:40:17,320 --> 03:40:26,000 >>THANK YOU VERY MUCH. 4473 03:40:26,000 --> 03:40:36,560 >>THERE'S ANOTHER R01 MECHANISM 4474 03:40:37,360 --> 03:40:42,000 CALLED THE KATZ AWARD WHICH ESIs 4475 03:40:42,000 --> 03:40:48,440 ARE ELIGIBLE TO APPLY FOR AND 4476 03:40:48,440 --> 03:40:53,400 PROHIBITS DATA IN THE 4477 03:40:53,400 --> 03:40:53,680 APPLICATION. 4478 03:40:53,680 --> 03:40:56,960 THAT MIGHT BE ANOTHER OPTION FOR 4479 03:40:56,960 --> 03:40:58,520 SOMEONE WHO DOESN'T HAVE 4480 03:40:58,520 --> 03:40:58,920 PRELIMINARY DATA. 4481 03:40:58,920 --> 03:41:07,080 JUST WANTED TO MENTION THAT AND 4482 03:41:07,080 --> 03:41:09,200 NEI HAS ONE OF THE HIGHEST 4483 03:41:09,200 --> 03:41:11,880 SUCCESS RATES FOR THOSE 4484 03:41:11,880 --> 03:41:12,960 APPLICATION S. 4485 03:41:12,960 --> 03:41:13,680 >>THANK YOU FOR BRINGING THAT 4486 03:41:13,680 --> 03:41:22,560 UP. 4487 03:41:22,560 --> 03:41:23,880 >>YOU CAN HAVE PRELIMINARY DATA 4488 03:41:23,880 --> 03:41:27,440 BUT IT HAS TO BE PUBLISHED OR 4489 03:41:27,440 --> 03:41:31,680 BASED ON SOMEBODY ELSE'S DATA. 4490 03:41:31,680 --> 03:41:35,280 THE PROBLEM IS IS THAT YOU HAVE 4491 03:41:35,280 --> 03:41:37,320 TO JUSTIFY THE NEW AREA OF YOUR 4492 03:41:37,320 --> 03:41:45,920 RESEARCH. 4493 03:41:45,920 --> 03:41:47,880 I KIND OF TELL THEM YOU CAN GO 4494 03:41:47,880 --> 03:41:49,560 AHEAD AND APPLY FOR KATZ BUT YOU 4495 03:41:49,560 --> 03:41:51,600 HAVE TO MAKE SURE THAT YOU HAVE 4496 03:41:51,600 --> 03:42:01,960 ALL THE REQUIREMENTS. 4497 03:42:06,080 --> 03:42:16,360 YOUR HAND'S UP KATIA? 4498 03:42:26,920 --> 03:42:28,920 >>I'M SURPRISED HOW LONG IT 4499 03:42:28,920 --> 03:42:39,280 TOOK THE 1.3 YEARS. 4500 03:42:42,400 --> 03:42:44,920 WHAT'S THE AVERAGE NUMBER OF 4501 03:42:44,920 --> 03:42:52,880 YEARS TO GET THE R01. 4502 03:42:52,880 --> 03:42:55,880 >>THERE ARE A FEW OUTLIERS IN 4503 03:42:55,880 --> 03:42:56,280 THE CALCULATION. 4504 03:42:56,280 --> 03:42:57,920 SOME TOOK SIX YEARS, SEVEN 4505 03:42:57,920 --> 03:42:58,200 YEARS. 4506 03:42:58,200 --> 03:43:05,840 I TENDED TO PUT THEM OUT THE 4507 03:43:05,840 --> 03:43:07,440 MAJORITY WERE ABLE TO GET ONE 4508 03:43:07,440 --> 03:43:12,720 YEAR AND THE AVERAGE CAME TO ONE 4509 03:43:12,720 --> 03:43:21,200 YEAR I TOOK OFF THE OUTLIER. 4510 03:43:21,200 --> 03:43:29,360 ONE TOOK 13 YEARS ON THAT. 4511 03:43:29,360 --> 03:43:33,320 THE MAJORITY ARE WITHIN ONE AND 4512 03:43:33,320 --> 03:43:34,280 A HALF AND TWO YEARS. 4513 03:43:34,280 --> 03:43:42,000 THE AVERAGE CAME TO BE ONE YEAR. 4514 03:43:42,000 --> 03:43:44,080 >>THANK YOU FOR THE INFORMATIVE 4515 03:43:44,080 --> 03:43:44,400 PRESENTATION. 4516 03:43:44,400 --> 03:43:45,880 I WANT TO THANK YOU SPECIFICALLY 4517 03:43:45,880 --> 03:43:47,680 BECAUSE IT WAS THROUGH THIS 4518 03:43:47,680 --> 03:43:50,520 PRESENTATION A COUPLE YEARS AGO 4519 03:43:50,520 --> 03:43:52,640 THEY LEARNED ABOUT THE PROGRAM. 4520 03:43:52,640 --> 03:43:54,440 MY GRADUATE STUDENT APPLIED AND 4521 03:43:54,440 --> 03:43:59,560 SUCCESSFULLY GOT ONE. 4522 03:43:59,560 --> 03:44:02,800 I WAS CONCERN ED BECAUSE I HAD 4523 03:44:02,800 --> 03:44:04,160 THE PRIVILEGE TO KNOW THE 4524 03:44:04,160 --> 03:44:06,960 INFORMATION THROUGH YOU. 4525 03:44:06,960 --> 03:44:09,560 HOW ARE WE ADVERTISING THIS OR 4526 03:44:09,560 --> 03:44:11,840 REACHING THE RIGHT CANDIDATES 4527 03:44:11,840 --> 03:44:22,240 FOR THESE MECHANISMS? 4528 03:44:24,400 --> 03:44:27,720 THEY'RE ALL BROUGHT AND SITTING 4529 03:44:27,720 --> 03:44:32,880 IN FRONT OF THE COMPUTER. 4530 03:44:32,880 --> 03:44:43,360 AND EVERYTHING IS THERE NOW. 4531 03:44:48,480 --> 03:44:50,880 DR. CHIANG GIVES THE INFORMATION 4532 03:44:50,880 --> 03:44:56,560 AND ENCOURAGE THEM TO CALL AND 4533 03:44:56,560 --> 03:45:07,000 TALK TO ME AND IT'S THERE. 4534 03:45:21,800 --> 03:45:24,840 >>I WANTED TO KNOW IF THERE 4535 03:45:24,840 --> 03:45:26,160 WERE OTHER MECHANISMS. 4536 03:45:26,160 --> 03:45:28,520 ANY STUDENT WAS NOT AWARE AND -- 4537 03:45:28,520 --> 03:45:31,840 MY STUDENT WAS NOT AWARE AND I 4538 03:45:31,840 --> 03:45:33,640 SAID IT'S A FANTASTIC 4539 03:45:33,640 --> 03:45:33,920 OPPORTUNITY. 4540 03:45:33,920 --> 03:45:35,920 >>I'M HAPPY WE FUNDED YOURS. 4541 03:45:35,920 --> 03:45:44,240 I REMEMBER THAT. 4542 03:45:44,240 --> 03:45:48,800 >>KATIA, A WORD OF THANKS FOR 4543 03:45:48,800 --> 03:45:49,160 RAISING THAT. 4544 03:45:49,160 --> 03:45:50,640 IF YOU KNOW, YOU KNOW, IF YOU 4545 03:45:50,640 --> 03:45:52,240 DON'T KNOW, YOU DON'T KNOW. 4546 03:45:52,240 --> 03:45:56,560 IT SOUNDS LIKE THE 4547 03:45:56,560 --> 03:45:57,240 IMPLEMENTATION DISCUSSION WE HAD 4548 03:45:57,240 --> 03:45:58,800 EARLIER TODAY IF YOU'RE ONE OF 4549 03:45:58,800 --> 03:45:59,880 THOSE PEOPLE WHO DOESN'T HAVE 4550 03:45:59,880 --> 03:46:10,440 THE MECHANISM TO FIND OUT WE TRY 4551 03:46:10,960 --> 03:46:13,640 TO PROMOTE THIS AN WE'VE BEEN 4552 03:46:13,640 --> 03:46:15,600 USING SOCIAL MEDIA AS A 4553 03:46:15,600 --> 03:46:16,720 MECHANISM TO PUSH THESE THINGS 4554 03:46:16,720 --> 03:46:21,320 OUT. 4555 03:46:21,320 --> 03:46:28,680 IF YOU HAVE OTHER IDEAS HOW TO 4556 03:46:28,680 --> 03:46:35,040 GET THE WORD OUT HELP US WITH 4557 03:46:35,040 --> 03:46:41,560 THOSE IDEAS. 4558 03:46:41,560 --> 03:46:43,320 >>WE CAN SAY LOOK WHAT I GOT 4559 03:46:43,320 --> 03:46:44,760 AND THERE'S AN OPPORTUNITY TO 4560 03:46:44,760 --> 03:46:45,560 APPLY. 4561 03:46:45,560 --> 03:46:47,880 WE SHOULD BE RECRUITING THE 4562 03:46:47,880 --> 03:46:50,480 AWARDEES TO TRY TO PASS THE 4563 03:46:50,480 --> 03:46:53,680 BATON AND GIVE INFORMATION TO 4564 03:46:53,680 --> 03:46:57,160 OTHERS THAT MAY NOT BE AWARE. 4565 03:46:57,160 --> 03:46:58,640 THAT'S ONE OF MY IDEAS. 4566 03:46:58,640 --> 03:47:06,240 >>THANKS, KATIA. 4567 03:47:06,240 --> 03:47:09,760 >>WE ARE THINKING OF HAVING A K 4568 03:47:09,760 --> 03:47:10,080 SYMPOSIUM. 4569 03:47:10,080 --> 03:47:20,560 THAT'S ONE WAY TO PROMOTE THE 4570 03:47:21,400 --> 03:47:22,960 CAREER DEVELOPMENT AWARDEES. 4571 03:47:22,960 --> 03:47:28,600 I WANT MORE APPLICATIONS. 4572 03:47:28,600 --> 03:47:39,080 I HOPE IT GOES TO 2% TO 3%. 4573 03:47:43,960 --> 03:47:44,160 ING 4574 03:47:44,160 --> 03:47:47,040 >>SOCIAL MEDIA AND SOCIAL 4575 03:47:47,040 --> 03:47:47,320 MEDIA. 4576 03:47:47,320 --> 03:47:48,000 THAT'S WHAT THESE KIDS ALWAYS 4577 03:47:48,000 --> 03:47:57,480 LOOK AT. 4578 03:47:57,480 --> 03:48:07,920 MAYBE TWITTER, INSTAGRAM. 4579 03:48:12,680 --> 03:48:15,000 >>WHEN THEY BROWSE THEY SHOULD 4580 03:48:15,000 --> 03:48:15,480 LOOK AT NIH. 4581 03:48:15,480 --> 03:48:24,080 THAT WOULD BE HELPFUL. 4582 03:48:24,080 --> 03:48:26,720 >>I FEEL A LITTLE RIDICULOUS 4583 03:48:26,720 --> 03:48:28,520 TROLLING FOR FOLLOWERS ON SOCIAL 4584 03:48:28,520 --> 03:48:31,000 MEDIA BEHAVING WORSE THAN MY 4585 03:48:31,000 --> 03:48:31,320 KIDS. 4586 03:48:31,320 --> 03:48:33,080 BUT THIS IS PRECISELY THE REASON 4587 03:48:33,080 --> 03:48:38,240 WE DO IT. 4588 03:48:38,240 --> 03:48:48,760 UNLESS PEOPLE ARE LISTENING TO 4589 03:48:49,640 --> 03:48:52,720 WHAT WE PUT OUT AND WE HAVE DONE 4590 03:48:52,720 --> 03:48:54,200 AN AMAZING JOB PUTTING IT 4591 03:48:54,200 --> 03:48:55,960 TOGETHER BUT WE NEED PEOPLE TO 4592 03:48:55,960 --> 03:48:57,160 READ IT AND WHATEVER WE CAN DO 4593 03:48:57,160 --> 03:48:58,520 TO GETS THE WORD OUT IN THE 4594 03:48:58,520 --> 03:49:09,000 COMMUNITY WOULD BE AWESOME. 4595 03:49:15,200 --> 03:49:20,680 >>IF WE ASK THE YOUNG PEOPLE IN 4596 03:49:20,680 --> 03:49:26,480 OUR LABS HOW MANY TIMES PROBABLY 4597 03:49:26,480 --> 03:49:29,920 NONE AND IF WE PROMOTE AND TELL 4598 03:49:29,920 --> 03:49:33,360 THEM, I THINK THAT'S THE KEY IS 4599 03:49:33,360 --> 03:49:43,600 SOCIAL MEDIA. 4600 03:49:44,240 --> 03:49:47,160 >>THANK YOU FOR LISTENING. 4601 03:49:47,160 --> 03:49:49,040 >>AND THANK YOU FOR THE 4602 03:49:49,040 --> 03:49:52,960 FEEDBACK IN MAKING SURE WE'RE 4603 03:49:52,960 --> 03:49:53,480 COMMUNICATING ALL THE 4604 03:49:53,480 --> 03:49:54,360 OPPORTUNITIES AVAILABLE FOR 4605 03:49:54,360 --> 03:49:55,800 TRAINING AND OTHER THINGS. 4606 03:49:55,800 --> 03:50:02,360 I WANT TO -- WE'RE GETTING CLOSE 4607 03:50:02,360 --> 03:50:03,680 TO THE END OF THIS OPEN SESSION 4608 03:50:03,680 --> 03:50:05,360 BUT WE HAVE TIME SO I WANTED TO 4609 03:50:05,360 --> 03:50:10,400 GIVE PEOPLE A CHANCE TO ASK 4610 03:50:10,400 --> 03:50:11,440 QUESTI 4611 03:50:11,440 --> 03:50:12,040 QUESTI 4612 03:50:12,040 --> 03:50:16,800 QUESTIONS MORE PROBABLY IF YOU 4613 03:50:16,800 --> 03:50:18,720 HAVE QUESTIONS FOR DR. CHIANG OR 4614 03:50:18,720 --> 03:50:19,640 WANTED TO RAISE ISSUES. 4615 03:50:19,640 --> 03:50:23,880 I KNOW PEOPLE ARE PROBABLY 4616 03:50:23,880 --> 03:50:27,680 HUNGRY BUT WANTED WE GAVE A FEW 4617 03:50:27,680 --> 03:50:29,320 MINUTES TO ENTERTAIN GENERAL 4618 03:50:29,320 --> 03:50:39,520 QUESTIONS. 4619 03:50:40,760 --> 03:50:43,880 >>I THINK THIS IS A GOOD TIME 4620 03:50:43,880 --> 03:50:48,440 TO BRING THE DATA MANAGEMENT 4621 03:50:48,440 --> 03:50:48,640 PLAN. 4622 03:50:48,640 --> 03:50:49,880 MY UNIVERSITY GOT INTO A 4623 03:50:49,880 --> 03:50:53,920 WORKSHOP TO LOOK AT THE 4624 03:50:53,920 --> 03:50:59,120 QUESTIONS THAT WERE STANDING AND 4625 03:50:59,120 --> 03:51:09,680 A HUGE ONE IF THE DATA HAS TO BE 4626 03:51:12,760 --> 03:51:17,360 PUT OUT BEFORE THE PUBLICATION 4627 03:51:17,360 --> 03:51:26,720 AND WORRIED ABOUT IT BE SCOOPED 4628 03:51:26,720 --> 03:51:28,920 THE QUESTION COMES IS IT OKAY 4629 03:51:28,920 --> 03:51:31,120 YOU PUT IT IN A REPOSITORY AND 4630 03:51:31,120 --> 03:51:35,800 THEN HAVE AN EMBARGO UNTIL THAT 4631 03:51:35,800 --> 03:51:37,320 GETS PUBLISHED OR IS THAT NOT 4632 03:51:37,320 --> 03:51:44,120 BEING CONSIDERED? 4633 03:51:44,120 --> 03:51:47,360 WHEN WE HAVE A THESIS OR 4634 03:51:47,360 --> 03:51:57,840 DISSERTATION YOU CAN PUT IN 4635 03:52:00,120 --> 03:52:01,960 EMBARGO FOR SEVERAL YEARS EVEN I 4636 03:52:01,960 --> 03:52:03,160 THINK THAT'S A COMMON QUESTION 4637 03:52:03,160 --> 03:52:08,760 WHEN TO RELEASE THE DATA. 4638 03:52:08,760 --> 03:52:10,520 AS YOU KNOW, THE WHITE HOUSE AN 4639 03:52:10,520 --> 03:52:13,320 NIH GUIDANCE, WE'LL HAVE TO MAKE 4640 03:52:13,320 --> 03:52:14,920 SURE THOSE MESSAGES ARE IN LINE. 4641 03:52:14,920 --> 03:52:16,960 THE BEST THING I CAN DO -- LET 4642 03:52:16,960 --> 03:52:22,040 ME FOLLOW-UP TO THIS. 4643 03:52:22,040 --> 03:52:26,320 IN FOLLOW-UP TO THE LAST MESSAGE 4644 03:52:26,320 --> 03:52:29,920 MIKE LAUER POINTED US TO 4645 03:52:29,920 --> 03:52:32,680 RESOURCE DISCUSSED ISSUES LIKE 4646 03:52:32,680 --> 03:52:32,880 THIS. 4647 03:52:32,880 --> 03:52:34,480 I'LL CIRCULATE THAT WITHIN THE 4648 03:52:34,480 --> 03:52:36,040 COUNCIL THE MOST UP TO DATE 4649 03:52:36,040 --> 03:52:36,440 GUIDANCE. 4650 03:52:36,440 --> 03:52:41,880 WE'LL ALSO POST IT ON SOCIAL 4651 03:52:41,880 --> 03:52:52,440 MEDIA IF I MAY INTERJECT MY VIEW 4652 03:52:54,720 --> 03:52:59,600 ON THIS, I THINK WE'RE AT A 4653 03:52:59,600 --> 03:53:01,320 CROSSROADS WHERE SCIENTIFICALLY 4654 03:53:01,320 --> 03:53:03,040 THE CULTURE IS THE OUTPUT OF THE 4655 03:53:03,040 --> 03:53:13,560 RESEARCH PROJECT IS THE PAPER. 4656 03:53:13,920 --> 03:53:17,200 WHAT I CALL 21st CENTURY SCIENCE 4657 03:53:17,200 --> 03:53:18,800 I THINK TWO THINGS IS IN 4658 03:53:18,800 --> 03:53:20,600 PARALLEL, ONE IS THE PAPER AND 4659 03:53:20,600 --> 03:53:24,520 THE DATA WE USED IT CREATE THE 4660 03:53:24,520 --> 03:53:25,640 PAPER. 4661 03:53:25,640 --> 03:53:27,400 TRADITIONALLY THE DATA IS 4662 03:53:27,400 --> 03:53:29,360 SUBSERVIENT TO THE PAPER AND TO 4663 03:53:29,360 --> 03:53:36,200 THE EXTENT WE CAN VIEW THE DATA 4664 03:53:36,200 --> 03:53:37,440 AS IMPORTANT AS THE PAPER 4665 03:53:37,440 --> 03:53:42,840 ITSELF, I HOPE SOME QUESTIONS 4666 03:53:42,840 --> 03:53:45,080 WILL TEND TO SOLVE THEMSELVES 4667 03:53:45,080 --> 03:53:50,120 AND THAT'S WHERE I SEE THE FIELD 4668 03:53:50,120 --> 03:53:51,200 HEADING. 4669 03:53:51,200 --> 03:53:58,960 WE'RE NOT THERE CULTURALLY TO 4670 03:53:58,960 --> 03:53:59,480 INCENTIVIZE. 4671 03:53:59,480 --> 03:54:01,800 >>IT'S A CAREER RISK PEOPLE ARE 4672 03:54:01,800 --> 03:54:02,040 TAKING. 4673 03:54:02,040 --> 03:54:11,400 >>I TOTALLY UNDERSTAND. 4674 03:54:11,400 --> 03:54:12,240 UP SPEAKING WITH UNIVERSITY 4675 03:54:12,240 --> 03:54:17,480 LEADERSHIP AROUND THE COUNTRY IS 4676 03:54:17,480 --> 03:54:23,000 THAT WE CAN DO THINGS AT NIH AND 4677 03:54:23,000 --> 03:54:24,760 ULTIMATELY WE WORK FOR 4678 03:54:24,760 --> 03:54:26,440 INSTITUTIONS WITH PROMOTION AN 4679 03:54:26,440 --> 03:54:26,720 TENURE. 4680 03:54:26,720 --> 03:54:29,600 AT SOME POINT WE'LL HAVE TO DEAL 4681 03:54:29,600 --> 03:54:32,600 WITH THIS IF WE'RE GOING TO 4682 03:54:32,600 --> 03:54:34,480 TRULY VALUE THESE THINGS WE'RE 4683 03:54:34,480 --> 03:54:39,640 WALKING ABOUT LIKE DATA SHARING, 4684 03:54:39,640 --> 03:54:45,080 TEAM SCIENCE, I THINK AT SOME 4685 03:54:45,080 --> 03:54:46,240 POINT THE COMMUNITY HAS TO COME 4686 03:54:46,240 --> 03:54:50,560 UP WITH WAYS TO VALUE THIS 4687 03:54:50,560 --> 03:54:52,160 UNEQUAL GROUNDS WITH THE PAPERS 4688 03:54:52,160 --> 03:54:52,480 THEMSELVES. 4689 03:54:52,480 --> 03:54:53,160 WE CAN TALK ABOUT THAT AT 4690 03:54:53,160 --> 03:54:54,280 LENGTH. 4691 03:54:54,280 --> 03:54:54,800 >>THANK YOU. 4692 03:54:54,800 --> 03:54:57,320 I HAVE OTHER QUESTIONS BUT IN 4693 03:54:57,320 --> 03:54:58,760 THE INTEREST OF TIME I'LL LET 4694 03:54:58,760 --> 03:55:00,360 THE OTHERS GO AND IF THERE'S 4695 03:55:00,360 --> 03:55:05,360 TIME I'LL ASK MY QUESTIONS. 4696 03:55:05,360 --> 03:55:08,480 >>THANKS, KATIA. 4697 03:55:08,480 --> 03:55:11,920 >>I HAD ANOTHER QUESTION ABOUT 4698 03:55:11,920 --> 03:55:14,200 THE DATA MANAGEMENT. 4699 03:55:14,200 --> 03:55:21,200 I'VE GONE TO SOME WEBINARS NIH 4700 03:55:21,200 --> 03:55:23,640 PUT ON AND THE MESSAGE I 4701 03:55:23,640 --> 03:55:24,840 RECEIVED WAS DIFFERENT THAN WHAT 4702 03:55:24,840 --> 03:55:31,200 OUR MEETINGS AND NOT ALL NEEDED 4703 03:55:31,200 --> 03:55:36,000 TO BE UPLOADED. 4704 03:55:36,000 --> 03:55:39,200 I KEEP THINKING OF THINGS LIKE 4705 03:55:39,200 --> 03:55:40,520 CELL CULTURE RESEARCH AND YOU 4706 03:55:40,520 --> 03:55:48,600 HAVE A NUMBER OF DATA POINTS BUT 4707 03:55:48,600 --> 03:55:52,320 YOU GET DIFFERENT OUTCOMES. 4708 03:55:52,320 --> 03:55:58,360 MY QUESTION IS AROUND THAT AND 4709 03:55:58,360 --> 03:56:03,360 SOME GUIDANCE IS IT REASONABLE 4710 03:56:03,360 --> 03:56:08,480 TO SAY OUR PLAN IS TO PROVIDE 4711 03:56:08,480 --> 03:56:10,120 DATA WHEN REQUESTED? 4712 03:56:10,120 --> 03:56:13,360 WITH THE CAVEAT, THESE ARE THE 4713 03:56:13,360 --> 03:56:17,320 SPECIFIC SITUATIONS WE USED AND 4714 03:56:17,320 --> 03:56:21,320 WE WOULD BE CONCERNED IF THE 4715 03:56:21,320 --> 03:56:25,240 CONDITIONS WERE DIFFERENT THAN 4716 03:56:25,240 --> 03:56:26,440 WHAT THE AND MAYBE THEY'RE 4717 03:56:26,440 --> 03:56:29,480 TRYING TO PUT DATA TOGETHER. 4718 03:56:29,480 --> 03:56:33,480 I DON'T KNOW. 4719 03:56:33,480 --> 03:56:36,880 DOES THAT MAKE SENSE? 4720 03:56:36,880 --> 03:56:38,520 >>IT MAKES SENSE. 4721 03:56:38,520 --> 03:56:41,120 THIS IS SOMETHING THAT WILL BE 4722 03:56:41,120 --> 03:56:44,480 COVERED IN DEPTH IN SOME OF THE 4723 03:56:44,480 --> 03:56:46,760 THINGS I'LL CIRCULATE AROUND. 4724 03:56:46,760 --> 03:56:50,440 IF I CAN ENCAPSULATE THE DATA 4725 03:56:50,440 --> 03:56:55,280 NEEDS TO BE SHARED, YOU'RE 4726 03:56:55,280 --> 03:56:59,880 RIGHT, NOT ALL DATA NEED TO BE 4727 03:56:59,880 --> 03:57:00,920 SHARED ACCORDING TO THE OFFICIAL 4728 03:57:00,920 --> 03:57:02,880 NIH POLICY AND ONE THING WE'RE 4729 03:57:02,880 --> 03:57:05,320 TRYING TO GET AWAY FROM IS THE 4730 03:57:05,320 --> 03:57:09,320 STATEMENT THAT DATA WILL BE 4731 03:57:09,320 --> 03:57:11,880 SHARED UPON REQUEST OR SOMETHING 4732 03:57:11,880 --> 03:57:15,360 WE USED TO ALL PUT IN THERE. 4733 03:57:15,360 --> 03:57:17,360 ONE SHORT ANSWER WILL BE TO 4734 03:57:17,360 --> 03:57:19,800 SPEAK TO YOUR PROGRAM OFFICER 4735 03:57:19,800 --> 03:57:24,920 ABOUT THAT AND ANOTHER WILL BE 4736 03:57:24,920 --> 03:57:33,320 TO CIRCULATE WHAT WILL BE 4737 03:57:33,320 --> 03:57:34,200 DISCUSSED AND I UNDERSTAND 4738 03:57:34,200 --> 03:57:35,880 THERE'S QUESTIONS IN THE 4739 03:57:35,880 --> 03:57:39,640 COMMUNITY ABOUT THIS. 4740 03:57:39,640 --> 03:57:45,160 AT THE END OF THE DAY THERE'S 4741 03:57:45,160 --> 03:57:47,440 CARROTS AND THERE'S STICKS. 4742 03:57:47,440 --> 03:57:49,360 THESE ARE STICKS IN A WAY. 4743 03:57:49,360 --> 03:57:51,240 I FEEL LIKE OUR COMMUNITY WILL 4744 03:57:51,240 --> 03:57:52,760 BENEFIT IF WE HAVE MORE CARROTS 4745 03:57:52,760 --> 03:57:58,400 TO ACHIEVE THIS CULTURE CHANGE 4746 03:57:58,400 --> 03:58:02,000 WE'RE TALKING ABOUT AND SOME 4747 03:58:02,000 --> 03:58:05,320 PEOPLE GET THAT AND IT'S A BIG 4748 03:58:05,320 --> 03:58:09,320 CULTURAL CHANGE WE'RE TALKING 4749 03:58:09,320 --> 03:58:19,880 ABOUT AND THANK YOU FOR ASKING. 4750 03:58:20,320 --> 03:58:25,800 >>I HAVE A QUESTION AND COMMENT 4751 03:58:25,800 --> 03:58:36,240 AROUND THE DATA SHARING. 4752 03:58:36,720 --> 03:58:42,480 >>I'M LEARNING ABOUT A DATA 4753 03:58:42,480 --> 03:58:46,000 SHARING LICENSE AND IF ANYONE 4754 03:58:46,000 --> 03:58:49,200 USES THE DATA THEY HAVE TO 4755 03:58:49,200 --> 03:58:51,480 ATTRIBUTE TO YOU AND IF SOMEONE 4756 03:58:51,480 --> 03:58:54,560 READS MY PAPER THEY SHOULD CITE 4757 03:58:54,560 --> 03:58:54,800 ME. 4758 03:58:54,800 --> 03:58:57,080 AND THE DIFFERENCE WITH DATA 4759 03:58:57,080 --> 03:58:59,240 SHARING MANDATE IS IT'S A LEGAL 4760 03:58:59,240 --> 03:59:01,360 MANDATE AND YOU CAN HAVE OTHER 4761 03:59:01,360 --> 03:59:02,400 REQUIREMENTS THAT ARE MORE 4762 03:59:02,400 --> 03:59:02,640 STRICT. 4763 03:59:02,640 --> 03:59:04,960 IT'S CHANGED THE WAY I THINK 4764 03:59:04,960 --> 03:59:05,920 ABOUT DATA SHARING BUT IT SEEMS 4765 03:59:05,920 --> 03:59:06,840 LIKE AN OPPORTUNITY. 4766 03:59:06,840 --> 03:59:11,920 IT'S ONE THING TO POST DATA AND 4767 03:59:11,920 --> 03:59:18,440 TO HAVE PEOPLECYTE -- PEOPLE 4768 03:59:18,440 --> 03:59:20,880 CITE ME IT'S SOMETHING I WANT TO 4769 03:59:20,880 --> 03:59:22,120 LEARN MORE ABOUT IT'S A COMMENT 4770 03:59:22,120 --> 03:59:23,440 AND QUESTION AND THE SECOND PART 4771 03:59:23,440 --> 03:59:26,520 IS HOW RESTRICTIVE -- IF WE'RE 4772 03:59:26,520 --> 03:59:27,920 GETTING NIH FUNDING TO PRODUCE 4773 03:59:27,920 --> 03:59:30,480 THE DATA, HOW RESTRICTIVE OF A 4774 03:59:30,480 --> 03:59:32,040 LICENSE CAN WE CHOOSE? 4775 03:59:32,040 --> 03:59:34,040 FOR INSTANCE, THERE ARE SOME 4776 03:59:34,040 --> 03:59:35,320 LICENSES THAT PREVENT ANYONE 4777 03:59:35,320 --> 03:59:35,960 FROM COMMERCIALIZING THE DATA IN 4778 03:59:35,960 --> 03:59:41,560 ANY FORM. 4779 03:59:41,560 --> 03:59:44,040 THAT'S WHAT I'M THINKING ABOUT 4780 03:59:44,040 --> 03:59:44,320 NOW. 4781 03:59:44,320 --> 03:59:44,800 THANKS. 4782 03:59:44,800 --> 03:59:47,000 >>JAMES, THANK YOU FOR ASKING 4783 03:59:47,000 --> 03:59:47,800 ABOUT THAT. 4784 03:59:47,800 --> 03:59:51,680 I REMEMBER WE HAD AN E-MAIL 4785 03:59:51,680 --> 03:59:52,680 EXCHANGE ABOUT THIS WITH THE 4786 03:59:52,680 --> 03:59:57,680 GROUP AND THERE WERE QUESTIONS 4787 03:59:57,680 --> 04:00:02,520 ABOUT THE CREATIVE LICENSE AND 4788 04:00:02,520 --> 04:00:05,360 AT THE TIME I LOOKED AND I'M 4789 04:00:05,360 --> 04:00:08,840 STILL NOT AWARE WE HAVE GUIDANCE 4790 04:00:08,840 --> 04:00:09,400 ABOUT CODE. 4791 04:00:09,400 --> 04:00:11,640 I WILL FOLLOW-UP ON THAT AGAIN. 4792 04:00:11,640 --> 04:00:14,000 WHEN I LOOKED AT THE TIME I 4793 04:00:14,000 --> 04:00:16,040 COULD NOT FIND ANYTHING ABOUT 4794 04:00:16,040 --> 04:00:16,240 THAT. 4795 04:00:16,240 --> 04:00:16,600 >>THANKS. 4796 04:00:16,600 --> 04:00:19,120 IT SEEMS LIKE IT COULD BE A REAL 4797 04:00:19,120 --> 04:00:20,160 OPPORTUNITY FOR RESEARCHERS. 4798 04:00:20,160 --> 04:00:21,480 THANK YOU VERY MUCH. 4799 04:00:21,480 --> 04:00:26,360 >>THE ONE THING I DO WANT TO 4800 04:00:26,360 --> 04:00:28,600 PLUG, WHICH WE PLUGGED BEFORE IS 4801 04:00:28,600 --> 04:00:31,120 THAT ABOUT A YEAR AGO IN THE 4802 04:00:31,120 --> 04:00:37,840 SPIRIT OF CARROTS IN ADDITION TO 4803 04:00:37,840 --> 04:00:39,680 STICKS, WE WORKED WITH EDITOR 4804 04:00:39,680 --> 04:00:42,080 AND CHIEF OF TVST. 4805 04:00:42,080 --> 04:00:45,800 THE IDEA WAS CREATING A 4806 04:00:45,800 --> 04:00:47,120 PUBLICATION TYPE THAT 4807 04:00:47,120 --> 04:00:48,000 REPRESENTED DATA SETS OR 4808 04:00:48,000 --> 04:00:50,000 SOFTWARE LIBRARIES. 4809 04:00:50,000 --> 04:00:52,640 SO THE IDEA WAS TO THE POINT 4810 04:00:52,640 --> 04:00:54,440 THAT PEOPLE COULD PUBLIC CODE OR 4811 04:00:54,440 --> 04:00:55,480 DATA SETS AND GET ACADEMIC 4812 04:00:55,480 --> 04:00:58,760 CREDIT FOR IT. 4813 04:00:58,760 --> 04:01:05,320 SINCE THAT TIME, EMILY CHU HAS 4814 04:01:05,320 --> 04:01:06,720 DEVELOPED THAT WITH AN 4815 04:01:06,720 --> 04:01:08,280 OPHTHALMOLOGY SCIENCE AN THESE 4816 04:01:08,280 --> 04:01:09,360 CONVERSATIONS ORIGINATED IN 4817 04:01:09,360 --> 04:01:14,720 DISCUSSIONS I HAD WITH THE 4818 04:01:14,720 --> 04:01:19,480 EDITORS AND CHIEF OF THE MAJOR 4819 04:01:19,480 --> 04:01:20,640 VISION JOURNAL AND MY HOPE WAS 4820 04:01:20,640 --> 04:01:21,440 LOOK AT THE BENEFITS OF DATA 4821 04:01:21,440 --> 04:01:29,240 SHARING. 4822 04:01:29,240 --> 04:01:33,320 WE'RE WORKING ON THAT AND IT'S 4823 04:01:33,320 --> 04:01:34,720 GOING TO TAKE AWHILE. 4824 04:01:34,720 --> 04:01:36,400 I'M NOT AWARE OF ANOTHER FIELD 4825 04:01:36,400 --> 04:01:37,320 THAT HAS DONE THIS IN THE SAME 4826 04:01:37,320 --> 04:01:40,360 WAY. 4827 04:01:40,360 --> 04:01:41,360 JAMES, THANK YOU FOR ASKING 4828 04:01:41,360 --> 04:01:47,400 ABOUT THAT AND AGAIN MORE COMING 4829 04:01:47,400 --> 04:01:52,480 UP. 4830 04:01:52,480 --> 04:01:54,800 >>AN ISSUE THAT COMES TO ME 4831 04:01:54,800 --> 04:01:57,320 SOMETIMES IS SOMETIMES DATA IS 4832 04:01:57,320 --> 04:01:59,400 NOT THE END DATA. 4833 04:01:59,400 --> 04:02:01,480 HAVE INTERIM DATA THAT LEADS TO 4834 04:02:01,480 --> 04:02:08,320 OTHER DATA. 4835 04:02:08,320 --> 04:02:13,520 AT WHICH POINT DO YOU SHARE THE 4836 04:02:13,520 --> 04:02:23,600 DATA? 4837 04:02:25,520 --> 04:02:28,480 ARE YOU GOING TO WAIT ANOTHER 4838 04:02:28,480 --> 04:02:34,160 TWO OR THREE YEARS TO HAVE THE 4839 04:02:34,160 --> 04:02:36,880 RESULTS? 4840 04:02:36,880 --> 04:02:39,360 OUR EXPERIMENTS USUALLY 4841 04:02:39,360 --> 04:02:39,640 CONTINUES. 4842 04:02:39,640 --> 04:02:45,760 THE DATA IS ALSO CONTINUOUS. 4843 04:02:45,760 --> 04:02:47,680 DO WE STOP IN THE MIDDLE TO 4844 04:02:47,680 --> 04:02:49,360 SHARE IT OR HAVE TO WAIT UNTIL 4845 04:02:49,360 --> 04:02:51,680 THE END? 4846 04:02:51,680 --> 04:03:02,160 I ALWAYS STRUGGLE WITH THAT. 4847 04:03:03,640 --> 04:03:07,080 >>I THINK THIS IS AN INHERENTLY 4848 04:03:07,080 --> 04:03:07,960 CONFUSING ISSUE. 4849 04:03:07,960 --> 04:03:18,480 LET ME TRY TO FIND THE POLICY 4850 04:03:22,720 --> 04:03:25,960 GUIDANCE. 4851 04:03:25,960 --> 04:03:31,960 I'LL PUT THE LINK IN THE CHAT 4852 04:03:31,960 --> 04:03:32,120 BOX. 4853 04:03:32,120 --> 04:03:35,480 THIS IS THE OFFICIAL DEFINITION 4854 04:03:35,480 --> 04:03:36,880 HERE. 4855 04:03:36,880 --> 04:03:38,240 BASICALLY ONE OF THE ISSUES 4856 04:03:38,240 --> 04:03:41,360 FOCUSES ON REPRODUCIBILITY. 4857 04:03:41,360 --> 04:03:45,760 I THINK THIS IS THE BEST SINGLE 4858 04:03:45,760 --> 04:03:47,200 GUIDELINE THAT GETS TO WHAT 4859 04:03:47,200 --> 04:03:49,600 YOU'RE ASKING ABOUT BUT I THINK 4860 04:03:49,600 --> 04:03:52,280 A GOOD BENCHMARK IS GOING TO BE 4861 04:03:52,280 --> 04:03:57,360 WHAT WOULD IT TAKE TO REPRODUCE 4862 04:03:57,360 --> 04:04:03,880 YOUR FINDINGS. 4863 04:04:03,880 --> 04:04:08,760 >>OKAY. 4864 04:04:08,760 --> 04:04:09,840 >>I CAN CIRCULATE THAT WITH THE 4865 04:04:09,840 --> 04:04:10,640 STUFF THAT WILL FOL ZWROE. 4866 04:04:10,640 --> 04:04:11,840 4867 04:04:15,640 --> 04:04:16,960 I CAN CIRCULATE THAT WITH THE 4868 04:04:16,960 --> 04:04:18,320 STUFF THAT WILL FOLLOW. 4869 04:04:18,320 --> 04:04:20,200 I KNOW WE'RE GETTING CLOSE TO 4870 04:04:20,200 --> 04:04:30,600 TIME BUT ANYTHING ELSE -- KATIA. 4871 04:04:30,600 --> 04:04:33,160 >>I WANT TO FINISH WITH THE 4872 04:04:33,160 --> 04:04:34,560 CONCERNS AND WE DISCUSSED BUDGET 4873 04:04:34,560 --> 04:04:35,920 AND YOU CAN INCLUDE THE WITHIN 4874 04:04:35,920 --> 04:04:38,960 THE GRANT BUT WHEN YOU HAVE FOR 4875 04:04:38,960 --> 04:04:40,920 EXAMPLE MECHANISMS WHERE YOU 4876 04:04:40,920 --> 04:04:44,400 HAVE A CAP AMOUNT LIKE THE R15s 4877 04:04:44,400 --> 04:04:48,280 OR THE R21s, IS THERE A PLAN TO 4878 04:04:48,280 --> 04:04:53,920 HAVE AN EXTRA PLACE FOR THIS 4879 04:04:53,920 --> 04:04:56,480 BUDGET OR WILL IT HAVE TO BE 4880 04:04:56,480 --> 04:04:58,120 SQUEEZED IN WHERE IT'S SOMETIMES 4881 04:04:58,120 --> 04:05:02,560 ALREADY LIMITED AMOUNTS OF MONEY 4882 04:05:02,560 --> 04:05:03,760 FOR RESEARCH? 4883 04:05:03,760 --> 04:05:05,160 >>THAT'S ANOTHER GOOD QUESTION. 4884 04:05:05,160 --> 04:05:09,360 IT'S A QUESTION THAT WE'VE BEEN 4885 04:05:09,360 --> 04:05:11,400 HEARING A LOT. 4886 04:05:11,400 --> 04:05:13,480 I'M GOING TO ADDRESS THIS AND 4887 04:05:13,480 --> 04:05:15,000 CATHY, LET ME ASK IF YOU CAN 4888 04:05:15,000 --> 04:05:25,400 COMMENT ON THIS AS WELL. 4889 04:05:29,800 --> 04:05:33,160 WHAT I HEARD FROM MIKE LAUER'S 4890 04:05:33,160 --> 04:05:38,920 SESSION LAST TIME IS YOU SHOULD 4891 04:05:38,920 --> 04:05:40,760 REQUEST BUDGET TO IMPLEMENT THE 4892 04:05:40,760 --> 04:05:44,880 DATA SHARING AND MANAGEMENT PLAN 4893 04:05:44,880 --> 04:05:47,560 AND YOU DO NOT NEED TO SUBMIT A 4894 04:05:47,560 --> 04:05:48,800 MODULAR BUDGET. 4895 04:05:48,800 --> 04:05:51,840 I THINK THIS THE ROUTE OF SOME 4896 04:05:51,840 --> 04:05:52,800 OF THE QUESTIONS PEOPLE FELT 4897 04:05:52,800 --> 04:05:56,320 THERE WAS A CAP TO IT. 4898 04:05:56,320 --> 04:06:02,680 WHAT I HEARD BACK FORMALLY AND 4899 04:06:02,680 --> 04:06:08,080 INFORMALLY WAS, WELL, WE HAVE TO 4900 04:06:08,080 --> 04:06:09,560 STICK TO A MODULAR BUDGET AND 4901 04:06:09,560 --> 04:06:20,000 CATHY CAN YOU SPEAK TO THAT? 4902 04:06:29,880 --> 04:06:32,880 THERE'S A HARD CAP ON THAT AND 4903 04:06:32,880 --> 04:06:33,320 FOR THE R15. 4904 04:06:33,320 --> 04:06:35,120 THAT'S AA GOOD QUESTION BECAUSE 4905 04:06:35,120 --> 04:06:36,240 THOSE ARE HARD TO GET UNDER 4906 04:06:36,240 --> 04:06:42,280 BUDGET ANYWAY BUT HAVE A USEFUL 4907 04:06:42,280 --> 04:06:45,440 PURPOSE FOR PEOPLE. 4908 04:06:45,440 --> 04:06:47,960 I'M GOING IT TAKE THAT FEEDBACK 4909 04:06:47,960 --> 04:06:51,720 TO A GROUP I'M ON AND GET ADVICE 4910 04:06:51,720 --> 04:06:57,320 ON THAT AND I THINK WHAT 4911 04:06:57,320 --> 04:07:01,040 DR. CHANG WAS FOLLOWING UP ON IN 4912 04:07:01,040 --> 04:07:03,440 THE CONVERSATION LAST TIME IN 4913 04:07:03,440 --> 04:07:04,800 FEELING YOU HAVE TO COME IN WITH 4914 04:07:04,800 --> 04:07:10,720 A MODULAR BUDGET TO BE 4915 04:07:10,720 --> 04:07:14,480 COMPETITIVE OR TO GET PRIORITY 4916 04:07:14,480 --> 04:07:15,080 FOR FUNDING. 4917 04:07:15,080 --> 04:07:18,280 THAT SHOULDN'T BE THE CASE AND 4918 04:07:18,280 --> 04:07:19,360 NOT THE CASE. 4919 04:07:19,360 --> 04:07:22,960 REQUEST WHAT YOU NEED IF YOU'RE 4920 04:07:22,960 --> 04:07:26,760 COMING IN WITH AN R01 AND WHAT 4921 04:07:26,760 --> 04:07:28,720 YOU WOULD NEED TO SHARE THE DATA 4922 04:07:28,720 --> 04:07:31,240 AND THERE'S EXAMPLES OF DATA 4923 04:07:31,240 --> 04:07:32,480 SHARING CALCULATORS AND THE 4924 04:07:32,480 --> 04:07:36,720 MATERIALS WE SENT LAST TIME BUT 4925 04:07:36,720 --> 04:07:37,720 WILL SEND OUT AGAIN. 4926 04:07:37,720 --> 04:07:42,400 WE DO ENCOURAGE PEOPLE TO BE 4927 04:07:42,400 --> 04:07:43,080 CONSERVATIVE WITH THEIR BUDGET 4928 04:07:43,080 --> 04:07:47,800 BUT IF IT DOESN'T WORK FOR YOU, 4929 04:07:47,800 --> 04:07:49,680 THERE'S NO RULE YOU MUST COME IN 4930 04:07:49,680 --> 04:07:50,840 WITH THE MODULAR BUDGET. 4931 04:07:50,840 --> 04:07:52,320 >>THANK YOU FOR THE 4932 04:07:52,320 --> 04:07:52,640 CLARIFICATION. 4933 04:07:52,640 --> 04:07:54,240 I LOOK FORWARD TO THE 4934 04:07:54,240 --> 04:07:57,440 INFORMATION ON THE R15s AND 4935 04:07:57,440 --> 04:08:03,920 R21s. 4936 04:08:03,920 --> 04:08:07,760 >>MY UNIVERSITY THE LIBRARIES 4937 04:08:07,760 --> 04:08:11,960 HAVE A DATA REPOSITORY BUT IT'S 4938 04:08:11,960 --> 04:08:16,080 NOT REALLY CURATED. 4939 04:08:16,080 --> 04:08:21,920 IT SEEMS LIKE THERE WOULD BE A 4940 04:08:21,920 --> 04:08:25,280 DIRECTION ON THIS? 4941 04:08:25,280 --> 04:08:30,120 >>WHAT DO YOU MEAN BY CURATED 4942 04:08:30,120 --> 04:08:30,520 REPOSITORY? 4943 04:08:30,520 --> 04:08:36,720 >>SOMEONE IS HAVING OVERSIGHT. 4944 04:08:36,720 --> 04:08:39,440 IT SEEMS LIKE ANYTHING CAN BE 4945 04:08:39,440 --> 04:08:41,960 PUT UP THERE AND WILL IT BE 4946 04:08:41,960 --> 04:08:43,720 CONTROLLED IN SOME HOMOGENOUS 4947 04:08:43,720 --> 04:08:48,280 WAY SO IT'S USEFUL. 4948 04:08:48,280 --> 04:08:53,320 >>I THINK THERE ARE MULTIPLE 4949 04:08:53,320 --> 04:08:57,520 PARTS TO YOUR QUESTION. 4950 04:08:57,520 --> 04:08:59,960 >>I THINK IT DOES VERY LITTLE 4951 04:08:59,960 --> 04:09:02,360 GOOD FOR ANYBODY TO PUT 4952 04:09:02,360 --> 04:09:03,720 INFORMATION UP THAT'S GOING TO 4953 04:09:03,720 --> 04:09:06,080 BE NOT INTERPRETABLE TO ANYBODY 4954 04:09:06,080 --> 04:09:06,280 ELSE. 4955 04:09:06,280 --> 04:09:07,880 IN THAT CASE WE'RE WASTING 4956 04:09:07,880 --> 04:09:10,400 RESOURCE TO PUT SOMETHING UP. 4957 04:09:10,400 --> 04:09:16,400 I HOPE THAT WE DON'T END UP IN A 4958 04:09:16,400 --> 04:09:19,480 SITUATION WHERE PEOPLE ARE DOING 4959 04:09:19,480 --> 04:09:22,560 THAT OR PURPOSELY DOING THAT SO 4960 04:09:22,560 --> 04:09:25,880 THEIR DATA ISN'T USEFUL TO 4961 04:09:25,880 --> 04:09:27,920 ANYBODY ELSE EXCEPT FOR THEM 4962 04:09:27,920 --> 04:09:29,760 BECAUSE OUR COMMUNITY LOSES AND 4963 04:09:29,760 --> 04:09:35,920 I THINK THERE'S COMPONENTS TO 4964 04:09:35,920 --> 04:09:40,520 CURATION. 4965 04:09:40,520 --> 04:09:42,960 ONE OF THEM IS MAKING SURE YOUR 4966 04:09:42,960 --> 04:09:44,480 DATA ARE IN THE SAME LANGUAGE AS 4967 04:09:44,480 --> 04:09:47,560 ANOTHER INVESTIGATOR WHO IS 4968 04:09:47,560 --> 04:09:52,480 WORKING IN THE FIELD IN SOME 4969 04:09:52,480 --> 04:09:53,320 WAYS THAT'S SOMETHING WE CAN 4970 04:09:53,320 --> 04:09:54,800 HELP CONTROL THE NARRATIVE FOR 4971 04:09:54,800 --> 04:09:58,720 AND I TALKED ABOUT THE COMMON 4972 04:09:58,720 --> 04:10:02,040 DATA MODEL CARRIE GETS AND 4973 04:10:02,040 --> 04:10:03,760 MICHELLE ARE WORKING ON. 4974 04:10:03,760 --> 04:10:05,920 IN SOME CASES THAT'S SOMETHING 4975 04:10:05,920 --> 04:10:09,360 THE INVESTIGATORS THEMSELVES 4976 04:10:09,360 --> 04:10:14,120 HAVE TO WORK UPON HOW CAN WE 4977 04:10:14,120 --> 04:10:15,400 REPRESENT DATA THAT YOU USE IN 4978 04:10:15,400 --> 04:10:16,160 THE SAME WAY. 4979 04:10:16,160 --> 04:10:21,440 IT TRULY IS USEFUL TO THE 4980 04:10:21,440 --> 04:10:23,480 COMMUNITY I HOPE IT WILL 4981 04:10:23,480 --> 04:10:24,520 STIMULATE PEOPLE IN THE 4982 04:10:24,520 --> 04:10:29,560 COMMUNITY TO HAVE THOSE 4983 04:10:29,560 --> 04:10:35,200 CONVERSATIONS. 4984 04:10:35,200 --> 04:10:36,880 WE KNOW WHERE PEOPLE ARE 4985 04:10:36,880 --> 04:10:41,920 ESSENTIALLY WORKING ON THE SAME 4986 04:10:41,920 --> 04:10:43,520 PROJECT AND IF WE COLLECT THINGS 4987 04:10:43,520 --> 04:10:44,640 THE SAME THERE'S GOING TO BE A 4988 04:10:44,640 --> 04:10:55,160 LOT OF BENEFITS OF DOING THAT. 4989 04:11:00,440 --> 04:11:03,360 >>ARE THERE EXAMPLES OF DATA 4990 04:11:03,360 --> 04:11:05,320 MANAGEMENT OR REPOSITORY PEOPLE 4991 04:11:05,320 --> 04:11:15,800 CAN LOOK AT TO GET GUIDANCE? 4992 04:11:16,400 --> 04:11:21,360 >>THERE'S A LIST OF WHAT ARE 4993 04:11:21,360 --> 04:11:29,960 CALLED GENERALIST REPOSITORYIES 4994 04:11:29,960 --> 04:11:31,880 AND IS THE PLACE I'LL SUGGEST 4995 04:11:31,880 --> 04:11:37,040 AND SOME UNIVERSITIES HAVE 4996 04:11:37,040 --> 04:11:41,960 BUILDING THESE AND WE CAN 4997 04:11:41,960 --> 04:11:47,960 CIRCULATE A LINK TO SOME OF 4998 04:11:47,960 --> 04:11:57,200 THO 4999 04:11:57,200 --> 04:11:57,400 THOSE. 5000 04:11:57,400 --> 04:12:02,080 >>I DON'T SEE ANYTHING THAT 5001 04:12:02,080 --> 04:12:03,440 SAYS IF YOU'RE SUBMITTING DATA 5002 04:12:03,440 --> 04:12:06,280 THAT WAY EXCEPT FOR GENOMIC. 5003 04:12:06,280 --> 04:12:16,600 I SAW THE GENOMIC. 5004 04:12:19,160 --> 04:12:22,000 THERE'S A LIST THAT NIH ABOUT 5005 04:12:22,000 --> 04:12:23,240 AND THEY WORK FOR SOME TYPES OF 5006 04:12:23,240 --> 04:12:24,800 DATA AND MAY NOT. 5007 04:12:24,800 --> 04:12:30,480 WE CAN DIG UP THAT SPECIFIC LINK 5008 04:12:30,480 --> 04:12:41,040 AND ASKED ABOUT DATA SHARING AND 5009 04:12:43,160 --> 04:12:43,760 MANAGEMENT PLANS. 5010 04:12:43,760 --> 04:12:45,160 YES, THEY'RE TRYING TO WORK THAT 5011 04:12:45,160 --> 04:12:47,480 OUT AND NOW THEY HAVE A SET OF 5012 04:12:47,480 --> 04:12:55,760 QUESTIONS TO GUIDE YOU AND IT'S 5013 04:12:55,760 --> 04:13:04,080 TWO PAGES THE PLAN IS TO DEVELOP 5014 04:13:04,080 --> 04:13:08,520 TEMPLATES WHETHER IT'S 5015 04:13:08,520 --> 04:13:12,040 EPIDEMIOLOGY STUDY THOSE ARE ALL 5016 04:13:12,040 --> 04:13:20,120 THINGS IN THE WORKS. 5017 04:13:20,120 --> 04:13:23,760 >>THANKS, CATHY AND EMMY. 5018 04:13:23,760 --> 04:13:26,720 ANYTHING ELSE WE SHOULD TALK 5019 04:13:26,720 --> 04:13:35,400 ABOUT OR IS IT TIME FOR A BREAK? 5020 04:13:35,400 --> 04:13:38,240 >>WE CAN USE A BREAK AND WE'RE 5021 04:13:38,240 --> 04:13:39,720 ONLY A LITTLE BIT BEHIND AND I 5022 04:13:39,720 --> 04:13:43,840 DON'T THINK THE CLOSED SESSION 5023 04:13:43,840 --> 04:13:44,440 WILL TAKE HOWEVER LONG I'VE 5024 04:13:44,440 --> 04:13:48,880 SCHEDULED IT FOR. 5025 04:13:48,880 --> 04:13:55,480 LET'S PLAN TO BE BACK HERE AT 5 5026 04:13:55,480 --> 04:13:56,640 TO 3:00. 5027 04:13:56,640 --> 04:13:58,080 THAT'S A LITTLE BIT LONGER THAN 5028 04:13:58,080 --> 04:14:00,000 20 MINUTES BUT WE'LL SEE YOU 5029 04:14:00,000 --> 04:14:02,000 BACK AT 5 TO 3:00. 5030 04:14:02,000 --> 04:14:03,840 REMEMBER YOU NEED TO CLOSE THIS 5031 04:14:03,840 --> 04:14:05,400 OUT AND GO TO THE CLOSED SESSION 5032 04:14:05,400 --> 04:14:05,600 LINK. 5033 04:14:05,600 --> 04:14:08,800 IF ANYBODY NEEDS IT RECENT SEND 5034 04:14:08,800 --> 04:14:13,640 ME OR NATHAN AN E-MAIL AND A 5035 04:14:13,640 --> 04:14:16,480 WANT TO THANK EVERYBODY AND I 5036 04:14:16,480 --> 04:14:19,400 WANT TO THANK JENNY AND VICTOR 5037 04:14:19,400 --> 04:14:19,800 FOR PARTICIPATING. 5038 04:14:19,800 --> 04:14:22,480 I'LL TURN IT BACK TO MIKE IN 5039 04:14:22,480 --> 04:14:23,480 CASE HE HAS CLOSING THOUGHTS FOR 5040 04:14:23,480 --> 04:14:23,920 YOU. 5041 04:14:23,920 --> 04:14:30,360 >>I WOULD SAY THE SAME THING. 5042 04:14:30,360 --> 04:14:32,600 JENNY AND VICTOR WELCOME AND 5043 04:14:32,600 --> 04:14:33,640 LOOK FORWARD TO THE THINGS WE'LL 5044 04:14:33,640 --> 04:14:36,040 DO TOGETHER AND THE TWO WILL ADD 5045 04:14:36,040 --> 04:14:42,000 TO THIS GROUP. 5046 04:14:42,000 --> 04:14:52,480 THANK YOU FOR YOUR ENGAGEMENT. 5047 04:14:55,480 --> 04:14:58,920 AND CATHY TALKED ABOUT WHAT 5048 04:14:58,920 --> 04:15:04,360 RINAD AND JENNY SUN HAD TALKED 5049 04:15:04,360 --> 04:15:09,800 ABOUT TODAY AND WE TALKED ABOUT 5050 04:15:09,800 --> 04:15:12,680 IMPLEMENTATION SCIENCE AS TAKING 5051 04:15:12,680 --> 04:15:16,360 CLINICAL RESEARCH FINDINGS AND 5052 04:15:16,360 --> 04:15:16,920 DISSEMINATING THEM TO THE 5053 04:15:16,920 --> 04:15:19,360 COMMUNITY AND CAN WE STEP BACK 5054 04:15:19,360 --> 04:15:22,080 AND IMPLEMENT BASIC SCIENCE 5055 04:15:22,080 --> 04:15:22,800 FINDINGS IN THE CLINIC. 5056 04:15:22,800 --> 04:15:26,920 I HOPE THIS IS SOMETHING WE CAN 5057 04:15:26,920 --> 04:15:27,960 THINK ABOUT BROADLY. 5058 04:15:27,960 --> 04:15:31,480 IT MAY BENEFIT OUR ENTIRE 5059 04:15:31,480 --> 04:15:31,760 COMMUNITY. 5060 04:15:31,760 --> 04:15:34,120 WITH THAT, HAVE A GOOD BREAK AND 5061 04:15:34,120 --> 04:15:35,720 LOOK FORWARD TO THE CLOSED 5062 04:15:35,720 --> 04:15:36,280 SESSION. 5063 04:15:36,280 --> 04:15:37,480 CATHY, THANK YOU FOR MANAGING 5064 04:15:37,480 --> 04:15:37,760 ALL THIS. 5065 04:15:37,760 --> 00:00:00,000 >>THANKS EVERYONE.